0001104659-11-026342.txt : 20110505 0001104659-11-026342.hdr.sgml : 20110505 20110505161753 ACCESSION NUMBER: 0001104659-11-026342 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20110331 FILED AS OF DATE: 20110505 DATE AS OF CHANGE: 20110505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS CAREMARK CORP CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 11814899 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 FORMER COMPANY: FORMER CONFORMED NAME: MELVILLE CORP DATE OF NAME CHANGE: 19920703 10-Q 1 a11-8716_110q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

For the Quarterly Period Ended March 31, 2011

Commission File Number 001-01011

CVS CAREMARK CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		05-0494040
(State of Incorporation)		(I.R.S. Employer Identification Number)

One CVS Drive, Woonsocket, Rhode Island 02895

(Address of principal executive offices)

Telephone: (401) 765-1500

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes[X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check One):

Large accelerated filer [X]		Accelerated filer [ ]
Non-accelerated filer [ ] (Do not check if a smaller reporting company)		Smaller Reporting Company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

Common Stock, $0.01 par value, issued and outstanding at April 29, 2011:

1,355,941,242 shares

Table of Contents

INDEX

		Page
Part I

Item 1.	Financial Statements

	Condensed Consolidated Statements of Income (Unaudited) - Three Months Ended March 31, 2011 and 2010	3

	Condensed Consolidated Balance Sheets (Unaudited) - As of March 31, 2011 and December 31, 2010	4

	Condensed Consolidated Statements of Cash Flows (Unaudited) - Three Months Ended March 31, 2011 and 2010	5

	Notes to Condensed Consolidated Financial Statements (Unaudited)	6

	Report of Independent Registered Public Accounting Firm	14

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	26
Item 4.	Controls and Procedures	26

Part II

Item 1.	Legal Proceedings	27

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28

Item 6.	Exhibits	29

Signatures		30

Table of Contents

Part I

Item 1

CVS Caremark Corporation

Condensed Consolidated Statements of Income

(Unaudited)

	Three Months Ended
	March 31,
In millions, except per share amounts	2011		2010

Net revenues	$	25,880	$	23,760
Cost of revenues	21,129		19,014
Gross profit	4,751		4,746
Operating expenses	3,440		3,336
Operating profit	1,311		1,410
Interest expense, net	134		128
Income before income tax provision	1,177		1,282
Income tax provision	464		510
Income from continuing operations	713		772
Loss from discontinued operations, net of tax	(1)		(2)
Net income	712		770
Net loss attributable to noncontrolling interest	1		1
Net income attributable to CVS Caremark	$	713	$	771

Basic earnings per common share:
Income from continuing operations attributable to CVS Caremark		$ 0.52		$ 0.56
Loss from discontinued operations attributable to CVS Caremark	—		—
Net income attributable to CVS Caremark		$ 0.52		$ 0.56
Weighted average basic common shares outstanding	1,362		1,386

Diluted earnings per common share:
Income from continuing operations attributable to CVS Caremark		$ 0.52		$ 0.55
Loss from discontinued operations attributable to CVS Caremark	—		—
Net income attributable to CVS Caremark		$ 0.52		$ 0.55
Weighted average diluted common shares outstanding	1,371		1,396

Dividends declared per common share	$	0.1250	$	0.0875

See accompanying notes to condensed consolidated financial statements.

Table of Contents

Part I

Item 1

CVS Caremark Corporation

Condensed Consolidated Balance Sheets

(Unaudited)

In millions, except per share amounts	March 31, 2011		December 31, 2010
Assets:
Cash and cash equivalents	$	2,162	$	1,427
Short-term investments	6		4
Accounts receivable, net	5,348		4,925
Inventories	10,181		10,695
Deferred income taxes	509		511
Other current assets	174		144
Total current assets	18,380		17,706
Property and equipment, net	8,350		8,322
Goodwill	25,666		25,669
Intangible assets, net	9,692		9,784
Other assets	740		688
Total assets	$	62,828	$	62,169

Liabilities:
Accounts payable	$	4,354	$	4,026
Claims and discounts payable	2,776		2,569
Accrued expenses	3,229		3,070
Short-term debt	300		300
Current portion of long-term debt	806		1,105
Total current liabilities	11,465		11,070
Long-term debt	8,669		8,652
Deferred income taxes	3,710		3,655
Other long-term liabilities	1,032		1,058
Commitments and contingencies (Note 8)
Redeemable noncontrolling interest	33		34

Shareholders’ equity:
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	—		—
Common stock, par value $0.01: 3,200 shares authorized; 1,627 shares issued and 1,354 shares outstanding at March 31, 2011 and 1,624 shares issued and 1,363 shares outstanding at December 31, 2010	16		16
Treasury stock, at cost: 271 shares at March 31, 2011 and 259 shares at December 31, 2010	(9,449)		(9,030)
Shares held in trust: 2 shares at March 31, 2011 and December 31, 2010	(56)		(56)
Capital surplus	27,706		27,610
Retained earnings	19,845		19,303
Accumulated other comprehensive loss	(143)		(143)
Total shareholders’ equity	37,919		37,700
Total liabilities and shareholders’ equity	$	62,828	$	62,169

See accompanying notes to condensed consolidated financial statements.

Table of Contents

Part I

Item 1

CVS Caremark Corporation

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Three Months Ended
	March 31,
In millions	2011		2010
Cash flows from operating activities:
Cash receipts from revenues	$	22,971	$	22,918
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	(17,445)		(17,581)
Cash paid to other suppliers and employees	(3,342)		(3,916)
Interest received	1		1
Interest paid	(150)		(155)
Income taxes paid	(169)		(207)
Net cash provided by operating activities	1,866		1,060

Cash flows from investing activities:
Purchases of property and equipment	(309)		(401)
Proceeds from sale-leaseback transactions	11		—
Proceeds from sale of property and equipment	12		12
Acquisitions (net of cash acquired) and other investments	(11)		(9)
Purchase of short-term investments	(2)		—
Maturity of short-term investments	—		1
Net cash used in investing activities	(299)		(397)

Cash flows from financing activities:
Increase in short-term debt	—		200
Repayments of long-term debt	(301)		(1)
Dividends paid	(171)		(122)
Proceeds from exercise of stock options	107		97
Excess tax benefits from stock-based compensation	—		11
Repurchase of common stock	(467)		(887)
Net cash used in financing activities	(832)		(702)
Net increase (decrease) in cash and cash equivalents	735		(39)
Cash and cash equivalents at beginning of period	1,427		1,086
Cash and cash equivalents at end of period	$	2,162	$	1,047

Reconciliation of net income to net cash provided by operating activities:
Net income	$	712	$	770
Adjustments required to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	374		358
Stock-based compensation	36		37
Deferred income taxes and other non-cash items	70		2
Change in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable, net	(423)		308
Inventories	514		68
Other current assets	(30)		(39)
Other assets	(52)		—
Accounts payable and claims and discounts payable	535		(115)
Accrued expenses	156		(335)
Other long-term liabilities	(26)		6
Net cash provided by operating activities	$	1,866	$	1,060

See accompanying notes to condensed consolidated financial statements.

Table of Contents

Part I

Item 1

CVS Caremark Corporation

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 1 – Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of CVS Caremark Corporation and its majority owned subsidiaries (“CVS Caremark” or “the “Company”) have been prepared, in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. In accordance with such rules and regulations, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in Exhibit 13 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2010 (the “2010 Form 10-K”).

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company’s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full fiscal year.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All material intercompany balances and transactions have been eliminated.

Fair Value of Financial Instruments

The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following:

§ Level 1 – Inputs to the valuation methodology are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

§ Level 2 – Inputs to the valuation methodology are quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument.

§ Level 3 – Inputs to the valuation methodology are unobservable inputs based upon management’s best estimate of inputs market participants could use in pricing the asset or liability at the measurement date, including assumptions about risk.

As of March 31, 2011, the carrying value of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and short-term debt approximated their fair value due to the short-term nature of these financial instruments. The Company invests in money market funds, commercial paper and time deposits that are classified as cash and cash equivalents within the accompanying condensed consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. These investments are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The Company’s short-term investments consist of certificates of deposit with initial maturities of greater than three months when purchased. These investments, which are classified within Level 1 of the fair value hierarchy, are carried at historical cost, which

Table of Contents

approximated fair value at March 31, 2011. The carrying amount and estimated fair value of the Company’s total long-term debt was $9.5 billion and $10.1 billion, respectively, as of March 31, 2011. The fair value of the Company’s total long-term debt was estimated based on rates currently offered to the Company for debt with identical terms and maturities, which is considered Level 1 of the fair value hierarchy. The carrying amount and estimated fair value of the Company’s outstanding interest rate swap contracts was de minimis as of March 31, 2011. The fair value of the Company’s outstanding interest rate swap contracts was estimated based on rates currently offered to the Company for similar instruments, which is considered Level 1 of the fair value hierarchy.

Derivative Financial Instruments

The Company is exposed to interest rate risk and management considers it prudent to periodically reduce the Company’s exposure to cash flow variability resulting from interest rate fluctuations. During the three months ended March 31, 2011, the Company entered into several interest rate swap transactions. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of long-term debt. The swaps had notional amounts totaling $525 million. The fair value of these agreements was de minimis as of March 31, 2011. The Company has deferred gains and losses in accumulated other comprehensive loss which are expected to be reclassified to interest expense over the life of the underlying forecasted debt. The hedges are expected to be highly effective; therefore, no ineffectiveness was recognized in earnings. There were no outstanding derivative financial instruments as of December 31, 2010.

Note 2 – Discontinued Operations

In connection with certain business dispositions completed between 1991 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens ‘n Things. On May 2, 2008, Linens Holding Co. and certain affiliates, which operate Linens ‘n Things, filed voluntary petitions under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The Company’s loss from discontinued operations for the three months ended March 31, 2011 consisted of $1 million ($2 million, net of a $1 million income tax benefit) of lease-related costs, compared to $2 million ($3 million, net of a $1 million income tax benefit) of lease-related costs in the prior year period.

Note 3 – Segment Reporting

The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate. The Company’s segments maintain separate financial information for which operating results are evaluated on a regular basis by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company evaluates its Pharmacy Services and Retail Pharmacy segments’ performance based on net revenue, gross profit and operating profit before the effect of nonrecurring charges and gains and certain intersegment activities. The Company evaluates the performance of its Corporate segment based on operating expenses before the effect of nonrecurring charges and gains and certain intersegment activities.

The Pharmacy Services segment provides a full range of pharmacy benefit management (“PBM”) services including mail order pharmacy services, specialty pharmacy services, plan design consultation and administration, formulary management and claims processing. The Company’s customers are primarily employers, insurance companies, unions, government employee groups, managed care organizations, other sponsors of health benefit plans and individuals throughout the United States. In addition, through our SilverScript Insurance Company and Accendo Insurance Company subsidiaries, we are a national provider of drug benefits to eligible beneficiaries under the Federal Government’s Medicare Part D program. The Pharmacy Services business operates under the CVS Caremark Pharmacy Services®, Caremark®, CVS Caremark™, CarePlus CVS/pharmacy™, CarePlus™, RxAmerica®, Accordant® and TheraCom® names. As of March 31, 2011, the Pharmacy Services segment operated 33 retail specialty pharmacy stores, 18 specialty mail order pharmacies and four mail service pharmacies located in 25 states, Puerto Rico and the District of Columbia.

The Retail Pharmacy segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, photo finishing, seasonal merchandise, greeting cards and convenience foods through our CVS/pharmacy® and Longs Drug® retail stores and online through CVS.com®. As of March 31, 2011, the Retail Pharmacy segment included 7,226 retail drugstores, of which 7,170 operated a pharmacy,

Table of Contents

the online retail website, CVS.com, 33 specialty retail pharmacies and 568 retail health care clinics. The retail drugstores are located in 41 states, Puerto Rico and the District of Columbia operating primarily under the CVS/pharmacy or Longs Drug names. The retail health care clinics operate under the MinuteClinic® name, of which 558 are located within CVS/pharmacy stores. MinuteClinics utilize nationally recognized medical protocols to diagnose and treat minor health conditions, perform health screenings, monitor chronic conditions and deliver vaccinations. The clinics are staffed by board-certified nurse practitioners and physician assistants who provide access to affordable care without appointment.

The Corporate segment provides management and administrative services to support the Company. The Corporate segment consists of certain aspects of our executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments.

In millions	Pharmacy Services Segment(1)		Retail Pharmacy Segment		Corporate Segment		Intersegment Eliminations(2)		Consolidated Totals
Three Months Ended
March 31, 2011:
Net revenues	$	14,014	$	14,587	$	¾	$	(2,721)	$	25,880
Gross profit	639		4,147		¾		(35)		4,751
Operating profit (loss)	397		1,096		(147)		(35)		1,311
March 31, 2010:
Net revenues	$	11,836	$	13,978	$	¾	(2,054)		$	23,760
Gross profit	782		3,987		¾		(23)		4,746
Operating profit (loss)	538		1,030		(135)		(23)		1,410
Total assets:
March 31, 2011	$	32,565	$	28,914	$	1,894	$	(545)	$	62,828
December 31, 2010	32,254		28,927		1,439		(451)		62,169
Goodwill:
March 31, 2011	$	18,866	$	6,800	$	¾	$	¾	$	25,666
December 31, 2010	18,868		6,801		¾		¾		25,669

(1) Net revenues of the Pharmacy Services segment include approximately $2.2 billion and $1.7 billion of retail co-payments for the three months ended March 31, 2011 and 2010, respectively.

(2) Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services segment customers use Retail Pharmacy segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services segment customers, through the Company’s intersegment activities (such as the Maintenance Choice™ program), elect to pick-up their maintenance prescriptions at Retail Pharmacy segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. As a result, both the Pharmacy Services and the Retail Pharmacy segments include the following results associated with this activity: net revenues of $558 million and $340 million for the three months ended March 31, 2011 and 2010, respectively, gross profit and operating profit of $35 million and $23 million for the three months ended March 31, 2011 and 2010, respectively.

Note 4 – Comprehensive Income

The following are the components of comprehensive income:

	Three Months Ended March 31,
In millions	2011	2010

Net income	$ 712	$ 770
Net cash flow hedges, net of tax	¾	1
Pension adjustment, net of tax	¾	4
Comprehensive income	712	775
Comprehensive loss attributable to noncontrolling interest	1	1
Comprehensive income attributable to CVS Caremark	$ 713	$ 776

Table of Contents

Note 5 – Interest Expense

The following are the components of net interest expense:

	Three Months Ended March 31,
In millions	2011	2010

Interest expense	$ 135	$ 129
Interest income	(1)	(1	)
Interest expense, net	$ 134	$ 128

Note 6 – Earnings Per Share

Basic earnings per common share attributable to CVS Caremark is computed by dividing: (i) net income attributable to CVS Caremark by (ii) the weighted average number of common shares outstanding in the period (the “Basic Shares”).

Diluted earnings per common share attributable to CVS Caremark is computed by dividing: (i) net income attributable to CVS Caremark by (ii) Basic Shares plus the additional shares that would be issued assuming that all dilutive stock awards are exercised. Options to purchase approximately 25.7 million and 25.9 million shares of common stock were outstanding, but were not included in the calculation of diluted earnings per share for the three months ended March 31, 2011 and 2010, respectively, because the options’ exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.

The following is a reconciliation of basic and diluted earnings per common share for the respective periods:

	Three Months Ended
	March 31,
In millions, except per share amounts	2011	2010

Numerators for earnings per common share calculations:
Income from continuing operations	$ 713	$772
Net loss attributable to noncontrolling interest	1	1
Income from continuing operations attributable to CVS Caremark	714	773
Loss from discontinued operations, net of tax	(1)	(2)
Net income attributable to CVS Caremark, basic and diluted	$ 713	$771

Denominators for earnings per common share calculations:
Weighted average common shares, basic	1,362	1,386
Effect of dilutive securities:
Stock options	7	9
Restricted stock units	2	1
Weighted average common shares, diluted	1,371	1,396
Basic earnings per common share:
Income from continuing operations attributable to CVS Caremark	$ 0.52	$ 0.56
Loss from discontinued operations attributable to CVS Caremark	¾	¾
Net income attributable to CVS Caremark	$ 0.52	$ 0.56
Diluted earnings per common share:
Income from continuing operations attributable to CVS Caremark	$ 0.52	$ 0.55
Loss from discontinued operations attributable to CVS Caremark	¾	¾
Net income attributable to CVS Caremark	$ 0.52	$ 0.55

Table of Contents

Note 7 – Share Repurchase Program

On June 14, 2010, the Company’s Board of Directors authorized a new share repurchase program for up to $2.0 billion of outstanding common stock (the “2010 Repurchase Program”). The share repurchase authorization, which was effective immediately and expires at the end of 2011, permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2010 Share Repurchase program may be modified, extended or terminated by the Board of Directors at any time. During February and March 2011, the Company repurchased an aggregate of 14.2 million shares of common stock for approximately $467 million pursuant to the 2010 Repurchase Program.

Note 8 – Commitments and Contingencies

Between 1991 and 1997, the Company sold or spun off a number of subsidiaries, including Bob’s Stores, Linens ‘n Things, Marshalls, Kay-Bee Toys, Wilsons, This End Up and Footstar. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the store’s lease obligations. When the subsidiaries were disposed of, the Company’s guarantees remained in place, although each initial purchaser has indemnified the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries were to become insolvent and failed to make the required payments under a store lease, the Company could be required to satisfy these obligations. As of March 31, 2011, the Company guaranteed approximately 83 such store leases (excluding the lease guarantees related to Linens ‘n Things, which are discussed in Note 2 previously in this document), with the maximum remaining lease term extending through 2019. Management believes the ultimate disposition of any of the remaining guarantees will not have a material adverse effect on the Company’s consolidated financial condition, results of operations or future cash flows.

Caremark (the term “Caremark” being used herein to generally refer to any one or more of the PBM subsidiaries of the Company, as applicable) is a defendant in a qui tam lawsuit initially filed by a relator on behalf of various state and federal government agencies in Texas federal court in 1999. The case was unsealed in May 2005. The case seeks monetary damages and alleges that Caremark’s processing of Medicaid and certain other government claims on behalf of its clients (which allegedly resulted in underpayments from our clients to the applicable government agencies) on one of Caremark’s adjudication platforms violates applicable federal or state false claims acts and fraud statutes. The United States and the States of Texas, Tennessee, Florida, Arkansas, Louisiana and California intervened in the lawsuit, but Tennessee and Florida withdrew from the lawsuit in August 2006 and May 2007, respectively. The parties previously filed cross motions for partial summary judgment, and in August 2008, the district court granted several of Caremark’s motions and denied the motions filed by the plaintiffs. The district court’s rulings were favorable to Caremark and substantially limited the ability of the plaintiffs to assert false claims act allegations or statutory or common law theories of recovery based on Caremark’s processing of Medicaid and other government reimbursement requests. The district court’s rulings were appealed to the United States Court of Appeals for the Fifth Circuit, which affirmed in part and reversed in part the district court’s rulings. In April 2009, the State of Texas filed a purported civil enforcement action against Caremark for injunctive relief, damages and civil penalties in Travis County, Texas alleging that Caremark violated the Texas Medicaid Fraud Prevention Act and other state laws based on our processing of Texas Medicaid claims on behalf of PBM clients. The claims and issues raised in this lawsuit are related to the claims and issues pending in the federal qui tam lawsuit described above.

In December 2007, the Company received a document subpoena from the Office of Inspector General, United States Department of Health and Human Services (“OIG”), requesting information relating to the processing of Medicaid and other government agency claims on a different adjudication platform of Caremark. In October 2009 and October 2010, the Company received civil investigative demands from the Office of the Attorney General of the State of Texas requesting, respectively, information produced under this OIG subpoena, and other information related to the processing of Medicaid claims. The civil investigative demands state that the Office of the Attorney General of the State of Texas is investigating allegations currently pending under seal relating to two of Caremark’s adjudication platforms. The Company has been producing documents on a rolling basis in response to the requests for information contained in the OIG subpoena and in these civil investigative demands. The Company cannot predict with certainty the timing or outcome of any review of such information.

Caremark was named in a putative class action lawsuit filed in October 2003 in Alabama state court by John Lauriello, purportedly on behalf of participants in the 1999 settlement of various securities class action and

Table of Contents

derivative lawsuits against Caremark and others. Other defendants include insurance companies that provided coverage to Caremark with respect to the settled lawsuits. The Lauriello lawsuit seeks approximately $3.2 billion in compensatory damages plus other non-specified damages based on allegations that the amount of insurance coverage available for the settled lawsuits was misrepresented and suppressed. A similar lawsuit was filed in November 2003 by Frank McArthur, also in Alabama state court, naming as defendants Caremark, several insurance companies, attorneys and law firms involved in the 1999 settlement. This lawsuit was stayed as a later-filed class action, but McArthur was subsequently allowed to intervene in the Lauriello action. The attorneys and law firms named as defendants in McArthur’s intervention pleadings have been dismissed from the case, and discovery on class certification and adequacy issues is underway.

Various lawsuits have been filed alleging that Caremark has violated applicable antitrust laws in establishing and maintaining retail pharmacy networks for client health plans. In August 2003, Bellevue Drug Co., Robert Schreiber, Inc. d/b/a Burns Pharmacy and Rehn-Huerbinger Drug Co. d/b/a Parkway Drugs #4, together with Pharmacy Freedom Fund and the National Community Pharmacists Association filed a putative class action against Caremark in Pennsylvania federal court, seeking treble damages and injunctive relief. In October 2003, two independent pharmacies, North Jackson Pharmacy, Inc. and C&C, Inc. d/b/a Big C Discount Drugs, Inc. filed a putative class action complaint in Alabama federal court against Caremark and two PBM competitors, seeking treble damages and injunctive relief. The North Jackson Pharmacy case was transferred to Illinois federal court, and the Bellevue case was sent to arbitration based on contract terms between the pharmacies and Caremark. The Bellevue arbitration was then stayed by the parties pending developments in the North Jackson Pharmacy court case.

In August 2006, the Bellevue case and the North Jackson Pharmacy case were both transferred to Pennsylvania federal court by the Judicial Panel on Multidistrict Litigation for coordinated and consolidated proceedings with other cases before the panel, including cases against other PBMs. Caremark appealed the decision which vacated the order compelling arbitration and staying the proceedings in the Bellevue case and, following the appeal, the Court of Appeals reinstated the order compelling arbitration of the Bellevue case. Motions for class certification in the coordinated cases within the multidistrict litigation, including the North Jackson Pharmacy case, remain pending. The consolidated action is now known as the In Re Pharmacy Benefit Managers Antitrust Litigation.

In August 2009, the Company was notified by the Federal Trade Commission (the “FTC”) that it is conducting a non-public investigation under the Federal Trade Commission Act into certain of the Company’s business practices. In March 2010, the Company learned that various State Attorneys General offices and certain other government agencies are conducting a multi-state investigation of the Company regarding issues similar to those being investigated by the FTC. At this time, 24 states, the District of Columbia, and the County of Los Angeles are known to be participating in this multi-state investigation. The Company has been cooperating in these investigations, and continues to provide documents and other information as requested. The Company is not able to predict with certainty the timing or outcome of these investigations. However, it remains confident that its business practices and service offerings (which are designed to reduce health care costs and expand consumer choice) are being conducted in compliance with the antitrust laws.

In March 2009, the Company received a subpoena from the OIG requesting information concerning the Medicare Part D prescription drug plans of RxAmerica, the PBM subsidiary of Longs Drug Stores Corporation which was acquired by the Company in October 2008. The Company continues to respond to this request for information and has been producing responsive documents on a rolling basis. The Company cannot predict with certainty the timing or outcome of any review by the government of such information.

Since March 2009, the Company has been named in a series of putative collective and class action lawsuits filed in federal courts around the country, purportedly on behalf of current and former assistant store managers working in the Company’s stores at various locations outside California. The lawsuits allege that the Company failed to pay overtime to assistant store managers as required under the Fair Labor Standards Act (“FLSA”) and under certain state statutes. The lawsuits also seek other relief, including liquidated damages, punitive damages, attorneys’ fees, costs and injunctive relief arising out of the state and federal claims for overtime pay. Notice has been issued to over 13,000 current and former assistant store managers offering them the opportunity to “opt in” to certain of the FLSA collective actions and over 1,900 have elected to participate in these lawsuits. At this time, the Company is not able to predict the outcome of these cases, or the possible monetary exposure associated with the lawsuits. The Company’s position, however, is that the lawsuits are without merit and that the cases should not be certified as class or collective actions. The Company is vigorously defending these claims, but cannot predict with certainty the timing or outcome of this matter.

Table of Contents

In January 2010, the Company received a subpoena from the OIG in connection with an investigation of possible false or otherwise improper claims for payment under the Medicare and Medicaid programs. The subpoena requested retail pharmacy claims data for “dual eligible” customers (i.e., customers with both Medicaid and other third party insurance coverage), information concerning the Company’s retail pharmacy claims processing systems, copies of pharmacy payor contracts and other documents and records. In April 2011, the Company announced that it had resolved this investigation by entering into a settlement with the Department of Justice, Department of Health and Human Services, and the Attorneys General of ten states (Alabama, California, Florida, Indiana, Massachusetts, Michigan, Minnesota, New Hampshire, Nevada, and Rhode Island). This settlement resolves a qui tam lawsuit that had been filed under seal pursuant to federal and state false claims act statutes. The settlement terms include payment by the Company of $17.5 million to the federal government and to the participating states and an amendment to the Company’s existing Corporate Integrity Agreement. The Company’s legal reserve related to this matter at March 31, 2011 was sufficient to cover the required settlement payments.

In March 2010, the Company received a subpoena from the OIG requesting information about programs under which the Company has offered customers remuneration conditioned upon the transfer of prescriptions for drugs or medications to our pharmacies in the form of gift cards, cash, non-prescription merchandise or discounts or coupons for non-prescription merchandise. The subpoena relates to an investigation of possible false or otherwise improper claims for payment under the Medicare and Medicaid programs. The Company continues to respond to this request for information and has been producing responsive documents on a rolling basis. We cannot predict with certainty the timing or outcome of any reviews by the government of such information.

In November 2009, a securities class action lawsuit was filed in the United States District Court for the District of Rhode Island purportedly on behalf of purchasers of CVS Caremark Corporation stock between May 5, 2009 and November 4, 2009. The lawsuit names the Company and certain officers as defendants and includes allegations of securities fraud relating to public disclosures made by the Company concerning the PBM business and allegations of insider trading. In addition, a shareholder derivative lawsuit was filed in December 2009, in the same court against the directors and certain officers of the Company. A derivative lawsuit is a lawsuit filed by a shareholder purporting to assert claims on behalf of a corporation against directors and officers of the corporation. This lawsuit includes allegations of, among other things, securities fraud, insider trading and breach of fiduciary duties and further alleges that the Company was damaged by the purchase of stock at allegedly inflated prices under its share repurchase program. In January 2011, both lawsuits were transferred to the United States District Court for the District of New Hampshire. The Company believes these lawsuits are without merit and the Company plans to defend them vigorously. The Company received a subpoena dated February 28, 2011 from the Securities and Exchange Commission (SEC) requesting, among other corporate records, information relating to public disclosures made by the Company in 2009 concerning its PBM and Medicare Part D businesses and information concerning ownership and transactions in the Company’s securities by certain officers of the Company. The Company is cooperating with these requests for information and has been providing documents and other information to the SEC as requested.

The Company cannot predict the ultimate outcome of the legal matters disclosed above. Management does not believe, however, that the outcome of any of these legal matters will have a material adverse effect on the Company’s operating results or financial condition.

The Company is also a party to other legal proceedings and inquiries arising in the normal course of its business, none of which is expected to be material to the Company. The Company can give no assurance, however, that our business, financial condition and results of operations will not be materially adversely affected, or that we will not be required to materially change our business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations, as they may relate to our business or the pharmacy services or retail industry; (iii) pending or future federal or state governmental investigations of our business or the pharmacy services or retail industry; (iv) institution of government enforcement actions against us; (v) adverse developments in any pending qui tam lawsuit against us, whether sealed or unsealed, or in any future qui tam lawsuit that may be filed against us; or (vi) adverse developments in other pending or future legal proceedings against us or affecting the pharmacy services or retail industry.

Table of Contents

Note 9 – Subsequent Event

On April 29, 2011, the Company acquired the Medicare prescription drug business of Universal American Corp. (the “UAM Medicare Part D Business”). Pursuant to the purchase agreement, the Company paid cash consideration of $1.25 billion plus $185 million (the amount of excess capital that resided in the entities that operate the UAM Medicare Part D Business), less $110 million (the amount of Universal American Corp.’s outstanding trust preferred securities which are being assumed by the Company). The UAM Medicare Part D Business offers prescription drug plan benefits to Medicare beneficiaries throughout the United States through its Community CCRxSM prescription drug plan.

Table of Contents

Part I

Item 1

Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders

CVS Caremark Corporation:

We have reviewed the condensed consolidated balance sheet of CVS Caremark Corporation (the Company) as of March 31, 2011, and the related condensed consolidated statements of income and cash flows for the three month periods ended March 31, 2011 and 2010. These financial statements are the responsibility of the Company’s management.

We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of CVS Caremark Corporation as of December 31, 2010, and the related consolidated statements of income, shareholders’ equity, and cash flows for the fiscal year then ended not presented herein and in our report dated February 18, 2011, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2010, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

	/s/ Ernst & Young LLP

May 5, 2011
Boston, Massachusetts

Table of Contents

Part I

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview of Our Business

CVS Caremark Corporation (“CVS Caremark”, the “Company”, “we” or “us”), together with its subsidiaries, is the largest pharmacy health care provider in the United States. As a fully integrated pharmacy services company, we believe we can drive value for our customers by effectively managing pharmaceutical costs and improving health care outcomes through our pharmacy benefit management, mail order and specialty pharmacy division, CVS Caremark Pharmacy Services® (“Caremark”); our approximately 7,200 CVS/pharmacy® retail stores; our retail-based health clinic subsidiary, MinuteClinic®; and our online pharmacy, CVS.com®.

We currently have three segments: Pharmacy Services, Retail Pharmacy and Corporate.

Pharmacy Services Segment

Our Pharmacy Services segement provides a full range of pharmacy benefit management (“PBM”) services including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management and claims processing. Our clients are primarily employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans and individuals throughout the United States. As a pharmacy benefits manager, we manage the dispensing of pharmaceuticals through our mail order pharmacies and national network of approximately 65,000 retail pharmacies (which include our CVS/pharmacy stores) to eligible members in the benefit plans maintained by our clients and utilize our information systems to perform, among other things, safety checks, drug interaction screenings and brand to generic substitutions.

Our specialty pharmacies support individuals that require complex and expensive drug therapies. Our specialty pharmacy business includes mail order and retail specialty pharmacies that operate under the CVS Caremark® and CarePlus CVS/pharmacy® names. We also provide health management programs, which include integrated disease management for 28 conditions, through our strategic alliance with Alere, L.L.C. and our Accordant® health management offering. In addition, through our SilverScript Insurance Company and Accendo Insurance Company subsidiaries, we are a national provider of drug benefits to eligible beneficiaries under the Federal Government’s Medicare Part D program. The Pharmacy Services business operates under the CVS Caremark Pharmacy Services®, Caremark®, CVS Caremark™, CarePlus CVS/pharmacy™, CarePlus™, RxAmerica®, Accordant® and TheraCom® names. As of March 31, 2011, the Pharmacy Services segment operated 33 retail specialty pharmacy stores, 18 specialty mail order pharmacies and four mail service pharmacies located in 25 states, Puerto Rico and the District of Columbia.

Retail Pharmacy Segment

Our Retail Pharmacy segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, photo finishing, seasonal merchandise, greeting cards and convenience foods through our CVS/pharmacy and Longs Drugs® retail stores and online through CVS.com. Our Retail Pharmacy segment derives the majority of its revenues through the sale of prescription drugs, which are dispensed by our more than 20,000 retail pharmacists. Our Retail Pharmacy segment also provides health care services through our MinuteClinic health care clinics. MinuteClinics are staffed by nurse practitioners and physician assistants who utilize nationally recognized protocols to diagnose and treat minor health conditions, perform health screenings, monitor chronic conditions, and deliver vaccinations. As of March 31, 2011, our Retail Pharmacy segment included 7,226 retail drugstores (of which 7,170 operated a pharmacy) located in 41 states, the District of Columbia, and Puerto Rico operating primarily under the CVS/pharmacy or Longs Drugs names, our online retail

Table of Contents

website, CVS.com, 33 retail specialty pharmacy stores and 568 retail health care clinics operating under the MinuteClinic name (of which 558 were located in CVS/pharmacy stores).

Corporate Segment

Results of Operations

The following discussion explains the material changes in our results of operations for the three months ended March 31, 2011 and 2010, and the significant developments affecting our financial condition since December 31, 2010. We strongly recommend that you read our audited consolidated financial statements and footnotes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included as Exhibit 13 to our Annual Report on Form 10-K for the year ended December 31, 2010 (the “2010 Form 10-K”) along with this report.

Summary of the Condensed Consolidated Financial Results:

In millions	Three Months Ended March 31, 2011			Three Months Ended March 31, 2010

Net revenues	$	25,880		$	23,760
Cost of revenues	21,129			19,014
Gross profit	4,751			4,746
Operating expenses	3,440			3,336
Operating profit	1,311			1,410
Interest expense, net	134			128
Income before income tax provision	1,177			1,282
Income tax provision	464			510
Income from continuing operations	713			772
Loss from discontinued operations, net of tax	(1		)	(2)
Net income	71		2	770
Net loss attributable to noncontrolling interest			1	1
Net income attributable to CVS Caremark	$	71	3	$		771

Net Revenues

Net revenues increased $2.1 billion, or 8.9% in the three months ended March 31, 2011, as compared to the prior year period. Net revenues in the period were positively impacted by revenue associated with our previously announced long-term contract to provide PBM services to a large health insurance carrier, which became effective January 1, 2011, as well as the positive same store and new store sales in our Retail Pharmacy segment.

Please see the section entitled “Segment Analysis” below for additional information regarding net revenues.

Gross Profit

Gross profit dollars were essentially flat in the three months ended March 31, 2011, as compared to the prior year period. Gross profit as a percentage of net revenues decreased approximately 160 basis points to 18.4% in the three months ended March 31, 2011, as compared to the prior year period. Gross profit as a percentage of net revenues decreased due to a decline in gross profit margins at the Pharmacy Services segment.

Please see the section entitled “Segment Analysis” below for additional information regarding gross profit.

Table of Contents

Operating Expenses

Operating expenses increased $104 million, or 3.1% in the three months ended March 31, 2011, as compared to the prior year period. Operating expenses as a percent of net revenues decreased 70 basis points to 13.3% in the three months ended March 31, 2011 as compared to 14.0% in the prior year period. The increase in operating expenses in the three months ended March 31, 2011 was primarily due to incremental store operating costs associated with a higher store count as compared to the prior year period.

Please see the section entitled “Segment Analysis” below for additional information regarding operating expenses.

Interest Expense, net

Interest expense, net increased $6 million in the three months ended March 31, 2011, as compared to the prior year period. This increase was due to higher average interest rates in the current period.

For additional information on our financing activities, please see the “Liquidity and Capital Resources” section later in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Income Tax Provision

Our effective income tax rate improved during the three months ended March 31, 2011 to 39.4% compared to 39.8% in the prior year period, primarily due to changes in our effective state tax rates. Such changes resulted from a combination of state legislative changes and fluctuation in our apportionment factors.

Loss from Discontinued Operations

Loss from discontinued operations for the three months ended March 31, 2011 consisted of $1 million ($2 million, net of a $1 million income tax benefit) of lease-related costs, compared to $2 million ($3 million, net of a $1 million income tax benefit) of lease-related costs in the prior year period. The decrease in the loss from discontinued operations is primarily related to ongoing adjustments to sub-lease assumptions as a result of changes in the economy and the commercial real estate market.

See Notes 2 and 8 to the condensed consolidated financial statements for additional information about our lease guarantees.

Net Loss Attributable to Noncontrolling Interest

Net loss attributable to noncontrolling interest represents the minority shareholders’ portion of the net loss from our majority owned subsidiary, Generation Health, Inc. The net loss attributable to noncontrolling interest for the three months ended March 31, 2011 and 2010 was approximately $1 million.

Table of Contents

Segment Analysis

We evaluate the performance of our Pharmacy Services and Retail Pharmacy segments based on net revenue, gross profit and operating profit before the effect of nonrecurring charges and gains and certain intersegment activities. We evaluate the performance of our Corporate segment based on operating expenses before the effect of nonrecurring charges and gains and certain intersegment activities. The following is a reconciliation of our segments to the condensed consolidated financial statements:

In millions	Pharmacy Services Segment(1)		Retail Pharmacy Segment		Corporate Segment		Intersegment Eliminations(2)		Consolidated Totals
Three Months Ended
March 31, 2011:
Net revenues	$	14,014	$	14,587	$	¾	$	(2,721)	$	25,880
Gross profit	639		4,147		¾		(35)		4,751
Operating profit (loss)	397		1,096		(147)		(35)		1,311
March 31, 2010:
Net revenues	$	11,836	$	13,978	$	¾	(2,054)		$	23,760
Gross profit	782		3,987		¾		(23)		4,746
Operating profit (loss)	538		1,030		(135)		(23)		1,410

(1) Net revenues of the Pharmacy Services segment includes approximately $2.2 billion and $1.7 billion of retail co-payments for the three months ended March 31, 2011 and 2010, respectively.

Table of Contents

Pharmacy Services Segment

The following table summarizes our Pharmacy Services segment’s performance for the respective periods:

	Three Months Ended
	March 31,
In millions	2011		2010

Net revenues	$	14,014	$	11,836
Gross profit		639		782
Gross profit % of net revenues		4.6%		6.6%
Operating expenses		242		244
Operating expense % of net revenues		1.7%		2.1%
Operating profit		397		538
Operating profit % of net revenues		2.8%		4.5%

Net revenues(1):
Mail choice(2)	$	4,535	$	4,078
Pharmacy network(3)		9,377		7,670
Other		102		88
Pharmacy claims processed(1):
Total		175.2		147.5
Mail choice(2)		17.5		15.5
Pharmacy network(3)		157.7		132.0
Generic dispensing rate(1):
Total		73.8%		70.4%
Mail choice(2)		63.8%		58.8%
Pharmacy network(3)		74.8%		71.6%
Mail choice penetration rate		24.1%		24.8%

(1) Pharmacy network net revenues, claims processed and generic dispensing rates do not include Maintenance Choice, which are included within the mail choice category.

(2) Mail choice is defined as claims filled at a Pharmacy Services’ mail facility, which includes specialty mail claims, as well as 90-day claims filled at retail under the Maintenance Choice program.

(3) Pharmacy network is defined as claims filled at retail pharmacies, including our retail drugstores.

Net Revenues

Net revenues increased $2.2 billion, or 18.4%, to $14.0 billion in the three months ended March 31, 2011, as compared to the prior year period.

· Our mail choice claims processed increased 13.0% to 17.5 million claims in the three months ended March 31, 2011, compared to 15.5 million claims in the prior year period. The increase in mail choice claim volume was primarily due to the addition of the previously announced long-term contract with a large health insurance carrier, which became effective on January 1, 2011.

· Our average revenue per mail choice claim decreased by 1.5%, compared to the prior year period. This decrease was primarily due to increases in the percentage of generic prescription drugs dispensed and changes in client pricing, partially offset by drug cost inflation.

· Our mail choice generic dispensing rate increased to 63.8% in the three months ended March 31, 2011, compared to 58.8% in the prior year period. This increase was primarily due to new generic prescription drug introductions and our continuous effort to encourage plan members to use generic prescription drugs when they are available.

Table of Contents

· Our pharmacy network claims processed increased 19.5% to 157.7 million claims in the three months ended March 31, 2011, compared to 132.0 million claims in the prior year period. The increase in the pharmacy network claim volume was primarily due to the addition of the previously announced long-term contract with a large heath insurance carrier. Additionally, we experienced higher claims activity associated with our Medicare Part D program as a result of an increase in covered lives under the program.

· Our average revenue per pharmacy network claim processed increased 2.3%, as compared to the prior year period. This increase was primarily due to the positive impact of our previously announced long-term contract with a large health insurance carrier which became effective on January 1, 2011, as well as drug cost inflation, partially offset by increases in the percentage of generic prescription drugs dispensed and changes in client pricing.

· Our pharmacy network generic dispensing rate increased to 74.8% in the three months ended March 31, 2011, compared to 71.6% in the prior year period. This increase was primarily due to new generic prescription drug introductions and our continuous effort to encourage plan members to use generic prescription drugs when they are available.

Gross Profit

Gross profit in our Pharmacy Services segment includes net revenues less cost of revenues. Cost of revenues includes (i) the cost of pharmaceuticals dispensed, either directly through our mail service and specialty retail pharmacies or indirectly through our national pharmacy network, (ii) shipping and handling costs and (iii) the operating costs of our mail service pharmacies, customer service operations and related information technology support.

Gross profit decreased $143 million, or 18.3%, to $639 million in the three months ended March 31, 2011, as compared to the prior year period. Gross profit as a percentage of net revenues was 4.6% in the three months ended March 31, 2011, compared to 6.6% in the prior year period. The decrease in gross profit dollars was primarily driven by pricing compression relating to contract renewals, and in particular the renewal of a large government client contract that took effect during the third quarter of 2010. The decrease in gross profit as a percentage of net revenues was driven by the aforementioned client pricing compression, as well as the pricing associated with our previously announced long-term contract with a large health insurance carrier which became effective on January 1, 2011. This decrease in gross profit dollars as well as gross profit as a percentage of net revenues was partially offset by the above mentioned increase in our generic dispensing rate in the three months ended March 31, 2011, as compared to the prior year period.

As you review our Pharmacy Services segment’s performance in this area, we believe you should consider the following important information that impacted the three month period ended March 31, 2011:

· Our gross profit dollars and gross profit as a percentage of net revenues continued to be impacted by our efforts to (i) retain existing clients, (ii) obtain new business and (iii) maintain or improve the purchase discounts we received from manufacturers, wholesalers and retail pharmacies. In particular, competitive pressures in the PBM industry has caused us and other PBMs to continue to share a larger portion of rebates and/or discounts received from pharmaceutical manufacturers. In addition, market dynamics and regulatory changes have impacted our ability to offer plan sponsors pricing that includes retail network “differential” or “spread”. We expect these trends to continue.

· Our gross profit as a percentage of revenues benefited from the increase in our total generic dispensing rate, which increased to 73.8%, compared to our generic dispensing rate of 70.4% in the prior year period. These increases were primarily due to new generic drug introductions and our continued efforts to encourage plan members to use generic drugs when they are available.

Table of Contents

Operating Expenses

Operating expenses in our Pharmacy Services segment include selling, general and administrative expenses, depreciation and amortization related to selling, general and administrative activities and specialty pharmacy store and administrative payroll, employee benefits and occupancy costs.

Operating expenses decreased $2 million to $242 million, or 1.7% as a percentage of net revenues in the three months ended March 31, 2011, compared to $244 million, or 2.1% as a percentage of net revenues in the prior year period. The decrease in operating expenses is primarily related to disciplined expense control partially offset by costs associated with changes designed to streamline our business.

Retail Pharmacy Segment

The following table summarizes our Retail Pharmacy segment’s performance for the respective periods:

	Three Months Ended
	March 31,
In millions	2011	2010

Net revenues	$14,587	$13,978
Gross profit	4,147	3,987
Gross profit % of net revenues	28.4%	28.5%
Operating expenses	3,051	2,957
Operating expense % of net revenues	20.9%	21.2%
Operating profit	1,096	1,030
Operating profit % of net revenues	7.5%	7.4%

Net revenue increase:
Total	4.4%	3.6%
Pharmacy	5.1%	4.6%
Front store	2.8%	1.3%
Same store sales increase:
Total	2.6%	2.3%
Pharmacy	3.7%	3.7%
Front store	0.4%	(0.7)%
Generic dispensing rate	75.2%	72.1%
Pharmacy % of total revenues	69.1%	68.4%
Third party % of pharmacy revenue	97.5%	97.0%
Retail prescriptions filled	165.6	157.3

As of March 31, 2011, we operated 7,226 retail drugstores compared to 7,063 retail drugstores on March 31, 2010.

Net Revenues

Net revenues increased $609 million, or 4.4%, to $14.6 billion in the three months ended March 31, 2011, as compared to the prior year period. This increase was primarily driven by same store sales increase of 2.6% and net revenues from new stores, which accounted for approximately 160 basis points of our total net revenue percentage increase in the three months ended March 31, 2011.

As you review our Retail Pharmacy segment’s performance in this area, we believe you should consider the following important information that impacted the three month period ended March 31, 2011:

· Front store same store sales for the period rose by 0.4% compared to the prior year period and were negatively impacted by approximately 45 basis points due to the shift of sales related to the Easter holiday into the second quarter, as well as the absence of sales associated with the grand reopening of the Longs stores in the prior year.

· Pharmacy revenues continued to benefit from incremental prescription volume associated with our Maintenance Choice program. Pharmacy same store sales rose 3.7% as compared to the prior year period, reflecting the

Table of Contents

strong flu season as well as a positive impact from Maintenance Choice™ of approximately 170 basis points on a net basis (i.e., a positive impact of approximately 220 basis points on a gross basis, net of approximately 50 basis points from the conversion of 30-day prescriptions at retail to 90-day prescriptions under the Maintenance Choice program).

· Pharmacy revenues continue to be negatively impacted by the conversion of brand named drugs to equivalent generic drugs, which typically have a lower selling price. Pharmacy same store sales were negatively impacted by approximately 260 basis points due to recent generic introductions. In addition, our pharmacy growth has also been adversely affected by the lack of significant new brand named drug introductions, higher consumer co-payments and co-insurance arrangements, and an increase in the number of over-the-counter remedies that were historically only available by prescription.

· Pharmacy revenue growth continued to benefit from the introduction of a prescription drug benefit under Medicare Part D, our ability to attract and retain managed care customers and favorable industry trends. These trends include an aging American population; many “baby boomers” are now in their fifties and sixties and are consuming a greater number of prescription drugs. In addition, the increased use of pharmaceuticals as the first line of defense for individual health care also contributed to the growing demand for pharmacy services. We believe these favorable industry trends will continue.

Gross Profit

Gross profit in our Retail Pharmacy segment includes net revenues less the cost of merchandise sold in the period and the related purchasing costs, warehousing costs, delivery costs and actual and estimated inventory losses.

Gross profit increased $160 million, or 4.0%, to $4.1 billion in the three months ended March 31, 2011, as compared to the prior year period. Gross profit as a percentage of net revenues decreased to 28.4% in the three months ended March 31, 2011, compared to 28.5% in the prior year period. The slight decline in gross profit as a percentage of revenue was primarily driven by the shift in the mix of revenue between front store and pharmacy. Our average gross profit on front store revenues is generally higher than our average gross profit on pharmacy revenues. Front store revenues as a percentage of total revenues for the three months ended March 31, 2011 was 30.9%, as compared to 31.6% in the prior year period. Pharmacy revenues as a percentage of total revenues for the three months ended March 31, 2011 were 69.1%, compared to 68.4% in the prior year period.

As you review our Retail Pharmacy segment’s performance in this area, we believe you should consider the following important information that impacted the three month period ended March 31, 2011:

· Sales to customers covered by third party insurance programs are a significant component of our retail pharmacy business. On average, our gross profit on third party pharmacy revenues is lower than our gross profit on cash pharmacy revenues. Third party revenues were 97.5% in the three months ended March 31, 2011, compared to 97.0% in the prior year period. We expect this trend to continue.

· Our pharmacy gross profit rates have been adversely affected by the efforts of managed care organizations, pharmacy benefit managers and governmental and other third-party payors to reduce their prescription drug costs. In the event this trend continues, we may not be able to sustain our current rate of revenue growth and gross profit dollars could be adversely impacted.

· The increased use of generic drugs has augmented the efforts of third party payors to reduce reimbursement payments to retail pharmacies for prescriptions. This trend, which we expect to continue, reduces the benefit we realize from brand to generic product conversions.

Table of Contents

Operating Expenses

Operating expenses in our Retail Pharmacy segment include store payroll, store employee benefits, occupancy costs, selling expenses, advertising expenses, depreciation and amortization expense and certain administrative expenses.

Operating expenses increased $94 million to $3.1 billion, or 20.9% as a percentage of net revenues, in the three months ended March 31, 2011, as compared to $3.0 billion, or 21.2% as a percentage of net revenues, in the prior year period. The improvement in operating expenses as a percentage of net revenues for the three months ended March 31, 2011 was primarily due to improved expense leverage from our same store sales growth, and expense control initiatives.

Corporate Segment

Operating Expenses

Operating expenses in our Corporate segment include executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments. Operating expenses increased $12 million, or 8.9%, to $147 million in the three months ended March 31, 2011, as compared to the prior year period. The increase in operating expenses was primarily related to higher payroll and benefit related costs, increases in depreciation and legal costs.

Liquidity and Capital Resources

The majority of our cash and cash equivalents at any given time represent cash in transit and amounts set aside in our insurance subsidiaries to pay claims. We maintain a level of liquidity sufficient to allow us to cover our cash needs in the short-term. Over the long-term, we manage our cash and capital structure to maximize shareholder return, strengthen our financial position and maintain flexibility for future strategic initiatives. We continuously assess our working capital needs, debt and leverage levels, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions. We believe our operating cash flows, commercial paper program, sale-leaseback program, as well as any potential future borrowings, will be sufficient to fund these future payments and long-term initiatives.

Net cash provided by operating activities was $1.9 billion in the three months ended March 31, 2011, compared to $1.1 billion in the three months ended March 31, 2010. This increase was related to improvements in inventory management, timing of payments to suppliers and growth in claims payable, offset by increased accounts receivable compared to the prior year period.

Net cash used in investing activities was $0.3 billion in the three months ended March 31, 2011, compared to $0.4 billion in the three months ended March 31, 2010. The $0.1 billion decrease in cash used in investing activities was primarily due to decreases in capital expenditures in the three months ended March 31, 2011 as compared to the same prior year period. Gross capital expenditures totaled $0.3 billion in the three months ended March 31, 2011, compared to $0.4 billion in the three months ended March 31, 2010. In the three months ended March 31, 2011, we opened 57 new retail drugstores, one new specialty retail drugstore and closed 13 retail drugstores. In addition, the Company relocated 49 retail drugstores. In 2011, for the full year, we plan to open a total of approximately 225 to 250 new or relocated retail drugstores.

Net cash used in financing activities was $0.8 billion in the three months ended March 31, 2011, compared to net cash used in financing activities of $0.7 billion in the three months ended March 31, 2010. Net cash used in financing activities was primarily due to the repayment of $0.3 billion in long-term debt and repurchases of common stock.

On June 14, 2010, our Board of Directors authorized a new share repurchase program for up to $2.0 billion of our outstanding common stock (the “2010 Repurchase Program”). The share repurchase authorization, which was effective immediately and expires at the end of 2011, permits us to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2010 Share Repurchase program may be modified, extended

Table of Contents

or terminated by the Board of Directors at any time. During the three months ended March 31, 2011 we repurchased 14.2 million shares for approximately $467 million pursuant to the 2010 Share Repurchase Program.

We had $0.3 billion of commercial paper outstanding at a weighted average interest rate of 0.41% as of March 31, 2011. In connection with its commercial paper program, the Company maintains a $1.4 billion, five-year unsecured back-up credit facility, which expires on May 12, 2011, a $1.3 billion, five-year unsecured back-up credit facility, which expires on March 12, 2012, and a $1.0 billion, three-year unsecured back-up credit facility which expires on May 27, 2013. The credit facilities allow for borrowings at various rates depending on the Company’s public debt ratings and require the Company to pay a quarterly facility fee of 0.1%, regardless of usage. As of March 31, 2011, the Company had no outstanding borrowings against the back-up credit facilities. We intend to renew our backup credit facility that expires on May 12, 2011.

Our back-up credit facilities, unsecured senior notes and enhanced capital advantaged preferred securities contain customary restrictive financial and operating covenants. These covenants do not include a requirement for the acceleration of our debt maturities in the event of a downgrade in our credit rating. We do not believe the restrictions contained in these covenants materially affect our financial or operating flexibility.

As of March 31, 2011, our long-term debt was rated “Baa2” by Moody’s with a stable outlook and “BBB+” by Standard & Poor’s with a negative outlook, and our commercial paper program was rated “P-2” by Moody’s and “A-2” by Standard & Poor’s. In assessing our credit strength, we believe that both Moody’s and Standard & Poor’s considered, among other things, our capital structure and financial policies as well as our consolidated balance sheet, our historical acquisition activity and other financial information. Although we currently believe our long-term debt ratings will remain investment grade, we cannot guarantee the future actions of Moody’s and/or Standard & Poor’s. Our debt ratings have a direct impact on our future borrowing costs, access to capital markets and new store operating lease costs.

Off-Balance Sheet Arrangements

In connection with executing operating leases, we provide a guarantee of the lease payments. We also finance a portion of our new store development through sale-leaseback transactions, which involve selling stores to unrelated parties and then leasing the stores back under leases that qualify and are accounted for as operating leases. We do not have any retained or contingent interests in the stores, and we do not provide any guarantees, other than a guarantee of the lease payments, in connection with the transactions. In accordance with accounting principles generally accepted in the United States of America (“GAAP”), such operating leases are not reflected in our condensed consolidated balance sheet. We refer you to the “Notes to Consolidated Financial Statements” on pages 66 and 74 of our Annual Report to Stockholders included as Exhibit 13 to our 2010 Form 10-K for a detailed discussion of these guarantees.

Critical Accounting Policies

We prepare our consolidated financial statements in conformity with GAAP, which requires management to make certain estimates and apply judgments. We base our estimates and judgments on historical experience, current trends and other factors that management believes to be important at the time the condensed consolidated financial statements are prepared. On a regular basis, we review our accounting policies and how they are applied and disclosed in our condensed consolidated financial statements.

While we believe that the historical experience, current trends and other factors considered support the preparation of our condensed consolidated financial statements in conformity with GAAP, actual results could differ from our estimates and such differences could be material. For a full description of our critical accounting policies, please refer to Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2010 Annual Report on Form 10-K.

Table of Contents

Cautionary Statement Concerning Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 (the “Reform Act”) provides a safe harbor for forward-looking statements made by or on behalf of CVS Caremark Corporation. The Company and its representatives may, from time to time, make written or verbal forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and in its reports to stockholders. Generally, the inclusion of the words “believe,” “expect,” “intend,” “estimate,” “project,” “anticipate,” “will,” “should” and similar expressions identify statements that constitute forward-looking statements. All statements addressing operating performance of CVS Caremark Corporation or any subsidiary, events or developments that the Company expects or anticipates will occur in the future, including statements relating to revenue growth, earnings or earnings per common share growth, adjusted earnings or adjusted earnings per common share growth, free cash flow, debt ratings, inventory levels, inventory turn and loss rates, store development, relocations and new market entries, as well as statements expressing optimism or pessimism about future operating results or events, are forward-looking statements within the meaning of the Reform Act.

The forward-looking statements are and will be based upon management’s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

By their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons, including, but not limited to:

· Our business is affected by the economy in general including changes in consumer purchasing power, preferences and/or spending patterns. These changes could affect drug utilizations trends, the number of covered lives and the financial health of our PBM clients. Further, interest rate fluctuations, changes in capital market conditions and regulatory changes may affect our ability to obtain necessary financing on acceptable terms, our ability to secure suitable store locations under acceptable terms and our ability to execute future sale-leaseback transactions under acceptable terms;

· Our ability to realize the anticipated long-term strategic benefits from our integrated pharmacy services model;

· Our ability to realize the planned benefits associated with the acquisition of Universal American Corp.’s Medicare Part D business in accordance with the expected timing;

· The continued efforts of health maintenance organizations, managed care organizations, pharmacy benefit management companies and other third party payors to reduce prescription drug costs and pharmacy reimbursement rates, particularly with respect to generic pharmaceuticals;

· The possibility of client loss and/or the failure to win new client business;

· Risks related to the frequency and rate of the introduction of generic drugs and brand name prescription products;

· The effect on our Pharmacy Services business of a declining margin environment attributable to increased competition in the pharmacy benefit management industry and increased client demands for lower prices, enhanced service offerings and/or higher service levels;

· Risks related to our inability to earn and retain purchase discounts and/or rebates from pharmaceutical manufacturers and to earn and retain retail network “differential” or “spread”;

· Risks regarding the impact of the Medicare prescription drug benefit on our business;

· Risks related to the change in industry pricing benchmarks that could adversely affect our financial performance;

· Increased competition from other drugstore chains, supermarkets, discount retailers, membership clubs and Internet companies, as well as changes in consumer preferences or loyalties;

· Risks related to the Patient Protection and Affordable Care Act, the Health Care and Education Reconciliation Act and other health care reform laws and the regulations promulgated under those laws;

Table of Contents

· Litigation, legislative and regulatory risks associated with our business or the retail pharmacy business, retail clinic operations and/or pharmacy benefit management industry generally;

· The risks relating to changes in laws and regulations, including changes in accounting standards and taxation requirements (including tax rate changes, new tax laws and revised tax law interpretations);

· The risks relating to adverse developments in the health care or pharmaceutical industry generally, including, but not limited to, developments in any investigation related to the health care or pharmaceutical industry that may be conducted by any governmental authority; and

· Other risks and uncertainties detailed from time to time in our filings with the Securities and Exchange Commission.

The foregoing list is not exhaustive. There can be no assurance that the Company has correctly identified and appropriately assessed all factors affecting its business. Additional risks and uncertainties not presently known to the Company or that it currently believes to be immaterial also may adversely impact the Company. Should any risks and uncertainties develop into actual events, these developments could have material adverse effects on the Company’s business, financial condition and results of operations. For these reasons, you are cautioned not to place undue reliance on the Company’s forward-looking statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As of March 31, 2011, the Company was party to interest rate swaps with notional amounts totaling $525 million. These interest rate swaps are intended to manage our exposure to interest rate risk associated with an anticipated long-term debt issuance. The fair value of these interest rate swaps as of March 31, 2011 was de minimis. A 10% change in market interest rates associated with these interest rate swaps would not result in a material change in the fair value of such financial instruments.

The Company believes that its exposure to market risk associated with other financial instruments, principally interest rate risk inherent in its debt portfolio, is not material.

Item 4. Controls and Procedures

Evaluation of disclosure controls and procedures: The Company’s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Securities Exchange Act Rules 13a-15 (f) and 15d-15(f)) as of March 31, 2011, have concluded that as of such date the Company’s disclosure controls and procedures were adequate and effective and designed to ensure that material information relating to the Company and its subsidiaries would be made known to such officers on a timely basis.

Changes in internal control over financial reporting: There have been no changes in our internal controls over financial reporting identified in connection with the evaluation required by paragraph (d) of Securities Exchange Act Rule 13a-15 or Rule 15d-15 that occurred in the three months ended March 31, 2011 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

Part II

Item 1

Legal Proceedings

Certain legal proceedings in which we are involved are discussed in Part I, Item 3 of our Annual Report on Form 10-K for the year ended December 31, 2010. The following discussion is limited to certain recent developments concerning our legal proceedings and should be read in conjunction with those earlier reports.

1. In January 2010, the Company received a subpoena from the Inspector General, United States Department of Health and Human Services in connection with an investigation of possible false or otherwise improper claims for payment under the Medicare and Medicaid programs. The subpoena requested retail pharmacy claims data for “dual eligible” customers (i.e., customers with both Medicaid and other third party insurance coverage), information concerning the Company’s retail pharmacy claims processing systems, copies of pharmacy payor contracts and other documents and records. In April 2011, the Company announced that it had resolved this investigation by entering into a settlement with the Department of Justice, Department of Health and Human Services, and the Attorneys General of ten states (Alabama, California, Florida, Indiana, Massachusetts, Michigan, Minnesota, New Hampshire, Nevada, and Rhode Island). This settlement resolves a qui tam lawsuit that had been filed under seal pursuant to federal and state false claims act statutes. The settlement terms include payment by the Company of $17.5 million to the federal government and to the participating states and an amendment to the Company’s existing Corporate Integrity Agreement. The Company’s legal reserve related to this matter at March 31, 2011 was sufficient to cover the required settlement payments.

2. In November 2009, a securities class action lawsuit was filed in the United States District Court for the District of Rhode Island purportedly on behalf of purchasers of CVS Caremark Corporation stock between May 5, 2009 and November 4, 2009. The lawsuit names the Company and certain officers as defendants and includes allegations of securities fraud relating to public disclosures made by the Company concerning the PBM business and allegations of insider trading. In addition, a shareholder derivative lawsuit was filed in December 2009, in the same court against the directors and certain officers of the Company. A derivative lawsuit is a lawsuit filed by a shareholder purporting to assert claims on behalf of a corporation against directors and officers of the corporation. This lawsuit includes allegations of, among other things, securities fraud, insider trading and breach of fiduciary duties and further alleges that the Company was damaged by the purchase of stock at allegedly inflated prices under its share repurchase program. In January 2011, both lawsuits were transferred to the United States District Court for the District of New Hampshire. The Company believes these lawsuits are without merit and the Company plans to defend them vigorously. The Company received a subpoena dated February 28, 2011 from the Securities and Exchange Commission (“SEC”) requesting, among other corporate records, information relating to public disclosures made by the Company in 2009 concerning its PBM and Medicare Part D businesses and information concerning ownership and transactions in the Company’s securities by certain officers of the Company. The Company is cooperating with these requests for information and has been providing documents and other information to the SEC as requested.

Table of Contents

Part II

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

The following table presents the total number of shares purchased in the three months ended March 31, 2011, the average price paid per share and the approximate dollar value of shares that still could have been purchased at the end of the applicable fiscal period, pursuant to the 2010 Repurchase Program.

Fiscal Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
January 1, 2011 through January 31, 2011	—	$	—	—	$	2,000,000,000
February 1, 2011 through February 28, 2011	7,806,313	$	32.84	7,806,313	$	1,743,635,778
March 1, 2011 through March 31, 2011	6,371,553	$	33.05	6,371,553	$	1,533,060,654

Table of Contents

Part II

Item 6

Exhibits

Item 6. Exhibits

Exhibits:

Exhibits marked with an asterisk (*) are hereby incorporated by reference to exhibits or appendices previously filed by the Registrant as indicated in brackets following the description of the exhibit.

3.1*	Amended and Restated Certificate of Incorporation of the Registrant [incorporated by reference to Exhibit 3.1 to Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 1996 (Commission File No. 001-01011)].

3.1A*	Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective May 13, 1998 [incorporated by reference to Exhibit 4.1A to Registrant’s Registration Statement No. 333-52055 on Form S-3/A dated May 18, 1998(Commission File No. 001-01001)].

3.1B*	Certificate of Amendment to the Amended and Restated Certificate of Incorporation [incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K dated March 22, 2007 (Commission File No. 001-01011)].

3.1C*	Certificate of Merger dated May 9, 2007 [incorporated by reference to Exhibit 3.1C to Registrant’s Quarterly Report on Form 10-Q dated November 1, 2007 (Commission File No. 001-01011)].

3.1D*	Certificate of Amendment to the Amended and Restated Certificate of Incorporation [incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K dated May 12, 2010 (Commission File No. 001-01011)].

3.2*	By-laws of the Registrant, as amended and restated [incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K dated December 29, 2010 (Commission File No. 001-01011)].

10.40	Letter Agreement dated January 23, 2011 between the Registrant and the Registrant’s Chairman of the Board.

15.1	Letter re: Unaudited Interim Financial Information.

31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.

32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350.

101	The following materials from the CVS Caremark Corporation Quarterly Report on Form 10-Q for the three months ended March 31, 2011 formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements of Cash Flows and (iv) related Footnotes to the Condensed Consolidated Financial Statements.

Table of Contents

Signatures:

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

CVS Caremark Corporation
(Registrant)

/s/ David M. Denton

David M. Denton
Executive Vice President and
Chief Financial Officer
May 5, 2011

EX-10.40 2 a11-8716_1ex10d40.htm EX-10.40

Exhibit 10.40

January 23, 2011

The Board of Directors

CVS Caremark Corporation

One CVS Drive

Woonsocket, Rhode Island 02895

Ladies and Gentlemen,

Over the past year, we have worked together to formulate a plan to effect a seamless transition in the leadership of CVS Caremark Corporation (the “Company”) following my retirement. In furtherance of this transition plan, effective as of March 1, 2011 (the “Transition Date”), I hereby retire from my position as Chief Executive Officer of the Company, although I will remain a non-executive employee of the Company through May 11, 2011 (the “Transition Period”), at which time I will retire from the Company. I will continue to serve as non-executive Chairman of the Board of Directors of the Company (the “Board”) through the 2011 Annual Meeting of Shareholders, at which time I will resign my position as a director of the Company.

During the Transition Period, I will advise and assist the successor CEO and the Company in determining sales and marketing strategies for key new prospects and important renewals, overall product/services marketing strategies and brand/message to clients, leveraging my experience, status in the benefits consultant community and existing relationships. My activities will include but not be limited to participation in strategy meetings, attendance at industry and trade association meetings on behalf of the Company, as well as attendance at important finalist and pitch meetings with new or existing clients as requested by the Company.

During the Transition Period, I will continue to receive base salary at my existing salary rate for the services rendered as a non-executive. I will not receive any Board retainer or meeting fees for Board service through the end of my term at the 2011 annual shareholder meeting. I understand and agree that, notwithstanding anything contained in any agreement between me and the Company, I will not be entitled to receive any award under the CVS Caremark Management Incentive Plan in respect of the 2011 performance year, any award under the CVS Caremark Long-Term Incentive Plan (the “LTIP”) for the 2011-2013 cycle, any new awards under the Company’s RoNA LTIP for 2011 or any additional equity awards, including the April 2011 annual equity grant, and I will not accrue additional credits under the Supplemental Retirement Plan I for Select Senior Management of CVS Caremark Corporation during the Transition Period. I hereby confirm that following my retirement I will be subject to the previously agreed restrictive covenants, including the ten year non-competition and non-solicitation restrictions.

It is intended that the payments described herein comply with Section 409A of the Code or an exemption thereto and that my services during the Transition Period will be performed on a regular and continual basis, at a level sufficient for me not to incur a “separation from service” for purposes of Section 409A.

I am delighted to have been able to serve the Company for more than 36 years and to assist in the transition to new leadership.

Sincerely,


/s/ Thomas M. Ryan
Thomas M. Ryan


Acknowledged and Agreed by the Company as of January 23, 2011


/s/ Lisa G. Bisaccia
By:	Lisa G. Bisaccia
Title:	Senior Vice President and
	Chief Human Resources Officer

EX-15.1 3 a11-8716_1ex15d1.htm EX-15.1

Part II

Exhibit 15.1

Letter re: Unaudited Interim Financial Information

May 5, 2011

The Board of Directors and Shareholders:

CVS Caremark Corporation

We are aware of the incorporation by reference in the Registration Statements (Nos. 333-49407, 333-34927, 333-28043, 333-91253, 333-63664, 333-139470 and 333-141481 on Form S-8 and 333-165672 on Form S-3) of CVS Caremark Corporation of our reports dated May 5, 2011, relating to the unaudited condensed consolidated interim financial statements of CVS Caremark Corporation that are included in its Form 10-Q for the quarter ended March 31, 2011.

	/s/ Ernst & Young, LLP
	Boston, Massachusetts

EX-31.1 4 a11-8716_1ex31d1.htm EX-31.1

Part II

Exhibit 31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Larry Merlo, President and Chief Executive Officer of CVS Caremark Corporation, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CVS Caremark Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2011	By:	/s/ Larry Merlo
		Larry Merlo
		President and Chief Executive Officer

EX-31.2 5 a11-8716_1ex31d2.htm EX-31.2

Part II

Exhibit 31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David M. Denton, Executive Vice President and Chief Financial Officer of CVS Caremark Corporation, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CVS Caremark Corporation;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2011	By:	/s/ David M. Denton
		David M. Denton
		Executive Vice President and
		Chief Financial Officer

EX-32.1 6 a11-8716_1ex32d1.htm EX-32.1

Part II

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The certification set forth below is being submitted in connection with the Quarterly Report of CVS Caremark Corporation (the “Company”) on Form 10-Q for the period ended March 31, 2011 (the “Report”), for the purpose of complying with Rule 13(a)-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

I, Larry Merlo, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 5, 2011	/s/ Larry Merlo
	Larry Merlo
	President and Chief Executive Officer

EX-32.2 7 a11-8716_1ex32d2.htm EX-32.2

Part II

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, David M. Denton, Executive Vice President and Chief Financial Officer of the Company, certify that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 5, 2011	/s/ David M. Denton
	David M. Denton
	Executive Vice President and
	Chief Financial Officer

EX-101.SCH 8 cvs-20110331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0010 - Statement - Condensed Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 0020 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0025 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0030 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1010 - Disclosure - Accounting Policies link:presentationLink link:calculationLink link:definitionLink 1020 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 1030 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 8000 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 1040 - Disclosure - Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1050 - Disclosure - Interest Expense link:presentationLink link:calculationLink link:definitionLink 8010 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 8020 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 1060 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 1070 - Disclosure - Share Repurchase Program link:presentationLink link:calculationLink link:definitionLink 1080 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0031 - Statement - Condensed Consolidated Statements of Cash Flows Calc 2 link:presentationLink link:calculationLink link:definitionLink 9999 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2010 - Disclosure - Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 8030 - Disclosure - Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 4010 - Disclosure - Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 4020 - Disclosure - Discontinued Operations (Details) link:presentationLink link:calculationLink link:definitionLink 3030 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 4030 - Disclosure - Segment Reporting (Details) link:presentationLink link:calculationLink link:definitionLink 8040 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 8050 - Disclosure - Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 3040 - Disclosure - Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 4040 - Disclosure - Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 3050 - Disclosure - Interest Expense (Tables) link:presentationLink link:calculationLink link:definitionLink 4050 - Disclosure - Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 3060 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 4060 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 4070 - Disclosure - Share Repurchase Programs (Details) link:presentationLink link:calculationLink link:definitionLink 4080 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 1090 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 4090 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.INS 9 cvs-20110331.xml XBRL INSTANCE DOCUMENT 0000064803 2011-01-01 2011-03-31 0000064803 2010-01-01 2010-03-31 0000064803 2011-03-31 0000064803 2010-03-31 0000064803 2010-12-31 0000064803 2009-12-31 0000064803 2011-04-29 0000064803 cvs:RepurchaseProgram2010Member 2011-02-01 2011-03-31 0000064803 cvs:RepurchaseProgram2010Member 2010-06-01 2010-06-30 0000064803 cvs:PharmacyServicesSegmentMember 2011-03-31 0000064803 cvs:SpecialtyStoresMember cvs:PharmacyServicesSegmentMember 2011-03-31 0000064803 cvs:SpecialtyMailOrderMember cvs:PharmacyServicesSegmentMember 2011-03-31 0000064803 cvs:RetailPharmacySegmentMember 2011-03-31 0000064803 cvs:PharmacyServicesSegmentMember 2011-01-01 2011-03-31 0000064803 cvs:RetailPharmacySegmentMember 2011-01-01 2011-03-31 0000064803 cvs:CorporateSegmentMember 2011-01-01 2011-03-31 0000064803 us-gaap:BusinessIntersegmentEliminationsMember 2011-01-01 2011-03-31 0000064803 cvs:PharmacyServicesSegmentMember 2010-01-01 2010-03-31 0000064803 cvs:RetailPharmacySegmentMember 2010-01-01 2010-03-31 0000064803 cvs:CorporateSegmentMember 2010-01-01 2010-03-31 0000064803 us-gaap:BusinessIntersegmentEliminationsMember 2010-01-01 2010-03-31 0000064803 cvs:CorporateSegmentMember 2011-03-31 0000064803 us-gaap:BusinessIntersegmentEliminationsMember 2011-03-31 0000064803 cvs:PharmacyServicesSegmentMember 2010-12-31 0000064803 cvs:RetailPharmacySegmentMember 2010-12-31 0000064803 cvs:CorporateSegmentMember 2010-12-31 0000064803 us-gaap:BusinessIntersegmentEliminationsMember 2010-12-31 0000064803 cvs:LaurielloLawsuitMember 2011-01-01 2011-03-31 0000064803 2003-10-01 2003-10-31 0000064803 cvs:PharmacyAndOnlineWebsiteMember cvs:RetailPharmacySegmentMember 2011-03-31 0000064803 cvs:MinuteClinicMember cvs:RetailPharmacySegmentMember 2011-03-31 0000064803 cvs:MinuteClinicWithinCVSPharmacyStoresMember cvs:RetailPharmacySegmentMember 2011-03-31 0000064803 cvs:MedicarePrescriptionDrugBusinessMember us-gaap:AcquisitionMember 2011-03-31 0000064803 us-gaap:InterestRateSwapMember 2011-03-31 0000064803 cvs:MailServiceMember cvs:PharmacyServicesSegmentMember 2011-03-31 0000064803 cvs:SpecialtyStoresMember cvs:RetailPharmacySegmentMember 2011-03-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure

0.01

100000

0.01

3200000000

1047000000

1086000000

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td>   Note 1 Accounting Policies   Basis of Presentation   The accompanying unaudited condensed consolidated financial statements of CVS Caremark Corporation and its majority owned subsidiaries (CVS Caremark or the Company) have been prepared, in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) regarding interim financial reporting. In accordance with such rules and regulations, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in Exhibit 13 to the Companys Annual Report on Form 10-K for the year ended December 31, 2010 (the 2010 Form 10-K).   In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Companys operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full fiscal year.   Principles of Consolidation   The condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All material intercompany balances and transactions have been eliminated.   Fair Value of Financial Instruments   The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following:   §         Level 1 Inputs to the valuation methodology are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.   §         Level 2 Inputs to the valuation methodology are quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument.   §         Level 3 Inputs to the valuation methodology are unobservable inputs based upon managements best estimate of inputs market participants could use in pricing the asset or liability at the measurement date, including assumptions about risk.   As of March 31, 2011, the carrying value of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and short-term debt approximated their fair value due to the short-term nature of these financial instruments. The Company invests in money market funds, commercial paper and time deposits that are classified as cash and cash equivalents within the accompanying condensed consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash.  These investments are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The Companys short-term investments consist of certificates of deposit with initial maturities of greater than three months when purchased. These investments, which are classified within Level 1 of the fair value hierarchy, are carried at historical cost, which approximated fair value at March 31, 2011. The carrying amount and estimated fair value of the Companys total long-term debt was $9.5 billion and $10.1 billion, respectively, as of March 31, 2011. The fair value of the Companys total long-term debt was estimated based on rates currently offered to the Company for debt with identical terms and maturities, which is considered Level 1 of the fair value hierarchy. The carrying amount and estimated fair value of the Companys outstanding interest rate swap contracts was de minimis as of March 31, 2011.  The fair value of the Companys outstanding interest rate swap contracts was estimated based on rates currently offered to the Company for similar instruments, which is considered Level 1 of the fair value hierarchy.   Derivative Financial Instruments   The Company is exposed to interest rate risk and management considers it prudent to periodically reduce the Companys exposure to cash flow variability resulting from interest rate fluctuations.  During the three months ended March 31, 2011, the Company entered into several interest rate swap transactions. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of long-term debt. The swaps had notional amounts totaling $525 million.  The fair value of these agreements was de minimis as of March 31, 2011. The Company has deferred gains and losses in accumulated other comprehensive loss which are expected to be reclassified to interest expense over the life of the underlying forecasted debt. The hedges are expected to be highly effective; therefore, no ineffectiveness was recognized in earnings.  There were no outstanding derivative financial instruments as of December 31, 2010.  </td></tr></table>

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Note 3 Segment Reporting   The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate. The Companys segments maintain separate financial information for which operating results are evaluated on a regular basis by the Companys chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company evaluates its Pharmacy Services and Retail Pharmacy segments performance based on net revenue, gross profit and operating profit before the effect of nonrecurring charges and gains and certain intersegment activities. The Company evaluates the performance of its Corporate segment based on operating expenses before the effect of nonrecurring charges and gains and certain intersegment activities.   The Pharmacy Services segment provides a full range of pharmacy benefit management (PBM) services including mail order pharmacy services, specialty pharmacy services, plan design consultation and administration, formulary management and claims processing. The Companys customers are primarily employers, insurance companies, unions, government employee groups, managed care organizations, other sponsors of health benefit plans and individuals throughout the United States. In addition, through our SilverScript Insurance Company and Accendo Insurance Company subsidiaries, we are a national provider of drug benefits to eligible beneficiaries under the Federal Governments Medicare Part D program. The Pharmacy Services business operates under the CVS Caremark Pharmacy Services®, Caremark®, CVS Caremark, CarePlus CVS/pharmacy, CarePlus, RxAmerica®, Accordant® and TheraCom® names.  As of March 31, 2011, the Pharmacy Services segment operated 33 retail specialty pharmacy stores, 18 specialty mail order pharmacies and four mail service pharmacies located in 25 states, Puerto Rico and the District of Columbia.   The Retail Pharmacy segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, photo finishing, seasonal merchandise, greeting cards and convenience foods through our CVS/pharmacy® and Longs Drug® retail stores and online through CVS.com®. As of March 31, 2011, the Retail Pharmacy segment included 7,226 retail drugstores, of which 7,170 operated a pharmacy, the online retail website, CVS.com, 33 specialty retail pharmacies and 568 retail health care clinics. The retail drugstores are located in 41 states, Puerto Rico and the District of Columbia operating primarily under the CVS/pharmacy or Longs Drug names. The retail health care clinics operate under the MinuteClinic® name, of which 558 are located within CVS/pharmacy stores. MinuteClinics utilize nationally recognized medical protocols to diagnose and treat minor health conditions, perform health screenings, monitor chronic conditions and deliver vaccinations. The clinics are staffed by board-certified nurse practitioners and physician assistants who provide access to affordable care without appointment.   The Corporate segment provides management and administrative services to support the Company. The Corporate segment consists of certain aspects of our executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments.   <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="bottom" width="22%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Pharmacy Services Segment(1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Retail Pharmacy Segment</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Corporate Segment</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Intersegment Eliminations(2)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Consolidated Totals</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Three Months Ended</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Net revenues</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 14,014</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 14,587</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> (2,721)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 25,880</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Gross profit</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 639</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,147</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (35)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,751</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Operating profit (loss)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 397</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,096</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (147)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (35)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,311</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2010: </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Net revenues</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 11,836</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 13,978</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (2,054)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 23,760</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Gross profit</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 782</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 3,987</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (23)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,746</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Operating profit (loss)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 538</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,030</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (135)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (23)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,410</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Total assets:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 32,565</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 28,914</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> 1,894</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> (545)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 62,828</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> December 31, 2010</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 32,254</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 28,927</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,439</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (451)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 62,169</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Goodwill:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 18,866</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 6,800</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">     $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 25,666</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> December 31, 2010</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 18,868</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 6,801</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 25,669</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr></table>   (1)          Net revenues of the Pharmacy Services segment include approximately $2.2 billion and $1.7 billion of retail co-payments for the three months ended March 31, 2011 and 2010, respectively. (2)          Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services segment customers use Retail Pharmacy segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services segment customers, through the Companys intersegment activities (such as the Maintenance Choice program), elect to pick-up their maintenance prescriptions at Retail Pharmacy segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis.  As a result, both the Pharmacy Services and the Retail Pharmacy segments include the following results associated with this activity: net revenues of $558 million and $340 million for the three months ended March 31, 2011 and 2010, respectively, gross profit and operating profit of $35 million and $23 million for the three months ended March 31, 2011 and 2010, respectively.  </td></tr></table>

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Note 6 Earnings Per Share   Basic earnings per common share attributable to CVS Caremark is computed by dividing: (i) net income attributable to CVS Caremark by (ii) the weighted average number of common shares outstanding in the period (the Basic Shares).   Diluted earnings per common share attributable to CVS Caremark is computed by dividing: (i) net income attributable to CVS Caremark by (ii) Basic Shares plus the additional shares that would be issued assuming that all dilutive stock awards are exercised. Options to purchase approximately 25.7 million and 25.9 million shares of common stock were outstanding, but were not included in the calculation of diluted earnings per share for the three months ended March 31, 2011 and 2010, respectively, because the options exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.   The following is a reconciliation of basic and diluted earnings per common share for the respective periods:   <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 26.88%; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="3"> Three Months Ended</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 26.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="26%" colspan="3"> March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> In millions, except per share amounts</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%">  2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Numerators for earnings per common share calculations:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $772</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net loss attributable to noncontrolling interest</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%"> 714</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%"> 773</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> (1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> (2)</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark, basic and diluted</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $771</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Denominators for earnings per common share calculations:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Weighted average common shares, basic</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> 1,362</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> 1,386</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Effect of dilutive securities:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Stock options</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> 7</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> 9</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Restricted stock units</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 2</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Weighted average common shares, diluted</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> 1,371</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> 1,396</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Basic earnings per common share:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $ 0.56</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾   </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $ 0.56</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Diluted earnings per common share:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $ 0.55</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾   </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $ 0.55</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr></table>  </td></tr></table>

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman',times,serif"> <tr> <td> Note 8 Commitments and Contingencies   Between 1991 and 1997, the Company sold or spun off a number of subsidiaries, including Bobs Stores, Linens n Things, Marshalls, Kay-Bee Toys, Wilsons, This End Up and Footstar. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the stores lease obligations. When the subsidiaries were disposed of, the Companys guarantees remained in place, although each initial purchaser has indemnified the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries were to become insolvent and failed to make the required payments under a store lease, the Company could be required to satisfy these obligations. As of March 31, 2011, the Company guaranteed approximately 83 such store leases (excluding the lease guarantees related to Linens n Things, which are discussed in Note 2 previously in this document), with the maximum remaining lease term extending through 2019. Management believes the ultimate disposition of any of the remaining guarantees will not have a material adverse effect on the Companys consolidated financial condition, results of operations or future cash flows.   Caremark (the term Caremark being used herein to generally refer to any one or more of the PBM subsidiaries of the Company, as applicable) is a defendant in a qui tam lawsuit initially filed by a relator on behalf of various state and federal government agencies in Texas federal court in 1999. The case was unsealed in May 2005. The case seeks monetary damages and alleges that Caremarks processing of Medicaid and certain other government claims on behalf of its clients (which allegedly resulted in underpayments from our clients to the applicable government agencies) on one of Caremarks adjudication platforms violates applicable federal or state false claims acts and fraud statutes. The United States and the States of Texas, Tennessee, Florida, Arkansas, Louisiana and California intervened in the lawsuit, but Tennessee and Florida withdrew from the lawsuit in August 2006 and May 2007, respectively. The parties previously filed cross motions for partial summary judgment, and in August 2008, the district court granted several of Caremarks motions and denied the motions filed by the plaintiffs.  The district courts rulings were favorable to Caremark and substantially limited the ability of the plaintiffs to assert false claims act allegations or statutory or common law theories of recovery based on Caremarks processing of Medicaid and other government reimbursement requests.  The district courts rulings were appealed to the United States Court of Appeals for the Fifth Circuit, which affirmed in part and reversed in part the district courts rulings.  In April 2009, the State of Texas filed a purported civil enforcement action against Caremark for injunctive relief, damages and civil penalties in Travis County, Texas alleging that Caremark violated the Texas Medicaid Fraud Prevention Act and other state laws based on our processing of Texas Medicaid claims on behalf of PBM clients. The claims and issues raised in this lawsuit are related to the claims and issues pending in the federal qui tam lawsuit described above.   In December 2007, the Company received a document subpoena from the Office of Inspector General, United States Department of Health and Human Services (OIG), requesting information relating to the processing of Medicaid and other government agency claims on a different adjudication platform of Caremark. In October 2009 and October 2010, the Company received civil investigative demands from the Office of the Attorney General of the State of Texas requesting, respectively, information produced under this OIG subpoena, and other information related to the processing of Medicaid claims. The civil investigative demands state that the Office of the Attorney General of the State of Texas is investigating allegations currently pending under seal relating to two of Caremarks adjudication platforms. The Company has been producing documents on a rolling basis in response to the requests for information contained in the OIG subpoena and in these civil investigative demands. The Company cannot predict with certainty the timing or outcome of any review of such information.   Caremark was named in a putative class action lawsuit filed in October 2003 in Alabama state court by John Lauriello, purportedly on behalf of participants in the 1999 settlement of various securities class action and derivative lawsuits against Caremark and others. Other defendants include insurance companies that provided coverage to Caremark with respect to the settled lawsuits. The Lauriello lawsuit seeks approximately $3.2 billion in compensatory damages plus other non-specified damages based on allegations that the amount of insurance coverage available for the settled lawsuits was misrepresented and suppressed. A similar lawsuit was filed in November 2003 by Frank McArthur, also in Alabama state court, naming as defendants Caremark, several insurance companies, attorneys and law firms involved in the 1999 settlement. This lawsuit was stayed as a later-filed class action, but McArthur was subsequently allowed to intervene in the Lauriello action. The attorneys and law firms named as defendants in McArthurs intervention pleadings have been dismissed from the case, and discovery on class certification and adequacy issues is underway.   Various lawsuits have been filed alleging that Caremark has violated applicable antitrust laws in establishing and maintaining retail pharmacy networks for client health plans. In August 2003, Bellevue Drug Co., Robert Schreiber, Inc. d/b/a Burns Pharmacy and Rehn-Huerbinger Drug Co. d/b/a Parkway Drugs #4, together with Pharmacy Freedom Fund and the National Community Pharmacists Association filed a putative class action against Caremark in Pennsylvania federal court, seeking treble damages and injunctive relief. In October 2003, two independent pharmacies, North Jackson Pharmacy, Inc. and C&C, Inc. d/b/a Big C Discount Drugs, Inc. filed a putative class action complaint in Alabama federal court against Caremark and two PBM competitors, seeking treble damages and injunctive relief. The North Jackson Pharmacy case was transferred to Illinois federal court, and the Bellevue case was sent to arbitration based on contract terms between the pharmacies and Caremark. The Bellevue arbitration was then stayed by the parties pending developments in the North Jackson Pharmacy court case.   In August 2006, the Bellevue case and the North Jackson Pharmacy case were both transferred to Pennsylvania federal court by the Judicial Panel on Multidistrict Litigation for coordinated and consolidated proceedings with other cases before the panel, including cases against other PBMs. Caremark appealed the decision which vacated the order compelling arbitration and staying the proceedings in the Bellevue case and, following the appeal, the Court of Appeals reinstated the order compelling arbitration of the Bellevue case. Motions for class certification in the coordinated cases within the multidistrict litigation, including the North Jackson Pharmacy case, remain pending. The consolidated action is now known as the In Re Pharmacy Benefit Managers Antitrust Litigation.   In August 2009, the Company was notified by the Federal Trade Commission (the FTC) that it is conducting a non-public investigation under the Federal Trade Commission Act into certain of the Companys business practices. In March 2010, the Company learned that various State Attorneys General offices and certain other government agencies are conducting a multi-state investigation of the Company regarding issues similar to those being investigated by the FTC. At this time, 24 states, the District of Columbia, and the County of Los Angeles are known to be participating in this multi-state investigation. The Company has been cooperating in these investigations, and continues to provide documents and other information as requested. The Company is not able to predict with certainty the timing or outcome of these investigations. However, it remains confident that its business practices and service offerings (which are designed to reduce health care costs and expand consumer choice) are being conducted in compliance with the antitrust laws.   In March 2009, the Company received a subpoena from the OIG requesting information concerning the Medicare Part D prescription drug plans of RxAmerica, the PBM subsidiary of Longs Drug Stores Corporation which was acquired by the Company in October 2008. The Company continues to respond to this request for information and has been producing responsive documents on a rolling basis. The Company cannot predict with certainty the timing or outcome of any review by the government of such information.   Since March 2009, the Company has been named in a series of putative collective and class action lawsuits filed in federal courts around the country, purportedly on behalf of current and former assistant store managers working in the Companys stores at various locations outside California. The lawsuits allege that the Company failed to pay overtime to assistant store managers as required under the Fair Labor Standards Act (FLSA) and under certain state statutes. The lawsuits also seek other relief, including liquidated damages, punitive damages, attorneys fees, costs and injunctive relief arising out of the state and federal claims for overtime pay. Notice has been issued to over 13,000 current and former assistant store managers offering them the opportunity to opt in to certain of the FLSA collective actions and over 1,900 have elected to participate in these lawsuits. At this time, the Company is not able to predict the outcome of these cases, or the possible monetary exposure associated with the lawsuits. The Companys position, however, is that the lawsuits are without merit and that the cases should not be certified as class or collective actions. The Company is vigorously defending these claims, but cannot predict with certainty the timing or outcome of this matter.   In January 2010, the Company received a subpoena from the OIG in connection with an investigation of possible false or otherwise improper claims for payment under the Medicare and Medicaid programs. The subpoena requested retail pharmacy claims data for dual eligible customers (i.e., customers with both Medicaid and other third party insurance coverage), information concerning the Companys retail pharmacy claims processing systems, copies of pharmacy payor contracts and other documents and records.  In April 2011, the Company announced that it had resolved this investigation by entering into a settlement with the Department of Justice, Department of Health and Human Services, and the Attorneys General of ten states (Alabama, California, Florida, Indiana, Massachusetts, Michigan, Minnesota, New Hampshire, Nevada, and Rhode Island).  This settlement resolves a qui tam lawsuit that had been filed under seal pursuant to federal and state false claims act statutes.  The settlement terms include payment by the Company of $17.5 million to the federal government and to the participating states and an amendment to the Companys existing Corporate Integrity Agreement.  The Companys legal reserve related to this matter at March 31, 2011 was sufficient to cover the required settlement payments   In March 2010, the Company received a subpoena from the OIG requesting information about programs under which the Company has offered customers remuneration conditioned upon the transfer of prescriptions for drugs or medications to our pharmacies in the form of gift cards, cash, non-prescription merchandise or discounts or coupons for non-prescription merchandise. The subpoena relates to an investigation of possible false or otherwise improper claims for payment under the Medicare and Medicaid programs. The Company continues to respond to this request for information and has been producing responsive documents on a rolling basis. We cannot predict with certainty the timing or outcome of any reviews by the government of such information.   In November 2009, a securities class action lawsuit was filed in the United States District Court for the District of Rhode Island purportedly on behalf of purchasers of CVS Caremark Corporation stock between May 5, 2009 and November 4, 2009. The lawsuit names the Company and certain officers as defendants and includes allegations of securities fraud relating to public disclosures made by the Company concerning the PBM business and allegations of insider trading. In addition, a shareholder derivative lawsuit was filed in December 2009, in the same court against the directors and certain officers of the Company. A derivative lawsuit is a lawsuit filed by a shareholder purporting to assert claims on behalf of a corporation against directors and officers of the corporation. This lawsuit includes allegations of, among other things, securities fraud, insider trading and breach of fiduciary duties and further alleges that the Company was damaged by the purchase of stock at allegedly inflated prices under its share repurchase program. In January 2011, both lawsuits were transferred to the United States District Court for the District of New Hampshire. The Company believes these lawsuits are without merit and the Company plans to defend them vigorously. The Company received a subpoena dated February 28, 2011 from the Securities and Exchange Commission (SEC) requesting, among other corporate records, information relating to public disclosures made by the Company in 2009 concerning its PBM and Medicare Part D businesses and information concerning ownership and transactions in the Companys securities by certain officers of the Company.  The Company is cooperating with these requests for information and has been providing documents and other information to the SEC as requested.   The Company cannot predict the ultimate outcome of the legal matters disclosed above. Management does not believe, however, that the outcome of any of these legal matters will have a material adverse effect on the Companys operating results or financial condition.   The Company is also a party to other legal proceedings and inquiries arising in the normal course of its business, none of which is expected to be material to the Company. The Company can give no assurance, however, that our business, financial condition and results of operations will not be materially adversely affected, or that we will not be required to materially change our business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations, as they may relate to our business or the pharmacy services or retail industry; (iii) pending or future federal or state governmental investigations of our business or the pharmacy services or retail industry; (iv) institution of government enforcement actions against us; (v) adverse developments in any pending qui tam lawsuit against us, whether sealed or unsealed, or in any future qui tam lawsuit that may be filed against us; or (vi) adverse developments in other pending or future legal proceedings against us or affecting the pharmacy services or retail industry.  </td></tr></table></td></tr></table>

CVS CAREMARK CORP 0000064803 10-Q 2011-03-31 false 2011 Large Accelerated Filer Yes --12-31 1355941242 Q1

0.01

100000

0.01

3200000000

1624000000

1363000000

259000000

2000000

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="bottom" width="22%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Pharmacy Services Segment(1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Retail Pharmacy Segment</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Corporate Segment</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Intersegment Eliminations(2)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Consolidated Totals</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Three Months Ended</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Net revenues</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 14,014</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 14,587</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> (2,721)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 25,880</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Gross profit</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 639</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,147</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (35)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,751</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Operating profit (loss)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 397</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,096</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (147)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (35)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,311</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2010: </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Net revenues</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 11,836</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 13,978</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (2,054)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 23,760</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Gross profit</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 782</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 3,987</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (23)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,746</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Operating profit (loss)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 538</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,030</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (135)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (23)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,410</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Total assets:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 32,565</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 28,914</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> 1,894</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> (545)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 62,828</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> December 31, 2010</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 32,254</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 28,927</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,439</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (451)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 62,169</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Goodwill:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 18,866</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 6,800</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">     $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 25,666</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> December 31, 2010</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 18,868</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 6,801</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 25,669</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr></table>   (1)          Net revenues of the Pharmacy Services segment include approximately $2.2 billion and $1.7 billion of retail co-payments for the three months ended March 31, 2011 and 2010, respectively. (2)          Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services segment customers use Retail Pharmacy segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services segment customers, through the Companys intersegment activities (such as the Maintenance Choice program), elect to pick-up their maintenance prescriptions at Retail Pharmacy segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis.  As a result, both the Pharmacy Services and the Retail Pharmacy segments include the following results associated with this activity: net revenues of $558 million and $340 million for the three months ended March 31, 2011 and 2010, respectively, gross profit and operating profit of $35 million and $23 million for the three months ended March 31, 2011 and 2010, respectively.  </td></tr></table>

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> The following are the components of net interest expense:   <table style="WIDTH: 60%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="60%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 38.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="38%" colspan="3"> Three Months Ended March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="16%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="15%">    2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="16%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="15%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> Interest expense</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 16.52%; PADDING-TOP: 0in" valign="bottom" width="16%"> $    135</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 15%; PADDING-TOP: 0in" valign="bottom" width="15%"> $    129</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.48%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> Interest income</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="16%"> (1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="15%"> (1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="3%"> )</td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> Interest expense, net</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="16%"> $    134</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="15%"> $    128</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="3%">  </td></tr></table>  </td></tr></table>

-2000000

-1000000

-3000000

-1000000

712000000

4000000

-1000000

775000000

135000000

1000000

129000000

1000000

714000000

773000000

467000000

25700000

25900000

1000000

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Fair Value of Financial Instruments   The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following:   §         Level 1 Inputs to the valuation methodology are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.   §         Level 2 Inputs to the valuation methodology are quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument.   §         Level 3 Inputs to the valuation methodology are unobservable inputs based upon managements best estimate of inputs market participants could use in pricing the asset or liability at the measurement date, including assumptions about risk.   As of March 31, 2011, the carrying value of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and short-term debt approximated their fair value due to the short-term nature of these financial instruments. The Company invests in money market funds, commercial paper and time deposits that are classified as cash and cash equivalents within the accompanying condensed consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash.  These investments are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The Companys short-term investments consist of certificates of deposit with initial maturities of greater than three months when purchased. These investments, which are classified within Level 1 of the fair value hierarchy, are carried at historical cost, which approximated fair value at March 31, 2011. The carrying amount and estimated fair value of the Companys total long-term debt was $9.5 billion and $10.1 billion, respectively, as of March 31, 2011. The fair value of the Companys total long-term debt was estimated based on rates currently offered to the Company for debt with identical terms and maturities, which is considered Level 1 of the fair value hierarchy. The carrying amount and estimated fair value of the Companys outstanding interest rate swap contracts was de minimis as of March 31, 2011.  The fair value of the Companys outstanding interest rate swap contracts was estimated based on rates currently offered to the Company for similar instruments, which is considered Level 1 of the fair value hierarchy.  </td></tr></table>

525000000

3 33 18 25 7226 41

14014000000

14587000000

-2721000000

639000000

4147000000

-35000000.

397000000

1096000000

-147000000

-35000000

11836000000

13978000000

-2054000000

782000000

3987000000

-23000000

538000000

1030000000

-135000000

-23000000

32565000000

28914000000

1894000000

-545000000

18866000000

6800000000

32254000000

28927000000

1439000000

-451000000

18868000000

6801000000

35000000 35000000 23000000 23000000

9500000000

3200000000 2 2 7000000 9000000 2000000 1000000 2200000000 1700000000 2 7170 568 558 3 2

10100000000

558000000

340000000

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> The following are the components of comprehensive income:   <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 32.3%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="32%" colspan="3"> Three Months Ended March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="13%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%"> 2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="13%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Net income</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 13.98%; PADDING-TOP: 0in" valign="bottom" width="13%"> $     712</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.68%; PADDING-TOP: 0in" valign="bottom" width="12%"> $       770</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Net cash flow hedges, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 13.98%; PADDING-TOP: 0in" valign="bottom" width="13%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.68%; PADDING-TOP: 0in" valign="bottom" width="12%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Pension adjustment, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="13%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%"> 4</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Comprehensive income</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="13%"> 712</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%"> 775</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Comprehensive loss attributable to noncontrolling interest</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="13%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Comprehensive income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="13%"> $     713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="12%"> $       776</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr></table>  </td></tr></table>

<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> The following is a reconciliation of basic and diluted earnings per common share for the respective periods:   <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 26.88%; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="3"> Three Months Ended</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 26.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="26%" colspan="3"> March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> In millions, except per share amounts</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%">  2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Numerators for earnings per common share calculations:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $772</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net loss attributable to noncontrolling interest</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%"> 714</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%"> 773</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> (1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> (2)</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark, basic and diluted</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $771</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Denominators for earnings per common share calculations:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Weighted average common shares, basic</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> 1,362</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> 1,386</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Effect of dilutive securities:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Stock options</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> 7</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> 9</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Restricted stock units</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 2</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Weighted average common shares, diluted</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> 1,371</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> 1,396</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Basic earnings per common share:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $ 0.56</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾   </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $ 0.56</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Diluted earnings per common share:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $ 0.55</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾   </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $ 0.55</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr></table>  </td></tr></table>

2000000000

1627000000

1354000000

271000000

2000000

713000000

776000000

83 1

14200000

12500000000

110000000

24 13000 1900

17500000

10 4

185000000

25880000000

23760000000

21129000000

19014000000

4751000000

4746000000

3440000000

3336000000

1311000000

1410000000

-134000000

-128000000

1177000000

1282000000

464000000

510000000

713000000

772000000

-1000000

-2000000

-1000000

713000000

771000000

0.52

0.56

0.52

0.56

1362000000

1386000000

0.52

0.55

0.52

0.55

1371000000

1396000000

0.1250

0.0875

2162000000

1427000000

6000000

4000000

5348000000

4925000000

10181000000

10695000000

509000000

511000000

174000000

144000000

18380000000

17706000000

8350000000

8322000000

25666000000

25669000000

9692000000

9784000000

740000000

688000000

62828000000

62169000000

4354000000

4026000000

2776000000 2569000000

3229000000

3070000000

300000000

806000000

1105000000

11465000000

11070000000

8669000000

8652000000

3710000000

3655000000

1032000000

1058000000

33000000

34000000

16000000

9449000000

9030000000

56000000

27706000000

27610000000

19845000000

19303000000

-143000000

37919000000

37700000000

62828000000

62169000000

22971000000

17445000000

3342000000

1000000

150000000

169000000

1866000000

309000000

401000000

11000000

12000000

11000000

9000000

2000000

1000000

-299000000

-397000000

200000000

301000000

1000000

171000000

122000000

107000000

97000000

11000000

467000000

887000000

-832000000

-702000000

735000000

-39000000

712000000

770000000

374000000

358000000

36000000

37000000

70000000

2000000

423000000

-308000000

-514000000

-68000000

30000000

39000000

52000000

535000000

-115000000

156000000

-335000000

-26000000

6000000

22918000000

17581000000

3916000000

1000000

155000000

207000000

1060000000

Net revenues of the Pharmacy Services segment include approximately $1.7 billion of retail co-payments for both the three months ended March 31, 2011 and 2010. Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services segment customers use Retail Pharmacy segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services segment customers, through the Company's intersegment activities (such as the Maintenance Choice program), elect to pick-up their maintenance prescriptions at Retail Pharmacy segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. As a result, both the Pharmacy Services and the Retail Pharmacy segments include the following results associated with this activity: net revenues of $558 million and $340 million for the three months ended March 31, 2011 and 2010, respectively, gross profit and operating profit of $35 million and $23 million for the three months ended March 31, 2011 and 2010, respectively.

EX-101.CAL 10 cvs-20110331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 cvs-20110331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 cvs-20110331_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Statement Statement [Line Items] Revenues Net revenues Cost of Revenue Cost of revenues Gross Profit Gross profit Gross profit Operating Expenses Operating expenses Operating Income (Loss) Operating profit Operating profit (loss) Interest Income (Expense), Net Interest expense, net Interest expense, net Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Cumulative Effects of Changes in Accounting Principles, Noncontrolling Interest Income before income tax provision Net Income (Loss) Attributable to Parent Net income attributable to CVS Caremark Net income attributable to CVS Caremark, basic and diluted Earnings Per Share, Basic [Abstract] Basic earnings per common share: Income (Loss) from Continuing Operations, Per Basic Share Income from continuing operations attributable to CVS Caremark (in dollars per share) Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share Loss from discontinued operations attributable to CVS Caremark (in dollars per share) Earnings Per Share, Basic Net income attributable to CVS Caremark (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted average basic common shares outstanding (in shares) Weighted average common shares, basic (in shares) Income Tax Expense (Benefit) Income tax provision Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest Income from continuing operations Income from continuing operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Loss from discontinued operations, net of tax Loss from discontinued operations, net of tax Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net income Net income Net Income (Loss) Attributable to Noncontrolling Interest Net loss attributable to noncontrolling interest Earnings Per Share, Diluted [Abstract] Diluted earnings per common share: Income (Loss) from Continuing Operations, Per Diluted Share Income from continuing operations attributable to CVS Caremark (in dollars per share) Income (Loss) from Discontinued Operations, Net of Tax, Per Diluted Share Loss from discontinued operations attributable to CVS Caremark (in dollars per share) Earnings Per Share, Diluted Net income attributable to CVS Caremark (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted Weighted average diluted common shares outstanding (in shares) Weighted average common shares, diluted (in shares) Common Stock, Dividends, Per Share, Declared Dividends declared per common share (in dollars per share) Preference dividends, net of income tax benefit Operating Cash Flows, Direct Method [Abstract] Cash flows from operating activities: Proceeds from Operating Activities Cash receipts from revenues Payments to Suppliers Cash paid for inventory and prescriptions dispensed by retail network pharmacies Payments to Suppliers and Employees Cash paid to other suppliers and employees Proceeds from Interest Received Interest received Interest Paid Interest paid Income Taxes Paid Income taxes paid Net Cash Provided by (Used in) Operating Activities Net cash provided by operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Sale Leaseback Transaction, Net Proceeds Proceeds from sale-leaseback transactions Proceeds from Sale of Productive Assets Proceeds from sale of property and equipment Payments to Acquire Businesses, Net of Cash Acquired Acquisitions (net of cash acquired) and other investments Payments to Acquire Short-term Investments Purchase of short-term investments Proceeds from Sale of Short-term Investments Maturity of short-term investments Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Proceeds from (Repayments of) Short-term Debt Increase in short-term debt Proceeds from Issuance of Long-term Debt Proceeds from issuance of long-term debt Repayments of Long-term Debt Repayments of long-term debt Payments of Dividends Dividends paid Payments for (Proceeds from) Hedge, Financing Activities Derivative settlements Proceeds from Stock Options Exercised Proceeds from exercise of stock options Excess Tax Benefit from Share-based Compensation, Financing Activities Excess tax benefits from stock-based compensation Payments for Repurchase of Common Stock Repurchase of common stock Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities Repayment of debt assumed in acquisition Cash and Cash Equivalents, Period Increase (Decrease) Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash and cash equivalents Net Cash Provided by (Used in) Operating Activities [Abstract] Reconciliation of net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments required to reconcile net income to net cash provided by operating activities: Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization Share-based Compensation Stock-based compensation Deferred Income Tax Expense (Benefit) Deferred income taxes and other non-cash items Increase (Decrease) in Operating Capital [Abstract] Change in operating assets and liabilities, net of effects of acquisitions: Increase (Decrease) in Accounts Receivable Accounts receivable, net Increase (Decrease) in Inventories Inventories Increase (Decrease) in Prepaid, Deferred Expense and Other Assets Other current assets Increase (Decrease) in Operating Assets Other assets Increase (Decrease) in Accounts Payable Accounts payable and claims and discounts payable Increase (Decrease) in Accrued Liabilities Accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Other long-term liabilities Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Assets [Abstract] Assets: Short-term Investments Short-term investments Accounts Receivable, Net, Current Accounts receivable, net Inventory, Net Inventories Deferred Tax Assets, Net, Current Deferred income taxes Other Assets, Current Other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Goodwill Goodwill Carrying amount of goodwill Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Intangible assets, net carrying amount Assets Total assets Total assets Liabilities [Abstract] Liabilities: Accounts Payable, Current Accounts payable Claims and discounts payable Carrying value as of the balance sheet date of claims and discounts payable. Claims and Discounts Payable Accrued Liabilities, Current Accrued expenses Short-term Borrowings Short-term debt Long-term Debt, Current Maturities Current portion of long-term debt Liabilities, Current Total current liabilities Long-term Debt, Excluding Current Maturities Long-term debt Deferred Tax Liabilities, Noncurrent Deferred income taxes Other Liabilities, Noncurrent Other long-term liabilities Temporary Equity, Carrying Amount Redeemable noncontrolling interest Stockholders' Equity Attributable to Parent [Abstract] Shareholders' equity: Preferred Stock, Value, Issued Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding Common Stock, Value, Issued Common stock, par value $0.01: 3,200 shares authorized; 1,627 shares issued and 1,354 shares outstanding at March 31, 2011 and 1,624 shares issued and 1,363 shares outstanding at December 31, 2010 Treasury Stock, Value Treasury stock, at cost: 271 shares at March 31, 2011 and 259 shares at December 31, 2010 Common Stock, Shares Held in Employee Trust Shares held in trust: 2 shares at March 31, 2011 and December 31, 2010 Additional Paid in Capital Capital surplus Retained Earnings (Accumulated Deficit) Retained earnings Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Stockholders' Equity Attributable to Parent Total shareholders' equity Balance, Value Balance, Value Liabilities and Stockholders' Equity Total liabilities and shareholders' equity Other Assets, Noncurrent Other assets Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Treasury Stock, Shares Treasury stock, shares Common Stock, Shares Held in Employee Trust, Shares Shares held in trust, shares Accounting Policies Significant Accounting Policies [Text Block] Accounting Policies Discontinued Operations Segment Reporting Comprehensive Income Interest Expense. Long-Term Debt. Stock-Based Compensation Earnings Per Share Share Repurchase Program Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Discontinued Operations Segment Reporting Disclosure [Text Block] Segment Reporting Goodwill and Intangible Assets Disclosure [Text Block] Goodwill and Intangible Assets Comprehensive Income Note [Text Block] Comprehensive Income Interest Income and Interest Expense Disclosure [Text Block] Interest Expense Long-term Debt [Text Block] EX-101.PRE 13 cvs-20110331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 14 R19.xml IDEA: Accounting Policies (Details) 2.2.0.25truefalse4010 - Disclosure - Accounting Policies (Details)truefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_FairValueOfFinancialInstrumentsAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseFair Value of Financial Instruments3false0cvs_InitialMaturitiesOfShortTermInvestmentscvsfalsenadurationRepresents the minimum period of initial maturities of short-term investments.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse33falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerRepresents the minimum period of initial maturities of short-term investments.No authoritative reference available.falsefalseMinimum initial maturities of short-term investments (in months)4false0us-gaap_LongTermDebtus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse95000000009500000000falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryIncluding current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date. May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.16) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 16 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.16) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 16 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20, 22 -Article 5 falsefalseCarrying amount of long-term debt5false0us-gaap_LongTermDebtFairValueus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1010000000010100000000falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.No authoritative reference available.falsefalseEstimated fair value of long-term debt7false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosureaccountingpoliciesdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalseUSDtruefalse{us-gaap_DerivativeByNatureAxis} : Interest rates swaps expiring in August 2011 3/31/2011 USD ($) $I2011Q1_InterestRateSwapMemberhttp://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00falsefalseInterest rates swaps expiring in August 2011us-gaap_DerivativeByNatureAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_InterestRateSwapMemberus-gaap_DerivativeByNatureAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalseInterest rates swaps expiring in August 20119true0us-gaap_DerivativeLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseDerivative Financial Instruments10false0us-gaap_NotionalAmountOfInterestRateCashFlowHedgeDerivativesus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse525000000525000000falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate notional amount of all interest rate derivatives designated as hedging instruments in cash flow hedges. Notional amount refers to the monetary amount specified in the interest rate derivative contract.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1B -URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5580258-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Notional Amount -URI http://asc.fasb.org/extlink&oid=6519104 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5579245-113959 falsefalseNotional amount17Accounting Policies (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruetrue XML 15 R11.xml IDEA: Share Repurchase Program 2.2.0.25falsefalse1070 - Disclosure - Share Repurchase Programtruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_ShareRepurchaseProgramDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseShare Repurchase Program3false0us-gaap_TreasuryStockTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Note 7 Share Repurchase Program   On June 14, 2010, the Companys Board of Directors authorized a new share repurchase program for up to $2.0 billion of outstanding common stock (the 2010 Repurchase Program). The share repurchase authorization, which was effective immediately and expires at the end of 2011, permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2010 Share Repurchase program may be modified, extended or terminated by the Board of Directors at any time. During February and March 2011, the Company repurchased an aggregate of 14.2 million shares of common stock for approximately $467 million pursuant to the 2010 Repurchase Program.  </td></tr></table> Note 7 Share Repurchase Program   On June 14, 2010, the Companys Board of Directors authorized a new share repurchase program for up tofalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for an entity's treasury stock, including the average cost per share, carrying basis for each class of treasury stock, description of share repurchase program authorized by an entity's board of directors, the number of shares repurchased, the cost of the shares repurchased, the remaining maximum dollar value of shares available for repurchase under the program, the treatment of the purchase price in excess of the current market value, number of shares held for each class of treasury stock, and other information necessary to a fair presentation.No authoritative reference available.falsefalseShare Repurchase Program12Share Repurchase ProgramUnKnownUnKnownUnKnownUnKnownfalsetrue XML 16 R10.xml IDEA: Earnings Per Share 2.2.0.25falsefalse1060 - Disclosure - Earnings Per Sharetruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_EarningsPerShareDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseEarnings Per Share3false0us-gaap_EarningsPerShareTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Note 6 Earnings Per Share   Basic earnings per common share attributable to CVS Caremark is computed by dividing: (i) net income attributable to CVS Caremark by (ii) the weighted average number of common shares outstanding in the period (the Basic Shares).   Diluted earnings per common share attributable to CVS Caremark is computed by dividing: (i) net income attributable to CVS Caremark by (ii) Basic Shares plus the additional shares that would be issued assuming that all dilutive stock awards are exercised. Options to purchase approximately 25.7 million and 25.9 million shares of common stock were outstanding, but were not included in the calculation of diluted earnings per share for the three months ended March 31, 2011 and 2010, respectively, because the options exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.   The following is a reconciliation of basic and diluted earnings per common share for the respective periods:   <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 26.88%; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="3"> Three Months Ended</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 26.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="26%" colspan="3"> March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> In millions, except per share amounts</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%">  2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Numerators for earnings per common share calculations:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $772</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net loss attributable to noncontrolling interest</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%"> 714</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%"> 773</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> (1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> (2)</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark, basic and diluted</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $771</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Denominators for earnings per common share calculations:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Weighted average common shares, basic</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> 1,362</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> 1,386</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Effect of dilutive securities:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Stock options</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> 7</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> 9</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Restricted stock units</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 2</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Weighted average common shares, diluted</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> 1,371</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> 1,396</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Basic earnings per common share:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $ 0.56</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾   </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $ 0.56</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Diluted earnings per common share:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $ 0.55</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾   </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $ 0.55</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr></table>  </td></tr></table> Note 6 Earnings Per Share   Basic earnings per common share attributable to CVS Caremark is computed by dividing: (i) net income attributablefalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for earnings per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=6945512&loc=d3e4984-109258 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseEarnings Per Share12Earnings Per ShareUnKnownUnKnownUnKnownUnKnownfalsetrue XML 17 R8.xml IDEA: Comprehensive Income 2.2.0.25falsefalse1040 - Disclosure - Comprehensive Incometruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_ComprehensiveIncomeDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseComprehensive Income3false0us-gaap_ComprehensiveIncomeNoteTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Note 4 Comprehensive Income   The following are the components of comprehensive income:   <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 32.3%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="32%" colspan="3"> Three Months Ended March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="13%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%"> 2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="13%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Net income</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 13.98%; PADDING-TOP: 0in" valign="bottom" width="13%"> $     712</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.68%; PADDING-TOP: 0in" valign="bottom" width="12%"> $       770</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Net cash flow hedges, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 13.98%; PADDING-TOP: 0in" valign="bottom" width="13%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.68%; PADDING-TOP: 0in" valign="bottom" width="12%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Pension adjustment, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="13%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%"> 4</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Comprehensive income</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="13%"> 712</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%"> 775</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Comprehensive loss attributable to noncontrolling interest</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="13%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Comprehensive income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="13%"> $     713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="12%"> $       776</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr></table>  </td></tr></table> Note 4 Comprehensive Income   The following are the components of comprehensive income:       Three Months EndedfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for comprehensive income. Includes, but is not limited to, the following: 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. Components of comprehensive income include: (1) foreign currency translation adjustments; (2) gains (losses) on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (3) gains (losses) on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (4) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (5) unrealized holding gains (losses) on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (6) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (7) the net gain (loss) and net prior service cost or credit for pension plans and other postretirement benefit plans.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 55 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e689-108580 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 17 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e716-108580 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e681-108580 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Reclassification Adjustments -URI http://asc.fasb.org/extlink&oid=6522872 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14-26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e640-108580 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e709-108580 falsefalseComprehensive Income12Comprehensive IncomeUnKnownUnKnownUnKnownUnKnownfalsetrue XML 18 R22.xml IDEA: Comprehensive Income (Details) 2.2.0.25falsefalse4040 - Disclosure - Comprehensive Income (Details)truefalseIn Millionsfalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) / shares USD ($) $D2010Q1http://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0cvs_ComprehensiveIncomeDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseComprehensive Income3false0us-gaap_ProfitLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse712000000712falsetruefalsefalsefalse2truefalsefalse770000000770falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A1, A4, A5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a),(c) -URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 5 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683 falsefalseNet income4false0us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse10000001falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryNet of tax effect change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges after taxes. A cash flow hedge is a hedge of the exposure to variability in the cash flows of a recognized asset or liability or a forecasted transaction that is attributable to a particular risk. The change includes an entity's share of an equity investee's increase or decrease in deferred hedging gains or losses. While for technical reasons this element has no balance attribute, the default assumption is a credit balance consistent with its label.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 133 -Paragraph 31, 46 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 20, 24, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 133 -Paragraph 46 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 55 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 24 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 20, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseNet cash flow hedges, net of tax5false0us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse40000004falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe increase (decrease) in accumulated comprehensive income during the period related to pension and other postretirement benefit plans, after tax. While for technical reasons this element has no balance attribute, the default assumption is a credit balance consistent with its label.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 158 -Paragraph 7 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 22, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalsePension adjustment, net of tax6false0us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse712000000712falsefalsefalsefalsefalse2truefalsefalse775000000775falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A5 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. truefalseComprehensive income7false0us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse10000001falsefalsefalsefalsefalse2truefalsefalse10000001falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to noncontrolling interests, if any. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4613674-111683 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 30 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A5 -Appendix A Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569643-111683 falsefalseComprehensive loss attributable to noncontrolling interest8false0us-gaap_ComprehensiveIncomeNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse713000000713falsetruefalsefalsefalse2truefalsefalse776000000776falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e540-108580 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 30 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A5 -Appendix A Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(3) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 8, 9, 10, 11, 12, 13, 14 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6508144 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e557-108580 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 truefalseComprehensive income attributable to CVS Caremark27Comprehensive Income (Details) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue XML 19 R18.xml IDEA: Earnings Per Share (Tables) 2.2.0.25falsefalse3060 - Disclosure - Earnings Per Share (Tables)truefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_EarningsPerShareDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseEarnings Per Share3false0us-gaap_ScheduleOfEarningsPerShareReconciliationTableTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> The following is a reconciliation of basic and diluted earnings per common share for the respective periods:   <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 26.88%; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="3"> Three Months Ended</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 26.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="26%" colspan="3"> March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> In millions, except per share amounts</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%">  2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Numerators for earnings per common share calculations:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $772</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net loss attributable to noncontrolling interest</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%"> 714</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%"> 773</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> (1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> (2)</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark, basic and diluted</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $771</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Denominators for earnings per common share calculations:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Weighted average common shares, basic</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> 1,362</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> 1,386</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Effect of dilutive securities:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Stock options</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> 7</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> 9</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Restricted stock units</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 2</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Weighted average common shares, diluted</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> 1,371</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> 1,396</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Basic earnings per common share:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $ 0.56</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾   </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $ 0.56</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Diluted earnings per common share:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Income from continuing operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.88%; PADDING-TOP: 0in" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 11.26%; PADDING-TOP: 0in" valign="bottom" width="11%"> $ 0.55</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.26%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Loss from discontinued operations attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾   </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="11%"> ¾</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 69.38%; PADDING-TOP: 0in" valign="bottom" width="69%"> Net income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.5%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $  0.52</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.76%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%"> $ 0.55</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.26%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr></table>  </td></tr></table> The following is a reconciliation of basic and diluted earnings per common share for the respective periods:       Three MonthsfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaTabular disclosure of the reconciliation of basic net earnings per share (or unit) to diluted earnings per share (or unit).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Topic 260 -SubTopic 10 -Publisher FASB -Number -Article -Subparagraph -Name Accounting Standards Codification -Paragraph 1 -Section 50 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 falsefalseReconciliation of basic and diluted earnings per common share12Earnings Per Share (Tables)UnKnownUnKnownUnKnownUnKnownfalsetrue XML 20 R12.xml IDEA: Commitments and Contingencies 2.2.0.25falsefalse1080 - Disclosure - Commitments and Contingenciestruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0us-gaap_CommitmentsAndContingenciesDisclosureAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCommitments and Contingencies.3false0us-gaap_CommitmentsAndContingenciesDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman',times,serif"> <tr> <td> Note 8 Commitments and Contingencies   Between 1991 and 1997, the Company sold or spun off a number of subsidiaries, including Bobs Stores, Linens n Things, Marshalls, Kay-Bee Toys, Wilsons, This End Up and Footstar. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the stores lease obligations. When the subsidiaries were disposed of, the Companys guarantees remained in place, although each initial purchaser has indemnified the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries were to become insolvent and failed to make the required payments under a store lease, the Company could be required to satisfy these obligations. As of March 31, 2011, the Company guaranteed approximately 83 such store leases (excluding the lease guarantees related to Linens n Things, which are discussed in Note 2 previously in this document), with the maximum remaining lease term extending through 2019. Management believes the ultimate disposition of any of the remaining guarantees will not have a material adverse effect on the Companys consolidated financial condition, results of operations or future cash flows.   Caremark (the term Caremark being used herein to generally refer to any one or more of the PBM subsidiaries of the Company, as applicable) is a defendant in a qui tam lawsuit initially filed by a relator on behalf of various state and federal government agencies in Texas federal court in 1999. The case was unsealed in May 2005. The case seeks monetary damages and alleges that Caremarks processing of Medicaid and certain other government claims on behalf of its clients (which allegedly resulted in underpayments from our clients to the applicable government agencies) on one of Caremarks adjudication platforms violates applicable federal or state false claims acts and fraud statutes. The United States and the States of Texas, Tennessee, Florida, Arkansas, Louisiana and California intervened in the lawsuit, but Tennessee and Florida withdrew from the lawsuit in August 2006 and May 2007, respectively. The parties previously filed cross motions for partial summary judgment, and in August 2008, the district court granted several of Caremarks motions and denied the motions filed by the plaintiffs.  The district courts rulings were favorable to Caremark and substantially limited the ability of the plaintiffs to assert false claims act allegations or statutory or common law theories of recovery based on Caremarks processing of Medicaid and other government reimbursement requests.  The district courts rulings were appealed to the United States Court of Appeals for the Fifth Circuit, which affirmed in part and reversed in part the district courts rulings.  In April 2009, the State of Texas filed a purported civil enforcement action against Caremark for injunctive relief, damages and civil penalties in Travis County, Texas alleging that Caremark violated the Texas Medicaid Fraud Prevention Act and other state laws based on our processing of Texas Medicaid claims on behalf of PBM clients. The claims and issues raised in this lawsuit are related to the claims and issues pending in the federal qui tam lawsuit described above.   In December 2007, the Company received a document subpoena from the Office of Inspector General, United States Department of Health and Human Services (OIG), requesting information relating to the processing of Medicaid and other government agency claims on a different adjudication platform of Caremark. In October 2009 and October 2010, the Company received civil investigative demands from the Office of the Attorney General of the State of Texas requesting, respectively, information produced under this OIG subpoena, and other information related to the processing of Medicaid claims. The civil investigative demands state that the Office of the Attorney General of the State of Texas is investigating allegations currently pending under seal relating to two of Caremarks adjudication platforms. The Company has been producing documents on a rolling basis in response to the requests for information contained in the OIG subpoena and in these civil investigative demands. The Company cannot predict with certainty the timing or outcome of any review of such information.   Caremark was named in a putative class action lawsuit filed in October 2003 in Alabama state court by John Lauriello, purportedly on behalf of participants in the 1999 settlement of various securities class action and derivative lawsuits against Caremark and others. Other defendants include insurance companies that provided coverage to Caremark with respect to the settled lawsuits. The Lauriello lawsuit seeks approximately $3.2 billion in compensatory damages plus other non-specified damages based on allegations that the amount of insurance coverage available for the settled lawsuits was misrepresented and suppressed. A similar lawsuit was filed in November 2003 by Frank McArthur, also in Alabama state court, naming as defendants Caremark, several insurance companies, attorneys and law firms involved in the 1999 settlement. This lawsuit was stayed as a later-filed class action, but McArthur was subsequently allowed to intervene in the Lauriello action. The attorneys and law firms named as defendants in McArthurs intervention pleadings have been dismissed from the case, and discovery on class certification and adequacy issues is underway.   Various lawsuits have been filed alleging that Caremark has violated applicable antitrust laws in establishing and maintaining retail pharmacy networks for client health plans. In August 2003, Bellevue Drug Co., Robert Schreiber, Inc. d/b/a Burns Pharmacy and Rehn-Huerbinger Drug Co. d/b/a Parkway Drugs #4, together with Pharmacy Freedom Fund and the National Community Pharmacists Association filed a putative class action against Caremark in Pennsylvania federal court, seeking treble damages and injunctive relief. In October 2003, two independent pharmacies, North Jackson Pharmacy, Inc. and C&C, Inc. d/b/a Big C Discount Drugs, Inc. filed a putative class action complaint in Alabama federal court against Caremark and two PBM competitors, seeking treble damages and injunctive relief. The North Jackson Pharmacy case was transferred to Illinois federal court, and the Bellevue case was sent to arbitration based on contract terms between the pharmacies and Caremark. The Bellevue arbitration was then stayed by the parties pending developments in the North Jackson Pharmacy court case.   In August 2006, the Bellevue case and the North Jackson Pharmacy case were both transferred to Pennsylvania federal court by the Judicial Panel on Multidistrict Litigation for coordinated and consolidated proceedings with other cases before the panel, including cases against other PBMs. Caremark appealed the decision which vacated the order compelling arbitration and staying the proceedings in the Bellevue case and, following the appeal, the Court of Appeals reinstated the order compelling arbitration of the Bellevue case. Motions for class certification in the coordinated cases within the multidistrict litigation, including the North Jackson Pharmacy case, remain pending. The consolidated action is now known as the In Re Pharmacy Benefit Managers Antitrust Litigation.   In August 2009, the Company was notified by the Federal Trade Commission (the FTC) that it is conducting a non-public investigation under the Federal Trade Commission Act into certain of the Companys business practices. In March 2010, the Company learned that various State Attorneys General offices and certain other government agencies are conducting a multi-state investigation of the Company regarding issues similar to those being investigated by the FTC. At this time, 24 states, the District of Columbia, and the County of Los Angeles are known to be participating in this multi-state investigation. The Company has been cooperating in these investigations, and continues to provide documents and other information as requested. The Company is not able to predict with certainty the timing or outcome of these investigations. However, it remains confident that its business practices and service offerings (which are designed to reduce health care costs and expand consumer choice) are being conducted in compliance with the antitrust laws.   In March 2009, the Company received a subpoena from the OIG requesting information concerning the Medicare Part D prescription drug plans of RxAmerica, the PBM subsidiary of Longs Drug Stores Corporation which was acquired by the Company in October 2008. The Company continues to respond to this request for information and has been producing responsive documents on a rolling basis. The Company cannot predict with certainty the timing or outcome of any review by the government of such information.   Since March 2009, the Company has been named in a series of putative collective and class action lawsuits filed in federal courts around the country, purportedly on behalf of current and former assistant store managers working in the Companys stores at various locations outside California. The lawsuits allege that the Company failed to pay overtime to assistant store managers as required under the Fair Labor Standards Act (FLSA) and under certain state statutes. The lawsuits also seek other relief, including liquidated damages, punitive damages, attorneys fees, costs and injunctive relief arising out of the state and federal claims for overtime pay. Notice has been issued to over 13,000 current and former assistant store managers offering them the opportunity to opt in to certain of the FLSA collective actions and over 1,900 have elected to participate in these lawsuits. At this time, the Company is not able to predict the outcome of these cases, or the possible monetary exposure associated with the lawsuits. The Companys position, however, is that the lawsuits are without merit and that the cases should not be certified as class or collective actions. The Company is vigorously defending these claims, but cannot predict with certainty the timing or outcome of this matter.   In January 2010, the Company received a subpoena from the OIG in connection with an investigation of possible false or otherwise improper claims for payment under the Medicare and Medicaid programs. The subpoena requested retail pharmacy claims data for dual eligible customers (i.e., customers with both Medicaid and other third party insurance coverage), information concerning the Companys retail pharmacy claims processing systems, copies of pharmacy payor contracts and other documents and records.  In April 2011, the Company announced that it had resolved this investigation by entering into a settlement with the Department of Justice, Department of Health and Human Services, and the Attorneys General of ten states (Alabama, California, Florida, Indiana, Massachusetts, Michigan, Minnesota, New Hampshire, Nevada, and Rhode Island).  This settlement resolves a qui tam lawsuit that had been filed under seal pursuant to federal and state false claims act statutes.  The settlement terms include payment by the Company of $17.5 million to the federal government and to the participating states and an amendment to the Companys existing Corporate Integrity Agreement.  The Companys legal reserve related to this matter at March 31, 2011 was sufficient to cover the required settlement payments   In March 2010, the Company received a subpoena from the OIG requesting information about programs under which the Company has offered customers remuneration conditioned upon the transfer of prescriptions for drugs or medications to our pharmacies in the form of gift cards, cash, non-prescription merchandise or discounts or coupons for non-prescription merchandise. The subpoena relates to an investigation of possible false or otherwise improper claims for payment under the Medicare and Medicaid programs. The Company continues to respond to this request for information and has been producing responsive documents on a rolling basis. We cannot predict with certainty the timing or outcome of any reviews by the government of such information.   In November 2009, a securities class action lawsuit was filed in the United States District Court for the District of Rhode Island purportedly on behalf of purchasers of CVS Caremark Corporation stock between May 5, 2009 and November 4, 2009. The lawsuit names the Company and certain officers as defendants and includes allegations of securities fraud relating to public disclosures made by the Company concerning the PBM business and allegations of insider trading. In addition, a shareholder derivative lawsuit was filed in December 2009, in the same court against the directors and certain officers of the Company. A derivative lawsuit is a lawsuit filed by a shareholder purporting to assert claims on behalf of a corporation against directors and officers of the corporation. This lawsuit includes allegations of, among other things, securities fraud, insider trading and breach of fiduciary duties and further alleges that the Company was damaged by the purchase of stock at allegedly inflated prices under its share repurchase program. In January 2011, both lawsuits were transferred to the United States District Court for the District of New Hampshire. The Company believes these lawsuits are without merit and the Company plans to defend them vigorously. The Company received a subpoena dated February 28, 2011 from the Securities and Exchange Commission (SEC) requesting, among other corporate records, information relating to public disclosures made by the Company in 2009 concerning its PBM and Medicare Part D businesses and information concerning ownership and transactions in the Companys securities by certain officers of the Company.  The Company is cooperating with these requests for information and has been providing documents and other information to the SEC as requested.   The Company cannot predict the ultimate outcome of the legal matters disclosed above. Management does not believe, however, that the outcome of any of these legal matters will have a material adverse effect on the Companys operating results or financial condition.   The Company is also a party to other legal proceedings and inquiries arising in the normal course of its business, none of which is expected to be material to the Company. The Company can give no assurance, however, that our business, financial condition and results of operations will not be materially adversely affected, or that we will not be required to materially change our business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations, as they may relate to our business or the pharmacy services or retail industry; (iii) pending or future federal or state governmental investigations of our business or the pharmacy services or retail industry; (iv) institution of government enforcement actions against us; (v) adverse developments in any pending qui tam lawsuit against us, whether sealed or unsealed, or in any future qui tam lawsuit that may be filed against us; or (vi) adverse developments in other pending or future legal proceedings against us or affecting the pharmacy services or retail industry.  </td></tr></table></td></tr></table> Note 8 Commitments and Contingencies   Between 1991 and 1997, the Company sold or spun off a number of subsidiaries, including BobsfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for commitments and contingencies.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 14 -Paragraph 3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 9, 10, 11, 12 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621 falsefalseCommitments and Contingencies12Commitments and ContingenciesUnKnownUnKnownUnKnownUnKnownfalsetrue XML 21 R3.xml IDEA: Condensed Consolidated Balance Sheets (Parenthetical) 2.2.0.25falsefalse0025 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)truefalseIn Millions, except Per Share datafalse1falsefalseUSDfalsefalse3/31/2011 USD ($) USD ($) / shares $I2011Q1http://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse12/31/2010 USD ($) USD ($) / shares $I2010http://www.sec.gov/CIK0000064803instant2010-12-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0us-gaap_StatementOfFinancialPositionAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCondensed Consolidated Balance Sheets3false0us-gaap_PreferredStockParOrStatedValuePerShareus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse000.010.01falsefalsefalsefalsefalse2falsefalsefalse000.010.01falsefalsefalsefalsefalseEPSnum:perShareItemTypenaFace amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 02 -Paragraph 29 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsetruePreferred stock, par value (in dollars per share)4false0us-gaap_PreferredStockSharesAuthorizedus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1000000.1falsefalsefalsefalsefalse2truefalsefalse1000000.1falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesThe maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 02 -Paragraph 29 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalsePreferred stock, shares authorized5false0us-gaap_PreferredStockSharesIssuedus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse00falsefalsefalsefalsefalse2truefalsefalse00falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesTotal number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 02 -Paragraph 29 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalsePreferred stock, shares issued6false0us-gaap_PreferredStockSharesOutstandingus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse00falsefalsefalsefalsefalse2truefalsefalse00falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesAggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 02 -Paragraph 29 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalsePreferred stock, shares outstanding7false0us-gaap_CommonStockParOrStatedValuePerShareus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse000.010.01falsefalsefalsefalsefalse2falsefalsefalse000.010.01falsefalsefalsefalsefalseEPSnum:perShareItemTypenaFace amount or stated value of common stock per share; generally not indicative of the fair market value per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsetrueCommon stock, par value (in dollars per share)8false0us-gaap_CommonStockSharesAuthorizedus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse32000000003200falsefalsefalsefalsefalse2truefalsefalse32000000003200falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseCommon stock, shares authorized9false0us-gaap_CommonStockSharesIssuedus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse16270000001627falsefalsefalsefalsefalse2truefalsefalse16240000001624falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesTotal number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseCommon stock, shares issued10false0us-gaap_CommonStockSharesOutstandingus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse13540000001354falsefalsefalsefalsefalse2truefalsefalse13630000001363falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesTotal number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 falsefalseCommon stock, shares outstanding11false0us-gaap_TreasuryStockSharesus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse271000000271falsefalsefalsefalsefalse2truefalsefalse259000000259falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesNumber of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28,29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseTreasury stock, shares12false0us-gaap_CommonStockSharesHeldInEmployeeTrustSharesus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse20000002falsefalsefalsefalsefalse2truefalsefalse20000002falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesNumber of common stock held in a trust that has been set up specifically to accumulate stock for the sole purpose of distribution to participating employees but not yet earned.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 93-6 -Paragraph 14 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 25 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6418455&loc=d3e16701-113920 falsefalseShares held in trust, shares211Condensed Consolidated Balance Sheets (Parenthetical) (USD $)UnKnownHundredThousandsNoRoundingUnKnownfalsetrue XML 22 R14.xml IDEA: Accounting Policies (Policies) 2.2.0.25falsefalse2010 - Disclosure - Accounting Policies (Policies)truefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_AccountingPoliciesDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseAccounting Policies3false0us-gaap_FairValueOfFinancialInstrumentsPolicyus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Fair Value of Financial Instruments   The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following:   §         Level 1 Inputs to the valuation methodology are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.   §         Level 2 Inputs to the valuation methodology are quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument.   §         Level 3 Inputs to the valuation methodology are unobservable inputs based upon managements best estimate of inputs market participants could use in pricing the asset or liability at the measurement date, including assumptions about risk.   As of March 31, 2011, the carrying value of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and short-term debt approximated their fair value due to the short-term nature of these financial instruments. The Company invests in money market funds, commercial paper and time deposits that are classified as cash and cash equivalents within the accompanying condensed consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash.  These investments are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The Companys short-term investments consist of certificates of deposit with initial maturities of greater than three months when purchased. These investments, which are classified within Level 1 of the fair value hierarchy, are carried at historical cost, which approximated fair value at March 31, 2011. The carrying amount and estimated fair value of the Companys total long-term debt was $9.5 billion and $10.1 billion, respectively, as of March 31, 2011. The fair value of the Companys total long-term debt was estimated based on rates currently offered to the Company for debt with identical terms and maturities, which is considered Level 1 of the fair value hierarchy. The carrying amount and estimated fair value of the Companys outstanding interest rate swap contracts was de minimis as of March 31, 2011.  The fair value of the Companys outstanding interest rate swap contracts was estimated based on rates currently offered to the Company for similar instruments, which is considered Level 1 of the fair value hierarchy.  </td></tr></table> Fair Value of Financial Instruments   The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair valuefalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaDisclosure of accounting policy for determining the fair value of financial instruments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 107 -Paragraph 8, 10, 12, 13, 14 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2155942 falsefalseFair Value of Financial Instruments4false0us-gaap_DerivativesPolicyTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Derivative Financial Instruments   The Company is exposed to interest rate risk and management considers it prudent to periodically reduce the Companys exposure to cash flow variability resulting from interest rate fluctuations.  During the three months ended March 31, 2011, the Company entered into several interest rate swap transactions. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of long-term debt. The swaps had notional amounts totaling $525 million.  The fair value of these agreements was de minimis as of March 31, 2011. The Company has deferred gains and losses in accumulated other comprehensive loss which are expected to be reclassified to interest expense over the life of the underlying forecasted debt. The hedges are expected to be highly effective; therefore, no ineffectiveness was recognized in earnings.  There were no outstanding derivative financial instruments as of December 31, 2010.  </td></tr></table> Derivative Financial Instruments   The Company is exposed to interest rate risk and management considers it prudent to periodically reduce thefalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaDisclosure of accounting policy for its derivative instruments and hedging activities. Disclosure may include: (1) Each method used to account for derivative financial instruments and derivative commodity instruments ("derivatives"); (2) the types of derivatives accounted for under each method; (3) the criteria required to be met for each accounting method used, including a discussion of the criteria required to be met for hedge or deferral accounting and accrual or settlement accounting (for example, whether and how risk reduction, correlation, designation, and effectiveness tests are applied); (4) the accounting method used if the criteria specified for hedge accounting are not met; (5) the method used to account for termination of derivatives designated as hedges or derivatives used to affect directly or indirectly the terms, fair values, or cash flows of a designated item; (6) the method used to account for derivatives when the designated item matures, is sold, is extinguished, or is terminated. In addition, the method used to account for derivatives designated to an anticipated transaction, when the anticipated transaction is no longer likely to occur; and (7) where and when derivatives, and their related gains or losses are reported in the statement of financial position, cash flows, and results of operations and (8) an accounting policy decision to offset fair value amounts with counterparties. An entity may also describe its embedded derivatives, and the method(s) used to determine the fair values of derivatives and any significant assumptions used in such valuations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5579240-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph n -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41675-113959 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Interpretation (FIN) -Number 39 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(n)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 133 -Paragraph 44 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41620-113959 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5579245-113959 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41638-113959 falsefalseDerivative Financial Instruments13Accounting Policies (Policies)UnKnownUnKnownUnKnownUnKnownfalsetrue XML 23 R15.xml IDEA: Segment Reporting (Tables) 2.2.0.25falsefalse3030 - Disclosure - Segment Reporting (Tables)truefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_SegmentReportingDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseSegment Reporting3false0us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="bottom" width="22%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Pharmacy Services Segment(1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Retail Pharmacy Segment</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Corporate Segment</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Intersegment Eliminations(2)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Consolidated Totals</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Three Months Ended</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Net revenues</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 14,014</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 14,587</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> (2,721)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 25,880</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Gross profit</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 639</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,147</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (35)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,751</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Operating profit (loss)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 397</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,096</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (147)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (35)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,311</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2010: </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Net revenues</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 11,836</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 13,978</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (2,054)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 23,760</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Gross profit</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 782</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 3,987</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (23)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,746</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Operating profit (loss)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 538</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,030</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (135)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (23)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,410</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Total assets:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 32,565</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 28,914</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> 1,894</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> (545)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 62,828</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> December 31, 2010</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 32,254</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 28,927</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,439</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (451)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 62,169</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Goodwill:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 18,866</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 6,800</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">     $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 25,666</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> December 31, 2010</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 18,868</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 6,801</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 25,669</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr></table>   (1)          Net revenues of the Pharmacy Services segment include approximately $2.2 billion and $1.7 billion of retail co-payments for the three months ended March 31, 2011 and 2010, respectively. (2)          Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services segment customers use Retail Pharmacy segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services segment customers, through the Companys intersegment activities (such as the Maintenance Choice program), elect to pick-up their maintenance prescriptions at Retail Pharmacy segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis.  As a result, both the Pharmacy Services and the Retail Pharmacy segments include the following results associated with this activity: net revenues of $558 million and $340 million for the three months ended March 31, 2011 and 2010, respectively, gross profit and operating profit of $35 million and $23 million for the three months ended March 31, 2011 and 2010, respectively.  </td></tr></table> InfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaTabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8721-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8736-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -Paragraph 27, 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8813-108599 falsefalseReconciliation of the Company's business segments to the condensed consolidated financial statements12Segment Reporting (Tables)UnKnownUnKnownUnKnownUnKnownfalsetrue XML 24 R24.xml IDEA: Earnings Per Share (Details) 2.2.0.25falsefalse4060 - Disclosure - Earnings Per Share (Details)truefalseIn Millions, except Per Share datafalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) / shares USD ($) $D2010Q1http://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0cvs_EarningsPerShareDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseEarnings Per Share3false0us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2570000025.7falsefalsefalsefalsefalse2truefalsefalse2590000025.9falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 171 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 13, 14 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 falsefalseCommon stock outstanding but not included in the calculation of diluted earnings per share (in shares)5true0us-gaap_NetIncomeLossAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNumerators for earnings per common share calculations:6false0us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse713000000713falsetruefalsefalsefalse2truefalsefalse772000000772falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, and noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683 falsefalseIncome from continuing operations7false0us-gaap_NetIncomeLossAttributableToNoncontrollingInterestus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse10000001falsefalsefalsefalsefalse2truefalsefalse10000001falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe portion of net Income or Loss attributable to the noncontrolling interest (if any) deducted in order to derive the portion attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A1, A4, A5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686 falsefalseNet loss attributable to noncontrolling interest8false0us-gaap_IncomeLossFromContinuingOperationsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse714000000714falsefalsefalsefalsefalse2truefalsefalse773000000773falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the income or loss from continuing operations attributable to the parent which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4613673-111683 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph b(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.13) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 truefalseIncome from continuing operations attributable to CVS Caremark9false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-1000000-1falsefalsefalsefalsefalse2truefalsefalse-2000000-2falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 47 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.14) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.12) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 13 -Article 7 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 15 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 falsefalseLoss from discontinued operations, net of tax10false0us-gaap_NetIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse713000000713falsetruefalsefalsefalse2truefalsefalse771000000771falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 19 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 falsefalseNet income attributable to CVS Caremark, basic and diluted11true0us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseDenominators for earnings per common share calculations:12false0us-gaap_WeightedAverageNumberOfSharesOutstandingBasicus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse13620000001362falsefalsefalsefalsefalse2truefalsefalse13860000001386falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 171 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseWeighted average common shares, basic (in shares)13true0us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseEffect of dilutive securities:14false0cvs_IncrementalCommonSharesAttributableToStockOptionscvsfalsenadurationAdditional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of stock options.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse70000007falsefalsefalsefalsefalse2truefalsefalse90000009falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesAdditional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of stock options.No authoritative reference available.falsefalseStock options (in shares)15false0cvs_IncrementalCommonSharesAttributableToRestrictedStockUnitscvsfalsenadurationAdditional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of restricted...falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse20000002falsefalsefalsefalsefalse2truefalsefalse10000001falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesAdditional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of restricted stock units.No authoritative reference available.falsefalseRestricted stock units (in shares)16false0us-gaap_WeightedAverageNumberOfDilutedSharesOutstandingus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse13710000001371falsefalsefalsefalsefalse2truefalsefalse13960000001396falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1505-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 truefalseWeighted average common shares, diluted (in shares)17true0us-gaap_EarningsPerShareBasicAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseBasic earnings per common share:18false0us-gaap_IncomeLossFromContinuingOperationsPerBasicShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse000.520.52falsefalsefalsefalsefalse2falsefalsefalse000.560.56falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 36, 37, 38 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256 falsetrueIncome from continuing operations attributable to CVS Caremark (in dollars per share)19false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00  falsefalsefalsefalsefalse2falsefalsefalse00  falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) derived from discontinued operations during the period, net of related tax effect, per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8, 9, 10, 36, 37, 38 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256 falsetrueLoss from discontinued operations attributable to CVS Caremark (in dollars per share)20false0us-gaap_EarningsPerShareBasicus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1falsefalsefalse000.520.52falsefalsefalsefalsefalse2falsefalsefalse000.560.56falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=6945512&loc=d3e4984-109258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 36, 37, 38 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256 truetrueNet income attributable to CVS Caremark (in dollars per share)21true0us-gaap_EarningsPerShareDilutedAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseDiluted earnings per common share:22false0us-gaap_IncomeLossFromContinuingOperationsPerDilutedShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse000.520.52falsefalsefalsefalsefalse2falsefalsefalse000.550.55falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 11, 12, 36, 37, 38 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 falsetrueIncome from continuing operations attributable to CVS Caremark (in dollars per share)23false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00  falsefalsefalsefalsefalse2falsefalsefalse00  falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income or loss derived from discontinued operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section E -Paragraph Question 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsetrueLoss from discontinued operations attributable to CVS Caremark (in dollars per share)24false0us-gaap_EarningsPerShareDilutedus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1falsefalsefalse000.520.52falsefalsefalsefalsefalse2falsefalsefalse000.550.55falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 11, 12, 36 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. truetrueNet income attributable to CVS Caremark (in dollars per share)222Earnings Per Share (Details) (USD $)MillionsHundredThousandsNoRoundingUnKnownfalsetrue XML 25 R20.xml IDEA: Discontinued Operations (Details) 2.2.0.25falsefalse4020 - Disclosure - Discontinued Operations (Details)truefalseIn Millionsfalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) / shares USD ($) $D2010Q1http://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0cvs_DiscontinuedOperationsDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseDiscontinued Operations3false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse10000001falsetruefalsefalsefalse2truefalsefalse20000002falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 47 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.14) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.12) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 13 -Article 7 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 15 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 falsefalseLoss from discontinued operations, net of tax4false0us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse20000002falsefalsefalsefalsefalse2truefalsefalse30000003falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryOverall income (loss) from a disposal group that is classified as a component of the entity, before income tax, reported as a separate component of income before extraordinary items. Includes the following (before income tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 05 -Paragraph 15 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 47 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 13 -Article 7 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.12) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 falsefalseLoss from discontinued operations, before tax5false0us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperationus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse10000001falsetruefalsefalsefalse2truefalsefalse10000001falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTax effect allocated to a disposal group that is classified as a component of the entity reported as a separate component of income before extraordinary items. Includes the tax effects of the following: income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b),(c) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 47 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 46 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 20 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6909487&loc=d3e38679-109324 falsefalseLoss from discontinued operations, income tax benefit24Discontinued Operations (Details) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue XML 26 R4.xml IDEA: Condensed Consolidated Statements of Cash Flows 2.2.0.25falsefalse0030 - Statement - Condensed Consolidated Statements of Cash FlowstruefalseIn Millionsfalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) / shares USD ($) $D2010Q1http://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$5true0us-gaap_OperatingCashFlowsDirectMethodAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCash flows from operating activities:6false0us-gaap_ProceedsFromOperatingActivitiesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2297100000022971falsetruefalsefalsefalse2truefalsefalse2291800000022918falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal amount of cash received from operating activities during the current period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 27 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 falsefalseCash receipts from revenues7false0us-gaap_PaymentsToSuppliersus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-17445000000-17445falsefalsefalsefalsefalse2truefalsefalse-17581000000-17581falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryPayments of cash to suppliers for goods and services during the current period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 27 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 falsefalseCash paid for inventory and prescriptions dispensed by retail network pharmacies8false0us-gaap_PaymentsToSuppliersAndEmployeesus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-3342000000-3342falsefalsefalsefalsefalse2truefalsefalse-3916000000-3916falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCash payments to suppliers for goods and services provided and to employees for services provided.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 27 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 falsefalseCash paid to other suppliers and employees9false0us-gaap_ProceedsFromInterestReceivedus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse10000001falsefalsefalsefalsefalse2truefalsefalse10000001falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryInterest received on loans and other debt instruments during the current period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 27 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 falsefalseInterest received10false0us-gaap_InterestPaidus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-150000000-150falsefalsefalsefalsefalse2truefalsefalse-155000000-155falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of cash paid for interest during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586 falsefalseInterest paid11false0us-gaap_IncomeTaxesPaidus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-169000000-169falsefalsefalsefalsefalse2truefalsefalse-207000000-207falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 27 -Subparagraph f -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586 falsefalseIncome taxes paid12false0us-gaap_NetCashProvidedByUsedInOperatingActivitiesus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse18660000001866falsefalsefalsefalsefalse2truefalsefalse10600000001060falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 truefalseNet cash provided by operating activities13true0us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCash flows from investing activities:14false0us-gaap_PaymentsToAcquirePropertyPlantAndEquipmentus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-309000000-309falsefalsefalsefalsefalse2truefalsefalse-401000000-401falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 17 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 falsefalsePurchases of property and equipment15false0us-gaap_SaleLeasebackTransactionNetProceedsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1100000011falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe gross proceeds received from the asset(s) sold in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller less the costs incurred in connection with the transaction, such as closing and deferred financing costs.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=6584642&loc=d3e51843-112757 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 55 -Paragraph 51 -URI http://asc.fasb.org/extlink&oid=6584642&loc=d3e51840-112757 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 98 -Section Appendix A -Paragraph 28, 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 13 -Paragraph 33 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 55 -Paragraph 50 -URI http://asc.fasb.org/extlink&oid=6584642&loc=d3e51831-112757 falsefalseProceeds from sale-leaseback transactions16false0us-gaap_ProceedsFromSaleOfProductiveAssetsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1200000012falsefalsefalsefalsefalse2truefalsefalse1200000012falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3179-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 16 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 falsefalseProceeds from sale of property and equipment17false0us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-11000000-11falsefalsefalsefalsefalse2truefalsefalse-9000000-9falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 17 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585 falsefalseAcquisitions (net of cash acquired) and other investments18false0us-gaap_PaymentsToAcquireShortTermInvestmentsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-2000000-2falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 17 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 159 -Section Appendix C -Paragraph 5 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 falsefalsePurchase of short-term investments19false0us-gaap_ProceedsFromSaleOfShortTermInvestmentsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse10000001falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 16 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 159 -Section Appendix C -Paragraph 5 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3179-108585 falsefalseMaturity of short-term investments20false0us-gaap_NetCashProvidedByUsedInInvestingActivitiesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse-299000000-299falsefalsefalsefalsefalse2truefalsefalse-397000000-397falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net cash inflow or outflow from investing activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585 truefalseNet cash used in investing activities21true0us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCash flows from financing activities:22false0us-gaap_ProceedsFromRepaymentsOfShortTermDebtus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse200000000200falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 9 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3098-108585 falsefalseIncrease in short-term debt23false0us-gaap_RepaymentsOfLongTermDebtus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-301000000-301falsefalsefalsefalsefalse2truefalsefalse-1000000-1falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 20 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 falsefalseRepayments of long-term debt24false0us-gaap_PaymentsOfDividendsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-171000000-171falsefalsefalsefalsefalse2truefalsefalse-122000000-122falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash outflow from the entity's earnings to the shareholders.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 20 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 falsefalseDividends paid25false0us-gaap_ProceedsFromStockOptionsExercisedus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse107000000107falsefalsefalsefalsefalse2truefalsefalse9700000097falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (j) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph i -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 19 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseProceeds from exercise of stock options26false0us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivitiesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse1100000011falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryReductions in the entity's income taxes that arise when compensation cost (from non-qualified share-based compensation) recognized on the entity's tax return exceeds compensation cost from equity-based compensation recognized in financial statements. This element represents the cash inflow reported in the enterprise's financing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 123R -Paragraph A240 -Subparagraph i -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 00-15 -Paragraph 3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 20 -Section 55 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6576910&loc=d3e11374-113907 falsefalseExcess tax benefits from stock-based compensation27false0us-gaap_PaymentsForRepurchaseOfCommonStockus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-467000000-467falsefalsefalsefalsefalse2truefalsefalse-887000000-887falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash outflow to reacquire common stock during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 18 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 20 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 falsefalseRepurchase of common stock28false0us-gaap_NetCashProvidedByUsedInFinancingActivitiesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse-832000000-832falsefalsefalsefalsefalse2truefalsefalse-702000000-702falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net cash inflow or outflow from financing activity for the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585 truefalseNet cash used in financing activities29false0us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse735000000735falsefalsefalsefalsefalse2truefalsefalse-39000000-39falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 truefalseNet increase (decrease) in cash and cash equivalents30false0us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsetruefalsefalseperiodstartlabel1truefalsefalse14270000001427falsefalsefalsefalsefalse2truefalsefalse10860000001086falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryIncludes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 falsefalseCash and cash equivalents at beginning of period31false0us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsetruefalseperiodendlabel1truefalsefalse21620000002162falsefalsefalsefalsefalse2truefalsefalse10470000001047falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryIncludes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 falsefalseCash and cash equivalents at end of period32true0us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseReconciliation of net income to net cash provided by operating activities:33false0us-gaap_ProfitLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse712000000712falsefalsefalsefalsefalse2truefalsefalse770000000770falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A1, A4, A5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a),(c) -URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 5 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683 falsefalseNet income34true0us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseAdjustments required to reconcile net income to net cash provided by operating activities:35false0us-gaap_DepreciationAndAmortizationus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse374000000374falsefalsefalsefalsefalse2truefalsefalse358000000358falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 falsefalseDepreciation and amortization36false0us-gaap_ShareBasedCompensationus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse3600000036falsefalsefalsefalsefalse2truefalsefalse3700000037falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 falsefalseStock-based compensation37false0us-gaap_DeferredIncomeTaxExpenseBenefitus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse7000000070falsefalsefalsefalsefalse2truefalsefalse20000002falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Deferred Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6510177 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 289 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.7) -URI http://asc.fasb.org/extlink&oid=6889476&loc=d3e330036-122817 falsefalseDeferred income taxes and other non-cash items38true0us-gaap_IncreaseDecreaseInOperatingCapitalAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseChange in operating assets and liabilities, net of effects of acquisitions:39false0us-gaap_IncreaseDecreaseInAccountsReceivableus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-423000000-423falsefalsefalsefalsefalse2truefalsefalse308000000308falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 falsefalseAccounts receivable, net40false0us-gaap_IncreaseDecreaseInInventoriesus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse514000000514falsefalsefalsefalsefalse2truefalsefalse6800000068falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 falsefalseInventories41false0us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssetsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-30000000-30falsefalsefalsefalsefalse2truefalsefalse-39000000-39falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets,or income taxes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 falsefalseOther current assets42false0us-gaap_IncreaseDecreaseInOperatingAssetsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-52000000-52falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of assets used to generate operating income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 falsefalseOther assets43false0us-gaap_IncreaseDecreaseInAccountsPayableus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse535000000535falsefalsefalsefalsefalse2truefalsefalse-115000000-115falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 falsefalseAccounts payable and claims and discounts payable44false0us-gaap_IncreaseDecreaseInAccruedLiabilitiesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse156000000156falsefalsefalsefalsefalse2truefalsefalse-335000000-335falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 falsefalseAccrued expenses45false0us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-26000000-26falsefalsefalsefalsefalse2truefalsefalse60000006falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 falsefalseOther long-term liabilities46false0us-gaap_NetCashProvidedByUsedInOperatingActivitiesus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse18660000001866falsetruefalsefalsefalse2truefalsefalse10600000001060falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 truefalseNet cash provided by operating activities242Condensed Consolidated Statements of Cash Flows (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue XML 27 R27.xml IDEA: Subsequent Event (Details) 2.2.0.25truefalse4090 - Disclosure - Subsequent Event (Details)truefalsefalse1falsefalseUSDtruefalse{us-gaap_SubsequentEventTypeAxis} : April 29, 2011 Acquistion {us-gaap_BusinessAcquisitionAxis} : UAM Medicare Part D Business 3/31/2011 USD ($) $I2011Q1_MedicarePrescriptionDrugBusinessMember_AcquisitionMemberhttp://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00falsefalseApril 29, 2011 Acquistionus-gaap_SubsequentEventTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_AcquisitionMemberus-gaap_SubsequentEventTypeAxisexplicitMemberfalsefalseUAM Medicare Part D Businessus-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldicvs_MedicarePrescriptionDrugBusinessMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2true0us-gaap_BusinessAcquisitionLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSubsequent Event3false0us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaidus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1250000000012500000000falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of cash paid to acquire the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 51 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 68 -Subparagraph f(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseCash paid in acquisition4false0us-gaap_BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse185000000185000000falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to assets acquired.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 37 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseExcess capital resided in the entity5false0us-gaap_BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumedus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse110000000110000000falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to liabilities assumed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141 -Paragraph 37 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 98-1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseLong-term debt assumed14Subsequent Event (Details) (April 29, 2011 Acquistion, UAM Medicare Part D Business, USD $)NoRoundingUnKnownUnKnownUnKnownfalsetrue XML 28 R16.xml IDEA: Comprehensive Income (Tables) 2.2.0.25falsefalse3040 - Disclosure - Comprehensive Income (Tables)truefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_ComprehensiveIncomeDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseComprehensive Income3false0us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> The following are the components of comprehensive income:   <table style="WIDTH: 80%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 32.3%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="32%" colspan="3"> Three Months Ended March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="13%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%"> 2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="13%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Net income</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 13.98%; PADDING-TOP: 0in" valign="bottom" width="13%"> $     712</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.68%; PADDING-TOP: 0in" valign="bottom" width="12%"> $       770</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Net cash flow hedges, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 13.98%; PADDING-TOP: 0in" valign="bottom" width="13%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.68%; PADDING-TOP: 0in" valign="bottom" width="12%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Pension adjustment, net of tax</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="13%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%"> 4</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Comprehensive income</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="13%"> 712</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%"> 775</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Comprehensive loss attributable to noncontrolling interest</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="13%"> 1</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%"> 1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 62.52%; PADDING-TOP: 0in" valign="bottom" width="62%"> Comprehensive income attributable to CVS Caremark</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.14%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.98%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="13%"> $     713</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 5.64%; PADDING-TOP: 0in" valign="bottom" width="5%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.68%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="12%"> $       776</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.04%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%">  </td></tr></table>  </td></tr></table> The following are the components of comprehensive income:       Three Months Ended March 31,   InfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaTabular disclosure of components of comprehensive income (loss) including, but not limited to: (a) foreign currency translation adjustments; (b) gains (losses) on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (c) gains (losses) on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (d) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (e) unrealized holding gains (losses) on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (f) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (g) the net gain (loss) and net prior service cost or credit for pension plans and other postretirement benefit plans.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Topic 220 -SubTopic 10 -Publisher FASB -Number -Article -Subparagraph -Name Accounting Standards Codification -Paragraph 1 -Section 45 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e526-108580 falsefalseComponents of comprehensive income12Comprehensive Income (Tables)UnKnownUnKnownUnKnownUnKnownfalsetrue XML 29 R28.xml IDEA: Document and Entity Information 2.2.0.25falsefalse9999 - Document - Document and Entity Informationtruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalsefalsefalse4/29/2011 I2011Q1SOhttp://www.sec.gov/CIK0000064803instant2011-04-29T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli02true0cvs_DocumentAndEntityInformationAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseDocument and Entity Information3false0dei_EntityRegistrantNamedeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00CVS CAREMARK CORPCVS CAREMARK CORPfalsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:normalizedStringItemTypenormalizedstringThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 falsefalseEntity Registrant Name4false0dei_EntityCentralIndexKeydeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0000000648030000064803falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherdei:centralIndexKeyItemTypenaA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 falsefalseEntity Central Index Key5false0dei_DocumentTypedeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0010-Q10-Qfalsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherdei:submissionTypeItemTypenaThe type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, and Other.No authoritative reference available.falsefalseDocument Type6false0dei_DocumentPeriodEndDatedeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse002011-03-312011-03-31falsefalsetruefalsefalse2falsefalsefalse00falsefalsetruefalsefalseOtherxbrli:dateItemTypedateThe end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.No authoritative reference available.falsefalseDocument Period End Date7false0dei_AmendmentFlagdeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:booleanItemTypenaIf the value is true, then the document as an amendment to previously-filed/accepted document.No authoritative reference available.falsefalseAmendment Flag8false0dei_CurrentFiscalYearEndDatedeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00--12-31--12-31falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:gMonthDayItemTypemonthdayEnd date of current fiscal year in the format --MM-DD.No authoritative reference available.falsefalseCurrent Fiscal Year End Date9false0dei_EntityCurrentReportingStatusdeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00YesYesfalsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherdei:yesNoItemTypenaIndicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.No authoritative reference available.falsefalseEntity Current Reporting Status10false0dei_EntityFilerCategorydeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Large Accelerated FilerLarge Accelerated Filerfalsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherdei:filerCategoryItemTypenaIndicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.No authoritative reference available.falsefalseEntity Filer Category11false0dei_EntityCommonStockSharesOutstandingdeifalsenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse13559412421355941242falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesIndicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, InstrumentNo authoritative reference available.falsefalseEntity Common Stock, Shares Outstanding12false0dei_DocumentFiscalYearFocusdeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0020112011falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:gYearItemTypepositiveintegerThis is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.No authoritative reference available.falsefalseDocument Fiscal Year Focus13false0dei_DocumentFiscalPeriodFocusdeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Q1Q1falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherdei:fiscalPeriodItemTypenaThis is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.No authoritative reference available.falsefalseDocument Fiscal Period Focus212Document and Entity InformationUnKnownNoRoundingUnKnownUnKnownfalsetrue XML 30 R9.xml IDEA: Interest Expense 2.2.0.25falsefalse1050 - Disclosure - Interest Expensetruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_InterestExpenseDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseInterest Expense.3false0us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Note 5 Interest Expense   The following are the components of net interest expense:   <table style="WIDTH: 60%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="60%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 38.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="38%" colspan="3"> Three Months Ended March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="16%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="15%">    2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="16%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="15%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> Interest expense</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 16.52%; PADDING-TOP: 0in" valign="bottom" width="16%"> $    135</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 15%; PADDING-TOP: 0in" valign="bottom" width="15%"> $    129</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.48%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> Interest income</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="16%"> (1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="15%"> (1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="3%"> )</td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> Interest expense, net</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="16%"> $    134</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="15%"> $    128</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="3%">  </td></tr></table>  </td></tr></table> Note 5 Interest Expense   The following are the components of net interest expense:       Three Months EndedfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for interest income and interest expense for enterprises that derive a significant portion of their revenue from interest collected on investments, loans, and securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 1 - 9 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.1-12) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 falsefalseInterest Expense12Interest ExpenseUnKnownUnKnownUnKnownUnKnownfalsetrue XML 31 R6.xml IDEA: Discontinued Operations 2.2.0.25falsefalse1020 - Disclosure - Discontinued Operationstruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_DiscontinuedOperationsDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseDiscontinued Operations3false0us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Note 2 Discontinued Operations   In connection with certain business dispositions completed between 1991 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens n Things. On May 2, 2008, Linens Holding Co. and certain affiliates, which operate Linens n Things, filed voluntary petitions under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The Companys loss from discontinued operations for the three months ended March 31, 2011 consisted of $1 million ($2 million, net of a $1 million income tax benefit) of lease-related costs, compared to $2 million ($3 million, net of a $1 million income tax benefit) of lease-related costs in the prior year period.  </td></tr></table> Note 2 Discontinued Operations   In connection with certain business dispositions completed between 1991 and 1997, the Company retained guaranteesfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6390789&loc=d3e2443-110228 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 43-48 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759 falsefalseDiscontinued Operations12Discontinued OperationsUnKnownUnKnownUnKnownUnKnownfalsetrue XML 32 R5.xml IDEA: Accounting Policies 2.2.0.25falsefalse1010 - Disclosure - Accounting Policiestruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_AccountingPoliciesDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseAccounting Policies3false0us-gaap_SignificantAccountingPoliciesTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td>   Note 1 Accounting Policies   Basis of Presentation   The accompanying unaudited condensed consolidated financial statements of CVS Caremark Corporation and its majority owned subsidiaries (CVS Caremark or the Company) have been prepared, in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) regarding interim financial reporting. In accordance with such rules and regulations, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in Exhibit 13 to the Companys Annual Report on Form 10-K for the year ended December 31, 2010 (the 2010 Form 10-K).   In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Companys operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full fiscal year.   Principles of Consolidation   The condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All material intercompany balances and transactions have been eliminated.   Fair Value of Financial Instruments   The Company utilizes the three-level valuation hierarchy for the recognition and disclosure of fair value measurements. The categorization of assets and liabilities within this hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy consist of the following:   §         Level 1 Inputs to the valuation methodology are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.   §         Level 2 Inputs to the valuation methodology are quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the instrument.   §         Level 3 Inputs to the valuation methodology are unobservable inputs based upon managements best estimate of inputs market participants could use in pricing the asset or liability at the measurement date, including assumptions about risk.   As of March 31, 2011, the carrying value of cash and cash equivalents, short-term investments, accounts receivable, accounts payable and short-term debt approximated their fair value due to the short-term nature of these financial instruments. The Company invests in money market funds, commercial paper and time deposits that are classified as cash and cash equivalents within the accompanying condensed consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash.  These investments are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The Companys short-term investments consist of certificates of deposit with initial maturities of greater than three months when purchased. These investments, which are classified within Level 1 of the fair value hierarchy, are carried at historical cost, which approximated fair value at March 31, 2011. The carrying amount and estimated fair value of the Companys total long-term debt was $9.5 billion and $10.1 billion, respectively, as of March 31, 2011. The fair value of the Companys total long-term debt was estimated based on rates currently offered to the Company for debt with identical terms and maturities, which is considered Level 1 of the fair value hierarchy. The carrying amount and estimated fair value of the Companys outstanding interest rate swap contracts was de minimis as of March 31, 2011.  The fair value of the Companys outstanding interest rate swap contracts was estimated based on rates currently offered to the Company for similar instruments, which is considered Level 1 of the fair value hierarchy.   Derivative Financial Instruments   The Company is exposed to interest rate risk and management considers it prudent to periodically reduce the Companys exposure to cash flow variability resulting from interest rate fluctuations.  During the three months ended March 31, 2011, the Company entered into several interest rate swap transactions. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of long-term debt. The swaps had notional amounts totaling $525 million.  The fair value of these agreements was de minimis as of March 31, 2011. The Company has deferred gains and losses in accumulated other comprehensive loss which are expected to be reclassified to interest expense over the life of the underlying forecasted debt. The hedges are expected to be highly effective; therefore, no ineffectiveness was recognized in earnings.  There were no outstanding derivative financial instruments as of December 31, 2010.  </td></tr></table>   Note 1 Accounting Policies   Basis of Presentation   The accompanying unaudited condensed consolidated financial statements of CVSfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for all significant accounting policies of the reporting entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 22 -Paragraph 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790 falsefalseAccounting Policies12Accounting PoliciesUnKnownUnKnownUnKnownUnKnownfalsetrue XML 33 R23.xml IDEA: Interest Expense (Details) 2.2.0.25falsefalse4050 - Disclosure - Interest Expense (Details)truefalseIn Millionsfalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) / shares USD ($) $D2010Q1http://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0cvs_InterestExpenseDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseInterest Expense.3false0us-gaap_InterestExpenseus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse135000000135falsetruefalsefalsefalse2truefalsefalse129000000129falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cost of borrowed funds accounted for as interest that was charged against earnings during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 34 -Paragraph 21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 9 -Article 9 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher OTS -Name Federal Regulation (FR) -Number Title 12 -Chapter V -Section 563c.102 -Paragraph 9 -Subsection II -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy. It will be removed from future versions of this taxonomy. falsefalseInterest expense4false0us-gaap_InvestmentIncomeInterestus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-1000000-1falsefalsefalsefalsefalse2truefalsefalse-1000000-1falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryIncome derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 14 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(b)) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseInterest income5false0us-gaap_InterestIncomeExpenseNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedtotallabel1truefalsefalse134000000134falsetruefalsefalsefalse2truefalsefalse128000000128falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net amount of operating interest income (expense).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 10 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.10) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 truefalseInterest expense, net24Interest Expense (Details) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue XML 34 defnref.xml IDEA: XBRL DOCUMENT No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the number of states participating in multi-state investigation under Federal Trade Commission Act. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the number of store leases guaranteed by the reporting entity. No authoritative reference available. No authoritative reference available. No authoritative reference available. Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of restricted stock units. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the minimum number of current and former assistant store managers who have elected to participate in offer to "opt-in" to certain of the FLSA collective actions. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The number of drugstores operated by the entity. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. A fixed fee that subscribers to a medical plan must pay for use of entity medical services covered by the plan. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents number of states which are involved in litigation settlement proceedings. No authoritative reference available. Represents the minimum number of current and former assistant store managers to whom notice has been issued offering them the opportunity to "opt-in" to certain of the FLSA collective actions. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of stock options. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Amount of gross profit from transactions with other operating segments of the same entity. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The number of states in which entity operates its pharmacies. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the minimum period of initial maturities of short-term investments. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The number of cases filed by independent pharmacies that were transferred to federal court. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the number of independent pharmacies which have filed putative class action against the reporting entity. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the number of competitors against whom putative class action has been filed by independent pharmacies. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents the number of adjudication platforms which are under investigation for allegations. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The number of reportable segments of the entity. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Represents compensatory damages sought from the reporting entity in a lawsuit. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The number of pharmacies through which the reporting entity supplies pharmaceuticals. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Carrying value as of the balance sheet date of claims and discounts payable. No authoritative reference available. No authoritative reference available. No authoritative reference available. Tabular disclosure of interest expense and interest income of the entity. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of type of transactions related with other operating segments of the same entity. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. XML 35 R21.xml IDEA: Segment Reporting (Details) 2.2.0.25truefalse4030 - Disclosure - Segment Reporting (Details)truefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) / shares USD ($) $D2010Q1http://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3falsefalseUSDfalsefalse12/31/2010 USD ($) USD ($) / shares $I2010http://www.sec.gov/CIK0000064803instant2010-12-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0cvs_SegmentReportingDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseSegment Reporting3false0cvs_ReportingSegmentsNumbercvsfalsenadurationThe number of reportable segments of the entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse33falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of reportable segments of the entity.No authoritative reference available.falsefalseNumber of segments4true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information5false0us-gaap_Revenuesus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2588000000025880000000falsetruefalsefalsefalse2truefalsefalse2376000000023760000000falsetruefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 1 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseNet revenues6false0us-gaap_GrossProfitus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse47510000004751000000falsefalsefalsefalsefalse2truefalsefalse47460000004746000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseGross profit7false0us-gaap_OperatingIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse13110000001311000000falsefalsefalsefalsefalse2truefalsefalse14100000001410000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No authoritative reference available.falsefalseOperating profit (loss)8false0us-gaap_Assetsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse6282800000062828000000falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3truefalsefalse6216900000062169000000falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 12 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Topic 210 -SubTopic 10 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 -Section S99 -Name Accounting Standards Codification -Publisher FASB -Paragraph 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseTotal assets9false0us-gaap_Goodwillus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2566600000025666000000falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3truefalsefalse2566900000025669000000falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 45 -Subparagraph e -Clause 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 68 -Subparagraph l -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 45 -Subparagraph e -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 34 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 72 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseGoodwill10false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Pharmacy Services Segment 1/1/2011 - 3/31/2011 USD ($) $D2011Q1_PharmacyServicesSegmentMemberhttp://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00falsefalsePharmacy Services Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_PharmacyServicesSegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$5falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Pharmacy Services Segment 1/1/2010 - 3/31/2010 USD ($) $D2010Q1_PharmacyServicesSegmentMemberhttp://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00falsefalsePharmacy Services Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_PharmacyServicesSegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Pharmacy Services Segment 12/31/2010 USD ($) $I2010_PharmacyServicesSegmentMemberhttp://www.sec.gov/CIK0000064803instant2010-12-31T00:00:000001-01-01T00:00:00falsefalsePharmacy Services Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_PharmacyServicesSegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalsePharmacy Services Segment12true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information13false0cvs_NumberOfStatesPharmaciesOperatedcvsfalsenainstantThe number of states in which entity operates its pharmacies.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2525falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of states in which entity operates its pharmacies.No authoritative reference available.falsefalseNumber of states pharmacies operated14false0us-gaap_Revenuesus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1401400000014014000000[1]falsefalsefalsefalsefalse2truefalsefalse1183600000011836000000[1]falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 1 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseNet revenues15false0us-gaap_GrossProfitus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse639000000639000000[1]falsefalsefalsefalsefalse2truefalsefalse782000000782000000[1]falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseGross profit16false0us-gaap_OperatingIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse397000000397000000[1]falsefalsefalsefalsefalse2truefalsefalse538000000538000000[1]falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No authoritative reference available.falsefalseOperating profit (loss)17false0us-gaap_Assetsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse3256500000032565000000[1]falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3truefalsefalse3225400000032254000000[1]falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 12 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Topic 210 -SubTopic 10 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 -Section S99 -Name Accounting Standards Codification -Publisher FASB -Paragraph 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseTotal assets18false0us-gaap_Goodwillus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1886600000018866000000[1]falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3truefalsefalse1886800000018868000000[1]falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 45 -Subparagraph e -Clause 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 68 -Subparagraph l -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 45 -Subparagraph e -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 34 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 72 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseGoodwill19false0cvs_CoPaymentRevenuecvsfalsecreditdurationA fixed fee that subscribers to a medical plan must pay for use of entity medical services covered by the plan.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse22000000002200000000falsefalsefalsefalsefalse2truefalsefalse17000000001700000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryA fixed fee that subscribers to a medical plan must pay for use of entity medical services covered by the plan.No authoritative reference available.falsefalseNet revenues, retail co-payments20false0us-gaap_RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntityus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse558000000558000000falsefalsefalsefalsefalse2truefalsefalse340000000340000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of revenue from transactions with other operating segments of the same entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -Paragraph 27 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseIntersegment eliminations, intersegment revenues21false0cvs_SegmentReportingInformationIntersegmentGrossProfitcvsfalsecreditdurationAmount of gross profit from transactions with other operating segments of the same entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse3500000035000000falsefalsefalsefalsefalse2truefalsefalse2300000023000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of gross profit from transactions with other operating segments of the same entity.No authoritative reference available.falsefalseIntersegment eliminations, intersegment gross profit22false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse7falsefalsetruefalse{us-gaap_StatementBusinessSegmentsAxis} : Pharmacy Services Segment {cvs_SegmentInformationByServicesAxis} : Specialty stores 3/31/2011 I2011Q1_SpecialtyStoresMember_PharmacyServicesSegmentMemberhttp://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00falsefalsePharmacy Services Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_PharmacyServicesSegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseSpecialty storescvs_SegmentInformationByServicesAxisxbrldihttp://xbrl.org/2006/xbrldicvs_SpecialtyStoresMembercvs_SegmentInformationByServicesAxisexplicitMemberPureStandardhttp://www.xbrl.org/2003/instancepurexbrli0OthernaNo definition available.No authoritative reference available.falsefalsePharmacy Services Segment | Specialty stores24true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information25false0cvs_NumberOfPharmaciescvsfalsenainstantThe number of pharmacies through which the reporting entity supplies pharmaceuticals.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse3333falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of pharmacies through which the reporting entity supplies pharmaceuticals.No authoritative reference available.falsefalseNumber of pharmacies26false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse8falsefalsetruefalse{us-gaap_StatementBusinessSegmentsAxis} : Pharmacy Services Segment {cvs_SegmentInformationByServicesAxis} : Specialty mail order 3/31/2011 I2011Q1_SpecialtyMailOrderMember_PharmacyServicesSegmentMemberhttp://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00falsefalsePharmacy Services Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_PharmacyServicesSegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseSpecialty mail ordercvs_SegmentInformationByServicesAxisxbrldihttp://xbrl.org/2006/xbrldicvs_SpecialtyMailOrderMembercvs_SegmentInformationByServicesAxisexplicitMemberPureStandardhttp://www.xbrl.org/2003/instancepurexbrli0OthernaNo definition available.No authoritative reference available.falsefalsePharmacy Services Segment | Specialty mail order28true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information29false0cvs_NumberOfPharmaciescvsfalsenainstantThe number of pharmacies through which the reporting entity supplies pharmaceuticals.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1818falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of pharmacies through which the reporting entity supplies pharmaceuticals.No authoritative reference available.falsefalseNumber of pharmacies30false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse9falsefalsetruefalse{us-gaap_StatementBusinessSegmentsAxis} : Pharmacy Services Segment {cvs_SegmentInformationByServicesAxis} : Mail service 3/31/2011 I2011Q1_MailServiceMember_PharmacyServicesSegmentMemberhttp://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00falsefalsePharmacy Services Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_PharmacyServicesSegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseMail servicecvs_SegmentInformationByServicesAxisxbrldihttp://xbrl.org/2006/xbrldicvs_MailServiceMembercvs_SegmentInformationByServicesAxisexplicitMemberPureStandardhttp://www.xbrl.org/2003/instancepurexbrli0OthernaNo definition available.No authoritative reference available.falsefalsePharmacy Services Segment | Mail service32true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information33false0cvs_NumberOfPharmaciescvsfalsenainstantThe number of pharmacies through which the reporting entity supplies pharmaceuticals.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse44falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of pharmacies through which the reporting entity supplies pharmaceuticals.No authoritative reference available.falsefalseNumber of pharmacies34false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse10falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Retail Pharmacy Segment 1/1/2011 - 3/31/2011 USD ($) $D2011Q1_RetailPharmacySegmentMemberhttp://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00falsefalseRetail Pharmacy Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_RetailPharmacySegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$11falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Retail Pharmacy Segment 1/1/2010 - 3/31/2010 USD ($) $D2010Q1_RetailPharmacySegmentMemberhttp://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00falsefalseRetail Pharmacy Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_RetailPharmacySegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$12falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Retail Pharmacy Segment 12/31/2010 USD ($) $I2010_RetailPharmacySegmentMemberhttp://www.sec.gov/CIK0000064803instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseRetail Pharmacy Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_RetailPharmacySegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalseRetail Pharmacy Segment36true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information37false0cvs_NumberOfStatesPharmaciesOperatedcvsfalsenainstantThe number of states in which entity operates its pharmacies.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse4141falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of states in which entity operates its pharmacies.No authoritative reference available.falsefalseNumber of states pharmacies operated38false0cvs_NumberOfDrugstorescvsfalsenainstantThe number of drugstores operated by the entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse72267226falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of drugstores operated by the entity.No authoritative reference available.falsefalseNumber of drugstores39false0us-gaap_Revenuesus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1458700000014587000000falsefalsefalsefalsefalse2truefalsefalse1397800000013978000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 1 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseNet revenues40false0us-gaap_GrossProfitus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse41470000004147000000falsefalsefalsefalsefalse2truefalsefalse39870000003987000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseGross profit41false0us-gaap_OperatingIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse10960000001096000000falsefalsefalsefalsefalse2truefalsefalse10300000001030000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No authoritative reference available.falsefalseOperating profit (loss)42false0us-gaap_Assetsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2891400000028914000000falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3truefalsefalse2892700000028927000000falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 12 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Topic 210 -SubTopic 10 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 -Section S99 -Name Accounting Standards Codification -Publisher FASB -Paragraph 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseTotal assets43false0us-gaap_Goodwillus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse68000000006800000000falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3truefalsefalse68010000006801000000falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 45 -Subparagraph e -Clause 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 68 -Subparagraph l -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 45 -Subparagraph e -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 34 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 72 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseGoodwill44false0us-gaap_RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntityus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse558000000558000000falsefalsefalsefalsefalse2truefalsefalse340000000340000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of revenue from transactions with other operating segments of the same entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -Paragraph 27 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseIntersegment eliminations, intersegment revenues45false0cvs_SegmentReportingInformationIntersegmentGrossProfitcvsfalsecreditdurationAmount of gross profit from transactions with other operating segments of the same entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse3500000035000000falsefalsefalsefalsefalse2truefalsefalse2300000023000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of gross profit from transactions with other operating segments of the same entity.No authoritative reference available.falsefalseIntersegment eliminations, intersegment gross profit46false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse13falsefalsetruefalse{us-gaap_StatementBusinessSegmentsAxis} : Retail Pharmacy Segment {cvs_SegmentInformationByServicesAxis} : Specialty stores 3/31/2011 I2011Q1_SpecialtyStoresMember_RetailPharmacySegmentMemberhttp://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00falsefalseRetail Pharmacy Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_RetailPharmacySegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseSpecialty storescvs_SegmentInformationByServicesAxisxbrldihttp://xbrl.org/2006/xbrldicvs_SpecialtyStoresMembercvs_SegmentInformationByServicesAxisexplicitMemberPureStandardhttp://www.xbrl.org/2003/instancepurexbrli0OthernaNo definition available.No authoritative reference available.falsefalseRetail Pharmacy Segment | Specialty stores48true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information49false0cvs_NumberOfPharmaciescvsfalsenainstantThe number of pharmacies through which the reporting entity supplies pharmaceuticals.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse3333falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of pharmacies through which the reporting entity supplies pharmaceuticals.No authoritative reference available.falsefalseNumber of pharmacies50false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse14falsefalsetruefalse{us-gaap_StatementBusinessSegmentsAxis} : Retail Pharmacy Segment {cvs_SegmentInformationByServicesAxis} : CVS/pharmacy 3/31/2011 I2011Q1_PharmacyAndOnlineWebsiteMember_RetailPharmacySegmentMemberhttp://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00falsefalseRetail Pharmacy Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_RetailPharmacySegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseCVS/pharmacycvs_SegmentInformationByServicesAxisxbrldihttp://xbrl.org/2006/xbrldicvs_PharmacyAndOnlineWebsiteMembercvs_SegmentInformationByServicesAxisexplicitMemberPureStandardhttp://www.xbrl.org/2003/instancepurexbrli0OthernaNo definition available.No authoritative reference available.falsefalseRetail Pharmacy Segment | CVS/pharmacy52true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information53false0cvs_NumberOfDrugstorescvsfalsenainstantThe number of drugstores operated by the entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse71707170falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of drugstores operated by the entity.No authoritative reference available.falsefalseNumber of drugstores54false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse15falsefalsetruefalse{us-gaap_StatementBusinessSegmentsAxis} : Retail Pharmacy Segment {us-gaap_ProductOrServiceAxis} : MinuteClinic 3/31/2011 I2011Q1_MinuteClinicMember_RetailPharmacySegmentMemberhttp://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00falsefalseRetail Pharmacy Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_RetailPharmacySegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseMinuteClinicus-gaap_ProductOrServiceAxisxbrldihttp://xbrl.org/2006/xbrldicvs_MinuteClinicMemberus-gaap_ProductOrServiceAxisexplicitMemberPureStandardhttp://www.xbrl.org/2003/instancepurexbrli0OthernaNo definition available.No authoritative reference available.falsefalseRetail Pharmacy Segment | MinuteClinic56true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information57false0cvs_NumberOfDrugstorescvsfalsenainstantThe number of drugstores operated by the entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse568568falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of drugstores operated by the entity.No authoritative reference available.falsefalseNumber of drugstores58false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse16falsefalsetruefalse{us-gaap_StatementBusinessSegmentsAxis} : Retail Pharmacy Segment {us-gaap_MajorCustomersAxis} : MinuteClinic within CVS Pharmacy Stores 3/31/2011 I2011Q1_MinuteClinicWithinCVSPharmacyStoresMember_RetailPharmacySegmentMemberhttp://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00falsefalseRetail Pharmacy Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_RetailPharmacySegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseMinuteClinic within CVS Pharmacy Storesus-gaap_MajorCustomersAxisxbrldihttp://xbrl.org/2006/xbrldicvs_MinuteClinicWithinCVSPharmacyStoresMemberus-gaap_MajorCustomersAxisexplicitMemberPureStandardhttp://www.xbrl.org/2003/instancepurexbrli0OthernaNo definition available.No authoritative reference available.falsefalseRetail Pharmacy Segment | MinuteClinic within CVS Pharmacy Stores60true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information61false0cvs_NumberOfDrugstorescvsfalsenainstantThe number of drugstores operated by the entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse558558falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of drugstores operated by the entity.No authoritative reference available.falsefalseNumber of drugstores62false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse17falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Corporate Segment 1/1/2011 - 3/31/2011 USD ($) $D2011Q1_CorporateSegmentMemberhttp://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00falsefalseCorporate Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_CorporateSegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$18falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Corporate Segment 1/1/2010 - 3/31/2010 USD ($) $D2010Q1_CorporateSegmentMemberhttp://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00falsefalseCorporate Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_CorporateSegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$19falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Corporate Segment 12/31/2010 USD ($) $I2010_CorporateSegmentMemberhttp://www.sec.gov/CIK0000064803instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseCorporate Segmentus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldicvs_CorporateSegmentMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalseCorporate Segment64true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information65false0us-gaap_OperatingIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-147000000-147000000falsefalsefalsefalsefalse2truefalsefalse-135000000-135000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No authoritative reference available.falsefalseOperating profit (loss)66false0us-gaap_Assetsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse18940000001894000000falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3truefalsefalse14390000001439000000falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 12 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Topic 210 -SubTopic 10 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 -Section S99 -Name Accounting Standards Codification -Publisher FASB -Paragraph 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseTotal assets67false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosuresegmentreportingdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse20falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Intersegment Eliminations 1/1/2011 - 3/31/2011 USD ($) $D2011Q1_BusinessIntersegmentEliminationsMemberhttp://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00falsefalseIntersegment Eliminationsus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_BusinessIntersegmentEliminationsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$21falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Intersegment Eliminations 1/1/2010 - 3/31/2010 USD ($) $D2010Q1_BusinessIntersegmentEliminationsMemberhttp://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00falsefalseIntersegment Eliminationsus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_BusinessIntersegmentEliminationsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$22falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Intersegment Eliminations 12/31/2010 USD ($) $I2010_BusinessIntersegmentEliminationsMemberhttp://www.sec.gov/CIK0000064803instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseIntersegment Eliminationsus-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_BusinessIntersegmentEliminationsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalseIntersegment Eliminations69true0us-gaap_SegmentReportingInformationLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseSegment reporting information70false0us-gaap_Revenuesus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-2721000000-2721000000[2]falsefalsefalsefalsefalse2truefalsefalse-2054000000-2054000000[2]falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 1 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseNet revenues71false0us-gaap_GrossProfitus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-35000000-35000000[2]falsefalsefalsefalsefalse2truefalsefalse-23000000-23000000[2]falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseGross profit72false0us-gaap_OperatingIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-35000000-35000000[2]falsefalsefalsefalsefalse2truefalsefalse-23000000-23000000[2]falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No authoritative reference available.falsefalseOperating profit (loss)73false0us-gaap_Assetsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-545000000-545000000[2]falsetruefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3truefalsefalse-451000000-451000000[2]falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 12 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Topic 210 -SubTopic 10 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 -Section S99 -Name Accounting Standards Codification -Publisher FASB -Paragraph 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseTotal assets74false0cvs_IntersegmentTransactionsNumberOfTypeOfTransactionscvsfalsenadurationNumber of type of transactions related with other operating segments of the same entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse22falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerNumber of type of transactions related with other operating segments of the same entity.No authoritative reference available.falsefalseNumber of type of transactions related to intersegment eliminations1Net revenues of the Pharmacy Services segment include approximately $1.7 billion of retail co-payments for both the three months ended March 31, 2011 and 2010.2Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services segment customers use Retail Pharmacy segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services segment customers, through the Company's intersegment activities (such as the Maintenance Choice program), elect to pick-up their maintenance prescriptions at Retail Pharmacy segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. As a result, both the Pharmacy Services and the Retail Pharmacy segments include the following results associated with this activity: net revenues of $558 million and $340 million for the three months ended March 31, 2011 and 2010, respectively, gross profit and operating profit of $35 million and $23 million for the three months ended March 31, 2011 and 2010, respectively.362Segment Reporting (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruetrue XML 36 R13.xml IDEA: Subsequent Event 2.2.0.25falsefalse1090 - Disclosure - Subsequent Eventtruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_SubsequentEventsDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseSubsequent Event3false0us-gaap_SubsequentEventsTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Note 9 Subsequent Event   On April 29, 2011, the Company acquired the Medicare prescription drug business of Universal American Corp. (the UAM Medicare Part D Business). Pursuant to the purchase agreement, the Company paid cash consideration of $1.25 billion plus $185 million (the amount of excess capital that resided in the entities that operate the UAM Medicare Part D Business), less $110 million (the amount of Universal American Corp.s outstanding trust preferred securities which are being assumed by the Company). The UAM Medicare Part D Business offers prescription drug plan benefits to Medicare beneficiaries throughout the United States through its Community CCRxSM prescription drug plan.  </td></tr></table> Note 9 Subsequent Event   On April 29, 2011, the Company acquired the Medicare prescription drug business of Universal American Corp. (thefalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.No authoritative reference available.falsefalseSubsequent Event12Subsequent EventUnKnownUnKnownUnKnownUnKnownfalsetrue XML 37 R26.xml IDEA: Commitments and Contingencies (Details) 2.2.0.25truefalse4080 - Disclosure - Commitments and Contingencies (Details)truefalsefalse1falsefalsefalsefalse10/1/2003 - 10/31/2003 D2003Q4_M10http://www.sec.gov/CIK0000064803duration2003-10-01T00:00:002003-10-31T00:00:00PureStandardhttp://www.xbrl.org/2003/instancepurexbrli02falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0us-gaap_LossContingenciesLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseLoss contingencies3false0cvs_GuaranteedStoreLeasescvsfalsenainstantRepresents the number of store leases guaranteed by the reporting entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse8383falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerRepresents the number of store leases guaranteed by the reporting entity.No authoritative reference available.falsefalseGuaranteed store leases4false0cvs_NumberOfAdjudicationPlatformsUnderInvestigationcvsfalsenadurationRepresents the number of adjudication platforms which are under investigation for allegations.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse22falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerRepresents the number of adjudication platforms which are under investigation for allegations.No authoritative reference available.falsefalseNumber of adjudication platforms under investigation5false0cvs_NumberOfPharmaciesFilingPutativeActioncvsfalsenadurationRepresents the number of independent pharmacies which have filed putative class action against the reporting entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse22falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerRepresents the number of independent pharmacies which have filed putative class action against the reporting entity.No authoritative reference available.falsefalseNumber of pharmacies filing putative action6false0cvs_NumberOfCompetitorsAgainstWhomPutativeActionsAreFiledcvsfalsenadurationRepresents the number of competitors against whom putative class action has been filed by independent pharmacies.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse22falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerRepresents the number of competitors against whom putative class action has been filed by independent pharmacies.No authoritative reference available.falsefalseNumber of competitors against whom putative actions are filed7false0cvs_NumberOfCasesTransferredToFederalCourtcvsfalsenadurationThe number of cases filed by independent pharmacies that were transferred to federal court.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse11falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerThe number of cases filed by independent pharmacies that were transferred to federal court.No authoritative reference available.falsefalseNumber of cases filed by independent pharmacies that were transferred to Illinois federal court8false0cvs_NumberOfStatesParticipatingInMultistateInvestigationscvsfalsenadurationRepresents the number of states participating in multi-state investigation under Federal Trade Commission Act.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse2424falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerRepresents the number of states participating in multi-state investigation under Federal Trade Commission Act.No authoritative reference available.falsefalseNumber of states participating in multi-state investigation9false0cvs_MinimumNumberOfAssistantStoreManagersToWhomOfferToOptForFLSACollectiveActionsIsMadecvsfalsenadurationRepresents the minimum number of current and former assistant store managers to whom notice has been issued offering them the...falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse1300013000falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerRepresents the minimum number of current and former assistant store managers to whom notice has been issued offering them the opportunity to "opt-in" to certain of the FLSA collective actions.No authoritative reference available.falsefalseMinimum number of current and former assistant store managers to whom offer is made10false0cvs_MinimumNumberOfAssistantStoreManagersElectingToParticipateInOfferToOptForFLSACollectiveActionscvsfalsenadurationRepresents the minimum number of current and former assistant store managers who have elected to participate in offer to...falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse19001900falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerRepresents the minimum number of current and former assistant store managers who have elected to participate in offer to "opt-in" to certain of the FLSA collective actions.No authoritative reference available.falsefalseMinimum number of current and former assistant store managers electing the offer11false0us-gaap_LitigationSettlementGrossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse1750000017500000falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the gross amount awarded, to be received by, or to be remitted to the entity in settlement of litigation occurring during the period.No authoritative reference available.falsefalseSettlement payment for subpoena received from OIG in connection with an investigation of possible false or otherwise improper claims for payment under the Medicare and Medicaid programs12false0cvs_LitigationSettlementNumberOfStatesInvolvedInSettlementcvsfalsenadurationRepresents number of states which are involved in litigation settlement proceedings.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse1010falsefalsefalsefalsefalseOtherxbrli:integerItemTypeintegerRepresents number of states which are involved in litigation settlement proceedings.No authoritative reference available.falsefalseNumber of states involved in litigation settlement13false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.info.cvscaremark.com/role/disclosurecommitmentsandcontingenciesdetails1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Lauriello Lawsuit 1/1/2011 - 3/31/2011 USD ($) $D2011Q1_LaurielloLawsuitMemberhttp://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00falsefalseLauriello Lawsuitus-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldicvs_LaurielloLawsuitMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalseLauriello Lawsuit14true0us-gaap_LossContingenciesLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseLoss contingencies15false0cvs_CompensatoryDamagesSoughtInLawsuitscvsfalsedebitdurationRepresents compensatory damages sought from the reporting entity in a lawsuit.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse32000000003200000000falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryRepresents compensatory damages sought from the reporting entity in a lawsuit.No authoritative reference available.falsefalseLauriello lawsuit, amount sought in compensatory damages plus other non-specified damages214Commitments and Contingencies (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruetrue XML 38 R1.xml IDEA: Condensed Consolidated Statements of Income 2.2.0.25falsefalse0010 - Statement - Condensed Consolidated Statements of IncometruefalseIn Millions, except Per Share datafalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) / shares USD ($) $D2010Q1http://www.sec.gov/CIK0000064803duration2010-01-01T00:00:002010-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$5false0us-gaap_Revenuesus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2588000000025880falsetruefalsefalsefalse2truefalsefalse2376000000023760falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 1 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseNet revenues6false0us-gaap_CostOfRevenueus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2112900000021129falsefalsefalsefalsefalse2truefalsefalse1901400000019014falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe aggregate cost of goods produced and sold and services rendered during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 2 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 falsefalseCost of revenues7false0us-gaap_GrossProfitus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse47510000004751falsefalsefalsefalsefalse2truefalsefalse47460000004746falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 truefalseGross profit8false0us-gaap_OperatingExpensesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse34400000003440falsefalsefalsefalsefalse2truefalsefalse33360000003336falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryGenerally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.No authoritative reference available.falsefalseOperating expenses9false0us-gaap_OperatingIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse13110000001311falsefalsefalsefalsefalse2truefalsefalse14100000001410falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No authoritative reference available.truefalseOperating profit10false0us-gaap_InterestIncomeExpenseNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse134000000134falsefalsefalsefalsefalse2truefalsefalse128000000128falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net amount of operating interest income (expense).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 10 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.10) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 falsefalseInterest expense, net11false0us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse11770000001177falsefalsefalsefalsefalse2truefalsefalse12820000001282falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 4 -Section 08 -Paragraph h -Subparagraph 1(i) Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 falsefalseIncome before income tax provision12false0us-gaap_IncomeTaxExpenseBenefitus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse464000000464falsefalsefalsefalsefalse2truefalsefalse510000000510falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 45 -Subparagraph a, b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690 falsefalseIncome tax provision13false0us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse713000000713falsefalsefalsefalsefalse2truefalsefalse772000000772falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, and noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683 truefalseIncome from continuing operations14false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-1000000-1falsefalsefalsefalsefalse2truefalsefalse-2000000-2falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 47 -Subparagraph c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.14) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 144 -Paragraph 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.12) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 13 -Article 7 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 15 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 falsefalseLoss from discontinued operations, net of tax15false0us-gaap_ProfitLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse712000000712falsefalsefalsefalsefalse2truefalsefalse770000000770falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A1, A4, A5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 29 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a),(c) -URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 5 -Subparagraph b -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683 truefalseNet income16false0us-gaap_NetIncomeLossAttributableToNoncontrollingInterestus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse10000001falsefalsefalsefalsefalse2truefalsefalse10000001falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe portion of net Income or Loss attributable to the noncontrolling interest (if any) deducted in order to derive the portion attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph c(1) -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A1, A4, A5 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686 falsefalseNet loss attributable to noncontrolling interest17false0us-gaap_NetIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse713000000713falsetruefalsefalsefalse2truefalsefalse771000000771falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A7 -Appendix A Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 10, 15 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph 38 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 87-21 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 19 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28, 29, 30 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 truefalseNet income attributable to CVS Caremark18true0us-gaap_EarningsPerShareBasicAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseBasic earnings per common share:19false0us-gaap_IncomeLossFromContinuingOperationsPerBasicShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse000.520.52falsefalsefalsefalsefalse2falsefalsefalse000.560.56falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 36, 37, 38 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256 falsetrueIncome from continuing operations attributable to CVS Caremark (in dollars per share)20false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00  falsefalsefalsefalsefalse2falsefalsefalse00  falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) derived from discontinued operations during the period, net of related tax effect, per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8, 9, 10, 36, 37, 38 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256 falsetrueLoss from discontinued operations attributable to CVS Caremark (in dollars per share)21false0us-gaap_EarningsPerShareBasicus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1falsefalsefalse000.520.52falsefalsefalsefalsefalse2falsefalsefalse000.560.56falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=6945512&loc=d3e4984-109258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 36, 37, 38 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256 truetrueNet income attributable to CVS Caremark (in dollars per share)22false0us-gaap_WeightedAverageNumberOfSharesOutstandingBasicus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse13620000001362falsefalsefalsefalsefalse2truefalsefalse13860000001386falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 171 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseWeighted average basic common shares outstanding (in shares)23true0us-gaap_EarningsPerShareDilutedAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseDiluted earnings per common share:24false0us-gaap_IncomeLossFromContinuingOperationsPerDilutedShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse000.520.52falsefalsefalsefalsefalse2falsefalsefalse000.550.55falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 11, 12, 36, 37, 38 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 falsetrueIncome from continuing operations attributable to CVS Caremark (in dollars per share)25false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00  falsefalsefalsefalsefalse2falsefalsefalse00  falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income or loss derived from discontinued operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section E -Paragraph Question 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsetrueLoss from discontinued operations attributable to CVS Caremark (in dollars per share)26false0us-gaap_EarningsPerShareDilutedus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1falsefalsefalse000.520.52falsefalsefalsefalsefalse2falsefalsefalse000.550.55falsefalsefalsefalsefalseEPSnum:perShareItemTypenaThe amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 11, 12, 36 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 20 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 7 -Paragraph 18 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. truetrueNet income attributable to CVS Caremark (in dollars per share)27false0us-gaap_WeightedAverageNumberOfDilutedSharesOutstandingus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse13710000001371falsefalsefalsefalsefalse2truefalsefalse13960000001396falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1505-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number 07-4 -Paragraph 4 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 40 -Subparagraph a -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 128 -Paragraph 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 falsefalseWeighted average diluted common shares outstanding (in shares)28false0us-gaap_CommonStockDividendsPerShareDeclaredus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse000.12500.1250falsefalsefalsefalsefalse2falsefalsefalse000.08750.0875falsefalsefalsefalsefalseEPSnum:perShareItemTypenaAggregate dividends declared during the period for each share of common stock outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 falsetrueDividends declared per common share (in dollars per share)224Condensed Consolidated Statements of Income (USD $)MillionsMillionsNoRoundingUnKnownfalsetrue XML 39 R2.xml IDEA: Condensed Consolidated Balance Sheets 2.2.0.25falsefalse0020 - Statement - Condensed Consolidated Balance SheetstruefalseIn Millionsfalse1falsefalseUSDfalsefalse3/31/2011 USD ($) USD ($) / shares $I2011Q1http://www.sec.gov/CIK0000064803instant2011-03-31T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse12/31/2010 USD ($) USD ($) / shares $I2010http://www.sec.gov/CIK0000064803instant2010-12-31T00:00:000001-01-01T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$5true0us-gaap_AssetsAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseAssets:6false0us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse21620000002162falsetruefalsefalsefalse2truefalsefalse14270000001427falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryIncludes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7 -Footnote 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 7, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 falsefalseCash and cash equivalents7false0us-gaap_ShortTermInvestmentsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse60000006falsefalsefalsefalsefalse2truefalsefalse40000004falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryInvestments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 1 -Subparagraph g Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.2) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseShort-term investments8false0us-gaap_AccountsReceivableNetCurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse53480000005348falsefalsefalsefalsefalse2truefalsefalse49250000004925falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a(1) -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3-4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseAccounts receivable, net9false0us-gaap_InventoryNetus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1018100000010181falsefalsefalsefalsefalse2truefalsefalse1069500000010695falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 falsefalseInventories10false0us-gaap_DeferredTaxAssetsNetCurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse509000000509falsefalsefalsefalsefalse2truefalsefalse511000000511falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference. An unrecognized tax benefit that is directly related to a position taken in a tax year that results in a net operating loss carryforward is presented as a reduction of the related deferred tax asset.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31928-109318 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42, 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31958-109318 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31917-109318 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31931-109318 falsefalseDeferred income taxes11false0us-gaap_OtherAssetsCurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse174000000174falsefalsefalsefalsefalse2truefalsefalse144000000144falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.8) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseOther current assets12false0us-gaap_AssetsCurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse1838000000018380falsefalsefalsefalsefalse2truefalsefalse1770600000017706falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Section 45 -SubTopic 10 -Topic 210 -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 -Publisher FASB -Name Accounting Standards Codification -Paragraph 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 9 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.9) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765 truefalseTotal current assets13false0us-gaap_PropertyPlantAndEquipmentNetus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse83500000008350falsefalsefalsefalsefalse2truefalsefalse83220000008322falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 8 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 12 -Paragraph 5 -Subparagraph b, c -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 falsefalseProperty and equipment, net14false0us-gaap_Goodwillus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2566600000025666falsefalsefalsefalsefalse2truefalsefalse2566900000025669falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 45 -Subparagraph e -Clause 1 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 43 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 68 -Subparagraph l -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 45 -Subparagraph e -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 34 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 141R -Paragraph 72 -Subparagraph d -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseGoodwill15false0us-gaap_IntangibleAssetsNetExcludingGoodwillus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse96920000009692falsefalsefalsefalsefalse2truefalsefalse97840000009784falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 142 -Paragraph 42, 45 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph ((a)(1),(b)) -URI http://asc.fasb.org/extlink&oid=6905858&loc=d3e16323-109275 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274 falsefalseIntangible assets, net16false0us-gaap_OtherAssetsNoncurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse740000000740falsefalsefalsefalsefalse2truefalsefalse688000000688falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseOther assets17false0us-gaap_Assetsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse6282800000062828falsefalsefalsefalsefalse2truefalsefalse6216900000062169falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 12 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Topic 210 -SubTopic 10 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 -Section S99 -Name Accounting Standards Codification -Publisher FASB -Paragraph 1 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Concepts (CON) -Number 6 -Paragraph 25 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 truefalseTotal assets18true0us-gaap_LiabilitiesAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseLiabilities:19false0us-gaap_AccountsPayableCurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse43540000004354falsefalsefalsefalsefalse2truefalsefalse40260000004026falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseAccounts payable20false0cvs_ClaimsAndDiscountsPayablecvsfalsecreditinstantCarrying value as of the balance sheet date of claims and discounts payable.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse27760000002776falsefalsefalsefalsefalse2truefalsefalse25690000002569falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of claims and discounts payable.No authoritative reference available.falsefalseClaims and discounts payable21false0us-gaap_AccruedLiabilitiesCurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse32290000003229falsefalsefalsefalsefalse2truefalsefalse30700000003070falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseAccrued expenses22false0us-gaap_ShortTermBorrowingsus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse300000000300falsefalsefalsefalsefalse2truefalsefalse300000000300falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryReflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.13) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.(a),16(a)(1)) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 13 -Article 9 -Subparagraph 2, 3 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 16 -Subparagraph a(1) falsefalseShort-term debt23false0us-gaap_LongTermDebtCurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse806000000806falsefalsefalsefalsefalse2truefalsefalse11050000001105falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal of the portions of the carrying amounts as of the balance sheet date of long-term debt, which may include notes payable, bonds payable, debentures, mortgage loans, and commercial paper, which are scheduled to be repaid within one year or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseCurrent portion of long-term debt24false0us-gaap_LiabilitiesCurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse1146500000011465falsefalsefalsefalsefalse2truefalsefalse1107000000011070falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 truefalseTotal current liabilities25false0us-gaap_LongTermDebtNoncurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse86690000008669falsefalsefalsefalsefalse2truefalsefalse86520000008652falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseLong-term debt26false0us-gaap_DeferredTaxLiabilitiesNoncurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse37100000003710falsefalsefalsefalsefalse2truefalsefalse36550000003655falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryRepresents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise separates deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets are classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, are classified according to the expected reversal date of the temporary difference.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31958-109318 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 109 -Paragraph 41, 42 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31917-109318 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6907571&loc=d3e31931-109318 falsefalseDeferred income taxes27false0us-gaap_OtherLiabilitiesNoncurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse10320000001032falsefalsefalsefalsefalse2truefalsefalse10580000001058falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 24 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseOther long-term liabilities28false0us-gaap_CommitmentsAndContingenciesus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00  falsefalsefalsefalsefalse2falsefalsefalse00  falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryRepresents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.17) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 17 -Article 9 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 19 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 25 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.(a),19) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14326-108349 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 5 -Paragraph 8, 9 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseCommitments and contingencies (Note 8)29false0us-gaap_TemporaryEquityCarryingAmountus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse3300000033falsefalsefalsefalsefalse2truefalsefalse3400000034falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe carrying value (book value) of an entity's issued and outstanding stock which is not included within permanent equity in Stockholders Equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.27(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Emerging Issues Task Force (EITF) -Number D-98 -Paragraph 2 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 4 -Section 08 -Paragraph i Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 28 -Subparagraph a -Article 5 falsefalseRedeemable noncontrolling interest30true0us-gaap_StockholdersEquityAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseShareholders' equity:31false0us-gaap_PreferredStockValueus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00  falsefalsefalsefalsefalse2falsefalsefalse00  falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 129 -Paragraph 2, 3, 4, 5, 6, 7, 8 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 02 -Paragraph 29 falsefalsePreferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding32false0us-gaap_CommonStockValueus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse1600000016falsefalsefalsefalsefalse2truefalsefalse1600000016falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseCommon stock, par value $0.01: 3,200 shares authorized; 1,627 shares issued and 1,354 shares outstanding at March 31, 2011 and 1,624 shares issued and 1,363 shares outstanding at December 31, 201033false0us-gaap_TreasuryStockValueus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-9449000000-9449falsefalsefalsefalsefalse2truefalsefalse-9030000000-9030falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Technical Bulletin (FTB) -Number 85-6 -Paragraph 3 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656 falsefalseTreasury stock, at cost: 271 shares at March 31, 2011 and 259 shares at December 31, 201034false0us-gaap_CommonStockSharesHeldInEmployeeTrustus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegatedlabel1truefalsefalse-56000000-56falsefalsefalsefalsefalse2truefalsefalse-56000000-56falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryValue of additional series of common stock issued to a trust (for example, a 'rabbi trust') set up specifically to accumulate stock for the sole purpose of distribution to participating employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 93-6 -Paragraph 14 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 25 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6418455&loc=d3e16701-113920 falsefalseShares held in trust: 2 shares at March 31, 2011 and December 31, 201035false0us-gaap_AdditionalPaidInCapitalus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2770600000027706falsefalsefalsefalsefalse2truefalsefalse2761000000027610falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryExcess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.30(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 falsefalseCapital surplus36false0us-gaap_RetainedEarningsAccumulatedDeficitus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1984500000019845falsefalsefalsefalsefalse2truefalsefalse1930300000019303falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cumulative amount of the reporting entity's undistributed earnings or deficit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 falsefalseRetained earnings37false0us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-143000000-143falsefalsefalsefalsefalse2truefalsefalse-143000000-143falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAccumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 130 -Paragraph 14, 17, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name FASB Staff Position (FSP) -Number FAS115-1/124-1 -Paragraph 15D -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14 -URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e681-108580 falsefalseAccumulated other comprehensive loss38false0us-gaap_StockholdersEquityus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse3791900000037919falsefalsefalsefalsefalse2truefalsefalse3770000000037700falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 51 -Paragraph A3 -Appendix A Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707 truefalseTotal shareholders' equity39false0us-gaap_LiabilitiesAndStockholdersEquityus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse6282800000062828falsetruefalsefalsefalse2truefalsefalse6216900000062169falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 7 -Section 03 -Paragraph 25 truefalseTotal liabilities and shareholders' equity235Condensed Consolidated Balance Sheets (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue XML 40 FilingSummary.xml IDEA: XBRL DOCUMENT 2.2.0.25 true Sheet 0010 - Statement - Condensed Consolidated Statements of Income Condensed Consolidated Statements of Income http://www.info.cvscaremark.com/role/StatementOfIncome false R1.xml false Sheet 0020 - Statement - Condensed Consolidated Balance Sheets Condensed Consolidated Balance Sheets http://www.info.cvscaremark.com/role/BalanceSheet false R2.xml false Sheet 0025 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Condensed Consolidated Balance Sheets (Parenthetical) http://www.info.cvscaremark.com/role/BalanceSheetParenthetical false R3.xml false Sheet 0030 - Statement - Condensed Consolidated Statements of Cash Flows Condensed Consolidated Statements of Cash Flows http://www.info.cvscaremark.com/role/CashFlows false R4.xml false Sheet 1010 - Disclosure - Accounting Policies Accounting Policies http://www.info.cvscaremark.com/role/DisclosureAccountingPolicies false R5.xml false Sheet 1020 - Disclosure - Discontinued Operations Discontinued Operations http://www.info.cvscaremark.com/role/DisclosureDiscontinuedOperations false R6.xml false Sheet 1030 - Disclosure - Segment Reporting Segment Reporting http://www.info.cvscaremark.com/role/DisclosureSegmentReporting false R7.xml false Sheet 1040 - Disclosure - Comprehensive Income Comprehensive Income http://www.info.cvscaremark.com/role/DisclosureComprehensiveIncome false R8.xml false Sheet 1050 - Disclosure - Interest Expense Interest Expense http://www.info.cvscaremark.com/role/DisclosureInterestExpense false R9.xml false Sheet 1060 - Disclosure - Earnings Per Share Earnings Per Share http://www.info.cvscaremark.com/role/DisclosureEarningsPerShare false R10.xml false Sheet 1070 - Disclosure - Share Repurchase Program Share Repurchase Program http://www.info.cvscaremark.com/role/DisclosureShareRepurchaseProgram false R11.xml false Sheet 1080 - Disclosure - Commitments and Contingencies Commitments and Contingencies http://www.info.cvscaremark.com/role/DisclosureCommitmentsAndContingencies false R12.xml false Sheet 1090 - Disclosure - Subsequent Event Subsequent Event http://www.info.cvscaremark.com/role/DisclosureSubsequentEvent false R13.xml false Sheet 2010 - Disclosure - Accounting Policies (Policies) Accounting Policies (Policies) http://www.info.cvscaremark.com/role/DisclosureAccountingPoliciesPolicies false R14.xml false Sheet 3030 - Disclosure - Segment Reporting (Tables) Segment Reporting (Tables) http://www.info.cvscaremark.com/role/DisclosureSegmentReportingTables false R15.xml false Sheet 3040 - Disclosure - Comprehensive Income (Tables) Comprehensive Income (Tables) http://www.info.cvscaremark.com/role/DisclosureComprehensiveIncomeTables false R16.xml false Sheet 3050 - Disclosure - Interest Expense (Tables) Interest Expense (Tables) http://www.info.cvscaremark.com/role/DisclosureInterestExpenseTables false R17.xml false Sheet 3060 - Disclosure - Earnings Per Share (Tables) Earnings Per Share (Tables) http://www.info.cvscaremark.com/role/DisclosureEarningsPerShareTables false R18.xml false Sheet 4010 - Disclosure - Accounting Policies (Details) Accounting Policies (Details) http://www.info.cvscaremark.com/role/DisclosureAccountingPoliciesDetails false R19.xml false Sheet 4020 - Disclosure - Discontinued Operations (Details) Discontinued Operations (Details) http://www.info.cvscaremark.com/role/DisclosureDiscontinuedOperationsDetails false R20.xml false Sheet 4030 - Disclosure - Segment Reporting (Details) Segment Reporting (Details) http://www.info.cvscaremark.com/role/DisclosureSegmentReportingDetails false R21.xml false Sheet 4040 - Disclosure - Comprehensive Income (Details) Comprehensive Income (Details) http://www.info.cvscaremark.com/role/DisclosureComprehensiveIncomeDetails false R22.xml false Sheet 4050 - Disclosure - Interest Expense (Details) Interest Expense (Details) http://www.info.cvscaremark.com/role/DisclosureInterestExpenseDetails false R23.xml false Sheet 4060 - Disclosure - Earnings Per Share (Details) Earnings Per Share (Details) http://www.info.cvscaremark.com/role/DisclosureEarningsPerShareDetails false R24.xml false Sheet 4070 - Disclosure - Share Repurchase Programs (Details) Share Repurchase Programs (Details) http://www.info.cvscaremark.com/role/DisclosureShareRepurchaseProgramsDetails false R25.xml false Sheet 4080 - Disclosure - Commitments and Contingencies (Details) Commitments and Contingencies (Details) http://www.info.cvscaremark.com/role/DisclosureCommitmentsAndContingenciesDetails false R26.xml false Sheet 4090 - Disclosure - Subsequent Event (Details) Subsequent Event (Details) http://www.info.cvscaremark.com/role/DisclosureSubsequentEventDetails false R27.xml false Sheet 9999 - Document - Document and Entity Information Document and Entity Information http://www.info.cvscaremark.com/role/DocumentAndEntityInformation false R28.xml false Book All Reports All Reports false 1 36 15 0 4 164 true false I2011Q1SO 1 D2010Q1_CorporateSegmentMember 1 D2011Q1 96 D2010Q1_RetailPharmacySegmentMember 5 I2011Q1_SpecialtyStoresMember_RetailPharmacySegmentMember 1 I2011Q1_InterestRateSwapMember 1 D2010Q1 64 I2009 1 I2011Q1_MinuteClinicMember_RetailPharmacySegmentMember 1 I2010_CorporateSegmentMember 1 I2011Q1_BusinessIntersegmentEliminationsMember 1 D2011Q1_RetailPharmacySegmentMember 5 D2011Q1_LaurielloLawsuitMember 1 I2010_BusinessIntersegmentEliminationsMember 1 D2010Q1_PharmacyServicesSegmentMember 6 D2010Q2_M06_RepurchaseProgram2010Member 1 I2011Q1 45 I2010_PharmacyServicesSegmentMember 2 I2010 42 D2011Q1_PharmacyServicesSegmentMember 6 D2011Q1_BusinessIntersegmentEliminationsMember 4 I2011Q1_MinuteClinicWithinCVSPharmacyStoresMember_RetailPharmacySegmentMember 1 I2011Q1_MedicarePrescriptionDrugBusinessMember_AcquisitionMember 3 I2011Q1_MailServiceMember_PharmacyServicesSegmentMember 1 D2003Q4_M10 2 I2010Q1 1 I2010_RetailPharmacySegmentMember 2 D2011Q1_CorporateSegmentMember 1 I2011Q1_PharmacyServicesSegmentMember 3 I2011Q1_CorporateSegmentMember 1 D2011Q1_2M_RepurchaseProgram2010Member 2 D2010Q1_BusinessIntersegmentEliminationsMember 3 I2011Q1_RetailPharmacySegmentMember 4 I2011Q1_SpecialtyStoresMember_PharmacyServicesSegmentMember 1 I2011Q1_SpecialtyMailOrderMember_PharmacyServicesSegmentMember 1 I2011Q1_PharmacyAndOnlineWebsiteMember_RetailPharmacySegmentMember 1 true true EXCEL 41 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C.&0X8F$S-5]F,C(V7S1A83-?860V,%\V.#=D M,60Q9#'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;7!R96AE;G-I=F5?26YC;VUE/"]X.DYA;64^#0H@ M("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-H87)E7U)E<'5R8VAA#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG M96YC:65S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C8V]U;G1I;F=?4&]L:6-I97-?4&]L:6-I97,\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K'!E;G-E7U1A M8FQE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5A M#I7;W)K M#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E9VUE;G1?4F5P;W)T:6YG7T1E=&%I;',\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]# M;VYT:6YG96YC:65S7SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U8G-E<75E;G1?179E;G1?1&5T86EL#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D1O8W5M96YT7V%N9%]%;G1I='E? M26YF;W)M871I;SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C M=%-T#I0#I0 M#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T* M("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I M=&@@36EC'1087)T7V,X9#AB83,U7V8R,C9? M-&%A,U]A9#8P7S8X-V0Q9#%D-S@U-@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL M93HO+R]#.B]C.&0X8F$S-5]F,C(V7S1A83-?860V,%\V.#=D,60Q9#'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'!E;G-E M#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^,"XU M-CQS<&%N/CPO'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,"XU-3QS<&%N/CPO'0^)FYB M'0^)FYB'0^,"XQ M,C4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,"XP.#3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]C.&0X8F$S-5]F,C(V7S1A83-?860V,%\V.#=D,60Q9#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$F5D.R!N;VYE(&ES'0^)FYB'0^)FYB2!S=&]C:RP@870@8V]S=#H@,C3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C$\'0^,"XP,3QS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!A;F0@<')E65E2!O<&5R871I;F<@86-T:79I=&EE2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M/B@S,#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S6UE;G1S(&]F(&QO;F&5R8VES92!O9B!S=&]C:R!O M<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#<\"!B96YE9FET'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$F%T:6]N/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-S0\&5S(&%N9"!O=&AE'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4@86YD(&-L86EM6%B;&4\+W1D/@T* M("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\ M<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\8CX\9F]N="!S='EL M93TS1"=&3TY4+5=%24=(5#H@8F]L9#L@1D].5"U325I%.B`Q,G!T.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,SY.;W1E(#$@)B,Q M-3`[($%C8V]U;G1I;F<@4&]L:6-I97,\+V9O;G0^/"]B/CPO<#X-"CQP('-T M>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQB/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M5T5) M1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI M8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@2!B96QI979E&AI8FET)FYB2!O M9B!N;W)M86P@65AF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL M93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!C;VYD96YS960@8V]N6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQB/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M5T5)1TA4.B!B M;VQD.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS M1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E1H92!#;VUP86YY('5T:6QI>F5S('1H92!T:')E92UL979E;"!V86QU M871I;VX@:&EE2!IF4],T0R/B8C,38W.SQF;VYT('-T>6QE/3-$)T9/ M3E0Z(#=P="!4:6UEF4],T0Q/B9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`\+V9O;G0^ M/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@2!T;R!A8V-E6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0@,"XR-6EN.R!415A4+4E.1$5.5#H@+3`N,C5I;B<^/&9O M;G0@F4],T0R/DQE M=F5L(#(@)B,Q-3`[($EN<'5T2P@9F]R('-U8G-T86YT:6%L M;'D@=&AE(&9U;&P@=&5R;2!O9B!T:&4@:6YS=')U;65N="X\+V9O;G0^/"]P M/@T*/'`@F4],T0R/B8C,38W.SQF;VYT('-T>6QE M/3-$)T9/3E0Z(#=P="!4:6UEF4],T0Q/B9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R`\ M+V9O;G0^/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@ M6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6%B;&4@86YD('-H;W)T M+71E2!M87)K M970@9G5N9',L(&-O;6UE2!A28C,30V.W,@2P@87,@;V8@36%R8V@F;F)S M<#LS,2P@,C`Q,2X@5&AE(&9A:7(@=F%L=64@;V8@=&AE($-O;7!A;GDF(S$T M-CMS('1O=&%L(&QO;F6EN9R!A;6]U;G0@86YD(&5S=&EM871E9"!F M86ER('9A;'5E(&]F('1H92!#;VUP86YY)B,Q-#8[6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQB/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M5T5) M1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI M8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL M93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!#;VUP86YY(&ES(&5X<&]S960@=&\@:6YT97)E'!O2!I;B!F=71U6EN9R!F;W)E8V%S=&5D(&1E8G0N(%1H92!H961G97,@87)E(&5X M<&5C=&5D('1O(&)E(&AI9VAL>2!E9F9E8W1I=F4[('1H97)E9F]R92P@;F\@ M:6YE9F9E8W1I=F5N97-S('=AF5D(&EN(&5A6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;B<@7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAAF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^ M#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN(&-O;FYE8W1I;VX@=VET:"!C97)T86EN(&)U M2!R971A:6YE9"!G=6%R86YT965S(&]N('-T M;W)E(&QE87-E(&]B;&EG871I;VYS(&9O2!P971I=&EO;G,@=6YD97(@ M0VAA<'1E2!#;W5R="!F;W(@ M=&AE($1I28C,30V.W,@ M;&]S"!B96YE9FET*2!O9B!L M96%S92UR96QA=&5D(&-O65A6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@ M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^ M#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!#;VUP86YY(&AA2!A;F0@0V]R M<&]R871E+B!4:&4@0V]M<&%N>28C,30V.W,@2!T:&4@0V]M<&%N>28C,30V.W,@8VAI968@;W!E2!397)V:6-E2!E=F%L=6%T97,@=&AE('!EF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\ M<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!0:&%R;6%C>2!397)V:6-E2!B96YE9FET(&UA;F%G M96UE;G0@*"8C,30W.U!"328C,30X.RD@2!P:&%R;6%C M>2!S97)V:6-EF%T:6]NF4],T0Q M/B8C,3F4],T0R/BP@0V%R96UAF4],T0Q/B8C,3F4],T0R/BP@0U93($-A$%M M97)I8V$\+V9O;G0^/&9O;G0@F4],T0Q/B8C,3F4] M,T0R/BP@06-C;W)D86YT/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@-BXU<'0[(%!/4TE424]..B!R96QA=&EV93L@5$]0.B`M,W!T)R!S:7IE M/3-$,3XF(S$W-#L\+V9O;G0^/&9O;G0@F4],T0Q/B8C,3F4],T0R/B9N8G-P.VYA;65S+B9N M8G-P.R!!F4],T0Q/B8C,3F4],T0R/B9N8G-P.V%N9"!,;VYG6QE/3-$)T9/3E0M4TE:13H@-BXU<'0[(%!/4TE424]. M.B!R96QA=&EV93L@5$]0.B`M,W!T)R!S:7IE/3-$,3XF(S$W-#L\+V9O;G0^ M/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@-BXU<'0[(%!/4TE424]. M.B!R96QA=&EV93L@5$]0.B`M,W!T)R!S:7IE/3-$,3XF(S$W-#L\+V9O;G0^ M/&9O;G0@2P@=&AE(&]N;&EN92!R M971A:6P@=V5B2!U;F1EF4],T0Q/B8C,3F4],T0R/B9N8G-P.VYA;64L M(&]F('=H:6-H(#4U."!A7-I M8VEA;B!A2X@5&AE($-OF4],T0R/B9N M8G-P.SPO9F]N=#X\+W`^#0H\=&%B;&4@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T9/3E0M4TE:13H@-G!T.R!03U-)5$E/3CH@ M6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,7!T M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[ M(%1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ MF4],T0Q/B@R*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)T)/4D1%4BU224=(5#H@;65D M:75M(&YO;F4[(%!!1$1)3D'0@,7!T M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@8V]L6QE/3-$)T9/ M3E0M4TE:13H@.2XU<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-O;G-O;&ED871E9#QB6QE/3-$)T)/4D1%4BU224=(5#H@;65D:75M(&YO M;F4[(%!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O M;G0^/"]P/CPO=&0^/"]T6QE/3-$)U!!1$1)3DF4],T0R/B9N M8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQB/CQF;VYT('-T>6QE M/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#%P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$ M)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQB/CQF;VYT M('-T>6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#%P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R M/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQB/CQF;VYT('-T>6QE/3-$)T9/3E0M5T5)1TA4 M.B!B;VQD.R!&3TY4+5-)6D4Z(#%P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;B<@F4],T0R/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQB/CQF;VYT('-T>6QE/3-$)T9/3E0M M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#%P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;B<@6QE/3-$)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/B9N M8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^/"]T6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4] M,T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3DF4],T0R/B8C,3DP.SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.2XU<'0[ M($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)TU!4D=)3CH@,&EN(#`N,#5I;B`P<'0@,&EN.R!415A4+4%,24=..B!R M:6=H="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#DN-7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXR-2PX.#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO M9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0@,S,N,35P=#L@5$585"U)3D1%3E0Z("TQ,"XQ<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.2XU<'0[($9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D=R;W-S('!R;V9I=#PO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,35I;B`P<'0@,&EN.R!415A4+4%,24=. M.B!R:6=H="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#DN-7!T.R<@6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,#5I;B`P<'0@,&EN.R!415A4+4%,24=. M.B!R:6=H="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#DN-7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXT+#6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,35I M;B`P<'0@,&EN.R!415A4+4%,24=..B!R:6=H="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#DN-7!T.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ+#`Y-CPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,35I;B`P<'0@,&EN.R!415A4+4%, M24=..B!R:6=H="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#DN-7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXH,S4\+V9O;G0^/&9O;G0@F4],T0R M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N M=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0@,C!P=#L@5$585"U)3D1%3E0Z("TQ,'!T)SX\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#DN-7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY-87)C:"9N8G-P.S,Q+"`R,#$P.B`\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,6EN(#!P="`P:6X[(%1% M6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#`N,6EN(#!P="`P:6X[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0@,S,N,35P=#L@5$58 M5"U)3D1%3E0Z("TQ,"XQ<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M.2XU<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/DYE="!R979E;G5EF4],T0R/B9N M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5)) M1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#`N,35I;B`P<'0@,&EN.R!415A4+4%,24=..B!R:6=H M="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#DN M-7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW M.#(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)T9/3E0M4TE:13H@.2XU<'0G('-I>F4],T0R/BD\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^/"]TF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#`N,6EN(#!P="`P:6X[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.2XU<'0[($9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B@Q,S4I/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,#5I;B`P<'0@ M,&EN.R!415A4+4%,24=..B!R:6=H="<@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#DN-7!T.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXQ+#0Q,#PO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,6EN M(#!P="`P:6X[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4] M,T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,6EN(#!P="`P:6X[(%1%6%0M04Q)1TXZ M(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T M9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0@ M,C!P=#L@5$585"U)3D1%3E0Z("TQ,'!T)SX\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#DN-7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY-87)C:"9N8G-P.S,Q+"`R,#$Q/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@.2XU<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R0\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#`N,35I M;B`P<'0@,&EN.R!415A4+4%,24=..B!R:6=H="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#DN-7!T.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXH-30U*3PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#`N,35I;B`P<'0@,&EN.R!415A4+4%,24=..B!R:6=H="<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#DN-7!T.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR."PY,C<\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,6EN M(#!P="`P:6X[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,6EN(#!P="`P:6X[(%1%6%0M04Q)1TXZ M(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,#5I M;B`P<'0@,&EN.R!415A4+4%,24=..B!R:6=H="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#%P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;B<@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^/"]TF4],T0R M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!! M1$1)3DF4],T0R/B9N8G-P.SPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P M:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,35I;B`P<'0@,&EN M.R!415A4+4%,24=..B!R:6=H="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#DN-7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXV+#@P,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#`N,FEN(#!P="`P:6X[ M(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE M/3-$)V9O;G0M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@-G!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/@T*/'`@6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XH,2D\+V9O;G0^/&9O M;G0@F4],T0Q/B9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R`\+V9O;G0^/&9O;G0@F4] M,T0Q/DYE="!R979E;G5E6UE;G1S M(&9O2X\+V9O;G0^/"]P/@T*/'`@6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XH,BD\+V9O;G0^ M/&9O;G0@F4],T0Q/B9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R`\+V9O;G0^/&9O;G0@F4],T0Q/DEN=&5R7!E2!S96=M96YT M('-T;W)E2!397)V:6-E2!S96=M96YT2!397)V:6-E2!S96=M96YT3H@;F5T(')E=F5N=65S(&]F M("9N8G-P.R0U-3@@;6EL;&EO;B!A;F0@)FYB2P@9W)O6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0@,"XU:6X[(%1% M6%0M24Y$14Y4.B`M,"XR-6EN)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^#0H\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'1A8FQE('-T>6QE/3-$)V9O;G0M3HG5&EM97,@3F5W(%)O;6%N)RQT:6UE6QE M/3-$)U=)1%1(.B`X,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+5))1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4Q%1E0Z(#!I;CL@4$%$1$E.1RU"3U143TTZ(#!I;CL@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!724142#H@,S(N,R4[(%!!1$1)3D'0@,7!T('-O;&ED M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S,B4@8V]L6QE/3-$)T9/3E0M4TE: M13H@.7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3Y4:')E92!-;VYT:',@16YD960@36%R8V@F;F)S<#LS,2P\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ XML 42 R25.xml IDEA: Share Repurchase Programs (Details) 2.2.0.25truefalse4070 - Disclosure - Share Repurchase Programs (Details)truefalseShare data in Millionsfalse1falsefalseUSDtruefalse{cvs_ShareRepurchasesByPlanAxis} : 2010 Repurchase Program 6/1/2010 - 6/30/2010 USD ($) $D2010Q2_M06_RepurchaseProgram2010Memberhttp://www.sec.gov/CIK0000064803duration2010-06-01T00:00:002010-06-30T00:00:00falsefalse2010 Repurchase Programcvs_ShareRepurchasesByPlanAxisxbrldihttp://xbrl.org/2006/xbrldicvs_RepurchaseProgram2010Membercvs_ShareRepurchasesByPlanAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2falsefalseUSDtruefalse{cvs_ShareRepurchasesByPlanAxis} : 2010 Repurchase Program 2/1/2011 - 3/31/2011 USD ($) $D2011Q1_2M_RepurchaseProgram2010Memberhttp://www.sec.gov/CIK0000064803duration2011-02-01T00:00:002011-03-31T00:00:00falsefalse2010 Repurchase Programcvs_ShareRepurchasesByPlanAxisxbrldihttp://xbrl.org/2006/xbrldicvs_RepurchaseProgram2010Membercvs_ShareRepurchasesByPlanAxisexplicitMemberSharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2true0cvs_ShareRepurchasesLineItemscvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseShare repurchase program3false0us-gaap_StockRepurchaseProgramAuthorizedAmountus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse20000000002000000000falsetruefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount authorized by an entity's Board of Directors under a stock repurchase plan.No authoritative reference available.falsefalseMaximum authorization under share repurchase program4false0us-gaap_StockRepurchasedDuringPeriodSharesus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse1420000014.2falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesNumber of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 1 -Section B -Paragraph 11A -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseRepurchase of common stock (in shares)5false0us-gaap_StockRepurchasedDuringPeriodValueus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse467000000467000000falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryEquity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 12 -Paragraph 10 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Research Bulletin (ARB) -Number 43 -Chapter 1 -Section B -Paragraph 11A -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. falsefalseRepurchase of common stock24Share Repurchase Programs (Details) (2010 Repurchase Program, USD $)NoRoundingHundredThousandsUnKnownUnKnownfalsetrue XML 43 R7.xml IDEA: Segment Reporting 2.2.0.25falsefalse1030 - Disclosure - Segment Reportingtruefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_SegmentReportingDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseSegment Reporting3false0us-gaap_SegmentReportingDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> Note 3 Segment Reporting   The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate. The Companys segments maintain separate financial information for which operating results are evaluated on a regular basis by the Companys chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company evaluates its Pharmacy Services and Retail Pharmacy segments performance based on net revenue, gross profit and operating profit before the effect of nonrecurring charges and gains and certain intersegment activities. The Company evaluates the performance of its Corporate segment based on operating expenses before the effect of nonrecurring charges and gains and certain intersegment activities.   The Pharmacy Services segment provides a full range of pharmacy benefit management (PBM) services including mail order pharmacy services, specialty pharmacy services, plan design consultation and administration, formulary management and claims processing. The Companys customers are primarily employers, insurance companies, unions, government employee groups, managed care organizations, other sponsors of health benefit plans and individuals throughout the United States. In addition, through our SilverScript Insurance Company and Accendo Insurance Company subsidiaries, we are a national provider of drug benefits to eligible beneficiaries under the Federal Governments Medicare Part D program. The Pharmacy Services business operates under the CVS Caremark Pharmacy Services®, Caremark®, CVS Caremark, CarePlus CVS/pharmacy, CarePlus, RxAmerica®, Accordant® and TheraCom® names.  As of March 31, 2011, the Pharmacy Services segment operated 33 retail specialty pharmacy stores, 18 specialty mail order pharmacies and four mail service pharmacies located in 25 states, Puerto Rico and the District of Columbia.   The Retail Pharmacy segment sells prescription drugs and a wide assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, photo finishing, seasonal merchandise, greeting cards and convenience foods through our CVS/pharmacy® and Longs Drug® retail stores and online through CVS.com®. As of March 31, 2011, the Retail Pharmacy segment included 7,226 retail drugstores, of which 7,170 operated a pharmacy, the online retail website, CVS.com, 33 specialty retail pharmacies and 568 retail health care clinics. The retail drugstores are located in 41 states, Puerto Rico and the District of Columbia operating primarily under the CVS/pharmacy or Longs Drug names. The retail health care clinics operate under the MinuteClinic® name, of which 558 are located within CVS/pharmacy stores. MinuteClinics utilize nationally recognized medical protocols to diagnose and treat minor health conditions, perform health screenings, monitor chronic conditions and deliver vaccinations. The clinics are staffed by board-certified nurse practitioners and physician assistants who provide access to affordable care without appointment.   The Corporate segment provides management and administrative services to support the Company. The Corporate segment consists of certain aspects of our executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments.   <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="bottom" width="22%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Pharmacy Services Segment(1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Retail Pharmacy Segment</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Corporate Segment</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Intersegment Eliminations(2)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> Consolidated Totals</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.5%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Three Months Ended</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="12%" colspan="2">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.5%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Net revenues</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 14,014</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 14,587</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> (2,721)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 25,880</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Gross profit</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 639</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,147</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (35)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,751</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Operating profit (loss)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 397</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,096</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (147)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (35)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,311</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2010: </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Net revenues</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 11,836</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 13,978</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (2,054)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 23,760</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Gross profit</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 782</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 3,987</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (23)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 4,746</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Operating profit (loss)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 538</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,030</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (135)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (23)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,410</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Total assets:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 32,565</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 28,914</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> 1,894</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> (545)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 62,828</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> December 31, 2010</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 32,254</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 28,927</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 1,439</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> (451)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 62,169</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> Goodwill:</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> March 31, 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.48%; PADDING-TOP: 0in" valign="bottom" width="9%"> 18,866</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.14%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 9.36%; PADDING-TOP: 0in" valign="bottom" width="9%"> 6,800</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.02%; PADDING-TOP: 0in" valign="bottom" width="4%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.46%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.68%; PADDING-TOP: 0in" valign="bottom" width="3%">    $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.82%; PADDING-TOP: 0in" valign="bottom" width="8%"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.46%; PADDING-TOP: 0in" valign="bottom" width="3%">     $</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 8.54%; PADDING-TOP: 0in" valign="bottom" width="8%"> 25,666</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 22.34%; PADDING-TOP: 0in" valign="top" width="22%"> December 31, 2010</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 18,868</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 6,801</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.48%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.5%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> ¾</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.84%; PADDING-TOP: 0in" valign="bottom" width="2%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> 25,669</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.5%; PADDING-TOP: 0in" valign="bottom" width="1%">  </td></tr></table>   (1)          Net revenues of the Pharmacy Services segment include approximately $2.2 billion and $1.7 billion of retail co-payments for the three months ended March 31, 2011 and 2010, respectively. (2)          Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services segment customers use Retail Pharmacy segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services segment customers, through the Companys intersegment activities (such as the Maintenance Choice program), elect to pick-up their maintenance prescriptions at Retail Pharmacy segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis.  As a result, both the Pharmacy Services and the Retail Pharmacy segments include the following results associated with this activity: net revenues of $558 million and $340 million for the three months ended March 31, 2011 and 2010, respectively, gross profit and operating profit of $35 million and $23 million for the three months ended March 31, 2011 and 2010, respectively.  </td></tr></table> Note 3 Segment Reporting   The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate. The Companys segments maintainfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaThe entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 falsefalseSegment Reporting12Segment ReportingUnKnownUnKnownUnKnownUnKnownfalsetrue ZIP 44 0001104659-11-026342-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-11-026342-xbrl.zip M4$L#!!0````(`$."I3[Y%WROPW4``%S1!@`0`!P`8W9S+3(P,3$P,S,Q+GAM M;%54"0`#_@7#3?X%PTUU>`L``00E#@``!#D!``#L/6MSVS:VWW=F_P/6;7?; M&4F6Y-A)[*8[CNVDGK5CK^TVW?NE`Y&0A(8B6("TK?[Z>\X!0()Z^)'8B:RH M,VT5$H_S?N&`^?'?UZ.$70IMI$I?K75:[34FTDC%,AV\6OOEO+E[OG=XN/;O MG_[^MQ__T6RRMR(5FNU/\(7-3L-_>\S1FK]N=S39K-G'H=4\GV,=7_>X$7YX89H#SK-R1I^;'HUV+VC]9KO3K';`!6-9 MS@C7WUJW+\NA1M9@N=KP(SOKOQT?G4=#0*0I4Y/S-!+A!O(&'";'2Z.>=3O/ M;YIA1_@)L9@`WXBH-5"7Z_!B%L)3-'5X=%Z^?+E.;]>`@8S]B#^W#6%U)OJ, M7FWGXTR\6C-RE"4(,CT;:M%_M0:\;'K^M:Y-O+9NE[&2$*DT%]ET(S`D740/>H[AW^9^VG-OZS]>Q%>^/']6+T0*OQK-E]^=#T<)[\]^[Q[V*RV,Q6>YF$_VP,X[3/L*$,OA M^>L2N8KW,XEQ&\]7\O<@\G?,97*B8Z%7(CB+'BLI?$PI/!,YD+M"^@F+VCV8 M?`/6R\/B_54\\^4U>8%KLROU_X+JO^!RL:=TIO`([6L1B=D(KZ2!I,&3[1!> M:8?K02)',J5HSBRU=/AA=R/"2F+PB&85-E8QQR+$'(LG%ZN8 M8R4-E32L8H[%CCD61V(.5SG+>>2G9NO++B^R7'XGUOB9\Q`LM19*H(WYE"OG$=?I(&;,'6,IT M(-)(8MO<.YX76ISTJ\?C2L%G8[\J_K8W_OOL]^,GTI<>DA$(0BGM/ M/NM#@]TT/DD3,#+O1<_(7+@VH26*FN[>)'0S36[3OZ6.X!XY"3^6:9&+/:"Y MC)9/`CW73[6*BR@_T4[T*F9/X[^2ML\C;>]E/I3IWJ_G)>YAP^X2"N$Q_T/I MO<+D:@0AY6P1O)$H*\E\1,D4L<3[X*=`[4C+##W5OBX&GCQ.+'>C/PL)G@G> M/FUA]'@%"`42>2=B/*@X%CTC_BPPR;J$_UR,,U'/QZ8(OWPB2*FF,/D9%ABN M>/:T!6P?Z'`)`=^E\#E7G:&SL5T^KF+;NXLZONZ+`%.$^,SN;-%J[U_D'M02 MA55/ZQ;4T@9312JMX/UROC\A0B/!#=C]G]Q78[9AA%_(OPH7QY7FK7PJ--V` MG=@AEI<@5).(XL1WQ0B_%:2F&'IGL$)2S%XQV&Y?I(IJPS=MZ-B(>)B[[#B] MJ'\;X'TK]8AN9@YK;@/IUM5/BRFFU-?.X.?=5JZ2==$76HL8U#7Z<,HUI.VH M8/&O/"F$EP06@U*/>&+`Y+U[L\:<:)[A]X#\]U48+DY/:B+4;F%!\'[;W02B MI?!ND0^5EG^).`"MN7D;9)X]';*7\\":W.)V<`Z-*>J@;-T5E%N@L"O?#L%) MD:-9P:]Y/088P?)U6/;4:*32SR,\=]AK+G`WB5[W&MQT!7PN,6L-J3I$)1?O9\"J:[;/7@T+5?3L/V8NL! M8#N7@Q0BF0B\YFX4J8+.DDX5NF]A+@""UPE0OP9.^>FQ?R;Y3LY[B6`F'R<0 M0?5A5-,`>[8[[2S?8?3G/A_)9+S]KPL(-PQ[)Z[8F1KQ]%^-'!\T##CG_L[: M/P?YSM__1BOJX'=<_<[\+L>[9V\/WVVSMDSMOUE.TW$0[NC'O3EY=]$\/_R_ M@VUFP:$';W:/#X_^M\TFP%EC"/>KM:Y=BH^RG;1G,EIT'5?U.ZQG]P2I-Q>V M]P>';W^^V&8]E<0..@=N]Z[@;M`V[U0N6(<1U-]T-ML[K.(E\\R6D_@.!=#$4 MC(/HCC*>HL$"F\>+6.*7,L$"0=9E["\#,AW3!S3[$%:FF!3![BYW(2[L_7K. M]MQG,9EO=P&.,/S(IH0Q(RQB0\+!U%4*ZYBB9V0LN09-8=\[37KV?"=3H0#+VF-)C8A8B< M'^R%(,&B7%-$([%^)4O+-HAZO3%ZF8269`8AL0)]: MQ<7AO`7*8\2]],0`L$D,``+S.!$&YOQ1I!'M5,IDH(*W+(@L1O82KEKD MJL&NAA+D!5$+N7MP/90]F5<2U-E`C`.R>;)O[1BVFZ8%;'1&":R92W&=?1%2`J$9N=!H,0SWV?5UGZ=GTH@'K6PMC(Q?0;!]: MC5*93%%P0)=@"!^04#2L"'VZ47?B`SJ6@);\49C9TI#>JQ3T'':W!@6$ M&@RDQA?!^`9+02R,X7I,,L-9GTOMU@?6XF*"Q$VFB:X,$E.!55P#(\RI4V*+]SY%QE0GL+:M%%X'NN%@>8CGJ^ M;:\RL4,BV]@JGT*]8T9PHU*@0`D'H9WCHFHD+-[I>`(A8-J8C$H/K0@`IRFV M=VII^&B2`JC(0(-+P@[USJ`Q].259-#Q_`W/3I`0P>ZX8K\`3O;!'@*@.'LY M5>Q+QZ6GE2_$L*A4LU5T^E'1Z<=8+&\`"Q>;AL'!'<+1%ML%10'W#TI'.@T_ M(A];\`0C(*O\N>:IX9&-%*M01;AN7[!3CT?*SM>K86_0?]@:#C#W32D)AZG) M=4&BL-*T^VN:UY`BEPF\LN%S/M1"-!,(IQ/PJTEA_?50@M_4T7!<^A9P_6J0 MRC+OJ,)NY!%Y_$OBF*OD$YX#R!MKM[J;,MUA%P>_730/W^T?O`/M;MJG M'P'O>R`0QEIF!J3?=+:>SUQNFST'2.:@VIE$]4%^L6F*A7^X`>$Z8D`U\%:B7!Q MLSTJQQ#/:1$\"Y6(U"!TB$-N-=T.&2-`F+E#^.L&AMJ!SG>IPL:58#^$8'<_ M1K#KTHRR:R!N2KB>9_^G!+XQK1%>%4C,<1?,K]PLU`X'FW^K>D;H2TJ[O">C MS4.M&3>8D)3FQ1+<7(XIKZ9,R_ZI86&'`!);(235OLIT"T+'496D^OADI4(K M%9I0H8V/\PV!`#O9#H*AJB@4%CUZ&!S!OQ(SG#(^,DYU6,8U^`\)OH%J/5BO MQ$(+E1[@>3J8HR7SW$5868%9Q2BS^1+O*8C*M#0?/EX;'EKTGEK8ODOQZ#$& MHE,UUXXM!$;N*-J%WS`\XF9(MI5^B.K\?`8 MRWJPTJ4`M73EP0^IN@)?."H+'`A<*[!,]F0B8.$D9@YX'Y;ZW*7B3)7?]%RE M%098HT,#T"@@MLX!>]M!?KC&FM#RS!:O,(/"&BLE9^Z(R+'''HU(S"\Y56;\ M.1P,&0"18$ED8.I2-1"!?`@<&N(!H/O++>+6-%7"PY*/(D[#3@45(W')X8W) ME:;P.U(F+S<(M2!8"&;,45Z?&COEM;PFF?"6N[90O<@5TCQ7.0"3J'00:.45 M2-^W+UN;#$QWXE/V;SOM5L<_:6`Q/A,4.&&(PV^R-!;83P.G0LLZ,`!*DQ3@ MD0(PBPX:^@+/(NOG5A1]V65(2,K\!]>W060E,)XATDE=3`O>@=,/Q@\5]+9) M=Y.!,&7FBF?4]Z,A7C5$E!AD&:1^!.#>S("Z[C\"))_&'A_8!_;[XSFQ,-YW MF6JJU:6;54'UH0NJ(.+B&OR8U8VZJF'\ZVR4C]5+?8!P!EUJ@18-9]I#0+1M MH&V@+44DYNDV[8=!%$RCR*6?J"LZ&/71NCUK1=WO:S6:@*J?%%%NXF^`/R MS[=:_`ERW<>9U"+K(" M1@9Q%E`>H@I+).J#"0*O4#MP7(H'_)?"UF42V2^]&83,0B?DB<&]0(!*Y=&* MFEX`IO=S,;8`7T6QS8YMG,%5&D!ZV+]\12T`2#AWMO&7[:017*=8G9C@`&Q% ML@9KJ%K[>FE79Z8QCA7S.V>>D+NC7[:#V/[4U4],$"W85??TW5JAZ^W3^]*` MYO+DK59%9@Y]90$>1_19'LA,3LJFCOWR$.KI-59_3!?S/<^$J8NY5KH-R<@J M.D[S>^7R9S9E`?%2$33S^9:ALJ,H)O&5M@*&=C(1%%.+_`H[!SHO7W;(O,*/ MYW6_J?$:('8J#`H.KC$7@AJ;,-W$LTF.IK*7R('K6[6=5FE!%P_Q3%/ID="U M-H>P,'<$2\,L'T)L[J1@T\C*L9,4',6XHG<7[5+[18;)?J=,$>I= MI:]Y^D$761Z-`9Y8S&X]K0TJ=%Z6_D'\S=0R5?"L%U^I"0>V_/OO^VZW_;QC(\)0\'N%:OG%^#,($/D_D/%&J@ M8#1]7((E"5L-LTV]X!*K=6&/C8?:P],]@X!5VPY1&[PNL3?[5,\T<4W(7MD] M\YWA*U=VNRNK':$X`K*2@BLG=M^\U78&H.UR%\C--O/WT)F_+-]@]H)Z]0:= M0/F]T_FU8+D]G:%'>W M(S26J[!#:#PO4XZ&4O2#)?%6(%WEP,L`6+&B)^3AAI!:8G=$`MI'N;LPX#Y\ M,R"Z/,R)J"P.RQ'DD/'5TRD/I:$FQ"EJTDJ3!/6DJL`.UZ\*FPY3SF,[N=.JBQLR7>T3Z2KUJZZ:5!\XM4?L M5&*=AR_Y@P!L/'@$$I22XM&L\*D@=LF@>328%T;_%M0D3`NJ)R(($WY1P&!? M/S8\:+H2!5S)_!07*X05KN#&S^GKX_#"C_'K5['I")5!X=__6JUI2NMC_"1.+9J![`U+_\U01W"R'#`T=-!86AP*M1)>V1$-Y,T2<@"IZ0<Q4MCJ4ECAO*P."Q\L"SV>M/%'2$NMBX%&@;@@!"0X=@MJ'D;L^:',#1.&-B*F@^+8D9,@>_W4R M=LIU\G5:ULOTS64PX8ZU>X]34^_:%;+5VD2E/#TY/[PX/`%] MIG":ZE,7)Z?;K+E1=8T$W2S?=)X_^X3.DT9UTW+1X9R^%;JYX>`_30J#`]:] M`9@U('QV=NUN'BXZUKONQF6^V(#6KZ5B+92#MC\5F%,^$K5B[AV::N:[0VH@,]]C&2PAM:H[B+6]L&C(`JEP?_%?I$4<@5)MR;["N]7ADZ^9E"? MB"HC5D?"M3>3)!-L*D:?PHA4MND%MW<5NSE.F\J;Z\T:W MN^4-)RF`LY2PLDW^GS6E4;4[.-*Y%:[LQ^`;GH0--,N5Q76C)JSM MYM8+_\9%T9%M$,//++OT=@I""F,#4_RL90"S1+A<3&VTK0F75A M(6`S`"_+[]62X?>C%UNZZNXZ$(?-S1O1JQ+(=:-72-O^969A[44U$> M](XH5:!T)%>12BC]@+1ED"HCW.5/P?%[$"GPPI-;I39?0KML2QW^%7@)(5)[ MR#%2D&C!K`CT&T`)IMFKS"N?<_E[/UCCZOXP/$X9=;*R5=9*)@H,827B4E0U$.R0*3+Z!D=0O?35 MA\G5W=F1\7VT=`A'/9ST")VZN!91X6[05-^+B,JEK"Z3_"9BP!-[5I1(S.`; M;%C`K*KJ&4X,"[6YB(:INZ.0^IO:U&G-;3#T],IMM0.5]X?[%S_C5NWO=MCK MD[/]@[/FWLG1T>[I.4``MB+AF1%KP`.($#..5R9>K;7MGS.LJ+@_0XB8#\%( MPCIKH,,8^./S\-#%;_FS.R=I9]?A^]B_/]W=WS]\][9YYH;AE0C_[.C@S>2C MUR<7%R?'[J%#I]MM;3S[KAI#QAP&K&%7D1RDK]9Z*L_5J(2[V_UN[6Y,PF+6_C[\E,Z'3O^F-X=:,[H:RCW#]H;)T\#'X/XK1?WH_U=27^K MOCS>H>DDF9RF."JA?RU&6+H7%=XA!=UP(L7,P;>1UBU@A]56\`K<;3U[,8/J MY52_W)5,8W5%W\D&>C&ZTS&7-1W@#1H!T/S4D^UV/CGMV#TZ?`LO(FJ27&-N M!_?'VU3#!F;W^%!)D-WU-%NWD(:5R_`I^9@[!XDWAXC=R1#Q^\X/]Q>H1=:[ M!^#G5ZZ:FU^Q9MHTN:Z!\[1UMEZNE.>K5IZOVJ^5F=%*55:JLO(S-W8L5]TP M=64)_\+B1POZNJN@;Z6,H3)^Q:JX%WPKH*Z*%WC]:T:IXNGQ]S%L[7+HIOT9 M]E@O5NDO5]FCU/T>2GLNJ$OYV-ZP.,`;%LOE63ZIE?[AQ+;WA(W/79.B8/*C MNA4M!\.\M$#V3T^-RRN567*5N9/#7FG,2F-6&K-R,BN567QB+J+*K)S,2F,6 MEY@+J#$K?5EV%C^@35P:Q5S2&EGW<]7(YC3F_S][U];<-HZLW[=J_P,J)U7C M5#%:W2_)S%3E-K.IDYEDX^Q)G4>(A"Q,>-$2I!W]^^T&28FT)8>291$D^V$F MDDR"0/?7W1\NW=SWFHJZQY?J-UA.(*9]$XK*7'HCI$K@*PN^76&(L$?8(\=7 M2ZD2^,CQ$?:,%M/.V3TA[T$B/="::P"\ALZ%!X-.;[1K.MSI/<*$^,]MN;0C MCE>12SR7F`:'R&AP*AD=#*?[7Q;VM!+1S0YDT;,?2P\L-+56_:`'1I*#I=P; M6MW>D,S58'/M]`X2$UELT6('X\99[&@Z(8LUUV*'G>Y!LXXA66Q.>M/.\""+ MG9I@L9=K;QZX.U^P.NO2`H'!QCKHC`^B=!1>B\8Z/,OJ'5&])*E=GXJ[O[HY67&H.OR<[O8C"Z(];[ MVB[>30L01B/W47%;[6QZ:$U&/9I,TV3:F,GTQ]MO6KS`=P63AS3:0]:>6-XK MWL&,YC5FPZ_)U+)G=6=CPI_1^'ML]U?IU*8WG%#X-1M_3?9_-+5N,'(;/+7N M68,>3:UI:GW?U+KB^A7=%XS^8L[5&YAGJ$DJ:GE4RF?8*?T?!K,I<>6#,J+&HX_NKN_F@AH<;@ M:[+SN^@/[HB5*][1@#:4 MS89?DZEES^H.JEGO)OR9XOZJ+=[5/3 MU/J^J77O7.4:O@01=QE72D3J!;E$DUUBG?1<>&J3X4NS`9@HUU@SQH.9@1`HP'8 M9`]X,1S=W1FGE)R&0+<^IXZ.F5_WQM5X3II?UV5^?;:B#7MTL$N@PV6TG%:EXY#KSNIJ[%2*HYI MJ3A]LE6RU49GX51OM4W+Q^F/K'%%LUA:$Z4U4&CIL:4RK-Z:?&R4<^=\5I M>CTNV^M>N5Z7F!%W.Z,-)#=38O"4\.N/>CL]K+<7O;O)A'M:'FS3$.^,],2? M6-D^36_WZ4\1L5!<"S^&,0<+%BT%^[3DH]'D$RE:@&A=`P:*`13?PWWJ5PBKDON*VON8%NY#/MKTHM+6!8K3D M$0ML.P[9S5+X]V#2CA4X7VB"Q4JPSPG4-I=G5\$U(38;L%4,\.)PJ1UK"P&GGVYQR80CGN>AF*P@]#1=Z9#8F@;T`VXC;N! M+]B<*PE/P&8NY`\%8K&K,%`J>T4UWA7 M;F[5Z`D.Y2K!$PPG!_H4_HJ$MQ)G(PMH'<@#FC6 M*XP+GN`^KG;+J&`2%+5KE\P_U9$>#H:39F7]^Z#87?SP\G\>"D)0F\&HV)G M^H/3]Z6:F)*D`9^=[OW\CU@]O^)\]>(RP<]GL0I"%/M;J6PW4'$HOHCOT6LW ML+_]^O>_,?9S=@/ZBU"`62D0VWO?!I?R9Q!MKP87"Y;]'5I<_/+D+0K\7[TG MOVIZCL_/9(`]?XXC>Y&(0']?<%#K^L5/MT3PDQ7A#Y82H5R\S&_=Y+=YG`.9 M['RO:KZF^T0P(W92Y:3:ZI?5UB`A6B`8-F298^R^9`7IL41\=S4Y/Q2"9X?9 M^;OTI>#7>)AX.I#?"OPJ.D!P%'9!NE)+=U_>N[%"+9A)MNG=A;GHZX^?W[[[ M_/S-QP\?7GVZA`[`/-[E*R5@1B]+/%>V1CON=T4&+%N,3EE60I:??EU_^_P/\("/HE'VJR:TL:OQQES"&!QZ^ M/ME9SM)K&"57`^X14VH4J90\XBV'GQCT2;-I!<5F@A M.^?3[^S*4=G>]G$QQU5RH#/;M:O]0$]3^G#I^4-(90FXH\[X('R/SBC#5IM` M?W>6PP--H'1DJ,0$CCAL:9[BB"2UCB3M$?;D?/ZKSDSGC&(RSUN493JYFT]. M<(XXTU(O:#\:R3%(3.9!NRR#*07M(XF+V=`V3VDTF+34[+KN'9CR(2IRVK..!N'MZ^"&P2:_?+O91,XSNX0L/X02CSF2$ M`*T/2'<"=U)-%NH>-F#0*D7=$J6;$O%MKI9LX08W;"F<*SRSB6?I\/0K_TX\ MP&`?^P@\`/QV_Y&=K(%Y6A34VQK4J]FGHUA,L?BNM#_AH4\\'^[\%:L(CS13 M)#Z#8S1OW:ZJ`Q,4_)L:_,W#>%4G(BKF&T>\C]L\W37C4`11G/-3G#<[LEN( MV+3&Z9_[?$2EFQJT0]$F:)_Y?$3%-&8R&35!:28>D"#^4AO^XF+B/X^B4,[C M).4U"A`EF#X>!JZ+6;ZZ$(50$;&[FCQ MALC/Z19O[M"?-_]WR=[P4'@\_$:^D_WP[OL*FA`["AQ2R<);)0M'^9*%F?Q8*L"[6IT7]?MP M6RI=)?YDU<1/;01EJA7Z.F$L%:Y(A-N(:H7CTU0K'!M1K7`TZ!PT]QR53CVG M8H7%J>?0\*EG`[.)3PC?)\#WKO>!/1#< MYZPA>2"X[U]5;$B)0N)&K>-&%:QR-HKAG%%.QKF+TA2GU*'7(YG-&;:>*@9W M=?2FU>`NQ6]*(?M(6F,XLHW36%GV4D9GIR,MY]DN)-9RC+#?W]IN:AEWJ544 MW$:0V`Y@=QXPA_=5LLE9X2O^@](S;0&HR;L\UR%F@W0&6&[Z(NA1,*IW'%D?"8?,U<^2UQ,RM%^Q"/MN.U=^\#>W^UJ"%"YF_ M$?/D;@1&&VB?7XN07PGFQ]X<.ADL"OU4+(@C%7'?28J%Z1P[&(P,'':!GU.H M#"?IB#5$5/;K].6SCC$J,1`E;Z6KE6PF3O(:92LW5EK[F$48R<#G;@:1:,DC M=A/$+O1"0*=4C+B"?SP$C?XK=UWH'@P62[.H"-TNO^&AHW3BIO@N0ELJX738 MQQ6VK;!SJSBTEUS!$U>K,/@N/1X)=\WZH\XDRX=@`$S\8;;Y(4/M%L;Z83<0 M*_)0MAA((?G5#[1XW!C3DU*$V]RU8Y=C5[`I9Y>:$OTL@E#?$>E4)R])=1)[ M4IT81I>DS]U>UV+0TY6P42;N&GHD;!ZK)(TU2,20V='XY49&;!5*&T:H^WX5 M"A`*]H`G'<^L&14*:M?7ZA5S4B?7EZFO3EJ1'I MR^-99W#0#O)X5I/\Y1_K^:PY9_W.085#RH#7VH,8M2>[SQP_;NZV-TVYDP8<](8"J MU+8A3IRWXH,%,W];0`>W:P[<"V(_,J<6!$65"CQ0[S&B2J^T#ZH@DE16"V+0 MF1Q$^.NP5U@'@#]&C#49X(VK_4`TJ7TT:8^P!^0W]=I)W<=(3'#-]9)D&U903@.X`[>6"7"T1U__"-T_6U4' M?0IV$0:>/O4O_1C/ZP4KC-N[RVM3,#;%HA\C&)OW9KZJWKU'$;JZ"-WI5IHI M.YGT*493C#8D1O\I(N8&2MW)5?$#'V-V&+ANDHN4Y/]1R&[/AG!%)QXJ90ET MY*%-"*_HR$.U#*0)!9KHJ`,QGL=:E;@W;9?X3WNBPWG/1U1*>R:]:LHR$?$Q MF?B<#-J5\IW)Y(@U/O.49N(!"2(Z!A.=#[BLHVF.(U7*=(23(SJZ/J4N5\&_ M$Z]IC_.O9EUG!%$`(T#+2FX3PS&9X9PEF^42FI7M>)358`P-K+D-J MR?O=*V,\9Q23>2ZC59M8K8_6(-Q-2F8%)DKC,R5OA\7,#<=4U2FJ&Q(5'Z7O'HL>]F: M?DVMT71=]F'D*I MKM!5E0&?5L#;A/"J"EW5K)2;>:JCC,BFT1I3-MXI_;%U4:#*],>*=_R/R0`C MOE-;I%>9ZUCU08/9$0<-S-,A)3LVD?R<*TW@M:[RL#;@&,Z4')LR:EN9T3[3F;#L&F9%T\+ MZ*,<#`KFI@3S'];GIF!.LX0FGT^Y7'OSP-VANO_IS;IW57=/PWO5O^L3\8_V M6$[CJH`?:#,U5!J=>"%"]:@UP(DYMT&5YM51R=B&D)LZ$1,FTD/G8BA M-9G&P+#9)V)&U8B53L10,*<3,4;BV/Q9`IV(H1,Q9#FU.A'SZ)2'#L;0P1CB M570PQ@#`FN]*Z&`,+<*T&?VM+0_SX+4?\[1)!V/"[4<,Z^5Z782>+?Q(A!OL MI5]/#+X3C>SG?\3J^17GJQ?OTM,LGT1XB8=8OH!V7[N!_>W7O_^-L9^SR]X$ MGBDU^U M%6C2E,H!>_\<1_=-J>99K1XW8^FW M_+/NE_F]3[O_80>`>[X7#%]3$@[3+R?M6MK7?EE\#!*:&D2"35DZ:QMU7[*< MYACW'5;0W5T0S8MP`A"4'6`1F8?>?3H3>2VB&R%\UIO->GK$\&%BL6@I4!8K M[J]Q0N>P`*9`J]AGP6+!./-C;RY"?)N3BN=*.I*'$DL\`N=W8P?W0U\'\U2L MP_%+Q2ZC0->`_"!]X:M,XL/12Y]]6:)%6>P/'JHE=UWX^+]\_?RU$.Q+L(9O M7Z6K`A\^P)6*O8,^_GNEN_I;$$0JXF&'O?>9AUVUN<*GW"QA1!S?UNQ!+S== M7#-7P`4._$EA?XK#7(7!M73T7Z]B'G*P28$CQ&OTY?GQZ(98,`?OE2P4=]A7 M?*B^."<2=B-"@8O+JP`?'"P*S\RWN'FF8C@Y`CDY($ZV5NM`SBJR43 MW%["[S*2W&6K.+27T)&0P?_A5T=XOEQ(N#,_,'QI-?Y[I\^%JVXX/O@_L0SQ M]H`IN$8MUB#;A;X[E<3FD8JES:9_N"WLS>"AK;G04T'I`Y2NP;:T]A9.%M+;U2V&'`FKW0ZI=B%^)YA'QM)A%U0JLNCI'OW M&,'-4D+#/,&,'2N5H$`[JCY`5%S+(%;0!XE8`W-P`CM&43V#>V6TU,_V.'05 M:$N"(^Q1TAN(L!Z#0"/\M)NAAA2,?-8!D?C\2F!3($U7BFN1X"-V(SWN%,02 MY8@BS*E^^YS<>&^DZP)QB@":UP(TB&V$"%KN7`-Z!!/I&^'\?18!85&O)6FQ M+:3/P0G#_?"SHWMAP8,5=$]K-+=E`[AJLX<`U-!C9XLG M[`+EIG6:26VR^6/VR_0E:!,U$R.2EF"/")R`040#>;D`I%`LP,+@)ZU07Z#X M/,1UJMQ/K_\H&G7Z>ZHP<$T*S<.5-A*(9PPPR9D#C?H.(`%QRAG#X4OL/-@H MB[BG1:A_8"Z_4;&,,I\&/5IHOS!?PXW::*!#`)*Y@."PP*=?0S_`"$"4"$OM M2H2#HV%7`4#+UQCF:PAA@".)*VPZ/V&UU(*S!D]A"*7UH M"#P1S#!L+AU]KRW"""R)!2#@,#\:V^724T4Q2`"^#8:*;O(B]1OZV8[6*EI& M,A#M0S<>5>]V@@@V]X+J49];'>X2XS-\MD;'8N>@N/-7C`/1W@%B5H3A0#'P M5NCU\@C9Z`$9A=;@@KL@TG2(W$Z9UR+DL:.OB*&!1/;_!HS`F"ZCI$T_B7/I M5^B95C3P!.'[(&$!H>(W-PC!@UCL5?B-^PK_^B&(I9+@[1*"!Q,0Z*LO.8@* MC`G"4R(U[<03;%IL'D?;5A/ND32LG:X3@J5JN>9NPC9>Q5>QB@HH&NN[;V-K MHGW9"ORAO(8(DXQVQ4-\.6;>ZR>F88>X;>T%B;O#\*XO!9FJV/,0D*",*]2? MI9^VNR?3)-J!6]4?X&>78]"DS84T90+/` MHA<+\,*;#N@1%I^=;S^,79TUH!G$@E\'X6;].'-_^&AT3!%T.'$@J"'$@MKR6+A,^=-Q.!`9Z1!_$KT#A:NN!]="D_U?L:QO# MR"(%L/&\ZTX:6PD?V'86.D)^+;6@_&AMI=W0,$D85,['9\XNP5]RY4;3OVEO M]@FEY>O^O;*CG/H31XB>8XLC]-%%W-QJ@5(Q$E$N5 MN3@86N:ND'/F.&JT\]Y52AU3_YBY\A+AW1'*#N4(CP%^WPH`'TR( M;_OT_&P"'(4`X"%\,\Z.[FL5`-RVP>,CV)BM$?_>U_$`4/M[PM6L6\;[5J"] MZ7;@\G\*G")J7?TSACZR2XAET!1P@RT[_/C^]RTQ?&9ESB71*$;L)'YK&&A\ M)S@XQ'MIPK#.81.&"VX7?!'^<1=+R(<8/9/_"*.^+\2<&+/T MKW&`Z-3!Z&%^#,VH7>+&;Z\B$+:&MU(I1VRH($83FQ#9T))G" M:EL#^6]T;N7D=T?X6QO<(_M$OJF)WS/2Q+%H/W7T>*7*-PX=R8=).PY1M1!] M,]^0C!=Y=!%(-\%AY#$97*977."8XT)5(E=L-#.C%&9AX&)L00>J>ZQU`UT4 MF2BS4)J&@JW(V1=[*_-?9S\`G=S,!#JN7E*[Z.$ M%L&T6FL59C=QI-='TEGU?]O[UMZVD631[PBOS`!S;F?6> M)/;$GAWLIX`B6Q9O*%++AQV=7W^KNIMO4B(I2J*D'F!F+(GLKJYW55=7H[L' MJH8FUVBR)X#TA+1F8#4Q[#(5[E:@:7<95H'#'<>WYKX580Z`GJTC>M31-90I MF'3.^,RG!3_TG];.=.U$.F3,[WIM;L2^-4& MKE`W*3`$@BKJ(ON.U-(`M#"U9EKF)4[.4I+^`X&#$U4C@892%NAJT?@VLFB^ M..5%T0T61')'-;D,A$X<>9WZ;-Z9;MSS\:DK&/E\%P+>9KJ2B=*4)\TK2"^RB!M"VMF MJ&)FOA>&'.AY4S6,"50MAS';+$,>716`M$(48%(&[8I]R4/("+.R\-9?%GL- MXBK4EE2Q`YVL5V:1@A#9AR!D'#868Z<\^)FQH!@UN$-%$TC<8;;NV!SJ,ABL`-)A"^$5W MYI3?`;&8#79Y1M@F\!<$57,%;!C@VB3@"-C?F1%FD8HT9[XK6'[,T-]E9BMZ M+>D#\!EY\8AT8WO/8&C;+5CO%`/Y1W4.43/\V0K?N3/5MJ2]F[Y3I`^>#2KF MP0C7CO2W/OB8UC.A2HTJU6"LCS8A M&K#?1\_4@H34%\IC(-RXFXAWNZ[\%W1T/ZX@2ASJ29G:@:CB=Z M,RTN+I"&RFC!@)\MVRF+/=1SV;@(T\DN:'8'8A^^+76'#JJE.TFR^7P3,'@P M`%HPFK`"/G79_D9H/]%MM3%MA7L`Z!VSG5P:-00$XTE./[QZBDX3'96"BSN8 MW&+XN3L_!\F=>PW,EF$MF=O-;4`>%BCZ<2DGI$VSE=.PE4&_0!NL8Q+,T4TM MW+>+LTJ^E/N4^2>&3)CS?5!,8B`_?,:MNB#U]DEW^:XG4[6690,%%=\ABFVN MT2"3,`M+]1OSW^AN.O#5#+>#&#?`5-%=?O:$+V+L+9"K:'XOE+L@%8D90O`* M'::.1JN2RZX5+YD8OJDPW>):LFDZDHECKA?N M&=%=;\U369Z%1E!+#YPK-9ISL,P@J;1F1LPP@V6TPEW%V,9MU-F>>HZ.>UL@ M3L@3*F%N6*)*(IUL,["[$Y44`-\/B5GVZ"H(`<+DTHSF(]=N=`;;MIB.CJ&" MBL0E"['BN(BO"]C^6;%9EIKY]7ZT1R-@RR%\1SP<)$*^IVN(#UV6K<.BMI;4 M[;.XSF%+O_&%$G-9EN$MIKH26G"V3X"_?;)02)Z)P=?"I(O6PH0Y!C?(I<-T MN0N,)99"<@09,=`DK/@A2,P[B1&B7A57_O2D*]T,XSF$2#HM.S$99CXQB([F MNJ@"`=KQ';JR.:\L@-O2/R#F!+9HH5@P349E8Z93CY0+3!;K,AO!LM_(=,2F MUN%MI+2&./JSR0PMP.JI)()5%HNHC/\4:V0S)V0>Y^S]N;`*P"2YF^`60) M<<`Y1&P197V#3(@;3DOZDH;1'0TOD=^^_K@"TL%KK72!"Y==9!@:$K*Z18`: MTX7<4Z9\A,I?47G)&=<>@3QD!U;C1(8X*H0L5\VS_GH@::E4-3)?1BJH$@UJ`9=*@#]"[K,"\*+-;(A MC1:L1OPA1;>E3\H4F!8\$5,#7\"AOE!D'_3CI\>KJ/N%>&$C^(X),\/QZJ/( M&AR+9@NXE?1K"4+?W-`!+N9D\S0"4@K26ZI)':Q+1WBJ2)288:%AHQ"%L3`)`F,0D^Y#.-[U*1 MT`<*]SCB+IV[V7>ARTBZ*+RZG&\]+"W`"+X6E`&"L90]IW-0-L7V#BI:$N;V@A00>RLC4?AD45/L"#A( M_U1,#WBF4"E#GHM$_4K3),QD4*PK9CHX"AB5U;LA#5!MO>KH=2_`B:"M>4.% MP4M%(SHU\+)H[:)?@P!O/MN*OU$?@!@$":G(%1O\$S.MX%*5@W5$8%&>E`B27 M<",+I.6)^U;$:P@K=Z/[`1J6[>))(<=1U+F'0./!(?#'86DF_H4ENI8+SZ#D M_0->=8`3"'Y\430>J'^=6^"AW#D0#V@_Q>LJ=2>*"8Y#W#N-5KA%JMLBE>W9 M96^4)$B/R(9;I$`&/#;'4UB.WS?=/,6941@=^B.)8M`(S&POP"\<\$4Y$:`` M_M_(H_9`6O#-?%X9!=7XIB5WI!`Z!L"Z%U.&DIV-H&=O#F6V M#YJ-^(MLGX1PSBX+<9=3HS1I44.>79"66>KDIDX$!.EMMC'FEUE%L]Y1\[FF MCBYR3G06:_H32Z:!W*O?@ZWKV+&8`6IK7OB;7F^?_1J+S&F^Q4DX1Y'-!KH! MP1('D0(D%F53>^G$3X#,HMADYY&B%:U\8T8+3O2C[0'4)(QMPKW$=&.0M`X. MC(53@KNJ4P&V%;9M!^16-/_$H\(NSYA;AD9+!9,5AG'Z9M:E3UH^Z1U`5Z)* M@N[-@OW#PG,G&WOQ[18LI\L`0V<%9]&J37J@+PH]YQV.37XF)^M0@P)`ABSC M@QH',PE>Y(U$65P.K5M8>HAZQ@\@Z'G<)`.TDO2ADT]M>BP;II[IJ`/IF4#/ M]H!@& M/@T&X/J>,E)6U`E>$0VCPA)*>FH[7H]025/$?/"XN8D>,78*)#7"@/Y[?Y%$5BYX6J12',E8!JHM MX:L%.=3X++1)0.4&`2&_!(T`[*Q&`2=*6YWO1"@\T85A#F5WAN-H:123>8QL M66T%VT'@,FVB;+"-)69OHOOJ-!2BW[(03L)LMJ^A"TFXA`A+7KC)?P+\I-1./Y>YCNE<3>BC80 MB8S`=7X4MK#6H!548[Z7WNJ1,@#>@`+LC1JDRDP@:;2\P(_H6"&UA?M(SY[! MUO,S#!<=#Q%+2^*7F(MD(:+MEV7[$6.08,D8L,4KNU:PMA4//?W`.%B7O[/A M9RX=_PPA'8OF0'53@V#=7E$`HQ#Z%:)A]XW40?\P0E.,>+S+J+D%*"\12-`[ MU%W/QTHD+DR?$PZ+%SW$>7087PTE2UZI$\(76^#@:S@^[4M$"1H,"_O%(ZLAP8\NV+7F!)C`W3%,Q0),'PE/^H3`6UF`5H MM1M57*2-6]E6;^5ZN+'^;QK1W]]B5<_J*WE&1Q@"S"\LR,KH\$:#XJNOM[#2 M_Y6N[[\^_/(N;X#D\-<$-Q.,._#Z?_PO666/W\%_AOUQIQ<=./%J./(-=YR> M5LL<@.7.Y1]LJ.BSZ1$>0'=:VJVIW;#S4!E#X?\O.[W+GAP?,/9J./*5GU[^ M:"C/V2/2+!D;+/9T&KR/0#[%^#=1[(_PC9,/8!RTQ&M)DGP$\;.O`>IG/`V7 M.>8GQ09+/%[%9 M[]BLC_<7$I84T._8`,"1O<%@TI>[_6YLL6MFRF,'QGAK&.*/3':(O!9O`?E` M^RJ!.T'!@'#LWJ:!L_8OQ?"(WS]RT[H[D37_^7CCOP:RW>[(H:XJ-MDZ`!F> MKCR(O&UP-[4(8)>#]7`%M*#Z)@^HY`2;@;ECE2D10(;%`-D``QMW\_S9[%D3 M$"F.C)H=SKL[9IH",^6"MHY="B*HU^WP?S)!6L\OJ0L/>1CARN>;))@KX(ZO(LQ5@Z`XF21`R!MZ`AG\00[LS;Q=+PUH1\H3U MS=4!VHB1W-GB4#ZJ+Q]3PNZE*5#`+G$,)RE@KMQOUYTV.VV>_U2=S(4OI1A\WWGNO^'MR%5,PDR-8]/__X$7^@0QNIJ ML>R-[._<\8J+C%J"8/YW>CPVBD0N.[D.8UP.]T?0I;SY/>2[[?X.+A0#VJ`2 M`,DW?;3MI2_[I#TH1TS_8"&..;6E=PQ2OW0L^2U5RBFJY\`R1$@>[A_OGN[N M\8H#NL?R`JBG.+[LAC>5,9E\*_]4GJ&:+'=U]-D_;]',NA_H7"3S*\W7Q24P M3UJSY5((SUD+SUG;M:"R58B*$!5A9]86,6(!0"@7H;#<8AMGDVT+[LSIZPJG M3PAC5!C/6!2O(SUAXJ+X9+F*D7?LX:CHNPM=>QJR&=D,;V3JS[66.\G[U24] M3W.;$.DSC#:GEU,Q&3H=R[+5?6SUL>WTB)5/T:`H\O).S.+*<1S_L3S90=?H.E!C3E!10'4^DG@57!?$69+\L,"=X3O"<4WU%B53"? M4'R"]QJ-ILSH7G#>5B@M*FUYD!4.M^4=!,1?"'87?B'8<%.H MQ.;*;Z\,CGIUX:@T.T6PE/'7FX.@;E+2BYYLQAY(*)=6.M&6EJ0TEN5^JR/W MA;@V6%S;'(2.QB/A,0V5V+[[4ZIJ*,O)#:"O7&[7TIBQTV0 MV,?58FH9&8T+Z[B4JFN$L*[%\MMN:]0]M?8) MIR:RY2R$$-FXR`Y*,5D1D>T<5&2[@]9XW!&Y4)$+;4PN]'?;HBVUK9E^8AT2 M3LN4['Q?_,#>S+`W$>S7:/;;Z<[X@;FOWY+[(E/5;/X[=O4G,B]'S'RGK/S> M]@8IM*X;._ZV2$`TFG-WRK>'C:;[K=%`%L&T"*8;$TS?!U>BL8!:>FM`="TT M9*,UY-$[EFO1VYN(N*;9['?*KJ7"!1OB6PH. M%!PHE*!@P0:C22A!P8&'YL#C"92/#+,B5CZ26%GTMQ":4?2WJ!%U)]C?0FZ- M>V*OM,GB*OI;B/X648GMM2:CL9#8YDJLZ&\A^EOXR!6G+!HNK*=>"M)M=09] M4=+18`X4[1I$NX98NX9>:S04[1I$:J\YJ3W1KN$X3,FI'RL9C;N"_1K-?J?L M2_=:$]%8M.'\=^SJ3R02CICY3EGYO>WV4F@59TI.A'./IU2F2KN&_F'V-T4P M+8)IT:[A1#3DT3N6:]$[Z(D-Y6:SWRF[EG*KTSM,OEOP7U/4WV';-?0&POPV MF_].6?^)T/J$.?>$0VNYU9?%/K4(K=>%UO*^VC4\6:YB2(KC$-=Y+U1BDU7B M,3F3QX5;P8(-\2<%!PH.%$I0L&"#T224H.#`0W/@\03'1X99$1\?27Q\X':& MA^FV*?2C:-2P6]2=7J.&7KX>IM9F]G1QQ'B>Z-](:=T1A5X,%5AS'.;OC..*ZDV,55G$4IVE'<;I"5H6LGO0IG,-+ M[:F=Q^D.6L,#1;$B)RIRHN(\S@E8EY,O1L=,G[@?I]D<>,K5Z)BX$AM#S>:_ M8]>`(K@[8N;;K?(3>07!>L=?,%0M-!9':>H/C=F?RM0@]4`]+`JU7`SJ`A%Q MIST(6#((B4%3PK>;H!V7@_:MG#Y,F#-R+SR&F%IIS7])16$:)V'Z0ES))B_$ M]&#-UDQRYT1ZF"OV0E%7TB.Q7W05?G#(\X+`@+JI&IY&)&6YM*T?^D)QB;&2 MWG3;76FJ&X9NF9)B:M(;N3T*OH!!;>(JN@&ZYG*IK'`@1YI9-IW+G=N$2`N` M=NY(Q-2()N548M&1,??0@O&<)5%=_05F;Q\%UW1/BVON3)?8/E,00U_HIN(" ML1T@C0%,(;F6Y+["OZLE9RM;,1U%I<^\E][J/X50Q,8*6-&=*ZYDJ:IG2Z]S M8J[A2=5S0/G"$)+G$.DK8[7@,;&82UIZ0%[*?"H:KT0&_@-6%GS5-=I M2W_A3.Y<=]C,3DL"S3[/D0EDQYS9$`VJ96OT3;XD"64#P(#7%,,RB315'!UF MP&'>ZAL1TI*>;6]U!9RU4``M[YDM\MI:@"^PXLY>?_BS`Q(? M`08)^**[.HSTUO'4N:0X]+W/"CYF*J8*8\PMF(H/,>C]C,`]V\KBIQ8P"@@M M)8&N?K_TEOBN;DN+R-M+())JZTO&3+"<#?343<X6Z$#7_)A<]7T_C0S#(,ZQ7!8",[>">;I>H@ MI1HX+'020`DG[>J]9"8LPIO!8"PMHMJ]U^\$7]2FQPMA$*#I#>+`='OUPW(8 MF\*.`>_=W?OEG>=:9Y#[V2/CI*]D:=E(@#L3<+N@*O[#BO_X M1'ZX'PQ+_?[;?_^7)/VBOCB1`:@.(XY[9ZJ@9ZY,S?_B]L>2F`YYPOF#$4`5 MP\\_8+[9KQ(@;>,U31SS,%R+]Z__<$JO[>/QEJ7<4TPN%9M)*F!J"7H!!1@8'<50YTB3",-:WKGM M_:^@H-,>(Q\/IH8=B*4^W'^]N?UZ>7W_Z=/5PR,``'&HH2P=`A$I,3`D50$U MOUYTV.>EHFG^9QYDP3`7H"1MC=CX]8'V^`:]=JF8>U!X*W]S5P"],)A=@R8N$QQ+"Z+IWD(R02.$ MZXYBD#].49'Y\";4\@'88[$1_#*5<7NFT?;ZI'"&?J`_QF?D0MSD^Q"G0.'NG9$L2'X'T13RB<[4;7F&1 MJ6Q`[DS?.W?2)/&$+3D;6R(/VX,LCM].TGUBN5B'8.)H*W^CL?*,#I.9.RL/9(YX: MIRX*NSB1EVOW;*JT;CDNYCZ<>W/6S%W(ORG$V17=FH9S=N,H5M1[*4*S^IR6 M_>QQ":^E"K+O$MM-9^:[')45S',VMG(HZBUK+\M^;XK6+(,V3U,77*.B6]0[D%8\<-9<9W6W@@C?BX._^&V6.IM95R2W[,J M\H4W<*H\WIQMEKVP]@F0K.&[*"5)4D#7G*P'T^VS,WM)'Z8M[SX7T<*"6.'+ MG(V>K^#+=-M=8$])L[RIL=W&RM'D00YS*['P?([!\RDH#LWU?DJD7RIT`VH< M@2OX2<5(?&19'_9G?Q,E7\PZT9W\(24;GI$NV>'XBR3#?3) M9AZXDS]39-W\^WES\=MGM MT'_",V(U@5)@??#4[6Q&5/=^EOE[A=7(A5:S:>)#T*:3L9K>T=(F:S6[H`V> M9[;)',1+?^'K^T+@51CERG5M?>I1@7VROE@FCF5;AD%/._+8HP8.VQ*$PNNY MHT=^X$+87S&EE)=Q%.QCQ5DS5UUQU+!> M,U,$'!'8(J>*?DTIF\W3U`Q6IOBD?(VR8#VZX-5^)7[S%>W&LU'`J#+\EV)X M!63D6_?SMW"$!]96!`'^3)L4I]3V<)0$>B,0<9BO8%&:;GC8%.*1J/`PMCZY M_4&;:VALW8LEZ`5<[_WL5K%-&,Z!\1[GBDVN%I9GQOAQL(D)Z'O.Q6_=P2@! M>BVP[']YG9SE37:_O'PK;>LO"D[D_.%!Q#Q;P4A7SC^(]DRA6T]\'N2\\@97X+(`T"0<-R/)O2:(84 M>Z$46X!TP+>42FT)YU45ESQ;MOY_;&QX7'$-C1`T2Y$GJG0>!4X_#^>Y=+>>+3C&%"&-@C#5FKV=\+[-^H:<#%PM^%+$7P7 M%2(J!I&^#&*G:?_4PS?2DN$+PJ4S7$6TW+]MU`Z.&S^K]847*,7ZE[YEHQ.'I6:54LB M.GJ(8-3`S+G&BHWD?VHQV+TIMA%TP1&!!Z@E\`Q#@B!UX9L&/?!/A`@)$4J( M4*^:;8@P,.?MB#,$*%">J>*.=@^=T@H>QZ6=@@/_R.&B(RT5&^R'#K8!OE,M MS]!H#U>@-4H9;^69(25YYJ+%.U_2KGJ.XRW\/J)3"[PR6W>^;]79L5;6.S:W M_8KZHSE]-%NL@:%BVQBV#&-=`=[PE.7/+=B^ISM*# M?!OVPU55C.4=WL\5V2WRY5)940;$,2,C:&3J1IM2:[RU;"08T#SB,WGD15-Q M>=P`/P#KS8((+]2@/';PG1@&+;,`EDE6/C///%,#^"&87Q";#K%4EJ#):;=6 MP"P`N;0(1[0,#.JT<@`"R;IVJ>* M09OI.G-"+1?SNG!U""*=>:X_S\%V&#K,HM%);:)H$-?C2"\$Q!*Q#/CZ;EJO M8`L7#/VUPC#11S9/-7M$(2L558G#FLCZWG#RL)ZZ.\260<('\P5P">.09D`1# M(@'->)=9VF\YR"NVTUAIP2,Z=DRNBIP6>Q5$C+*+"[]@#V3J?JN6XP831*4@ M,A"\D2.\?FC,A9?1FO*$K[EC`W$8,W#N6BX`8UCF;0.QT.N:S6AO<*XQ?-E'[XL-0YDD MB']P?.9$A@SC$T3G7*?1`0M0NC9Z@-&C[:9QE*"5+*Y4T&O)4!<]G<`R7;D\1W[B/ZN3HG&6-_:>ST72A,G*D'"%#7[^?CZ M-Q\ZG1RB4.22Z\XE@W23'V#"F5J(:QET_;EZ]L.40!6`)X?>A(?*G%Y.0#=9 M4*V#H@%%X:DD3ZW1^=!_A->HTS8SK%=0(G80J+">^ZCV9K:U2$`U,SS59>%6 M[!X`MBU9LI5]*Z8):<\W>!@FM"0'-)U-7=J4YHW>R^%[+0JX.2QI+KW"\V`9 M,(]-%;+OI=)USNG>%$4K?<[CJ*??4VBB^(EB!9AAYE''.QC-2:(*/"GSF25: M8G#[5XP$RA\3(1A#XE%=WD*2D+8E^>C5*]A<<6;M$,D1K= M1*1/1EQ,/#6CJ$8($@T`I' M#+'I,T!Z/AY>$%JJ!^#]C./9M,RP!:B'^8.?3$S_(N+XML[_4:Z5"-_A35`` MIJ*\!F-$?0HMU*N9$1PG1?Y]QB=LZ?/-=MR\?^$2P?;2PX+EK\!SUR"F'T%* MZ79T9,`U&^)WO&@C.LPCB%]VL0;(7'*GO`H\X544P=45_+8*YXN'\T8`OOOR M<5,YQ@.HJ(O?>JR4.V?$<$KV^7[&[V/18^A)S>;CYQ$$![C573W2&VT8>K[Y M=[KX=[[P.5/(XQ!R$-,0U`;=9T4W[O&RA4H`RN/B`#ZZJ.7#)UA%$54\&\$M M!U5W$(V]\QO("H`%;NG)X1M'4RC;G<8ARJT%9''O13QM[(BG9+,!R(QKL.*#`9RIS\9%,%052/2&10TN)L58Z\[FHS' MA:`M1<_1.'5TJ08C4I*FO4G:,:AN1.310!X--QO<;2B;*OROP88,^L/Q9"+7 M3N)!+R4O.]#69<6XPU&X>ZB*VI`*2KBX#>F`/N[T-CHVM?+D1O"O6)57MA0! MA8;]P5HI*AM?,F'O#H8I3#-(,J';/'T)MNN.)^D@:*O)BW&7/)Z4F38G[.GU M>NM]X[OMW)!!OQ!A?K(=>C MF^=?2T:(@^7N>O.$P'7*BE4W[6U4YNQ.2:'JINSW%E,7%*E^.OXM+5(P1K<_ M6>LF,Y@J2A20>GN)DB?=X6#&8?%W\DQ;"%7!N==M\'S4<4/[@9Z:?2%7:J(S2]8&6*?W1__; M9[F3WBO)V\#)FB0-%%V)J\-"G"NZO>W^-;<6\;><*YO`:.MW+TK`6&K.$&1Z MO!993S%@A(5ELE/+\280]"3Y_;+\,7__"/0H2N?24^X.VNP#VY-]0ON5./`1 MJPGH('^:^EI7:LTI^M)09TV]>^BS<2[7#/VU]:"LF,JEF;D"6JN(J50O@IY6BT)_#?R2X$"@O(N=$Q]E8=IV_UI'[E7IG9O M@C8G?Y&IH[N$;_67VKX&W!??OBX'YF?=]%QR#0#J:@70!L/Q/B#[BU;T7__K M,8`J6M=1"N!!`8#OV$&%ST'9^?WL$8\^H"-S%SGX4+WNI>`,:1QB[RNLHT0> M?3`4%_T[YT^L*6.OZ<_)7G&%04M8^H(SY3N0035T>4]2]H.[/%0:M@-PSXLM$88<\U)+F\)> M/\6;1[78,D'_;I<:=G+-Z-Z#.P[Q!JY'=_XG:--\??_IT]7#(P"@`CJ4I4.`LR'R=Y8*GFC^ M]:+#/B\53?,_\T;-,,R%-+6PRA*_CA)XCQ=(#+LE;Q8<=NN[`RO_7$ZR!76% M,SB;+T+7I8;Z*CVR M$W34YQ\W4')2CI)/]#319W::Z#;G--$)$%EN=[(D:\M[HHY`_"('0L[63"-W;LWX1@)%.><'7<:]8>EN+O MBO?:5,+A68M`MSW<@0@4M@P'$8'.*1!..$EGYR3E('NT/_UUS)[.'M'4/&U1 MU-.)O%R[@U/ATKGC8NV=.3D-0E/S6+NH!U.(M2LZ+LUF[>;1K*#S4HAD1R!$ MPF?9=GOG"W'YEM-Y.2U[O#.W!C3EN1E;N1)M^1AN$9-F,NZH0F*D#HID>P,-RE)LU=M+6/S*%C_9K;`EF83=GZ/\ M$'Y`@W7L#OP`F5^7OD,E^[A:3"TC\S*)2>?,4@I'QG"G9]0/LT\G;+&PQ6EL M/V#1)S;_#^[#%I9X#XJQ>7F[0Q5,".-_JL:_>3Q^J(J(`_L;_5.@W6D410@7 M9_\NSG7&Z1;AV)R-TM]W?<1!-S7$#L4YL?:>ZR,.[,:,1H-3(%H3"R2$_W(T M_@N]3TB)M)?!FWV`2^A5?99A1&_R$U[.V9B"@YUW.:B[ M/-J)Y(UP?NI+WJ3IH&@TWF&JK61V>`J,4-[S*L@'1R"F$>^+_1G>PKL)ZCIZ#QSZ M?N&2C?'RNNK=\@N?'XA->QM_):IEJKJAT]:=HKE>V%P/;Q:GMV6'Z,$ZJJGB MZ"J]-5S3#0\O@?7OT,8K[;'YW@(>=!"W>)TW[<]G$V?)KN'FU]X[HA]?X_KQ M3=J]4I6IP\F1]./;3.>]=E"",+8,F@L'L0WR(.O`TK`]+L6.W>&!FN.5U[+) M[G@'0;#T?5YO%0'LT>L=0\95'4HRE4 M$5]1SU?8ESXNSCZ8+W/FK%W,$)XO:S>/9G62[`B$2+@LV[KO7[P%7E9HV0[= MOL_?W%<50_4,=M5PWG;^:?HWQ[63FN>1-$$U'QH@/)[=9"6:U^="^#\-]G_JVD0^<`/3"MVJA>-SM*R]W_J( MP_H[HU&%'%_SB-;$`@GAZ#38T<%>$\S-T72'>SI$BS@Z![]R1O@U#?9KZHYZ M!V`%#MB?Z*W\D_!PSHC)&W2:91_)]E4],0\I'V=ESG3,[[[ M1%/S5,99;6*=[:F;,V?Q<]K,.BW:-7)/:S\-Q(474PG;-\2T%KHISOTV)-"M M`4M'<-3HJ/!Y#OF5>MBN\6>+C@NAXH#1$1GL?6W,_$60TXDF*2_$5IY)S$8[ M?#]&6.?F2O5.K'/WD.*8%F8Y-,PR2)8%F;Y*,QR;T]F^='% MVSRMI>B.U7#I/;F@>"2L;Z/9;1%P1K;@F$]`'M4VA7!VFNSL-/3\XSF3KI'''X5;T]R_4;#8\M9,7;V+<)\Y@"&/>%&.^L3^W,.8B2CCE^I3'U6)J&1FD M^YL\Z:1)MV;@7/)G_27\C_.1G)/K`EY29HZ0:*+B13A4.^T!+CRG\]'_YUKQ M(K(O@OO/N>/WMDF?YE%3U,.*F'HW MN,Z9=*(BYD0<&U$1<\Y.CZB($3F9DV'#TZZ(&1P&K:(B1AAS41'32#YN?I0@ M*F)$18R0G*.JB-FYRR,*8T1AC/"K1&%,`QBV^:I$%,:(),PY<__9MH?9.O?3 M/&J*PA@[_!/->C&HXZRG$M,E=L![_&/-S%?3RGYYYSF7SXJR?/^HSHGF&>1^ M=LOK6AZ(_8CE+%^):IFJ;N@T;_2$+S\!Z3\8EOK]M__^+TGZ)1@#6_Y^)4O/ M5N>*0QYLZ]E6%E>>.[=L@%V[6E@>K%XCJKY0#.?7B\OQ!=UI@N&^DMFO%S?= MCMSYH_OMS/-=Q%5/##5^_EHTV\'Z+Z.I=>%40[(@I5.\0)L'PE+8DH8O9'8 M$#";K;\PN$SR;+D(HR:YMF(ZBDJ3Z2U)455B8&X=6Y\G%Y]XU-3>`2$L@-T& M94C'QO5'GV)8I-A.29A/S86RDJ9$6EB:/M.)U@*$N8`DS/+;DHL(,BDXTQ5% M4Q;GN!)%'&"E+=UX-E+_(YG:GF*O0IY$6GQ68/+P*T:$*/+#U0(7FI+R_&R3 M9Y@>)Y3[[:ZTX,S&>J;BUS$^0]94EK"T'V`;**K?](>CX"T8W/$4D#DDHH^9 M-!^V&R/9M1OH;.,4-V#7%*/T";M8 M&M:*D"?;<]QM0-J(E=SY$HZ;-W7(?SSP5&]?X#^.\'WR?)])S/<)T"91O`F? MIZ#/ZR5IMO?4Y'/)!L=T0F!OI`Q\PYM0\ M)`Q0Z-B`H2,+H'X<^J6B:Y*J.',4(4?7^+8[`OD&XNQ!X'PM#<^!K\:#P-91 M6!46*\'CY(>*JU.5I>["PMRY@MX)#JE)0"'F&KGTME'V(]OC)_270@O]J249 M.,4;&8QJ#A1YF(WZIE$GTD5=@]2:$1N)&%Z)RGT_!&A*\%$%C,@B]%,X!KDC M66@!`"!,XV0PQ](`0*?$)#/J+5KA6.Q+55=LACCJ$$*&-I`U0)$CR[@,?A1 MPB%0Q:(B7DG7UU]_%-U&'J"(/-P_WCW=W6-VBAC4Y?M9HCF6RVZXR2Q3&7G\ M7,<&=38Z3MA'RK5C*;,,J)D3D,L7PJI>OQ#W?O:D_%ACAV]2=I@F'T9R+\,, MYXU?%R"=#$!&P]*`J"_.^]_!VP?%1H@&CH--/A$:-H73=S:Y(Z`:R<5OX]XO M[W*'"V?[XF$&YWYVC5\_8<3#%,23]9&@DC2N+<^.YHCNOGS<1`<&@,SF+S;! MVL25QD*A!]!SEI;VSP:9\'SK?BZ8LPK\VGYW?=(J`XXXW+[^NT)3Z>@HY]>6 M`P2^XK;S%@W#"E`Q?T![E)]YXU3]YJO'AXCJN`'-X<_$%O,M,F%V2D[N#M(Y MN9+@;ESK0X!L7257!@@ZM;&?=`6,*[4U5]RT;/2NZUNX7&39A2%/"PZS26@) MP7@MX37S^<[\[!FN[N`O=^8+<5S]F1?Y59"C;C\N2*4F#.']K)OZPEOXH\!Z M\'G3I5KALV(JSV"QGZR_YM;B'JWWDW6_=#]:]L=/CU?7EF&PI-`52X?<.9\5 MC>0KI5R=T*.4V!$$1=[2\H5_VYC(>I&[9D2H]$@(46Y@X=4R'HDSL7`K);Q0B`F#I^H9&LX=JO-F!;J M!U#N"T75R5J)#725HAN/Q'X!W<'5$G]_Q;]U'LDS3I1240SZA("'DU?5N,!5 MQ'5\+;Y/;3L>5->V<:BW)CV@D<00@]RZ^M/QJD\HV1`:O.E+&L_JB?"AQR9[IGYP?,Y]L? M2P@KJC!AK]]/L4=JV.UFS5AEK]=+K;+HK"QR^I0P9,56*_?D%!TS!MYVYBQV M[:==T8TSWV&Q`OAS['>.%ZQY++WP2[F7$I:\T6N!(0,%EW)W7!4&'S\?;6MQ M'9R&O0_.SWP@,]#S[#F(IT'CZZ9E0_CB3W!E:O%1;L'0N*O/Q)U;&O.:T1A4 MX2EYE-J:V2/`3<54E@QTQZE-D@-C"@;D3/>!I24KV(9AAF1ECET'`!EH':0U M2PD`UJ$>GC`\3"`_6#;UT2(UUD_6%\M$Z&P(0Z@.8]2H)6>W&]`:L/S,3&$% MH:A[^3>18XGA+-7SL)@T@%,9/(1!RV#6*MH*U?^OD.FW,2LZ[2Z#S9'M25+:+`1VIZ[O17W2- MF%I(&J(:2CSK7F`;(T%[W*[-+"/,G:Y^`-*;:\`W_]2C+4IX735`\]`I\U.H:GJAZZ3SO]E%/"6A^UQ#O'>$[$7 MQ1(Q.8A*R4/6L%M/G,)!*D^R>=HK5<6:-^@ MUT]E(-?-4!LL:51,NJF]LN*0(+I,U[)7Z_.P.5B0._(X(SP/AZP\69KK.\-) M:IWY4]WP^D0(K-EVX%;$[J1VH]:,7Q<@*10,TCL.A<&XQT,I[)'*:)!'*;%+ M#[OEM!G:KO2DVRYSW$MOIM8T77IYHU$GI4/73/9@8Q6PNWHP%!/3U:CME[0Z MH8K\CGN#U$K7S5`;+"D\C'O=E,$M#LGOEJ6]ZH91P=`/AL/T+BD?KM(DJ:7A M%"G]D3W%G0ENXK,.^CJ0YML?/#U;?8V3X20C,[EYIMIA2Z%F,AIG[266A"RB M#S#E5U7N1QG;UUDC;S]Y"@_#<I=DF)>:.8,?VB!8IBJU,>K`::5;+&[X>*%)8Z'5&:7>A&`Q! MU/+!LFWKE=XZ4AX'G=3T&>-N.W'&LLM/^\DRG_'W&S*M[HV/TPY3QKC;3ISV MU.1.*O[8/&\-/"[+_6%ZY@V/7 M!$=&;F*0[;\5@.*)+):6K=@K5FKD)^S2+74*,DQJ/WKM!/7!DF:4E$]6`A), M!.LLBX=I3;J/\TQ,6K/]P]'?F[KQZX4+)K8(4M[5-G9RD>^2`3$7!)K!9LG= M;:&M,.8&*"-)]HK9<3GK0&)LS*UF3,M7R?EB_1LJKG'2[Z=-!\0= MWZTJ/FN1YA`5GZ^BC6>C/LIYV#S1#4# MEE8?DUXG91;+@A7YG9KVC"/86'90H'HP!WF7&X9 M&AY5` M>K`ME1"-5O0$YUSPG.H+:SM2_GA9=Y(N/MDP2P(D947]QR?KT5LN#1U[E)0_ M[3'JI[5EQL@;I\:M$6[LJAS;ZO73.R_K)\FGCU]DRS:>UQX9S("^TFQIJ4B,F2H=INT3;`O+8K0/JS\=/'M6%G[OQMFJ1FJS(-F6T.5 MI+U_D)TP/XB6;FT^85^8F&7FVQFD&9C<++O5`2U94I;G%VR$<'.569H[*L"6 MQ8>;V7`S<#E*G7=ZV&,TN`K67)NB5`" M-PLJ-%I(QQ*%9DK&T>%CT=.-/VY&JD_(FC:@$#JWO:@\6Y_4%L57>J>>0I@=DX2[U`95F3;6&ZI=TW MP=OF!YKI:_R8$]$P<4'`#<(1/NJF8JI;JIVTG=X*@&QN^VC989,Y,*!A8K3* M6?0TAC=.4S-8&7@/7!4A6[Z'TMG]A0+)5?05D9)S` MR1JYAMFS,)#2QD5F]^M%:FN%`U4SY(-X5;.T5]T&2A:%@`0R6`>;`)=K+W^9*S M(VBL2-UYE4AQ,Y!%9MX#]%G*+"LEOP/HPR1Z132GJQ,W3E)4C#=7@N?!E/;3 M-LY2+U"9[6+DG4"5J.VNLMF4,MM%)JH=M$QE7)"2Y6&+8AF=HQH0>9D^?%%M MZCV`GX'LG0"_W89YECO3G<@I\[/C#?.L',IHD#YMO.,-\TPSD:Y'W->&>=F= M@=HVS+,F3A>"U[5AGNE2Y[3&W/6&>2;*TXV0JVZ8EVD1%^]^M:8*>'U?D'=[ M@B"_\<=V$,3Z!AT("V5@V(@'0S>_OY]9EFM:+OD$'Z0?]"MWM22_7A!^^^,% M_]:V\'J>N>LNW[][]_KZVOXQM8VV93^_`[>P]PY_?H$-2XV-2INE M6[8_Z-Q&V/ZF:]]\.+X1@RR^=-@9=/SG#&5*8*%^V^_P]W>QV?Q!8E." M9K`\6R6)L8())W(?=&N_S#K]=^&=A0$#FL^`+_/RS\>+W[[0RSYYLW-K1J]_ M\ONU2WX_?:[MR1V)6=]()-J2>SF]#H_:?($NU?WL40E8F]*SM.,QC*1P[\N0$__(EW M,T5U+R-X8C,`CV=1T9_.RB*+96O$_O5";B>I796WAKAG/.HG^"'2HSQ\))N] M=HV@3%#VBR.P-?UNMY?`44:_[_#1P^!J+4A[Q9DL=WK#_B#)5RP0#G\]#)J2 M4.P5,[T.2+K<&R@WY>%ZP_D;LH+X'HR M^/6@VCH)XY[TT:0['(R[*?_(UY+![P?6UDDX]\0W,&ZW/TEJ:Y]B_J\UQ"5= M,-6]X:"NP(0F2?RX@QCZ0C?YI7[T^EA";R)^A7\!.!:YA!79SGOIK?Z3%!LB M"'+8)<&JZMG2ZYR8:Z(=U7-7;:TE\XDSO7'3:STPJCH?3\&/WDS(:K5X%'Z)M\21)$78I$6ZG]TTM=_7[I+?$-W986 MD7>B-_X"&MU-----QR6*QF)63/W1JYOG9!%;!,Q@[):"16B12>2V)%W!;'@A MMF>X&T'"7W+!\F-[?&AF&0;M3,-'=O"6:@L+-H"K7W4Z"6""TW'U7C(3:80W M@\$XN$L;IW[3ZX>7:V,VH%PBH(6`+-GEB\:J$+X`B-X@#D.W5QL(C$&WDTD$?#M4F;X)'#AP%):/>$ MI%X'(C08O4`<$#S:G#@@"?V>D-;M=`>#83^)M#!)Z?]^8+E+PKDO]'1[GKT48_DFF/]X MV/@[#F%1O"0\F4_P`;[_Y1V"H;_'_\+'_P]02P,$%`````@`0X*E/MPC@BB* M$```=>X``!0`'`!C=G,M,C`Q,3`S,S%?8V%L+GAM;%54"0`#_@7#3?X%PTUU M>`L``00E#@``!#D!``#E75MSVS86?M^9_0]:]UF1G6R[3:;9CGQ+,^/$7MO9 M]JU#D9#%AB)4@+3E_?4+D*!$@KCQHO#0?6EJ\9R#<_D`'-Q_^GF[CB:/B-`0 MQ^^/3EX='TU0[.,@C!_>'WVYOYS^>/3SO__^MY_^,9U./J`8$2]!P63Q/+E, M_P@3FDY^^]6+@\GI\-POCK._Z?A4?1A,F/Z;LM#=\?K9)D\VXV M>WIZ>O7TYA4F#[/7Q\23+D2 M^W9!HD+`F]FN+"T%_VM:D$WY3].3U],W)Z^V-#@2*O+/#H44Y-L:O;#IY.W; MM[/LZXZ4"0J2'6U9[O>S_.,1<]QDDKN.X`C=HN6$__OE]F.EC#!>XE?^(_4] MPGQ#OK[R\7K&"6=W"8O,&L7)]?(C"^":*YJ)2YXWZ/T1#=>;:/?;BJ#E^R,F MA_GBY.3X3>Z)[^HR9IWU.O4B'M*[%4))"Y4J[-VU.?/HZC+"3[2%*GO>'O4X M\R+_=1=E<@'=-3H/J1]AFA+T`>/@*8RB>1Q\C%E]?`@7$9I3BA)ZCA(OC-HX MKY'X/JTYP^L-02L4T_`1Y:CNPPJ#V#ZU9QY"!-'D8KMA1?6BN49DGUI?>"1F M'0B]0>1NQ>CZ4%LGLZRWS^I"&F7=Q17[NU(9L9-WF&HH06OV1.F!Z?B"[J._'S[Y]1 MDFMPA>G.G9&W0-'[(^6W)$RXF=5OLZ'4OR%X&28*W>L?A.*E#U6M2Z&>DZH! M'O$+*>Q_:W&N=NN"8D;3]3J3-@U9K`O^)<%KG6>Q0>V2=N\F%?9)@B=E-DP" M1$3B]83"AU62_S%8C/:J7C+CSW"',V' M*G^$->,4+3$1V<"]MT7T4QAC$B;/A559SE.6W<_#Q^::#684R$%O'LA/XNQ[4U0GF9:,6 MTN&U5_(R[JE'0U_"DI%&N$I-`Z095O5%3-%,QTS;QO/[2F[G.?HJ]W`5QQQ8 MIVERDR,JU4=9EMM,M50&N%F))EV-.^Q:R&F1#8P4BNV=TP:4C4H#ETK4=NJ$ M49KL-]YH&GF)2M/,%U1`ZIZF]1!:MF[J5?Q-&OL*/YPZ)H?8M<$WN,-8NP2? M-@%3PO_RPE!,7R^%KYK:)W\6VX:B4Y%9NUKM2+G)!7`XD% M7"O,-][/XX#_PV>N'[V(SU;/DS./D&=6M?_K1?6EPB8\Q1*B$\_0P99#B]L9 MJ\""D)PM.[I)!`>5NQ4FR3TB:_W./A.)\(V2!&#<'4PQAUDM`-SP9N[[.&6J MW2(?,2PN(KXBI6FT'4B+-MQ$"C#:#4PS1]TL2$3_#9CH`IB];HH$4:A7T&.G:'2#LA]_/(B]<<_!EZV(E#>29 M=AM=,;NNI8,:05?+'()H$`5N,,``1U(46)MJ*]V^WFKHH`;>U3*WVJL3!6[D ML5L-.,6$X">^:*Y;.ZE3R$LG)0JH8;9;XQ!@I1!P@XX;7 M:QQKXZK[O+N$1_H,-:(6.QS"69<`;DQP3Y!'4_*LC::>H.BKZP10(VJUQ2&F M*AFJC'W8\]PEY&5'4>@O*`H^QA?K382?$;HG:>VJ@"8L]:JL9X$*AA;V-JOR M!JFJ1'Y8P,R#(.1V>=&-%S*%S[Q-F'CR)A(+53&9KZ&"B@0WJQR"KQ4$+A^_ MY=?TQR@H#K[-?3]=<^M0<(Z6H5^[(LF=87<7HI4!*AX:V^H`#1>9X'+XDI+9 MM(3B=0U^,%)SD5%+[OV*8"-NJ&#JY@671J=I`0)F_X)U*'7_C`^L(X0WB(3\ M!CR?YWWH'.7_RKE3"U;C@4(-ZY#W4'$-;PA^#%E\3Y^_4,34V]U4.?>3\#&; MM9`\TYQQ?_.4*^-P5;]5W'$'KU3:@R:EBYNJG$L%-^G`M/81"K)3^';8.5+O M#QT8J0>]TZPI4'!3Z^7KS1P+%$<8S`7!@Y'WG)U@O<=WZ683A:PKE:&CIRC@ MHJ`8'42L5G:!A4HXO$OO%&KR8SABJ.Z`"Q6U'B,5ZA>`%X/U_6*G6A"\R;9R M*UA<\IB?FZY=K^5"JNB4:J2C@X^[W3UU1_52P*V>%RKRR2())ZI/TE7IV:>Q MXX5Z6J)ML@W`:=W;NNC+7RJWSKN/@ZOHB;K.L4=$FP:OILV+AK#,HO M4FDQ:C8PFD?-*L87,VJV>^40HV9EJ>"6=_?9U-QGQA*D/72NS79=&6N)KY41 M7%-F0A+NX!.75DY1=C4=MI>I&FP/VP#>L"VNM>:V].4AC%BZN8+:%GRD'^I#>U;L.KZ3!/KZ##7WB]] M]IO&4N'MQZGI[W!K92,>'?2`W6O9$^::WH+9$6S&.S,!34S4VV@7F#5BTG:F M+P-H;7S1:Z=JA!J/B4LPLY'MMM1JR,8&)D=[.^!'7X(:,@!W)5POST-N:ER;(S-0 M2%E]F6)L(+%;V:5]40E70P/H1H-L,_!UIBR]V"+BA]2XV\!(KTK2E?2C`U%# M#_3496F*4@,,SH:$BZV/*+WWMN)EY"OC&XY51*-#2-.MG:`ATX^N!GDXNJ^W<[3BRU7%XD$ MN=:@.%%+MR?JJ,<&FF;6=VI<+`6!&V7+*RL?X_IC>Q*6FK#L]XW;6<:&JA9^ MZ+;#W*$T>*OZ=;V+]P#KN;T3K1929=KQ8TEO>:\@JA0#[]!"7>$;@C9>&!0M MK6A@6297>DG'"JLF0K1X8U8H2B/H1,J*DIW:<$S7ULS!V^O$CRNR!@^1G\L,Y;V$G_]+K+RZ8 MTK"88"6SO`ADF?W0-[AJI143GL>P`5:N%'P&KA7DG(6XMFUJ(2\"EDU]='G;Q0J?$N):J>)=:5!&X=[C*,F9^O^$4LL@VE M^RL-RW/M!0A_MQ`P'@1V]DXK-+8I%=Y^6X,5S'!W&):([9#CQ!`MSAH4=YLK MY':K<_+AJI5C],P52F5SI?J82[%4'"'=K0$?G>]:-$:=O-FV&1H^^5760CV?HE&)_Y?W@#4<3JW9)0L)%FO!QUCWF;[7A.&&A M9#H]%+>2N3NGBW2[0UM)'_!HI`.(\*'=63TNJ2]*//W1KR;@LOB1[I4\%$2< M-U3VK("\Z]+AW-+P[X@=/]^P_]$8O^;,U8C<=OW2.SH,_TORBB9[J:.<2 MK'6T?0E_L3K:5RB&JZ,=+(!^9,W@QW['(?V..U[\.&.X<85;RHU`G=[U0JCXU;".3KF^OD0U^#;W016.6]%6RIO@ZZ)*)V?W89HN\ M!J(45[YN?B<&WL6[^\O`<@,T?8"-;!=E#1GT<#M9UR#N.GGF0VS#MZC%JY,L M\\E.6PW=I#*'[E\FE#"I_+8_4%SZ-O![#EP'?BG"&>MSPSAE_A4[='"LV$_E MR%!Y]<'(,.@^*46$<`LSY6U/>P'[%Q[,XL#-D=J5[F$-X;"%.&-P9"L*#>#I M!.:^UQ?L);K5BA>RVE!I#UI4DM;\JL[F14&[JV=:H+9%D?"V"E5-Y>E5;BT* M]L9JEL3;L"K;80LK^*R@D>E-\@.;8'`73?R:*8&"^2-3]@%]3M<+1/B%A%'* M?LWR='J=)C3Q8MZ82X!JR2T"V;X), MM1[FK03:N4?Q@?]GX5'$?OD_4$L#!!0````(`$."I3[2YZX#$B$``'KY`0`4 M`!P`8W9S+3(P,3$P,S,Q7V1E9BYX;6Q55`D``_X%PTW^!<--=7@+``$$)0X` M``0Y`0``[5U9<]PXDG[?B/T/6L^S+!_;,^..\4[HU_#@\/?B(IR8*"1`=W+P>?RG_% M15X>_//7((T.3MZ\???G@\-#+IK$Z>\_\C_N@IP<,/UI_N-S'G]\M2J*S8]' M1T]/3Z^?WK^FVOP,0^#C)5-]OOKD*Z/N.#13<&069.TN+S_S`!<9F1XS"D95JP^G9%DSB,27Y&BB!.;"S$:'5I^PUYX&RY M)AN:\;Q<6"[3Z=+NGRB-GN(D.4ZCSREK<1[BNX0*)1[=*+4[I>QP6'/F?E=DHK\K*NR%&%0*AWBDEYEY,_ M2I;=^2/[PPD6L,J^U4$6MH8W_^S;ONUWXK0XBN+U42-SM&+F9&%Y1P[9KR3E MH8#>4DE'V79HO)/]H?(`TN[`Z(BN@S@]7)/U'J MW9I+[H,R073:-O8VNAT8'"2)0Q.YMKY1S-`XC7D`>L'^.\B'/!`Q,,]"ERIW[(+^K?"KSPX<@V!SQ-N2()$7>_E*U*H=O MWC9![Y^:GW_;6L+<(Y_9/[>-5!+3C*[E`$1?<84#@:'9O;H.[C@)C3P8? MQU[4'X<>="0XSH:^,!*VBAH^&A'V/J-K91%3C=F=93\>B&H."GHP3DZSB&1L MI/>&#_5J]O_(>Q@2?7Q59"7I?F1])*/X>5*E9M6J#LP\`/^<;YL,P:2KH@G^. M8'\W*^QUE+,U__@N+[(@+$:@2Z2$(I%IVRG@T'@#TW]CG=)WY=)"7#[$5@#O MT;EKPL;<)1F'&^.?&_.W/\]$2%TA4ZGE?1)*M'`F=JF]Z%1.:Q^-6`OC2N-O_XB]@5$;UC#N*Q'C+[78-@"3B/F+,=(S M)-!R;0W:?_8@V.;T^\3*IU[.*ADM&W[2-#\A]S0CM=QM\$SR+W%*L[AX:3VK M5B?[6L[_*-GG+Z184?;ED8E4RV5@`+_7G`>#@OWD[#/-YRI_=,W9HX%-9?R+ M!Y61>=(T$R:\E455NA)%4+4;#=N8*=D@FY+K3+QG:4[+E5G+:2=+4T= M^>!1'>';5VK_2-2YQ^*HRWM6R97,QR4%^:Q)NA26&I6`%?=T.6QG]V:E5#T/ M`@Q3Q0]-8?0^^`NVU'HDE/WT+5#SSL,RXG3\LNCZK-,W!6>>WE]V3"T+)(DL MLFFY-N_D\7"O!/1SK@P@0E>#1^9P96ME=7&XT(P-7K`-TP]4W7! MH8P:SZE*HU^)E%GBAFNCK+Q8$S<)]/&TL]!C,4);,A7M2V@"*8TR]6+M'W00 MT^1CFGKO*8/QS(@.$H5>[!SXE<0/JX)$QX^,F`_D:\D+[O*^LC._+`M^YI?/ M=4$4L$K;%*!96M\I,Z4DC*ADF)$7.QK&3IW%2+1%.63&)$[X-,AIKK8<94'J3@<8@O24 M+7K`,(P^^8+1W`90O6V]?SL:E=(%^^_.KX88 M7'@U^U'[B^^W0GR_%>+[K1#?;X58U!T!8VCGOB'@^ZT0V$I\>?\I3EG_%P?) M%WB)@Y:Y!/Z`L>"\&[#OBR'2&[+$,ZDLD)=["'QN_ M1A_GYC@&$*IQ"62W0C'G^UBA%ZT?OUB67TK)_N('G1Z#I+JFLC@-LNR%C6-_ M"1+Q6@.3-.T0$95F)FI(H*9VKO:Y,=1<#0EQ&KT@Q\V*9L4MR=;R(YDJD;99 M@T2\0QKAB!I86($7W5=S(W-^34+"&,?"\*^D."VSC(^>1@TY0K1MUE6BWN%K MX)@:9[4B+Z:9.0-3IOL%.H,O?MHN5_4^>8>?PG`U7L.$7LS*GI%[PO@2W0;/ MM;W2ZHB0;`I!)>D=F'BWU-@J]7AQ-<9EL2)9;1N,L%R@O>U$%/`.3ZT3:ABA MY%Y<=:$"3N6NYW#9(P6#-.\5"%<9W9"L>+E*@I1?W\##Z@T/O\3>#R/:'>.4 MBWJ'J(%C:H#5BKRX":%]XF*$[?CG]M*V]F?O,),8K,:G2^3)B?OA&R.,)>?/ MS?T!$IQ,DG0W0NF3>(>OA:.Z2!:CT(]S\[TNG9_EU84^HHP8_?1DO,,:XPHZ M!NIK\.-P?6T7&`"!D8]_`('&8F(=7\Z<7\3!79PP8XEL#AZ0$%9E("T+F8_' MN&K"!"&G9$[R>J!0J(-#P`)/\'4^X(`$U3BQ3J! MMO75-D^+:6]=-+2*%G;>%8,^PZ03'VHAH&K./_5A4#M1$R"("@I,@\R[T-!; M;>R9+T49*RXNX,+B?B)OZ"6"`WJ-7BQ#5!-V&![H!?MSG4O"'NT9`G65+B^6 M.F[)>D.S('NI+X1O]^L=K_F0;@0Y2K8I&[6LG\";^(?`7J/.CSEPQ2ONXSD1 MO63OX*1,TD_D\;YA9D94ROQ8QZK.;JYHPFS):W9*]_O+!(&3(%*="YF+-W#6 M9DI>5>A^S*-,9X4M)_:ZL::)Q"KCH),`"HGM-AI18C:2:[&@&)>&C);IK#?3 M`+J\V-G?.Y@.GO"0?!;/^R\`48TS>#A%15[,W]]F),C+[$6*IER@#4%%`:\1 MU3J$QQ12Y447TR-;?;G(/T@2?4[/UYN$OA!RFY7"$P8F2<2:+$_B-1D M8,5%HO;FHN,P+-=EPN+KZ(RY&`I/P.$3;!\2UR;PF@_&#N.I@5'MQ6I$S[!J M?HVU9YN,K/C=$(^DNT=/\B:69>IN&X!1:J_)-*TH#!H=TWR\6!@1?=(.@[7# M7[_YH'4(#SFDRHL%COZD71II,<:*`QL30?&%3(49NCUUARJN4,C M=;N.<<_H=CB@8+V8>'>$O3WR^]SM5%^MGSYL;3J+,Q(67TBQHK)G3151D-"HNK!AJWAQV$1/U:C&F%5&27= M7=2@E)Z)*(8$H*9N][F"RZNYWD&=AQ]T"5ZJ34&W]*;<;)*8C73'%)%+M+0` M))9#!:U[EO!#>KWH2P'+^.TCS4(;`GY(6DZ%@?22::%PVQE%AGEXL3K>;\?: MU^'K"_F$]RPPHD!7(H@NAR5XAZ=W(F(&7JR&MV;QI=L1'Z!/W3TSW:?%X*UP MR`[?H4(OEKOKI:_;X)GD(*3@U\$S;-W7!0&K6"P9#[#7($P M\65A@^PP9$+T8X,[#/-?=F&0\>AW^4K`627DPI'1IB$PJC1&W" MF6KD!`+0"073KYWF)@S'E/JLO9B`N@D2^W69#FS!-6`,S]=O`S MGN#'IVCG^1$I%DDT\Z*8SC!4GEYT`_W!,[?Z\I[]$I7<*P)>LXA/`,QB2!(L MDE?&!>&@X4)DZ<=\V+B%/2GS."7,Q'JO:/7J3/U%F!^S2"KK,E5)E\DY^\+9 M0;>IS-R+>3?!9,030D9I9,SSZ9$AQY0S?)G($=>4SQG-.QDHMLH8EADEDG:E MWQ#/;`ID%UVJDFE>SDL"+EJ/U:W'Z,MDG77!3&>>2=8^SU3NI22`VC;($BR2=<4$X;0"E6<(DFW?@>_X3R_BSF M[J;"Y@&%Q*A+[DLLDS5:5]UUNH,\8&;,.\W"0H*MJ8K)%9W8]L(NB=@BB8)T M>CI;Y!G!E/%G^TC?\NTBBF9R3IL&Z+3D:1;)+)OB<-MY*7*%.3?S9<%\GT$: M\;_X1KW'(.&F7Y$LILSOD-^@2LY(_?>(>C9)VZM)39)ZONHPH1A,UAO,LO$B M.()-/B[:-R#`VZE-TBC9-$ZS2!JI'9_.'T&_%Z,V_.D3L\51A0+L80Z5#9XS MS$&A.%@@58+HQ?S8#.QSS;W]!JWW<<$O+A4CT]&'+OQL/_@58V(`H@K'$(&D M(HLFD-RJ]B(\/([^53;;MF[I-0DIBX(3PISK[JN]I=-JRRZR$!JNG?BQ2/;N MI;BGUX3=$,^+8?Y"Z]3^:]1>G__<9"2,J\4-%B4?K]G`/?YW]=]1T2(DMX]^ MRB5G:CIVR@MJ4CC]%F(75M6/C2JL\:)[A5?71HQ3"VU?;@>%OE&>H8ID'Q23 M&>)%1],^MKN]%^3\F9M(FN5=H6%#28]>-)9)?Z/$,RND_31R&HN\6`T;SU#V MW&K>WI%$,N8)NYN!L`F_4:Y:%]T^:&MBG(\+_Z+]QV'(GS3.Z]O2@#O]39)( M20PDF8F^%O0"2:DMA#X=\9G")(,R\R(2%$WE9Y=2EINXZ0XE*V507W;AU)&[ M[9(S@UR\".Q$&Z\RL@GBJ`T&FAB`#7JJEZ;`NR>F*9'2"Z5DX;RS*"B7A,1E M[WOQUE7P8M1D#62UT98K?S"":1V?Q>QU38G M+_82@'9F)8EZ+Z]A."1)HJ+1.,GRF:0N!,=D$C+S8G>`EO=\IMF*86@EV*8+ M5K)\%IH6U`X;.4GVXF'">=YL/(MS_EY>F9'&;N;F%4WBD%EYQA\Z3N9[S?&, M9&P$SF];NY`\YZB0V,Y"BQ(S3K>WQD`O.DJ^"H[,\*:CJIRISO)^Y0(4U5/4 M(P7MC,OBGG7L/#EY^1H4O%Z)[SJJA03`!T*SONPH`YHB?8*IL'W<4::CQP8/ M@/T:K`GXKJ-*1`"U)S+?:XX:T"C*)QC4OL(AMGU%"T96V-(T)[;D/BB3P@6X MRIU:EO"^LX.7!2P59F_>-XBQ'W[[1+.G((MNGH+-N]<_O+EB#19K\,]*%GDQ MV7=?!H%E`Y]1FL9M7)J90F5EK:1V#L,X=_HYRDB]GEPPM'V=*"@(-QGDAEIH M]#302,A3]%$N8>"6*9+>)V79CH,5'1B/=&,5R:9&1!)QXR\FG]F1!N-N*W\1 MX3BNZ'?0N.$\^F(V[OTM>2P7MZW36<19#QG7IV$^Z(0HNWY#Y7H7+M53)"@ M1NX.]IL@LJE.%RG5>])%\6._GU-F=,F'K9^"D!RON7="_*D6VT:@$K&%,`+I MI@T;Y*HG]UZ.SI31NCNMS;J\[_>][>FYZN:\KLT6VH$*MIVQ4;%0MCEH'BL MVB&K;'T8&",L/695*7I9^8TK;>AGM_?D^KA MEBM^Q*-Z&D@ZQ[.;;(19(L?9+(3[>RIFNQAA5Z9U->G/?M2D)BCN-PK2ZJ"0 M%3@-R2Z.F'J'I[$+U"^=4WGO!V/.2!YF<67?Y?TO01;S11MN^DF0*Q:X<,D$ M'FF2+8Y21L4PC5VZK#IF_>^L9YQ[[2??E,I/QV5DQ1/O;'ATYK878;Z>K M('T@^6?>HK:-,F^(!\%,7C>_U0-9M\&S.%>TOSR[R:8]Y+F0"C$'`#:U:4]V M2MO\'US.J3)_PWC#?>G>A^#3(?S:N?I?XVJ"3]&2')%B*10U=MZ*8)A<)K]_ M`/)!&8=_-6/X<;Q(\F"!Z-QJCZ)0"U%DL5Q"NW^ M-#*ILNE8],&;;O#0?H;W2$S2T)62A8:][KHU0IRZ*9'!W)R+WZGH;FUP7 MN[M[>Z-I^Q9WXU<.;/)&R;9D5,K.NN5["JVH62D,^&>>;45'=78^K*HV%H'[ MC`??A)U;PY3S[1K'84IU[H!7!4,J*V"'I;8H('V`$=H@;H>C0Q1'\U^;+*99 M7+PP7'>RN_!J%;"&(V2-1O88AZ2U#MP6C))MKRM6RLYUY[>D[E$SWX"8H-L? MK%$D>PG&(XRG-6._.=YDK M(%0+M2\]P$+^`8?R1HF93(/DK:LYN\JV/ZBF"YHH_CR)UW%:Q7$YB+=9HJ;$ MD(G\XX.5MTI^8#5*+L]S6+T;TT:1>]UG0",GC;@L,);K7_0(RK0T7`RCM(#M MH!-PS))I'-F-&ZJQ`B(!PI7Y!X=86#34U@\V-!GI>.QF*+DO"ABU>1X,+9VR M0-W$N>6!TQ9MPR^73XJ7&R9/X"A'*=-B#5S`\.&$1S-W$N%%`&ODL#G*.O4^3"]<930J MP^(R:\P'1@N0B!!6@'J6/'9$>>U@O`@#L&!JF!-C_S[EK$HJ1Q52.1GQ`8WS M#225L%`3[_H$A[3V&`R5J0]KC9,A]PUP:-!HC;A;O/>\*ODE3LN"G#*Q.(0# M4JE`&Y&*`C-%+I@Z21$>`0B*.JL8%-#D=-G13?7]$OR+9J=E7M`UR:#)3%%` M:,4`'4L.31`>.PA,H(*?ML`Q&R%,Z;#/NTN"-0-F8!'8.VGEVEM(I'+SA2,* M0"C>LSZE18W5=2%R33ZT9).A%FKY[&!#H8@EVLHFS!;O704;O\;%*DY/?[G9 M;ON0SU(;IP-"$W6ZN9[*UE9<:N]]'WUI1N,P1I/![I:KNB,2NCOW\`DDQQ'\ MN6'1>)>]J>M6F^H1F>R@<6AOS&N()SY*(1<874O8$_`$5]Q5A%+'5"BJKQ_L MJ]S]AL@VUVHG;M[E73]AT1VE&@&J$Q_!*Q5?%-A(I^VAEV>P^QV5K0UG6?F0 M5QV(!'I18`1V3V!1\$H=LP>TK]+#79;7Y)&DI8#T^.?M/N?FYT6@*G'"',M. MD=-]CVX0_"FC>7Z54?'M=>!+4P3]+XN`4NZ*.9H#73"@EG>IN`%T^W14=VG, M"%B%1%,JD,0B@-:[9@XXJ!,&?M:K]L"W2\$7.N=]A=0,4>T3HS@06S4P;I8W MESAJ@2F-GN+N+';;_(Y^;MO>]N=%H"=QPJ+5W2J2W&#E]&C05?!2VU1UW"-@ M9)^WQX%&GQWED^Z5C?];>.+]N@R&\8' M:W*>LJ)[D0RLIBD;#<=X/U40D,YN_6?PE2(.'ZMX&9@7[LFY;]5.: M1K&L:[95T>NN@S;/5'H!K3_/4K=CC>.47S87I`\Q?U2[&D#: M7^4&ORS)_2`7\2.)JLP:S^I?QGE?2.YJFZ:D?7O23HFS3FB[U\K(D).7>G6; M/Y.@OK/-C5KA(K>):O=ZN]M$GM"=%6>_Z;$S/4$#CL^@AOFVBMJ2 M3\];1%'UN6MH"(*BL`'_L305]GMZ3%1HF^M^F:K<';MGKL[ZHMUM%D35@`?> M;"O[W)2:\'FF4?&4MHIJO33@!I03YX>8@P\-U2?S^B:.+74IA:IFDNLW%PU. M*;A=Q8)&-/"AT=H+;YVQUH^"040=EJGU!>194&Q#`G75-0R�S0U$]_@^"] M4M&DC_$M\-T/&Y6=R9[XZ/2:WN;@TBE-JX6'_)HD]5VBJWC##VB?TD>2!FF1 M?Z7%+>6OYA')-3TN5+5[?*:HFBEVMFW6J-.20])1%E]/LV0'IU\^!8\TXP'6 M!5\!XQ94R_H@`5&R;<.FE%T>A4Q\G\@1358^!+:J%4;=24BKM*/-H[BT\[/, M>W^H"B8\?ESF)11G#Y(CD.8)>IV?&$2+8TP M5F4QL17"Y>CA$54%XWMOKA^O^5:W?U=C"7SSI%&@;[!D"I;&R,EEM*M&39J[ MAT=Q%6Y\)>-A`$Y8ST`N_`VQ3?1]5\RJ:%-IV<4?8*#N> MF70A"2M0?WW>5*%W-T^E`%F^ M?8/%=BPIQW8KN41L)6Y.QK;3N_O&N,\BE=K^.B MNJJFVFZ7\@LB2,HO&[:?5793&_C-C`.#A!BMJ0%ZP09LA>!L=5ZP"9J[5@O) MO)MA]AH!!46ZTZ^9>;;+<`7J"+RFLE M/Z1YB9P9Y?'-D$08\'M`$VBZWCE/E'/W[IGB<@[H(F`#(9(D]")XRLNX`.=Y MU4(MV+#03`,(3*VF2,_D:`[T5O!)]/E0QU6!OF[.SRKM]OYDD[1>\$46MDXI M!GPT:YC++@[I\6-6:.[64A!.MU+R[ZU3P`_2`71O,%P,:(69L-7EXM@NP%=ZMI9.3 M0S_[S(`.61A\_?8[6*V$`:VZ;Y$#XEK_W"P`]^E-H(%Z?YX+(FRRF&9Q\<*X MX,=2=J_?`Z<%I-_;5ZF$[W.M)FKK-M5[H\&[FP,`%'E8Y8'@!NCM-5+RZ-;_ MWA[G&J:WEVIR>O)V=[#S?V8$;O'1\@HJ#.7GBP)TB$M(H7)7,UQH.P&$VH4T M$9.X(O2AWK`%BA9_9=Q:"D8( M9HF:(D(FFBF6P+<0U-)_'44&N7&R8'/9_=/QHQY2OZZ`3P"/*SQ:0;"!RE3^S&&T2Q$3"L2 M1=`K68DPSF\9X<[5=G-G')+CI,J\JG+!79PP"9(?YWFY)@A&&JN2TQ.O:JE< MM2TL)\0UR-SI[3A@C]J^N'9"4N9;&`<9R_]S^C._Q2*Z*8)".))BD*(I-4R* M13#)W'5SPJ#RF'PP<]\M6GNW3MU86[=FL!KCEFRD9A'<M!@`4`!P`8W9S M+3(P,3$P,S,Q7VQA8BYX;6Q55`D``_X%PTW^!<--=7@+``$$)0X```0Y`0`` M[;UM<^0XLA[ZW1'^#[AC.]P3H9XW[5E[]IXMAUK=/:OK[I9N2S-KQX3C!%6% MDKC#(FI)EEHZO]X`"+[CE0`(E-1?9EID9@+%?#*1`!*)?_T?C[L,/,"B3%'^ MUV]^_.Z';P#,UVB3YG=__>;7F_>O__LW_V/U'__#O_X_KU^#7V`.BZ2"&W#[ M!-X?_I%6Y0'\K[\G^0:\^>''G_X,7K\FI%F:__$7\I_;I(0`R\_+OSR6Z5^_ MN:^J_5^^__[+ER_??3G]#A5WW__TPP\_?O^_/GZX7M_#7?(ZSRPWW[`N MDM<:C33DCQ-Z]IM^_/GGG[^G;UM2+&A3M;1]N?_R??WR&_SA`*@_78$R^!EN M`?G_KY\OA'WZ^7M"\7T.[XA.;E"59!^26YCA9JF[V&6R>W1=P MRQ>8%<5`'OE*/Y.O]..?R5?Z3]-FOK?NL__N3GN:D2 MO"9/7O_P(P/K?V*/_^VZPC]O!_,*_Q1X@?]9-JW0'_C7;\0$55J1'\\I8(D.Q1J.FJ+_D_1(YV-6V`7!(1[J;DJ$[S+<`^*G8/[ZU^MO0+J1 MD*_:9__Z?=?YZ0\^*X8Z3(IUTR/\3\5/813?KQ'V8OOJ==;_0=L"[:1Z0>I/ MV?\H?P%3.E`A()3A6+W_]I.1M?C3+>Y(IUWP.WD.Z(O_8'^#8'XT?LQ_7/K8"YUBX'2![TL0P;(E6S;_"@FWR?9'HXPQAU;SMP.16 M)69>0C$,&&F&N(5/L`+%D>A'9/CZ&EK.R,]165UN63]&^N>^8S]I^,X*8-QF M[`Q_+%*,L2'EBOP)T+9155BD\;\_DGZW(>(&)!WL?"G/J8N8J4/B+!HMQN$P M3-0HH M_PH+-]XG1Y*/-01:CZ"#F0]=&?J*Z:*(IH M[?0HU7;J1FW+N?3+/5DA3O.[=X][F)>36:#P/?N!T_=6"!0V9^?J>6+%,)Q2 MK]I'H'D6%I!BM2#EIQQ"$6>?QL)87Q88FD.=+"W$&T+(L-=BA(7H)R`_?FB( M1L'HP*$W*"KSG/PAY/2Y(D0P6KI#R)+C9C-VO\=?YQSE>$`_X#&=#>XH+]_` M+2I@37>3/,+R8YJC(JV>FA]SEF^&4M[]\X!??X35/<)O'C`)2:X83QX#M-R. M[LNU;&GZBW\BVQADR0[+7-)R_5@-IOJ`.!G0M0BZ)L$M;1/4@D`M"?1$G32Q M%NW0"7CW6!4)*C9IGA1/=4[6"3@_[`X9%OB`!6VW<%V59-/U_!Y_"%B"-`=G MZS4ZY'1F\7Z`/KN0!U74G)`XJNK61;++]O9+!="X_A= MN$/"?<<4,WQGY2NYS=B%_78-SK-M=4OQQ/-H5.MRCV.N?D^U]7L";I,R70-R?'&39H<*;HY(Y8(%G#DJ7VZ<>9<4.1X[RRM8 M7-]C-;PA"CB[+?$D<3W>Y]"B93]>3FN%<*UNV(U3JB;$T)=SKIK7`+\'E.`$ M4!+P>T,4^(24GI*1D3*&!B%EZ0PD%(*-VJSZ#&4 MI;UX>T*'@=J0*6OLJQE\3!FL2,A`J;VF,!!BLBX0#M0++P9ZPW9O48[">MW! M&G5[$K(8'[Q*<[!!6984]:!%1ZO`*4Y+(W_^>IH?[(<:]=ZF)4,0W'1=Q5.C MR^U-\J@__LV0PQT)3>0X=!\SNN]R=#1K7M>7F$CEC9A]_L&82183T);L9T8] M?L[!I,"?S(.(&]Q>R"A,5Y.HH6SZAO)\1N$P]J,W,H>U MH,"K@SJK@CJK@1[6<#RN_IDOUDA6^R) MBM(IVX#%:.'.$"[+.<&_P_3NOH*;LP?LI>_@I\/N%A:76]JU\O)0D0*9I#@G MSSG.XF4?RXS7RIIF==/.R9HV*38[,TFKAAPP>E`SD"E%S0)Z/%'XZWD@0E;* M'1JLD8C.D&-%L-.Y02`@DW&EA7+"H%QOG_>W@4J`.D8ZP-2/`X\J2T):-`H] M-U`;Y7I@B;@-S.*U0IJ`: M+/A.J1RL4@F;=K%8RQ.N6EJ:\C0+K?A-4^<&O&(OHUC]$:L/:7YLWKK-A'B\ M*K,,'CRL23J!16]7+[KD^OF`D"_EV4,BIE013)$=B*>^0@5YT,^.OD'#8UI- M$KQQ1HE-(]J))[,:\;R5;_/#?:>QS.R;34;`K"8-DF):^8`U,$GV/])SAU8& M9)!KX,!0M1,2YK1EDK?P7/R!T[7I9^,6M/*)OIJU"]A]-6Q/7]CE&9OG8]BG M7PU[(=@]1\..,R'1(@?1(NUPN02JY9,+G>5'S4\A?!:S#4WPS] MDITNRAGK>I@:>@RZ$HVF"VG+Y4J+N;9.CTY;@J'#3%N!:E[-V,&5_ M.7)V=^V&I#G-:I;ZT=L(5-?RBG(TFX\N?KV@^9MRQF($58.3'_D0Y.F+!;E6K;2%81[NB-W;NNZ99@DN`;7@V-V8VND)+$%7W![% MFS:B?QQKS,L]GL>(HBW')5*X\""6'"',U!1,XJ-92R+*:V$NA\`B7K^!T;&4 MY[*%E>Y)/U?`BBGW$G>9]79VH2X>OTFIK@&__[I&O.[ZSG.<-FM9U&@@S;!D M5V/>T14=,<&76?$B"42Y*](:8@S+%P4$^?+EN_QA_267\')L!U9EO#Q90IR9 M,R9CY"Q)\\IY^7(ILW[",P#N36UX63,CM MHP*-JJMVCMB\4>/B,T)9IN7!HO#I8.X8=&P(P>Y66*E/&`*"7*-XF$-YE\NLLU*B'E']G)1VSE% MPG6%UG^\31_2#SPGB@Z#1B6@R1)&JB2-P2BGJ3 M&K48Q038KU4I+`.G.ON%HBA(6@:,BQ[)7T.XH;O9;5_/6AU/`B8MZN[POI3: M]OBP3E>LC_DK&I&>,);RKAJ"VL*Z4:"C"1U$Z2D;&:ID$/20OH&S' M1[@=:+WU=OLDW8`M*D":8T>'C?())/D&[/%/7!?8#=)\RDU:TJK_&W#[A#UB ME:096;[X@HH_P/X^*7;).OR0.Q,R0E=H"9J@+N\LW[S;[3/T!*=QJ!ZUV!4. MJ%U;"J\KSEWDJ!$CPQGP\ETG-:"6*#JKX&I;9B$2>(AMI<\DM9O%X.3?";O" MU=`YXX^'JGNRM3(`&'R>`#-PQTX@%F:YH*FQ\9G,-1XF6^PZI)R%@@FILWF= MJ!/NE@@X+>A-Y2:,H\6!MA)*0Q#/3$ZH6NXT3@$$S@QNS,&?OBV'&F]+`<[` M4Q\$9H`IGAE@=";];B"SY(';NB=7>*051OVHCMH=6!1-DI MNAYAAUKR9^C#;)P/CV1?;'S8K*/HGQ[SH3/'0>$LY0V,MGL3EC5ZY7E]&VB*EA!^W\FE%[TFJENF+HJ52Z"--0D[7O5X0!I/FW M$>XYSP`-FJ_/25U23?Y!0=+(L.KTD/3BD&V.4J_IRF$/M+P$I)<`54D1W07! M&GRXN<@?<-0]Z*,@>W6^`/GP(Q/@P[0U.NQE.)*W:VSC,G&JX:GE[0U/T63" M6N!,Y0;TL2IW!A(Y2J<0$=R=KK@&1STONS9M@1Y-=FT8>!N.=@L!/$06Q-GZ MGX>T@+C7>'2NGJXP_BJR!8B?[@F),"%"EW&2&Z%D=+2OK=M!5QD3&NWI;'(K MQ0SR*!@U:,A/`&4XJ=,J&IY8=KVU,LC$6PBP9 MBZ[P=[A/2E(?9$MF7)2R3LYX23!5IVPL`=3E1IKK)(,?(-;[;;+^XZ9(\I*$ M'BC'HV6S23HR#@,.]@EU.*PLU:!+=J.)7D-BD]3A7Q$BT%*!'EE=1+>A#&N. M)C!`,Q0U-#\-QL[N8L";T\G*`K"C0\`@UZC$3*^S%H95Q_9,D2=R_;ZQ%R9K MCW3T(N M('4,[4T:=/6XX8IL;JZ#'_'L7!]]HMFY1()D?AX%='TO)BV!83+ZG).Y@#CE'7]ZBH;F"QN^@`H!J< M9#RB48G+X]:F9=UR/`X)FC(P7JX$[LA#*5_C`'8'+J(U4BDDQ-:I@2214?)8 M)=88"'^^!Q,_0.SO1Y!1H^P@&.\XX1""VB.#!Q"&7(W2&0R,F(2K4A[,T:AC MKE>GS.U03X1@E2K*,<$,&9*%`X-108M7MGP0"HB>EZ\\X9$,#!^3ZE"DU5.T M`X-7'.HO8OE`8HSYO[P[=*US@G6$&N<)2X4NE$RI\\/\'1@P[Y"+E$MI$]TQ M@T.=;\S-PCR6)$PMW,Y(S#2P!^:0W,B>D[YI8F;!'=K[-$_RM<6!!@T!(:WX8&&A0`>9JWG,]RSA:G>I.,MO)V<93#AX:STB'F< MS:^5W7*WSB-K2F]:+98P6N5YU5'B2?:W_=4>0A[/]%J-"N[L6A=,G*FUD)4_ MLPX)06\K/!Z1R"I\%"2!$M`+'%OD;9XU\G26=7QA+U#5R+(\X'$*7FX_H/Q. M8PB0,_`J2/(9W%4$E';(835)43N:90'Y[./*DHR*K*H2NAC=O0(!_+J!.JCA M&!N?3U!!,`C0_!6@](&W:0)JVD-LU"'2_>!#4Q!1=P:P+"P/X\CWXNEHDMTE5F0S[$\)IWE;/I7M*3'00NO#2[K#E_:C68D'T+*-L)=WFY&F#AK.]QV00IN0'@Y2\E MW#W*ILO)D+VB:>$4U>SDHA?` M!+!QAXAX?4MD@+Z0&.FV M%M%4"R)C!+.F=4_.5[M13;MBM)P@2XF?X9X=Z;[R=8VR\KFB3&/IS0/.8CS#-H*X.:/QF;6E#N^X\?9& M[;DXI3/K3-JQG-29VNILP#&+U>>?8;\C_R"TA#TE& M.G<%BQ1MFA-2;V']_Q$^Y["RSV7$:F4^4_J/' M<`)J%M`>>'O5<'T;U@9G`0C9:'9HK282.A..$[M.0[`@$&["L+2%Z::!*1DY MU@V^Z3]@)^VE8%@4F2V/XM"CTQD.*XOB"4>0OR7906]8$O!(QZ,QCP=C%G3+ MQP@T;L*GM<'H%FX\B>^HOK M*BDJT]'$.1S;NC"\08+@\1;>I7E.`$FN(Z$]?[Z@-!LMXH?EJ3DLW^62*>]2 MH#Q5@!*2FPE>`!Q/GQ<<_^0P3V,I*/Y)`L5GC+P_A4->\!TS5IAR?M5'#0'R M'329`!^[$QH=]K*C)F_7>)M")DZUP];R'E'51QV+T([ZJGS9A-OW[,+U%I#[*4A/=N`X<[> M0E:PW!!YMOG'@96;OT$-E"#^!1<40!]0B9_;#:(^FV!*\]*$E6?R^:/MAFI/ M/1.[-2\-KGI2B>6U0-B'V.C&_5?WD"\%\9I!,ILB#8ISP! MGU"^9_>-AT[4TM$V,M#+T$(E#)VAA8"1TZ'/`YKJ*BC=:PJBI$?P/%`C\NRN M<;.E@PKM[`H2-1+8N*;Y/'=(^D59,>; M)Z&E%G4;7LJI+6,#K:[8AIFJ1F3!@9QWU1`T:U2D=`:C`:\85>`,9%U](T.M MC(,%*5,_8`@'*,F(L3AD:;KP/99"+P#K M+8>7):SJP21+D]LTH^NC)W05'6T!W&[ANBX8WSO+&'KI?!DPBX:>9>$<Z;G0"IOLSW&6)&W^7:HR:DD[TJ(+F&J5F88NM19_GFDJSFG=$) MF=+[F@@1NF4M(8[MS:3CKAVY9MLFAJDE4N3Z&?-)NYK9;AB0^3B5`&H1L5FY M$?PDYC\#QD*OH"-+YBYBM0;OPU(@LR`#68WQ]0$3Y15;C'K)6-1\T MG"*M&PKB'`+L`35C,\$:4C%L'5PE3T;[!B-ZY:9!0^]IX7;4'5_;!5TSD55:R)-W5 M>\F;M!P2/#_,F>\0V*,NL$#9XLS( MP3M%6D2!.SG(-YX,B-JVB-SX(G6G#?7!V:,89_3! MIQ_OZ8!8-P3DRC*("Z.QA67G+4N91+<8P^2N]).NBEPB2_/>,:>SPQJHJ2+4_L=[;)0*,J MG:<&'+-L?7YEH;R`6%WBSC9_D.7>V9:V,(W\SC;',#6L[.@)J`M64Z)/0%=F,E"BL@C9+C4M6Q$%%=8.G-+63HP751EB1D;35<#@D MEF50Q(W:5L+A2I;5/N$PK.C3>C+8>QZZZHE$4TCGTX[KG4PI^]5.EE"ZX\HW M#G1/J]YTVD^/7_OB>C>V^E\P+IH@^#&;03G`S[Q'AYU MAQMA*.@<.4ON#-:'IYYP9R;[?=-7[2Y>[Y7E?L2T$=L=MX%$V:9!C[`]:_=$ M?5[HM7_.ET>R3S9>I>\H^FOO/I3F>&MHANXB.RFIJSKQ%HNI\I:O.WB3/-;S M7&$HID$YJC?(HW12&D[2!3=U!OD-J&O!\?BZ*G"DL&#].J8H3$>ODZ)O:A`P M[$L8IJ7>E@2,ESJ"#G$CK!_X/-"B*@_H"B_+>=+>\3N^`Q43L$_`(;!"O[A! M.R_)E2L&.8=\U3\B'8D?E*@'J;_H$,53N@Z\_K7LU+59*SO.T\+SM"WR6G;Z M7GI'4K#4)H&U0[AZ\$?ZZ!QYH:C\CP*,&EY'`$!?RG.:F3%3A\2YW!#)43D7 M$U7*=R/-E+F<([DJ2"72ZND**ZDZRS?DKND]V5:8+CKID+*?+B6U`JY.)^R< MD*(%,9ZEC*OF[0F@[VDJ=TL1P<*6EG:1B1J&9B#CZ*PB#'"\$/<8_.> M0@=VT`F^C.\..B(?ZAX\RWG87Q#:?$FS;(3*\6/V@]O'5F`?"[?SB#UI8O2V M1*OF7V%!.?F^2/1QAE!KWG:P$4^"(G(SB@.?H: M;SVJ.?M;DC$@S_'^\P(`K/>K6P@F#(+!(VQ_:!-O=1\AWHP&;\4ZUC)X.Q7A M#:R'D<"SQ9\@:O"/OZ47Z[FK]-SE>1=+NRX7Y#56<9LE^!B6:T7KM++EV?&Z MK`L5>%A6U]!$MY`>SP*Z2"/R)7,O.C$;(G3.6^GHY/2(=")PR'HZ6ATU(C(R?D6?L-N3D1- M9*L/LXQ8ND,L[$4L^1YRM4W.KTC5VXRV7-KIB17_*/!ROLD:#+P*N,>,`M7Y M)3LO/5$0BA> M&CX*N-HJVKUW\O3]2DK=XT@**7%T M-*VC)%0D0S*'D%-#R:.R_530FJ_S4?VL#;P-/,3-U;>R;-9,C2^X<87R.]*7 MMU@'_#A.0M%L7'$H[+8RQ$U:;EQQ!4OV,#CTJP]M#7CRN`W2P,>D.A015-V5 M*0QI?.+1KL:4L+>KL8#FW6YBV0.`KH&P#[''EIRBG*QS=#<#A'=GGF>. MYOJ2>2K7V(.?H?0P8=4B!-\]8BH-PCV42B'7' M,F(.R3B:Y([)0HUS!N6.EC\N^P6&MPC-"A\TV2C2H,P<`SJAV7P4!"D,V//' M0A>H2SXM$<@G=U7V3=H9.P>IT8I6Y3<^\[!LX"`"[*BBJ04GUSFO()P.2ICI MJ+BXA>$"P,I724'WZ(J_N*`C0&F4&70,J84+#NKX9C5AOP"A!\-1=\#.$TOE M*VK5";QO7;$N2K>KH4ZD_^4YA>P4%K$\2MP7-'0)EJ@O'74#%FG=0V=P6>J?0WJ M]R>@S4T\B^"8LIZ&D9$FAG8B9>E,)11\G/I73R@B7O8SW$"XHXEW.58GRBO< MH8S`*,UQKV#YC(`DVR,Y0= ML,S(DGNHFG35JX0.S[$04*$M6X66+$[1SOY%C'B,P M2BC:FKM3"LN*J<(F[3PF7["L,.J4?M4^K)5^`NCS$W!1E@>X"5T05:PLI/%Y MQ\5/)X3]FJ?^M6[FZ)1%$1VHORZ'VP"@K`&P3PIV0NH___#=#S_^!?SPW8^@ M)"ZP!,FAND=%^N]P\_^2B!."E,($H`*@0U5624YV,8\3->*BN7:X6<[]G:/= M#N5"WR=ZW1PJ';^V.\PE:,SR!-=4JN3@UIAX53^)T-,)58-4WW-T,&M$U3N/ MY56[CEV;E9IIFF.M:)%'.SW!G>'YM!]/_OS3?VM>,-]&SO;]>'+Z+W]JGO<\ M'4A(JD:QO@>G/YX`8I:,_,\__8DOYL^G`C%OX1KN;F'12/KAV!`I/%`Z&Y,+ MKG\6,"D/Q9/0=XH)FI7.*8'=^I2P0AZJTC>M:SI27^N]9S#NZ2"&\GBHZVZ:0)FHW#F3[&W6J.R^@OXZ;]U MD2'7$?[T+S_W"")S M35BFP:28Q54(HNR4LZ!3UI)6A"(6,`I.:T)`*$&:@X864.)H0@,U''CA@BZ( MI@&$D),;5`1$GF,WO@@$VZ7.$MPSV%7D.?;SLDK'9 MI.1H6))=)2GNUGFR3ZMD?(V#@JJID"&@LJN`(&_:LCJ&4+BD[(&`9]6]`.0- M,2CV+G#Q`X7RD.:G'I4]X!/WBAXLB`:WU3#<@:*N0U5_&!P1[K-#Z$(8EE@0 M%L%PA(;E'-]G6"5I#C?ODB(G1]O/UNO#[I"1@?DMW*;K=!P6ZS.P3Z/!8&4+ M^AVR1:D\OM M3?(XCFGG<7?5X(RX;:N`S>FJ=>4XPT:EI<*,9*WZWK].+A^P@)H'O")N,@V4,)-1 M5KXJZKE'5Q=,92.4Q1=9SO5X;G&V<&T4=JFSM"R*B*9?$65"8U_F0M2L M@SHH'-&*JA83#E;.XHS=*QY5X1.API#6!^;4KQB3CDI7+*!]]_5-[$'0536) MX?)A&]5+BY=8*C_46<^KI+@L\'RS@ALZ-;B"!Q0%,7J>[QG1N4(D-P5%"34PQD]/C%1TW M#`E%IRYZ,40J#KR^2G.P05F6%"788U32J#=PDHE?6.H=>O4%S%"C19UV>]8> M_)..$B)B[N@P(79HBJ*.N!P-.&WHVMR$=>K]679Y1Q.3:0GU+#`I!2ZXAC3F M$1G0DC#RZ,D=HHGKN2)\3GO1EOY9H;"V(0N-X8B!QKZE)H&5_<2HZCIY0;A%R;>7:L56F0N-7TV>#%QH_,1 M$]9]7G:E)#1\*(=:XDC[U,[-A-,5]RYUV(B9I?1YA<[U,L[21V)M2\U&#`^) MY?28Y.:S%)R\NUY'J)(YX4A+:MGCRL0GNT!6D.H*FDO2!AS3V@I^5@`-NN2L MLL*L13\=_E%=A8@7H$V0P#NV;K;TK,'(/;(>#')./?H"R)/5(8MQH=D7_#2* M)G@!8,"2.L*590U*40$=5XN!&EUP7"Y'<_U/QL#BRR&[0LW4`4>V7NP*-]IE:2R1$]"C (%50B3^IBS4_1M&,/JK', M)^+A>L[HBM[*%_?T]"P"_7A1;TD\^'61\V$A=(TQK/O:XD+;']*VVSL([97.*P1>'K':M>IXSU!\7)6\N>[, MG-&@JK<+79'EQH-R%S3YU;[C<*\S0&-46UGFC/7YS:HL+XM5 MOY&L;\B*JH/',0HL@TZ;^M_N\*DSPJP?2CIL_'#*!@W\@)3`(K?=XF#["F7I M.H7EV[1<9PB/:%!P[:P)2U<(435M*,W\+%Z@QO_8P1L,Z:FSIL> MDUUE(*..6=:#TVU+4C9(3\2J1P^$-H,&6B>XD;%B+1X>P6* MH@&BV\NDE$C*P$:UQC@%WC"*G>+0&]V"$4&&D3:.,#-Y1X6";G"0!U&F;*Q M;Z+-9F59IIVS<_(&K8G-2EO(JD$.M*PIF4,!S175T/CTN7NS&LN`F<;V#6\ MV\&\^@SWJ""FK#0M?88F:E(SV`U4VAVRC)9TVI&,3&KV%:,!+5'@$4E?U=. M@N`+8P;*1[.4,UD,4[,.UL',D3;;?BYR'//#LGKWN,==1TA]U<=K2@KZM!%4@3?!`YJK+$Z]>`WN417Y&1"<;6'-#7'-`3VE;>DS ML&^AP6!E3_H=LK,DK7;$-J3!OFKOT8SDL+.!KI&Y.H:VHN;KK,0<4O-'("+_ M,]QC^-UCL[PJT%V1[-0CD"%;,P+ILMF-0(:=LQR!]%N3C$"Z0NKT%]"1`D8; M>`0RQ0.:JZS1"*3)W1N!9D)PN;U[W)<]*I/LEP(=]N5%OLX.&[:@)UL%%^WJ MNQ+7;0?9B;/=)G+R8ZRWCVQ[(=U6LA.^:B2`6L0):(4,-E]Z.U$GH!,44=J! M,^@BU_B9;&E921UL=1VQ=3E-?(C:R$BR1*R[NI&9C"C)(EZC63!-3[AI)\S1 MT^=0;C6[2HK2[Y*OS6;-/"@-_NEVCE`.28?DG8%0U*8="[Z/'M<>+3)U0)!R==X>MS/.T_;& MK1AE[`V9N4/@Y>2*O;2%AE%%J(L%)CNF,+KO).C5K6)V':B*O MRTQEXP$+SP;9JG'..&R@-DEKG8]79OXS!$U37V/&O-.1*`+HD_%J#/27"6C1 MB!8:TLN->_T47-'()J7AI'\[LE1IL^Z2O?7,C,]1IW9736IW1$.$7&?<[&Z% MF^>2\G.Y?0+`J3-VA`/B4(=)_L>K?)%+=*'^Y=S:.+=3Y-J4=(+T8T<(5S;O M-ME8#^)B+DYJ<40N3ZU+87JQPO4)R<7)Q+X!XM0-.L8)<8>Q)Z'/`8?(-;J$ MQ[(U1=.*[.^6.$8]ISD\=S`?UMB2+%'/8.[5%C5@MJ[9:-Y1^QJC1FW*BS8: MB%KUZ.EZQH`CSL6,F5!"=AJ>5G74ES&L[!@GDIU7(`T"Z*;>OA#2+PFZLI*D MRX-W?ETMM#Z01G&;[W"3U=-%OD7%CN:-BFIJ&;`T!RAT6.S2N`TZ97D00J\E M21ZVCH!50T6MK*8#/<+`&=974/"U[Q%;A- M<[AY`W/\C^H*@Z<\V_SC4%*?\`E6E]N;Y!%'K"G:8`92#Q^SU/\?683'%IA: M?+1@9?X>?[*=M_#3,;%S\='>B@H=;BRS;;H3P`0#)AE0T:"3?0*P=("V`,L/ MZ[1\F@5:`(A#E^BAHOS;?Z:KZV.'M> M!APV89-U]:RJBO3V4"6W&;Q!GS!Z\,0)(PGWX:[9Z-7(YYPA39+N:2+->=+> MC)_B/EG4K!-FN7XFLKF)@/V(Y`3TY1#[&4IJ!&NM@7JW5-$VTS5)8@&1E4/C2H]*M!25%S'"85 MQ>#?GGJ_(@XV&+"1K@X.9DGWY==L?JJWX&%FIV:YNUEM:00771$:)OCH MPPTKJ]#QE@[,3NT[YS2BY4N/WJP-5T50E62S@I?8K7L:W*21GB**V3!GA#51 MF^:2)Z!(WZ\K/#N@6UFB*OE2JO8D$Y_*\N2&M&G;$TDBX;*C%WP>;,;YAF3Z MTV2%$F7IADRY0$M9DN$ZAC."*FTBS6\_/CW!)>Z?D-""QX(5HIJNW!#;'*&/ M_[*M]CUX:5G3F]>0936GL4Q9?>X!Z:K]&_Q.GX2NQ<17`Y)_O7$I[3Y-OV"V M3(L!<'B]AGE2I.CL,1U?Z2ZE&:-R0.,&G+QF'6%T)%H#J@..#K$GH'D!?B>O M8H$N5V53!$LT.P9RGY2#9YG^%X0UZ\6O>;F'ZW2;PLU;M$O2?`QM%5T#;R&= M'<15S5O"7")>`G4AUZIY=0)Z+\'O]>O0D%>J$FE_]A'T1>0]^.OB(X!GO]R^ M3_,D7Z=)=H7*5)+U:,(R]OLR%C?#@$:G'(T*\I8T!@F9`%&L_B;!4M<07-_# MX$6:C(`P'4WTX3,>7"2_?9^A+J;8W(>G4SJ:DKNQ+V`EG M=L5K0IHQZIX:BP:D!A; M"X^%8RXZ`%KPJ/FP-]R)C92F.6+.I;$[/2QKUO)HN4"TY+@PEV,U!GTD\Q>Y MQI#6%QZ=$N:1]DX(ZZA_053O]AEZ@I!>)7?Y)8=%>9_N2?KFN^O+*WJ&N;R@ M_Q;=\#9;0&,/Y@+LC&5VARTM:4Z[$C,S%[=J>.JK!D'+18]6!+;#^3!"]IH= M6;"QG)YY6Z-YT:NQV.E/')CV+I#\##,2TY^CLBIIC^D5DU?)$XWO1:4"'$GK M+L:RDF9[ZQDKWH5!LATKR<",!F`"CFI:X*\OJ5WO#:" M(JI*X`JUR#%V)K?[V`@=7.YSM&;E^CZL6*V+WEX2YZQ.+LD;N$4%2V^Z21XY0[Q#J;VAWH54:]_D\*?9#_UN.B-W M4B[:$%S<=])46WY%I'T+B`,1W)=Y`FZIS(8C^'%NUS!'GD`V=7H.A`^=WW.Q M2\=GIX[(0.N:I6596^"F;X&H=V,M,\'@9[%CMSU9R'$,UAK?=PG5U MN>6^UPDX=&7(P@NE#/=.2[?;'D('C:8-_9!2HC`L(""O6D#3JY MPS'$KLRYJ$0I7$F$%K#$(+V\*6@.P/4A(#(`X[&8UM!XN59@-,@N;`=+9M/> MP\TA@Y?;\?VLO:IS;Y[82]&RO*64-A-WGA3+/%VKKMMF\,P[DGUJ*>%;9;4&('$%BG&$\2U@___AXK,+M'=[Q&`<97C]#@KTT M2VN'3VJ*W4.Z;I[D3_^U!+>',LTA'H++FIDF&Q&2=9O,N.XG,VZ;_%90MFF- M+]N`A->,1V)"LZL4=^V/;Y9]]\A.]3:WS](S8^IA=J:14YG9?5># MK7GS.A[%5.I@P)U^(S#,7QO,9Q6(G9 MX+MA5::%*P*QV0L9@_&30Y84=(+;98:003:YNROH7!TD.W3(Z;I/VME4PFP* MMC9UQQKY[JL%JIM'KQ%:^FD6'A7C-8G9( MVD;`+.@M/QUVM[`869."BGT7$965"2N:M@L%Q<+%=B?B675K),V;$U"_"VM# M*N4AS4\]1+^`N,/VDFAP'?(XQ`4-5["+S>O/@QUN00EI`-\N$3`_#.D]'X%# M$5N\B,*(N!#C^3TUK!6:L;;IR@JBDQMN6<9*#$O[%>&L5.KZ$F[IQ"3 M5]33/S+2T]`6 MV*MJ4+:3"S&E98"@[(*KH%+6D"Q2$/.-?6E-VW>I\7E2'9TC`^V,@PHA0S^P M6!Y,KORG!QC5VYI!@>42$-^PM!E:LYRM>[S+TEV:UTFK7(]HQL0^D":3E368=@6C)+BJ78]4^!B5]'G@75*HHI/5A1WN7/-+>ON1"6G>> MJN)&__5\:!!$IEV"($ANT:$"Y0@B4465-H@1IH$XP(R]/_N(YV*7Q086`]9NIYN!V9]R/R+A+,BG0WA:UD4>@K)^%1:-8(4CY$8?HFY!UL/.M5==>RU*_6GYJUX-`5/YI#B)$ M'LD&$]:9$V?YYC+'Q/#O\+9,*[Y#TB,>Y4X(B)WL;\L[XF9[6]B&>G];P+HZ M_^WZ^SVCB6-'6Z'1R9:V%@(8KN4\TRWMY0'CVB5Z@XZ6L^RCJW&:<4UJW:). ME4GA%G>S/6V=\G:Y9JG2=9&5@+S'[6'$.54V^G;>I1Z M6QSNZN5PP2@U)1B-4CT")V"<-NAFE!K(5:.P1][#8/3B^D,6)J-1AT6NUTF@TY9;D#JM239<](1 ML)*6'`._$TI`24/7/#%!`YJCKM'.DP9G;Q7\\X6H';O(@&^;$[184>I!G/: MGV60(G&KL[:LSQUY#/;T>5WOMBJ2O$S6-)\2?$FK>X!P5%TTI6^Q(8\/W)?) M+I*HVP*+.G:NAV>US0OD:'F`2$QBJ4%I&8L@`]8@+1OVDHI)I>?>J[[%O$2T MSQCCG@/>C>;`L^+_A:!^JI@=D'N`>G"GK.#JY<)=5+@J*-P=5$]]G^9I!3^D M#W!SEF\N\@W<=D_&E;3>/'U,_H&*\RPI2UI$:QP$.A8[J:UJ*=91`3PW/\Y5 MY57KWNC4Q;-L9%"7M9;UFK*")-^`3AQ[R*G<>OL$J%!`I;*JK:&7+5S#G5-@ MSZDA-4[+D71>\;WG8*'^JKX>@:V2(/@,E#U[)9,[9IY9:[-I9[/UPTFURV&^ M$[7@';7@-6DK]!0Q>M-55Y"-W7B7VX"X*9(-W"7%'_S#F:+7[,-.7ELY(5%C M=L,]1ZK8%4R(5]T3\*JSW.RIMMUOP]JB4#U(]4V'EC&FZA"NTO#\6B.'LD([ M6)RCO"J2=572"X;)JFX0O8I8D-GM0E13M\1&E%WE M"@<_PK*ZA5T/)#4P;`2O&FYR7TG-3D?1HB^#/EDW4D".Z%QQ70L*7%?#!3B1 M2Y2,*G182.S5\3A*NW$=K49I0:.T^[6M.86N5!2-/0EKWD1G4;,'Z??)`RI( M@/H!)B4DK5Z2K2SN**Q%R[Z4G-;*'VAUPVZ@5#4AMF,YYZI]#3+ZGMHAW3P, M:W-ZJD5&*AC:C)2E,XI0N'$]4'A"T,C5;X5P"NS#7>))Y(5](&J^'S59'?@@ M2/RS$])XWGE"[$S+JN.6OGINVQ(3G"=R-6/Q/J)$0TOT(3=@&-GX+%D]XS\: M8W":+1*-3;"LD9BN>@H+<^%@%@709P]_XQ;HOOSD;JF1N9@QL>^ER61EP68= MLQN^M-L2FZ:FB-5D\#FI4U=X5W^&M5%#9*!YBAM:H!YO9W'Q`-'UW&4Q2-(D M^,.NV0Q=)T7Q1$!87ZE)-TD3_,FU[M4\P>\:0;<)[M8:@O(>P@J0ZZ]/P"W< MH@(+6.-??\CH83C<3%&E_\Z*4Y!]V]T^20N:T[6^3XH[&'HGUJ\=B,:B([8$ ME\?PEC.#4TZ0=,*R:$=&\:SQ*,@C7`:/R^W(OQ='9F<]E_3N<0_SFUGQ'1]1P[L^)M/I,@'%%,Q$R01)O`F2.Q.FT1T,& M=[H3&9!]S>.7Q3--=.LC%C(-T%U$C'"L"7F&VTO"ML:D?D%T+S>0*989)M-] M+>IVGB^GMHPFM;IB.[-7-2(+'.6\JXMQBNEDR`D=*>HI&QFJ9!P92IGZ(6$X M-#D=$3R"JEZK564N/R]8B:?`?H`5Q22#SH?TIQ4#Q%>_E_GI*)>/ MW.-M1N1MB;@H//A9MXK=GQ`8+!7)!6@L%PD$>)MIRSOL;]E(V.Z\J;9`G'KY MJ+=OT>>,UJ!5"-.::FNA5&.RS9>C-^&.`^B:0]//-=1S>$<$S%M86@3Q&@.8 M:*ON)4)^S@J3?]!',19^@N-R6WK$ZC&.$/LR\UY'O(U==1NSK):P*LK#]!CY6;[#T/T;(M14S*6]C*,91L8QY MG7=5OL:X=9T2&(9"!^5I&E)0,[,D=_:LV<>JZ\\`(@)0&=&4HID)14[]"BM0 M,\.?*XU7G>(8K,-?Z9@([(36WT]N<=!<@$U:KC-4'@IJ,VEC'\T>>ETBACU, M:T.*Z?ZK\/:BKN_R0BS&93YC7.9R^LV*G&A&>5,FET1_8U-Y\78@JJP8C1TL MF6PRZ-8DN83[MCLT,GAKFXK,:\KZ&,A(J#2K>$"[&D=@H??H^:I`B@\X2?KM M$PVR>[WITG&JQFR5ML66H_&%IDJ5G"V8I=8E_N*TO$DJ7(5C`M.K>L%GC28N"T)A6J!#I?N\QQOG4?;`OB0K'>T=. MX3'P=/5P>+Z/BE@?8G&"*Q.9;)/[$:FE?4Y_5EV#MQ55\3F[*:% M55\,Z.2`1E!]W4I/%)DH-L(`E@:H.'JZ)OAN@5M<(R^X&GHD)Z([]_5%SZ^P MDC%>?F]X`N_>R76)M+[]Z.I8'FGO]MB%@.%TF'&$#S(,?#KLR#5VJ"C!%A5# M;[YF0P1UZCWW7_[E>$$BO%':`4R6(#HU)4OAL>ZF.P` M?CB*OTW*=$US%+CQ?'\$>,X0%8T*RX!TR>V.9@RK(W\\.<@/N,.7]5VV>&B? M;'SH,K1;($H&RV5OW0[9;HMHM"-;`5>RKX:!.5O\:@A!1RF(V4.OG&L#`YGK M;KR6KN+KKZJ'QI_3#&WO,*RW9"@0*0+7'0)1]WF3$0+/?[L&YQB%Y":AYXA# M\:Z.3R0N-P[\':9W]^2\SP/NRQW$D\!;6%QNZ9A57G:+@6_KH.!MF^)("\D* MYA=NA;(/[TBHER.Z_V?.S1Z33N:,R2C/=O88YV:7YDJWYQ6Y\H M8C@.^PL<>;#.3G[$V>8?ASI%QB3D,)YMD1J4[%O) M**V,7:,+;DZBRAL26ZF,K[OGC^9:?4->@8X!,(YOHCHZJJ-T9*">H35)&#I+ M"8$FLV%!'&QYP!'QY`+H/`^HB%RO:["X=)D__J#K,L>48I?94KH&^;@+WEQF MKR$CJ+=\4Y?YXP_'Z#(G2I?9@0`A8BMH&*16X!U-'EVF+8YJE\F%SO.`BH'+ MM`++O9YBV>IN1W5[!($0N/1_C49V@*$:D9[$I$:'?(LKB03CN2 M>@]J]A6EZ8%I`VHJ4).=L&69P,4=]`&`S'4T*M>@Y.L59@B.,Z=K'-[AQFY$ M;_PT'MG7_6,LT1P\\8,W8:$DWOS=@&W?'GTYMF MYME8S:WVZ)0N7@,;JE[+OGAHT3`NRJ9G6TO@:S%?[@!FD&"'5J[185.W;I]"TZ5"!95^E#6CV18]4)R[(I M.D>XKZ?9H8M"6D!%Z.D<@,691WOS=(55>?:83I8*E(0"W]8C=(KP:0?<>KF! M?'V$]]BF_NX$O'D"Y#WXG5!$YOC&R_2/%MT.TQ@QQC=<" MUU<.%^Q/P.T3V&.^R%SB/!3I.D<['#ESDZ2!3\D.OD6[)!W?.*5'+'"7(V*G MAL#OB%NW.6E#WPQ&K#SW27TGH0&_UU21N5"!JH4&((6&P`2&/&(S6`Y)OMVJ M,TP1]_I;@N>%AY*ZSA(<\DU;GB?Z:-,.7;HNU@V^G+G:#VE>YV@KO.R$3N!@ M.SJG%C%IWJU;[8O71W_'Q9M[D[?U2:+(O.A4E4*(B[0NP'9++H:U;WRX78QT M"Q-9^'G\$-%U@#8@67!3J*U=?PWOR'B*NTFLK;Y[82^Y*Y7P)DWN) M]"4XND+"N,N6_GA6PSHW1NC+&]Q!Q-Z`E@_T&.G'-!O$LC9H-^R:WC!+LIW(\WAQ+[K+)DW2IY2WPZM.V6L8S6D8&>EBO'$G8>EOVAD`:#E[N2K0YK"N+HMK M6#RD:\@Q$QD)^Q1<$BNCD#5J9PL"R6(3X#*LV-.2ULQB;^*`O%1?2.<##P'. MH^QPK:/Z)>M:;>!6?&/FFZ>/R3]0<9XE)6]`F,G=5KPRX[8L/S2KJ[:UL$P; ME54D,I.UZAC85;*3NXE)$$BY`&6+PACG0@I9*GI@2=( MVT/H@'XY+R&Y3%L1&LS@9!_9A-/7??%^P@&S!F==(3\-`]AM\A^.)P28`QV= MR^7UAGX#`5J7SL31#NMS,:5C M[?K#N:$0+:N/:QB_K.YA0:ZK*>`]S$O6R!*QN-/MO-$?CHF M]E8^VEM1H6`@M;T7M2<8=))!4H):]@FYE(3L@6'Y81V<3[-`"P!QZ"@]--0Y MTY=@WTY3.YZ!F=-[E+"IKI/R'FPS]`7<,P/.:P.NOAJP+=*>EPDO.%M*TH(> M#KS(YCA`DT2V>C^8P.:V\6$PD`G0Z."^&0#&`: M2'R^"!2-,TM@<+FQH#>`U5VY@8_5&]S@'R.XJPG99Y(06EF:N@-V_ETJ7VQ, M$K95[UWCL<'OY#V@!(&7J#0TBO0__M!(Q/2=92P/%*=^V#E>ZFL8FK8F7T(1^&P!;<.&'+I1*_8 MYQB\LK(F7B-V3GPD46P0`$5^>LU-L,=('^'A3?WRR/9)QO"M$_18=&/TISZ MN5FZ(Q[K/"F*>K-IAPXY7:/.6H5NCDBA(L]CKM+Y,20JOB3%YOI+LO_INW_Y MX0IB&.35VP.\R#'M3]S:[T8\3?RHQ6,W5IMTRS)VU&Q*,D!K25B1=_\%,&)0 M8FJPP0,U(0D\*!MA`,W2T6@XUF'M#<:1`,YUV8V%H,(0DFE.41FX&(=/6`KCQ`6`&6*9]8.@IH>$8K*P^L%-G09)DZZ64C]H M%67@T?>7PN(IUR'3$F?I2Z3*R8K7AVG=A274[6E!=+;6CVD)U`P`ZD7/>1"8 M':(VM\0VCK-*Z#E^XD#'KDF'E/TJ*:D5>G4Z8>>U%"V(@2QE7'4WG#K]O*"'9I&U^&FCPP8_Y7/"C\A#1HV@4[?3 M$#\@.OUF=8-G&KD"2'0Z4K0U=>I2J^!+4H(])J,I#9OZT@="N*=);8$G)@[1 M=[H4^I:<=-Q67>#T/EG#,[JT-YEYR,G:Z8>`S#(HE3=N.Q$12I?%I0*F%5TY M[%Z=`/(2U&]#AZ4*'2+=#SX.3_G4_1AU25@XGK`X1`<9JL_:E?-KF*>H`)]0 M!9P M]_)-QI,B"Q'-9&F."+M8QJ+3EI.K>2U+(IXY`E<-%^A,M6$$A!,05D!XZP-7 M_:2DP*&.#=Z0"P",`J,9DGH!TU%`W^T$,08+H!/*Q@:2"`*7<+`6SC>#`WO) M4DG*WIU5;0+.)SB>.LSF;\LDF?);%DF:V5W;$DGFSX M1L\:ARZ.-!=?R%KGX$(AF+Z99'B!KG342XPUMO4RX?P]Y&&`*]H4`L)WQ"[ M[+W]PE^2-/^`RO(S7).B)>DVA9OW6$%GZ_5A=\CPK]I..^=SD:VXT;[>^&#T[]$.'A% MQ'\+^@T`XGE`KPF`VP`I;J2M,-*V`UA#$0SSW@V*LS/OU70GF_MN6^-E"+P$ M'^$I7>49N(JFW,@=%E6"5QF6!K%O*":^(>GY!D0+$:T'A8@()X%7VDP9X.,> MOPH<2AV_@U#G_QR[BYA_ZUE]^\'H!I&ZBC[OJ@Y-\N:V#A6YW84=FIVQO+-# MW8KDV@X5\ZJY+:=_,36]1">BFPRTM8Y,53.ZPD/!U;O%(RBPG-\[Z1-B9'0B M&2CIY.9S\B7HY;YE`S;\[]OF^IB2W8L2^BY*Y]@37L?F#7U>O#/_"F!M!@T/ M[>0"5^T.^?/2.M>WJMG5GCJ*VK<&"-"R&.D-P4H^/9M9!FA+>FTGD.O?&GST MOGH^]N;X:WOTS?;9']/\4,%S3):NN6=-Q03L]W$(K$Q#W*"=S^7*%0.>0[[J M/PN+78E6D/I##I$YI>N0Z%^YKOVP_+J/L'^;YW"\G(/"[+2,,ZLTR0?'3D2DCO)_E=U MQLW1(TDKZMQ_(7/O"$E-`SHBT%#%D=P=,RAIF./SYZJC3-&CS^A8D^;! M.#_0.^U[-P:[#ED-XIZ==U,=5W*/L-FC_R^'I$CR"L+--6:`'TCM\_&:OI2& M_4(^C94=2)NU&]%%HL50YW.LNL>`/@?UB["`ENL+:7W?(7"YI!U:EU*^TQUF M1Q@@PVL/!25%07;D*!`-D;'@P/'!7E=0.)U,8_M!5P<,<-[(W<-1E M!1[!Z.<"/-:SW+/-/PZ;=$VQ<)4E%5GN*W_--["XR!]@6:5W`YB,)KV&W*,Y ML"ZWD^C1L*MN9LCZC:J#2EU9O0BSSP):'G`@3&#`%4?$:0JG20`Z#X^C:%13 MR#0XC1'/7JJ&!(#UL+9(T@?V?@3L].4"6S65?U[0]E3.)`2Z99&2`.SU6E6" M@R@.[$G1%)!D&:S_C&71:C$[4"PX+&T'L\,T](GYXTM<_+%GSK/C8W M#)O[[%"R[/D,"H(4WQCU'K5J-N`>9]BGKNK0U4?K5U+%HOTF$9K1`HF)_,- MO8ZY61%2MJ6>4RA$]*;)O<2)FA0TM*`FCF-6H`F,R63`"%"C&8"<=QKXA\>A MKR0+[XCD9+-UD]L4SYVP^]J0//'>3G@]N;U/,%*W:89CE7T#7'H"#"2UFA)Z M@K"*<%O[VQ:VR;/WMZHU%[^0G!W2M-,J M%BQQ,]#E1,T=:7PBNXNWI`W;A21"V9);N/@LO;DI>Q'X]BVYNI#>UQW=Q\6E M[=W,M9CV70<"SG`P&NCY0S:;T;%A_?8)_'_H/N^^+IGVG>%&\$2F3I##L\=# M$7H":`[@T3AS?:"-N`= M30R-1$WGB;&;@*]UN\#&(%W56_>L(^E;!W].<)^4X!;"O)L4\)<%(UG2"V%" MJ@6_YVY$/E8'0UO08.U0;3));T#9ONP!1;76&-(:9L>65\D3\?PWB%S*59ZG M#VEV!?,DJ]+)"30=4O9EI*16AJS3";NX3]&"V!ZEC"OV%K#7@+X'+4%8L])2 M+3+1P=!$9!R=)81!C=-)MQ?PD*BG@4_%X+.F\-D_-_B((HZH`>0X5\H/AD;9 M44/X@'V2;@#)WKXK8#TXW<+Z89Q'XQPB3C"JNT>DKNTG"$G7$Z9O-:T3:;*?-T[&8TH".*RAS$*A>9A`HD?*.8<`D- M8V%4^1S3W8*+.[8W\-H^6WAICO/Q`LSOF.\88Z.Q?PJO8Q__72!2+PYPB$A7 MQ>+(1=KK=)\0[5SD'P\X^*!)#(/#89.[66UD\,O*:9>+(.N`->G=]>76%9<`"=P=>5VC]QPC? MMF*JYI;[F6(L[P&WZ[S=JNNPZ\)E"5SU.4+."FA?TF0E6"3OH^`$5$/HB M<4L8(E>8&!K_7&G]N\6/R3)<+S1$92-DU#O;;%+26VPD96T=:;[.#ANX(7,E ML@*Q3K(UN1XTK>])V:39@505?W=U#1(\'`+,@T/YY@J5/:K(@GJ294\U*1D\ M(;U*E)!04]MWIE:2?@1>A0AO:Z*A]L59F\M%B;A,[?2;%1?[X!4VL]KROGWQ M9B!8AHC'#/Q&I[3)RSUO>VLVOTD\.N#W[P!XW5T@`ATU:VGK`VD&,6<-4,9X M!(;/Q9:9Q4O@:6+H?3&&%AX0X$[70P+CG,2--7X14\-Q#6*.L6P5O1TIFAVG M"X4&].GB$Z&R;S_',`%R;30VL9XGH_$;W7V&)?YS7=&K2-9__)I/RTY;RS&) M]KAR_+L16?<7B/X$S5LZ$ZY4@VBPXV>!(95P!%Y!"D8S[Z"!:Q,?P1-GZ"LB MLI#EP\?E#*7.>FH-H!X9#U1?QQ57>C8&JSCSF9E#B/AS08M8/AXMN`9X#(&I M;ZNS"507LCJ+P+6"=_3NU[=I2>[&^YCDR1WMTU6!\)M==YH_K_$XC5GGBVC# MU1DB+!W/_$[;!JFS6I8YF1D"5QT78&R@XP.,LPHJ8'UU]GU!;H'`(VYK+AMF+KO.7/9U&R_6 M,L2!Z0NP#;=;UC$8QJBBTE>CL`1&;$9A<8\>.Q+Z&3[`_#`V(M'K]H:\T6O+ M.Y_XC=E%9QRILCN<1L2K<_1ZS\Z^LV>AKUP2:`2I/N/X*J4A5?_>))]*=1UX M6*F79LN!;?J(_=T6XF]PGU2@/-R6:SQ;PWZ=?)0$[""YV3(C5XR2HT8E=H3) M$[U(](#](W:HL+Z8JZ$K8?&0KB$I0OP`B^[J=L(?_,(N4_2(KXL+A!^7@[,= M>,B@"BM0U'^6)_A?59)F6.V-RPA^A:"QMH47K\W5MM4Z!E;>'9%]4R1YR@MX9A*,`Z5IW78?OU"^-VY0&JH;A5GP?T7_77*P@C M_7_O??A0=";$D+W6IT&HF9QA"!HWTGVL5P3%_/!X6L6@7?754\",SL2^I-4] MNZ<6[6%1GWIFC97-7D"9[&`<=6_"&(5LP>(9FX7KI8JP-G&J;1,5HFL5[9@! M,UK*Z,6.";*EB7#PGQW\?4SS0P7/,5FZ_CMV?VE^_MLUN_CNZ1K+@"7W/CIC M/O:U]/FL#-RX>W:!G4ES8CO6E[+JD])A*\T!)F[NVWT"-7E8`S7'")JMOZ$Q M:K-W-A@;,%W'80M#E%.-*WZ.BNH'%KJY60\/IR1J"$5>[<*#'91DL&G7-=HE` MMS%9/*@G8\4(04=)"PD2VM.`Y1[H[[`">EJ=H4]_;7H-W-P!OV8$W[00&GZC[1:]X2G[,^'4[XUX. MO*H;RZ#Y^O[1FNPBGT,G`->%_Q#*@W\56S//TR$^#32BZ8Y<(@(,#?/'TB MU@AI#DU3NNSL,1W'^^:,(D,0,[HU#F4''1N,K#T#(Q*+X1G6[1.HR5G: M:3[04J:\H$WPEOWX\5LKU`N:LD/Z5*@8W6/:5?<@CDA,I`RD^(1#J(Z(.G@J MM!D"DLU(PHFLY$03@`Z('.&4U[`KN(YDZZ!VP-(#[TDOW(DAOE%HCH-FB88G MH.[3\K`M`T((B']*=OQ`1$8R@7>/Q!&XIXVZ@O9`L@ZP>PP#6)/GD4074F5Q M$"U4Z03/'24/S6*]+X?EC\D_4'%^*"NT@T7)<=5B@B9;8DI@M_LL;-`R_X$G M5[*+/"5?T6>@?1B%0Y;H!ZD_Z6CO=D+7VZ15JGDYT!+#N=P.>L3UPDJZYEXX M(9W=O3VJYNT`+1,ON7A'R+6B+AEMP1#FD3AIM2Z1]G\=G.6;P1+."(P:E.T)/C&EY;D=91><'."1M2([RR/F6_5>@B3?D/.R MO;7(5Y]0!<%_#[P9IJ-A9*"+\7$?(4/_Y,_RT#'+'A`[4@^X(=D!8^0,")X' M8,3G`=U")@JW^C8MUQDJR?3SMJR*9%WI.UHQK]KU+O,)P2F\S>%:6 ML%*;\BQ>]G'->*U,>58W[4S9M$FQ*9M)6C7DU(X[!E!SA#7E>7!!5FH`O`3T[?%B0'REI3T*EO-V5P7:'-8TN+IFU6.XRYM* M.O81Q'160%1XV"4I?G#9U#ZX9J4/+K?7R0Z^H\?O1G!U(XQ]5DMA5A;G MYHYF7Z`"_R-=I!DE1+\Q5OX&/U)IO>UCZ3FZG`E-O*Q,AMKR"!;W+ MY3,D"DJSE$9)FD/9'"&3$RQ;=PF9;JF:ZS-A66P ML18\0R$1(KDGDUYY]I)-0CV:AC2*$&,K76&`9?4YJ6!W2$)W?FC$/1E-];@= M>0ZCKKH:/W4;U7$2>K(&(V;#`@A/[X1,&?%(:08ICC^8@\F)&]`2PK/_^##M M:1A<'-JT7#>JZLL[DQTZ-*L?27D/MAGZ`K"X.UCO-"9EB=9IG7A![Q9)&U,@ MU_P$WG]8&NSJ46]9N"\XSM6KLMR-?.Z[9HP:O+.S5EXSEN/+2*3$Q`:4[6Y# M'-OO?`4@Z8<;`;A/TH.G3'L+@H_<+/L9[C$T[I,2LIO$S@[5/2K2?X>;,^K# MQJ@T8FK@JL=DAV.CCKD8:G0;E,!?3\3J8_)(J_(E[$T]K3KD&SQUHG,F4+1" MFBOX`MN.&4S0/"V.K$V+MV>&T:#2V9KY4I"D*^3TPO".M+L_N*,&-?ESQJ(P M>%D$CY MLM]Y:`%\V@[QR^'`Z133&1RH$V7;!&,G>LQH$'E$-W@P]7@E7']W MAQZ^W\"T=G;X'V,?AQ_]6YT2\QG>I>1<2UZ1T_TCB,E(V$_EDE@A6M:HG5\3 M2!;#F,NP8CE)W6-:.R$L@*6:0CJ?=@A='F4'7!VE^X7M.9Y.%DEV@6<$C_\3 MCE.=I30#X(YI'"!7T*P+Z$Y%J[`[YFC`RYX#^@+@-S'`5Z0PI/6!>0`>D8X1 MK-"^+PB_938!JY^ MQOOP2/;%1M7.>A2]*F<2G?E&UQ6]?^-=OGF;5"*8<6E&>!O2.`$>MUDW"!R+ M5D-QR-%ALGZ.'0?: M6UBNBW3?OU)IC#<.R1AV?1(WZ.,TZ@B$0\D:6.PS]"#9>QP),GF*F@)4K,XQ M3GN4'+A*=.X+M>>'HB"&DI;K)/O?,"GX@[R*K*FY)"*S*Z^D:-RRDI)8NJ1H MDHAIQ=Z`^A4@[R(9]Y4Z1+H??%3S2$#=*V^D"0N_\_R_PRS[GSGZDE_#I$0Y MW%R4Y6%RQ;$6[6#>+Z)U,/]7=,/%.H"X"=5Z@(BS61<@[U__00A`0P%JDA@6 M"%0:1D::X"T8"%C&"P>:\/%K&[^A[)!72?'T/LU@,:YW*J49V,*8QH$-")IU M@?VI:!7FQQP-UMOGH'X1`\)%^D):WY>'Z!'I&,D*Y7M>Q:W'F/:L]7655`<^ MD.6DPS5=/JF+I5UI)YRL$I:4"[T\AG;]5X6X73'VFN"&#"O4.UX]5<'",-% M8"['9"U8"S5^[8':X#D.LNY0P=_3X%(,T#^D<`!Z;I,NL#X6K(+XD+Y!-GT* MFL@1QB# M/6@!8!R#Z(-F&(E(^";QB`'.?&\E=HM`[_&3R35VMV%]CI._BV%@4*6^RM2C7,H.[@'BZO:A`PS+`KOQ;$F21N28R-"KE7W"M!W@0^#*#6( MM+_V$/E"\MX9CX5AX>Q?Z#,('*#K.T[T.^06^8:WF6BP1^X?=6XJ,4:'P!9D=Y*8`RK$ MU<_O4?$E*3;]J@/C$%J'M@FCI;2.;H66=,,RG%8TH7-/-(]S<&$T(QA6DHGE MXFB9ACDW2*L!T<38,A;>G=++PL?I:3M/*"(AR'M.X15.P1;P*BE!0LJ4K;'C M"7RIITMPB4(4'_`*X8Q[J8B7V]^2(B5%7TCGWB3EY$9S4[:)BU:P.3(WOKSF@@_.[_'B(/E1?X)5K\D:4[>DOL9SG%8\1Y'%7^C5>#>;;=P M76&2R^U-\C@RKD7;;$YM+-*FW3&0)3^+Y;F2A;HJ.:BR2`]6O68`;4=6+?\$ M=,T!UA[VI`"+`Z3)IJ@^\6.`M$OR1+Z`NN434+=-J;'#Q%,-8?GJ8ORC^N4YF>7"5\[/$02=&I3-$4D)I=TI2747+`]*2AN0G)64 M\*VD`4\7K)R`LZHJTMM#19!D.*2B M*LG$0ZH'5)'A:XBK^MHTD(PP=/[;-8Z4"TB6)YX'DD3C@FLLS=X]_W38W<+B MPPTLDNP<0W*\@V[&Q'ZY)I.5D9AUS,[]:K1BA!CY2@A1$#2AW6;@R1@>8I;FA+>KR=6<4#1#/'O6&IAHFHKL5R MD"0>_>8>@KP%YIH"XO_D%=C?)\4N6:?X?76?5.`+++"W M'T)XRR"$M*_>\X8%HT(1XSB4XMR/,)!R3\#,*:Q&7.X*!1IUF"C63MO,":89()R&[!BBL;=J@K40X@ M3Z,,[CQ*89X?5^WAH(S;.WNG>V+-`,__7P"R'<$-44$)2^%VD'*+SK>@QJ1]?>+%"I> M#JUO#F6:P[+L=8D3G2BHV`\745GA5]&T'8K%PL58%O&LFA=]S4<1G*BTAS2_ M]1#?`N(.Y9IP"(MU\L\"\H,4;7H)_H?TSBV!VQWW-C%NQLPZAMQ\.VF((@EJ M]%4O-1X96B1F-&"3&Y047[.WIS["3;I."GA5=!FU;XO#7=,#;F!CQL2^@B:3 ME>&8=K3;$IN0IHC5KVHH1WI\7;&%`_P M7&]'+09!LAWU&>XQ#3U\GS!?=`)^S=,'6)1)1BJ^%UA2#LY1L0^\P>07E:(- MIF5P&32(^H`?7%1PIS%KF)"*0Z>.U'74-.F$\X"IWX)1K-0Q"J83A`!0BO@B MI*ER9<&1"`KBN*CED(9$"^#&:3*U%_CPRJ,\%[R(/*U[Q`3UJN>HK"ZW+,#? MO*LK&";E_562;M2.5H=;['NEW*[-2J>KSCVTHE$CJY/*XOMQPD(2(!HF5LVR M/K!$^*(S5BU`R>S7`)%B@Y8)D=IX-(CV/78L!6R:74S0NB>?GIZ$:?E>%G@- MQJ-%X!MTU+IBEY!?X6D?/,MHXW2(36[3#%/`\JPL\0168P@S%B4>S_1%N78% MQC_"^4AGT@,C[Z`OF#\&-OR`"@"=!-`3`9B,Z%R*.3IE_F4NUL6N1ENBU.\< M@>'X'E##VP\9:C^@_.XU[OP.;.!M!9*O5L''0.QVL=S@W"^E=?TEV7/W;.1$ M[&,*B*PL7MZPW2`HE"TV3P'+ZF)8V8T4YBD!?-RG!;E?`$>]9X>[`WY-=!#6 M&!6:1'H??F@^?-K.,/2`,7L7\@R'N>MT3XY5D\L`$_S;+[=OL?N[P7ZP_M/IJ7E`)3XF]]"_+`\P$W@+6]OD!0< M0_,-R=FAA+30[`?TY5V^N=Q^)D591N`V9]0IO#UD]%=&F=M!CR6YQ^W-K*P\ M%-.K[LJOU7T",`.]71Z;)>6)I7BF-F;TJBW+\,8L4)]?LPIS$*@N5_[;!V(- M"H.?`/)/6$.7C"X%5^HB MQCD.A4:%C9NJQJ3N\:$ZD`LK,=SH?1N!PZ.%H"T(EI:%MI_0Z6_IW?V\V(G/ MJ1,\C3C]F3"_BQ[#ITF#,TUW)$QSS>B<@GQ.3&5!XB' MN)/H[`$6R9W1/7%JEDG@)6%Q9.;B%ES=.:KY`48&/;A-B#'&?4FP4H!V0DGZ:CN>G2Z#S=%Q:>H#0$SQ!+=#A[AX=*CI7'<#Q MA'S^+_?I^KZ>Q\(]*BJ2(`GK4VUHN\7FQR32-`HJ"Y!_W^)9+[E+9]\[[PXV MQ>$.[/&O*2,I2NT[2Z+M&W2YKW!8]?[#]=DYRC*XIN'6FJBWO"@_)INQ=7ELH:DUXZ$% MN_H@_GZR914;+QV3U!OQT-Z*"07=H-O*!50P:"03DR*R`15._L+BZ46MI`'0 MM0!8$R3EBS02N*")1XM!"V!T5"C%?4.]JBHOP/2=UQ$Z?BQZSF*+\11Y*@B9Q;O$Q+5P)QE>]:!#@E\ M<$L[VAS:DUCHD),P"#-_@[`IDU)P^-]K6%2DOAM;_:>N9MVYFJ3^(:&+)AVI MCQ&68_KJ92P_K,MK1YZ#BSGM(@T[GT*=!XDL=E\C"VMP/B^K]SMM>T>[D-_= M(++NQ'+R+W)U9^?,X*P;,YG,S6_,O]NU_A`+3/%L^FCIA>[+Y\HM/.H_2-UE/16$;#9&E*]+@ M5__A`\4OP7_,GK-^2*OTCH86U[#"WXE$&DV?ZUW-B_P!90]P<]&C&'DE.R%, M/S.%6#E2NX[;S0EGMRWV>#-%KCH^T#T^Z4WIV&9XPTWBI(XPK->RQ!YR`X6A MCYDGJ_,=QV,*KJMT7:`WA!OOY MT%.$L,8B"NE?D+FX#*WCL97!-?/,0)1F\:(M01"JAX]]\D3_3];5R\/M'L$\`05BT_)'?#;)"LA.1>)\`RV^)+B M/](='NSVV!&LLR3=E;3%IO5#OB$K:WBRVZ9>DVER_4=*DE+179'L`B_QJZ$F MM7T>*B7&3YQ38[3K)-]6B49'F_*=%/' M@V0,J$\K'$M-=0'@9M13ET*7>8&YTN9448_!!EP-0U$9`!G$>%=QG(COXC@! MM8CVIJJ7;A[V5PUX,I"^8C[@?^&'S2/\GULL!3_YOU!+`P04````"`!#@J4^ M]M_):2TR```*30,`%``<`&-V&UL550)``/^!<-- M_@7#375X"P`!!"4.```$.0$``.U=67?CMI)^GW/F/_3T?>[%W3?)[9R;F2-O MB<^XVQ[;26:>?&@*DIA0A,+%;=]?/P`7B02Q%$!(!-A^Z44L5*&J/A3VPC__ MZVD=OWI$:1;AY*?71V_?OWZ%DA#/HV3YT^M?[\[?_./U?_WGO__;/__CS9M7 M/Z,$I4&.YJ\>GE^=%W]$>5:\^M_?@V3^ZOC]T8?O7[UY0TGC*/GS1_K'0Y"A M5X1_DOWXE$4_O5[E^>;'=^^^?OWZ]NO'MSA=OOOP_OW1N__]?'D;KM`Z>!,E M61XD(7K]BM#_F)4_7N(PR,O*M8H_/:1QP^#CNZTL(07]WYN&[`W]ZT;;[?O:L^OB:&>_6J M,EV*8W2#%J_HW[_>7`CK].D=I7B7H"7UR1W.@_@R>$`Q$5ORR9\WZ*?76;3> MQ*CY;96B!9]AG*8=?M1*GZB5CKZG5OI;7\R[P77>?W7U:AHE"_PV?,S"("7( M2_]\&^)U)>4V)]S6*,FO%A>D>:R1NM:$#ZG4T='[CQ7._M;G,;Q>QT%,&\SM M"J'NW*#J_':92% M,\QLUO1GC.=?HSB>)?.+A/2(R^@A1K,L0_DP(\OXVJS_ M"5YO4K1"218](N-X*>=GL[[$&"A%67[VM"$RAM65Y66SGI&Z_Q&=C?K+.>]S?&!YHC&K!\&KN!]+%ACL`[/<\ M^K;@$3'7/=?=A@ZVD%,WR6[5J3:)^1 M3^5@\Y+\T!&'GG*4S-&\$4AK/'B%NQ3>B(]QV)$8TTTLG'*W-*B%^NTK+"\]^"N$#L MJDYM!;U"M1V`A;J6:(-QEG:M$J1A(X+\LX?$[AYD3?%N4R+O3;B*XBV(%RE> M:[H6&QJAK<^/KR`B7^7X%514D1$1>$.+TXTCG,Y1^M/KH_=T:WK3\+BL?"BT M5&DF,@K)4'L'<'1HEBIFLR)?X33ZURX"<2$I(N9"L4?L*0052MN`7E\$'W(? M)@2YBRPK0'#K$DJ@5A-Z#3.NLO8@UK#GP^OCA.!U5>3TY,Z\M:LJP1B'6@*T M-K77:!.K;0]R'1E\W/W=4]S1^15.=$9X&B5J1T!*>(-!??7-<`B2P\?B=_YC M43&D`U#VL>?O8`ZN[F"L08=QWT\%8]PQG()*A"W?1F\P-2UA2CYN^V$J>!(/ MVB"D(F1Y.5S34-@2Q@`#M7]X"K2[%`59D3ZWM&7P):&HKG2(T`4)'1PL-MM$RB M110&2$R$_\EN=VD5:C:\8(5&"PE:KL6&1NB&`XA(&@Z@HO:XT>-F M)'B)"/8CPGD0I>524ZN/NDA(K8`ZLK!G09.P%&[R3[6GJLXLO_8R] MD6>X0O,B1O3N=G6Z]89,CEJ8*TTN'(*:E6[&HIJEO8D(P\QB.#K5E6FQ*W(A M6`@N6EL*%8+;/JIPH5NLZ16AQ<8;"439!F=!_'.*BTUVD81Q09=\5147CA-UPP^T0N5(97!%)CYUEM\9?`E5>PE5U;6H2YQEYZ2) M\>O[!>57B[O@B;&)2=':+EI%O0HW`XQB'EKTA`Z?=//R.8W9V?;5!5CD&"UP MNKW3R(+;,E=9/##@ZE63V(\I!W7$=NHS?'W!_89$%#U;+%!(@@?W.Z390'G( M&HF2A_]-0M-,EAN`6KK@0+L5N+LP_NPE][(TY.SE95`--N$%FJ4B=8'QEM"$ M=1,NF\%+*/5W8-*JX4ULHCQS>D,IK5P.@TB9^'13D.7EI=%;73=G:]E*?W7\ M7']4KY\;<>FMH^MQ\25@6#&241`QE;R_75\7XHHLW>98[5&6BT@5F(S*UK#2 M*SM:N`)54Q2ES`KK&,B!F&0&`CS0.MVHI%4'&J!T94]\P*/.KN9T^_,Q//&' MANV]Z([0LZ=Z4ZBI&/QX@0D?WD$#+3[^A2-;-AL8F0948]J#)U[.;TO-CI<- M4!5<"X,,E%RL?)=\M)"AYTJLK7DW(H"DU;=H%%(F M/BH19QA]:??[69+A5)3N>P''&EJE>R,,6&E_@L0PNQC&#&VA$QLDL(]M6`H4 M;`);59``TV\/O:CH1SP%5%6M@E`UC.77510@!G!@S*/#8;1``?<]MF&;;J!0 M"J_.!!D(G?A8@Y]7^UL.'^H%"BF(-*\_Z+$1WH,`LO$C.%BRDD&$,)<\[36( MSC-9EII4FZ`LS\J\+J46 MU\%S>:-;_K14F#J MO?&B"DGP`C4F``5&"T.]AWD$`49))]#5@:"@X2\,5[3;T-4R:!.7\/[&&J_= M-8%ONPGO)IAL+6]0B),PBJ/ZZ@%H%<&$26\-08N))Y'!BHE,PH:IX(DM&`C> M4K8U/^%R5\]/-(LU+05:S(U$LZ*H(2?BI9MUH-5KNXS-.@L<^P/%])+/`&+2,J-\F_!&OV\2`923/CXI&,=_MN%>BD)E7NPPE;QD>V)G7*(TPJ?K\-,A% M7N72,.[MTGCG9YF*PQS.<):\)G@@S\](K>:T9N=QP#Y9Q/W69);M?//&PS*5 MS#S+<)2\R7=HCYZB+$RC33NY#>M8#@GKWS:)?VX6*SC0VQW&DD?R#N3TDR*E MMCLG<[@@_C\4I/P8KB)KIN`B,F\``%34#`1BYI+7[0XZ(/\=Q?%_)_AKD(ZLR5.^0LY7(H.%KH4GD%`IMX0SS-\!0X__-K==?$0 M1^%YC(/>:1G1]XZSV]\]<[58M2&.[G`5N/F0"W5UX(&_5`POT.T!G'RUV+`? M,'V[6+,W,'C!^&B,=<'=5.><_,(.%A14S-H@2^4--&!J#EL?[/$6@."02X3= MNE4KF&H8<.BX0&C3>0H%L:HVP-#A+H!#:WW1A?,^M\5#AOXJB)"S1_*'M;-Z M7;;J!(C8:_,%Q1YGR>4D9Y]E;,>R)G M8$2-U?*+0"]MME6W\J2V7-\."5_#BL3/1LI3ST+[K-FV3KX[XW(B;_84L6,E M!97`\0V5*[[O>I/C;;Y:4H>7/'DNWO)RU,NG>!U$[$ZKDD[LZ9K.&5^SON2[ MFZN=W.$U8X'/&X8N>'T6_E5$6435^(S6#[T-->'W9E.]]]TE[S*NPVI]E'ZM M6)8;YWU6+GCTN,BB!&59JWJ<:*V@JJTAHG+&QVRTAJD%B]9"7JUWNYSR,OUG MBOA1&TPO\7R7?C0,J'PL@(%,VRX@!`)$F&`8#XL!W!G'9S2/Z'SG.MT=T3E- MBV53&V[DUBM4&P)8R"G?\QV+#2V@AD)''@4%5(ZCO0.9@Z.+'*T!742/5!PM M=J2N=!:*:9V&NB;3.SE[@Z<@10LP;H"*)GFY6M1MI5X;/@FRU740S=4X@Y06 M0T]:VJ70U<<7'X<:YE"&KZU,`2CELBQ>Q'<#I]?;2\U1B&9Q*;RT4O`0Q80" M9;,L*]8(`%IM5F($PUGY"&=30PW&MH9@@\=*K0"=._[[4M`!Q-7B&"5H$851 MD)*J7B2_)E&.YO2\%6+[;HT2M7$A)9P'F[[:>I@"\=\>@'UO8S_%Z3!9/4'3 M=!;&(9+/1CL\,FR<1ZLE`^TK++)"+8Y17=@D[&4L,MXEW$_^NN,@BT)@UB\N M;7.434H[X@L"S>,3YZ315&D;"E+/W5ODI,)E7:LJ6=2>O% M]S,>:@]Y*J^.T.JE`$UA^TO_/3IP:3RI#(#F._V_(#*'N@N>X!`VX,,%LPX? MWV!M;J-!`-<2*\ABX"?4N8:"=$60+L@#^$%TTX26@*4@7X(!;'`>Q([!YC2* M"S(_`F>9TQ3:>\,^U/Y''HN$9B%562THY@ M\-BF*_!;'MV``6W$R6R$XSG(AUAJ(-PU14]ZK%.K"NNL8)V4%V"$::@--"%; M1T8^+]G8^T<#22284S=%C^@6A45:[I!4[XVC>=4]KC=%!8)^1N_9&A<):R"K M/)LCB%9X.M0V9:<4]F%`DTSNENHQJ;&3/*<],&3("PG"AJ"0)Y@V,H&-5TM$ M@B8UL"'#M]TH3P!"*4VS0?C,R+L\-]GZ#?Z@M@+@V$#-\G/&I@FR" MEO1E1><[".U@KQVX'<:AMK;6`JHSJRR'7Z,>L"@]8!7:&Q1J6<`(CRH)@GSA M$^BV95VRK+MU&#PR'4RZ26%R<3_=_SN*EBNZ\/U(<+Y$S6GA7B*T>O%[MTA1 MGLX4S,WM,JV=98FI1[/_O9C1=+G`5F4FM5`%-0KO%))16_T&>._5*5JXU@V&:OLV61,6'S955I^8Q96-JM!K&/.3/0<`>>-8MKM?_](*<7`W7N M3YNN\2EDV/.`*!AYY0'YK2];/NA)F=3NTQ[/G]Y_M'$"=?SNT86MF/N_'V(S M9FQ;C[5J>?_=7M'>I43:ZH7*WQ1EMP?V"53MV!E9)Q M-0%G&#JRJ&0+((^HZ@"J4RK"8^IRLBUD!&2^8`>DI1&(1)PG=R:V4JQ2L[;) M%R0*L2(R)@3UR'S!$TC+`4&ISWGX/+N+ISMVP<.%\0*]:YFB%5$Z>D25#2R/ M&7@25.,&K3*U[V%E1FO.URE>1#GG=&?_0ZU0Z\-HC53/$5BB3;=I@OC2YMGF M-ZGAPE6^0BFW]:718T`O1V?_4P1QM'BFD\OL%S1?HG9"C0C/RPV-@`[RJ[\9 M8.U10NW3?4CP!^K[MZ]AF]E+Q2:U!2:VT")*T+Q*TIQ?QT&2[=9U+#6^P1*4 MC<]&7@)R:\TOL82%#PIZXJYN.7SD1;#8EZ\D1;#0MFUD23#:\';@(++$.O-'` M&\`TP+QW8&Y1];T%5(VWNE8^YT*'=5>+2K_17H;8UH3[V#KW8_,&<_?C>&]+ M-_6X#5$2D-$Q[_UP&0VK3X=FO`<&^;;',&6Z+:_+JWPYFL]#L'[V?M2WP^L: M_IID&Q1&BPC-^6^'J^@:/POIQO`U43$! MV[9W!.,[6]RP16J`6W6+@6!5SM/GPV[0(TJ*WI-T[,^UO;8_C^_LODNQL-H" M-U^VG]K:%96T6`\=7#T16FO7&VASOFV'UNUOCOI;I@#$Z4SY:37MGU.<9=5F M'N-WSI?::.TOCOI<7'F(QSNE!6N\)OYV8()=)VQ*EO6)"C:F"[\WNQN][XXB M0*4(!`<<'H+5%D];_U9!88XK"06+"!?R70$Q`4QYI4`%(.N5IU%BZF?4/8Y2G`:Y<^-D6;)O,OE[*^" M?/Z,\A7=?&W.E^KG'+4N&9R\U)YD9]O*6,:'-;\#UH[?HG_P=&BP-4D=M.H# M$MRV)Z3JM),^E=.85BD%QQ^'DR@?C<]8>7E'P+T]\Z'!V_H^N6FGH(1V\!_B#Z*:) M+0'+:1V)>7FEQ@[^[#T^H\2EE3=E?!V-6LVIIXA]_(1ZSD]O='+/PB8XP#RS M1T8G?AP`%6B9TRCL3$$5@@TYU)%:1AT5&,'BZTQ7X34]X MP(@VXF0VZ?$'T%8-/K8&$>9:EU)UQHA]JA'3`,NKC16)*KJH$7#K M7)^NN3A]%UZ=K^/^Z`?&$LZE[.@%!N&%_ONC3R)E=DR<&?&:/Z?Q\6C`)O_X M8WS#YS0^JAX1<>TYC>,@#NB;KBN$\O%S]UPMSJ.$U"<*XFN<165,YCM"IPC; MSF1%Q@\E=O,7C3%*@KA$KZ^#L/:NXWM)\Z1T]TN:IYUVA=/\#J5K M<5('&4G3[_!('(0-0!452O@L)M;[A"$NB%XW*$2D'9!>]PO*3XJ4&ISMBP"D M3<\D(W40+!JJJ4`C9V5QV](!\-!VD1#>S[PD1?U/K<<]T/<#O*X43XK!PXV7:=X@]+\F;[P M19-ZT=G6IG[CBP$`A'27RD),ZB`\-%13H47.:EH)KG[&>/XUBF,&*.S/37[D MYF<'`2"HLLK9NV(64RHYX-@+HG.RC,C<:#OX.7NJ,TT)G*Y39)<`55W$0;`8 MJ*J>ET!83BQ%4FL\13.OJ,:>?9K^\+-%XR!P(,IH#$+;/&QF5'(`&I6"W!$H M=^CIHK>YU84--NVD'')HF'D9!0]1'.41$FVD22AJT_$H'-U24RL#V5?CE3>36M5G]U(5=$UFZ=".EV:7>)D234\10^"W3()13,RY5"XB@RU-B!D<-E,:U],VD1CMD+DPD6WA7KAH)2?B!`T7EJTTX@9P\0H0.M1+6+X^%-,Z0-"R@Q`R M4/+^N0P^N:LPTM03!"@USVEMNY5+P!!0J0G;*^A^`0FL&PA",F[3VMJ[0^L- M3H/TN7JPJSE0/5O390,&/R#:VLQR6E=1I*,A"$@*AA/;IJ'Y+:+JW#4]K5\F MF5JB)(QZ#^@"*%MI1$24KL((KAUL.4_&SO==WS(;R@K'1(NL:B3"Z^$JPNU- M.R&AH_M#8-4@VT0R9M-:Q;MN:ERJS+MX):'8'DWK4XR($B4.,$0I%B8BKM4! M-0XW>YM%CRA]P*,CI95XB7L_3_"YG\G*"X`HU-%!1Y^5O0TD-Z!QEZ(@*])G M(3C$!,U0MT_@.$"4*NE`A,?,0C_CU`-9K69090?\!<7SB^1LO8GQ,T)W:=%[ MQ$VG2#_.B(LX#BT#M0WCD82]A2TII^`WF\^C2IGK("+JG@2;*`_8([<*JF:+ M6T#E.*Y@RNE`27MLHZ.(,PG]BUL9V&Y4(J"=I$B15*LN@1[7*1"QYA-BR].\&C5=IQ9`XS MAE8XU)4TK?VYOG&4RT_*92?7P:5420<_/&86]]EL?]A[]+FH0#R5P'[U/< M?^@GO59L58R719CFVCJ/\==L_!3"=M/GON2%?V)>\L%:/ MX55/J27+;<]Y&J4HS#^C?(5%CP_H%6J.Y\$*C0\C[H3!2&7(M`'*V)6;D-8R M]H0(S!=N,&EUMA^YE(EA M+W@N3Z7=X=MBLXDC4B46;V**!F,<"I]PI530&$L\SA:Z3*=V-CE*TB19]78N M`$T\:C&R.M1^HTRBN$7$=:5,[5A'.UQ?)"2BHBRO\@#W'D"$D')ZS1ZI3Z"# MJVRCO^R+F-;-XD8_>MJ``1?OTRXIVNZ31^"1J&0*EBY+"ZZNAH+E@K,V<@A[",@:-K:(--`5E/ M,Q$RK27=W81H%OY5D!8MS.8LG*A""_;FK,J"HT%S`/CP`--T(:M?B>X,5RW< MPE*=4T.&VR!&ERC(T$,0_GF7!DE&C$*4(Y9LIF'LWA6\1+.9!2CA*6[UC6$# ML""I$PNZK34!JO[5@OPR+ZAY$#CR^<*JR^]=42#HJ*Q@:RHKP`V-\]>Q@=2\5.[9M;3'O`"I589 M$9#=>J/2,H*U'[:T!%V=US#]73;M=SX0T&H5$HX:)@5;$Y/L9_2@`UQ?K\C! M;66\"&:\^.4KA(U-8P/&.L*_B77=\R@)DG#`NBZ`@1S:,@9^K>O"33%@75O%J<1M5#2V\224##+46T*3S&F5M9*;.-) MF=S9X%K)4AE$F/0@OI>X4^NL#GP>GSM#3LW M):9)9=)\JKB[__#-(:^G\MZQ9W*(JL+>6>+HB))SGU+O]`F`@?;%6$]/G\!- M,>#TB53(M%*-$]4744Z3J?>75ID/NS74YH-KDQ0(.+!$-=`D1"*D7A7=,I_6 ML8_9_(^B/@%[AV]0B,FD*D;$2KN$_'=X6/S;IXCMDS-[$.%I0SB`N6TTJ?U4 M\4LUC%/%]K[J%?U M@+RD/M/J8/C;)0Q\Y43-U6\^T61!"S+*8?`JJLK4PFU5X6UNI[,GJBNJ-_]Z M(1=$O0V[LR`KLFW;)/_22A8.2N7W"7+@Y:<++`-S;> M8=J`3O6F=>*GK_DL#'%!#%PE!N6\!:-31-@$.$5&`[\!.+F05IJA"V:X6#Y$ M>>*FED6IKS6]XID0:?U#"R!:(2#;M-XC4:RX70AVY$SMLD-?W>L4;8)HWHR8 MZH$2F;.63WARLR4-8R)$*XB)]S`V,)5=?,,J,+6[&!*K`3$NH%"7+D! M[(*T)VMJB9+$0Y_KX%EK@,K0*T>G#;WW>)0;8#_CTJVL:9W\YBJ<%D2#W?NI M$$`*BL@PR1:9`BSE9K".S)ZX:24Z4K9&NL%B!%BS?,=!^,BWFI1]X)5'.OY) M0)D"6/'.MN"\'X=EYPG8.^72X/@04+\Y?G_T#Y&G77EV_!+\*/']A_\G)N4"7B_@-[]OT`1P?'Q_$^4R7>?_@.AF-X MMD0W%OYL[8W??_C>UO;X^$BR^?[7_8=/QC<=?#",M?L@]Q_9OM/X2L@_W_7& M@:3[_;/ZQOW4L2MZRE$RWV4>Z8T2HV2!WX:/64C&A>L@_?,M":+5^/LTRL(8 M9T6*ZND:J>8UCJ.05/(4Y4$49Z_U?4I$E8YZ_[%V$_GAGB-@)US0V6@4:7H. M2!$#F')5.@^BM+QB=;6HXV@07R1$2%%V70*M-$O5BD%+C7=T1\=9V-0,S#D< M@$PZ!P'+$DQ.#KT(QT7;14)B1Q!_#O(B+:,(*.F]9JEM9P@K-1K:=- W1 M!1Q0;+4B!A3G".;L=,22!*"2[)=N)/HTP!0XHZ<&<$"I._U'Q]8B$ICT:#AX MV='X"AR1EE80U&+>;,#[B9U3E$:/`7U=C+=()_BZ/>C?_>K-($FNEME@J,=3 M'&(<1$/==WB$9#@,BC&*A/U^<,MZY[NUS$PPP'O/PE M6*-3O`ZB_AU*,4G/PRT2!_S+=2(&J21RW^-TI!4][1`%PFA_?`9K1]0RGA2JTPSZ065<<#7'$]B,Y5%KM])*">T M,,[2IP9&7-XEXPDR_[D)NT19IH]-@M%H[,^[CA_TM!L4;F(744HJG(R+"3PK"W\0`@;9;/ M9:0.N+[O7ZREGP@'EYT\25)^4WLZADY0=W/8\R!$LS6=P_2BA9QL&S($9*Z" M!Z@7"#AB7D+0>+K$^`57JE3Z72W:/6%S`JE\RF%GJ5Y4&L"BB58F+%P%H@5[ MP**;D9Q)+9`#5)[M%NV^H/X1!\/RG"$SK+RKH!UJ"1!B#80(XZVGB_8[35O+ MS3^3:0@]AG6#PCC(LF@1H3E]B&$6AL6ZB.EMK:N3"V(]7!W9.ELL$#W^@*YI M5B6<](&];S&]>85E,:XVDP/9%3A(V5==A(WN>]\;73T3:`.]0Y^D6;3MBT\0$-"]=BE8HROPJ>O',N[9Z^[B@QDN7&.[14NZJ'B#-KC<.+=\B:W'7G6% M#5Z@N8"O+F"K]][*J&5FU>$#1@,%55UM$=5XF2[@AL=0)9G$%TH)-$0*.4]J M5_,V7*%Y$9,9$&N5"])HTW5ILN/G^B,WRX8YAZ;E&'#P!)[#C6,"72.I#EXF MV.8T.2XRTF5E6=,4.7<*0+1LKA0N[7C0&@`6K&0 M>V&!^ZW;MX]]10'F82S719`$BL>R='*7U1[N)%RO`@*QD,`K?8Q"U-2`>[@< M1-N\PBBE';L#Z9\QU]&-VROLSI@K6.W_GLE-.7K?54/L40#E=J0JIG3/FW"] M%+Z4,K+::7,]>8)3TA?0NPH2)\J)FJ>@^43NN0ZDC<)K(AZ"#(QC=HI-Y"_7 M?K*JNF=QM(Z24KF,ZW&]0K7-@(7<0X21M@J$0'D*DK%;;.)UU9BQ7M5S\$;: M0/+NV$E,[NUX6\\.=H;<2IG[[Q%D=9"-K`$%`)`9?0P.];H"(9"QN4*4"A"' MNU9\NZ'OK\;Y\RVA1_P>0TK3.)Y+XZ2O^YT$1$&X@W<=A8#O`;WZF0Q`KRA_ MN6,%9*QO63+?W"M7ZSW'\VIR+I&7.\*O]?Z]K][XD^58B:.Y/"T?9-? MNH1"'Y9*"#'Z'3UD4<[W*(R86401$'OB:RV531RO$N#@M.\ZQ?,BS*_26AO. M2%]&TN"#1^+KB!Z@KY51/%^.NQC)"*RE(WPE71QC`?8Z2(D&*=4'1YUFF0!#SVO]4O!V*?H_R592<_':[W1,2+[IHE^/$ M?7FY\9[L4OH6F^O//,PE$L7V$@H1#G8>DK!W*7J-2*.(X&PDMXBO78Z!/6SN M!2CD"MY.=>(62I,SJVXMG-=/A`1,ZK$6P=A+$C`<8(!R\J-_//;M1&1MMHX< M616\CI"C)=TIGY]&&7V_YW.0!,OR3!(9G9,OZT:C$YS,HW)OE(')$!:M[#K: M++R!F@4#F8'13+`[V?*D8:L\.Y?MVEGU7M#N'@03Q%3D3$@3DGN#.DW%AX4[ ML1`?$G*>IL4R*\>*`O#T"1BXM`B\`XA0N6&0:+,5+ZYZ>&GC!CVBI.AAA?UY M>VZR_MD;7`@4,4/#CIEXA<9##/R@B8F^N<;[4!FQ_\08,8G7,\-#A MY\CLR`XDMN\5[E*F,-"04-0VY5%X`Q6U>F:0X?+E0\?3K'6S+$.]%^BZ/S8) M9:H?O<$$5PDSL^)X_>&(/2_T(QO.O41RSG0CS<].#-#][XW^!(H9]QY:9 M8(KJQ*3B!%\'SY4^Y="'<:WH\_::!O/9&U9\IW_4'SY`A7$QK+A/< MI4&2!6&YIM),B>X(/_)GZPMG*(/2P<8Q0ZF)6`%*/41S MR?IJ<1NLT5E"#/\L6,P9QHQ9`C)DY@WTK1IMV'*3:16:-O"23P;.X?X3&]X' M9Y1QYC;E_=%[?M\%O5#I_I'R^Z./C(J`4^5N'["\/_I.]XRE_X=^[H^^-S_W MXT(.NF9Z/TMH(L0@648D,%2K/N;IZ.PNT_"JIDIE9U266?"!E;460[?Q^SQ* MHAQ=1H]H7E9ACA:[7]@:'3]7K8R^1B+O6NRP[?4V`]F.-LXR0PC>FT6[0R^M MVG7SGPVME8,G-C64X'15AJ6WBSMZI1TXTFD)EWBHZ41'/H?5KUH>TJR7?Z#> M:2!\;WX`!QBXN1Q&`[@I&-4X!EBJBV7-J@`@RZ^"@[`E$_QY.9KDW[X0?:[- MV/OL*IJDD,!*/;7@PI-%(=.7X2`>SHW[98.2M75U2DZJ/S8WV?[Z8JTZ.9AQ M5U)_0!]L6%H-9+?Z7A/@R?&JW>=J5$$!RP/TM?Q#"O52V`E.RGE;=H/B4KEL M%6WH?>P3_(B2@.9=Q_D=ID^"(4%"$QNLFL,/0UBY"$A5UVW1=F"$BKKX8779 M/V3/@T>I-Z@*+0FV]I1V]91PGXJD),-4K-]#`JB$=L%CC MS.WBO<^`RJ-+\"E/AUP]QZG(/4:GIBELP5,MUN4+H-PJGSV%<3&/DJ7@<+Y> MH=W!7$@ACP%H9!9[41(F?%+]N*3MM=[TGJWIZ8]_E2:&AT\%`W5`%3'P&.&# MS76`H"NLR/#KMY\JY"=H2;F[B_TOB#V"`R-68YH23Q._?3,<`*NE4'MW@'$> MQ.ZBLMT:SYXV*,G8\U%FA0&1F%/8O[-.@ZPS\$23KFQ'AKP>[:K>?["VK^KE M2N+]T9'-Q407CO/>KLC'&[0ITG`59*A..#7@*"__K"I7BOI]:)5V_P8IB:S<`R44AY:Y7,_P#,OC.#CY^LX2'A7592$ M`E^W"%UQ>'_?`*R=U,6[A7X9O\,[EEJHJ]_1. M`,_=+.-#O+G*Q!DZ8Q:\N:JDW%X<%5,ZXVF!#[&.HG)7=R54USPEG`_RY@^G M!D?OH>YF*<7NWE+ZZ6Z!HA;-\^&@N&OHKZ00QG!V].^!E9?\LTLVP>[Y4 M;;5[.GF^S7'XYT[/^6F11LGR&J41GI@K:+W%VP\?2UAK68]J=U'1M^Z9YX5^0JGT;_*[:6=WWX/4ZRLOL,^6Q MZH0F9T`)S9L^=J(#6=54:ZI&9;=I#W7*CA;S:.[93N5XZ[%RHEIA`=%H,1BH;3>.:AQ1?$Q9!$@/.XJJO.74X&4'*1TZ5T!RIJ(/3@(U-:@1>AM#Z&&"G[ M7X>Z#,B4`L4QO@R^9D64^T@K@=*;=(.Z.7-'AHNCG(DB#)$=H7KZ66MWB9'`C MI6E2U7%I_)O/0'0=.)T1B'`YUC3)SF?S/XIY%)::7\=!3A-*9K\FI*87R2/* M\FC)NV=@6)IY8PU:VC_,#;//0#1J"W=D%1OXINUY%--E^(+:YQ'-0@D\886$ M;]]R"_D+1BUK6,*@2J8C;\A)H58[3!8KH"J`<3T)R/J;ZY-[C2F4!N]CB M2!/BRXU5$^;=\R#-HS#:!-4K"Y\+TD@R^J4SXR0.HG7]'IY\,U)2@+\GR2O@'WJUK6#UO`1?GC#` MNK'@^#E*HG6QWBY.91EM7DE>KIA^#I)@263>83K/NEJ0JM[AJTU..I#SR]O9 M"8YC%+:F7A?9YV#.]OE[E-`\.K0'"?Z!?_]V'MA:]E)!I]ZE!6EX5BJ2+._P MKF\CO9E:99-V-5B83A,S%S;1UF;+^H=H>`/JZM:SNY=1,RJ\13DQ'S54=TQ) MAHXX+K,[["C8\=0@)LT8RXR)?XW!BK6&CL4,Z^#Y2Z0\M7D9/)5T$LR.G+/3 M*BS5.3JM(*\6LXN,1UZ":_A1N'LVWX[R,)SXYDC]A?[Q$&2(_/+_4$L#!!0` M```(`$."I3XS'FF%T@P``)F$```0`!P`8W9S+3(P,3$P,S,Q+GAS9%54"0`# M_@7#3?X%PTUU>`L``00E#@``!#D!``#M74MSXS82OF_5_@>N3MF#+,O.S,:N M<5*V;,VJ2HY4EB>36PHB(0D9$E``4+;__39`4J+X`"%J9L34,H>43'0W^N.' M!AH/8C[\\AKXS@9S01B]Z?3/SCL.IB[S"%W>=#X]#[L_=7[Y^9__^/"O;M?Y MB"GF2&+/F;\YP_!/(D7H_/X94<^Y.^]?O'>Z727Z*KQKX:YP@!R)^!++7U&` MQ1JY^*:SDG)]W>N]O+R<$;I@9^Y&N(B#*/]RYK*@=W'>[Y]?7O;!"Q\'F,HA MX\$]7J#0ES>=OT+DDP7!7L2&!.W*T"HQ8ZC'8S M>DK(DUN]M%?O>E%A(AJ*[A*A]59V@<1W=40IDTA"`.EGR=/U6C6P^!$\5%K727MY MP@M'V[E6[^6F(TBP]A5&_6S%\>*F`TVSFS3'/]8U*<<"@D17 M[HQW;5'+*'2&%ZL97*<,C'>^)280=W-617P!\ M@'PW].OC=G?ZS83MX44!;.@)"26U47M;]6:"]M&\`/08S;%?"Z^O-+\I5&7F M&<`YZL>GIU'U`*,=FT'$Z>%MLAC!:!L`*@*];?[QMKJDPAV%/\,@=^YTG:T2 M_!XPZF$J8(2&7X+YQ-/#]59$.&SA1*8_]++VLE6%8&="?]:_L_U$K!V+F#0S MD6:ON-]8B_7BIPD+7X><.^2K`6>VPEA&O.P],5-R84E);-+1-D5+A@T94RBE M].O[=TE9&VP")U=!G+R*B:?>GF9;+6AV:LNYH M\RTA983<$^'Z3(09&_6+JM850ZUI-ML&;'#\E4F:.+G(,VX:N19 MAG+E9FXN<]S$!IRMA9:5:E8^,N:]$-^_I=X(P-,EF?OX5@@8N;,$F41-7/UT M?I[C*K'EJ(6PG34G,M<25TW<@`4`?`4#/=G@](3(+&(.JA]S1.W9:*=!UO1` MF\8`7#Z\KE4NEJ4F6VRFY5V.ED3?B0VTE%13,F9T^8S5TOA<9OG8*S-W9OG$ M32EWE;:CU%LJ+'(!R=PO=PCJ5/T+-&`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`!)5^WXK); M!0Z#G^@=[47QW0XVSJ0U?XT4E3=7RIO^>VMOBF^,L'P;B8*J^%UM&K*W2-A4 M[G.^IU4'NOD*B!(OM`>%5V?TL"_%UE9W9ZN60[D;.>K[HYXKHW[4<:#B*I?#PK8R9N.K;[0?-YV!CTB@TE&]T1U"'CE%;VK> M'8VR,$#_81");E[0EZQ,G?1A(':H0!QV%$E42&RNV/G(7K1)2`2,>A MQ/>5F9N.Y*&Z>4&7S:-OHJ%JCCTBD\=K0,6\9UU?U$W*ALQTO#1/G9UTP\@K.6ID:*'V&@V#FCOP80I#"]F& MP=OZ&OLN(/>=8[[#5"IPZC`KVH4T<&,IWC!ZLOM!!H`6H@T#E_ZBTH2L2JYA ML(J_233V&]8:#8.:VU8Q@+21;1B\XOT'(Y/6&@V#^C%$'*86&'O0&#D>8_`^ ME7R5%'_;,:!RNA,-19/%%-YZ@-0$9DA\-9T)U1+>!M^Z&O06A:W\J8>VQ$_= M&T!=C(O;)5*OX_.*!?O>BEN.`85:Z,G"/%#]U*AAF8OB'MB0#;$GV** M?$G2+=$L]2WGY1Z>%T_+#X;&20`S47_(^`*#.\DWTP7P"B0;"C%I=/J[13%% MD#.Z9(U4YCBBCR'P(U1)-%,CR_053.DV>Z#ZJ=MLXO:M]V?HD6BA:NHCJ:9P MXA/UP)VTQWF\UHI-03I0/?\S#`9B@3G'WC,;8O`6^0,6KH<>X1400.B6>F>L[)`B`\L\E:79\]',]N!\SWL9OJ3$?B$7FI M:/XFQO\6;^Q!^PYY.]O%,D1O-:B):1'O+_$5"&V!\1C`62R)UXR4ZU[C+;MBA::RB5/#$7MB2RU*_=$J#7+ M:-J@).*EV=U:&?5(9@)23_O4Z;7>!Q+10*WGW2B:\"2^*COP_U1)9@_I0-U3 MXQVP>,WL"6\P#=/G=W(EISFV<_@F<^H,0)H2<$H(:'H+8MATMM%M['O83G>& MZEPO'L-\W=/?>,`(,%>?0"C;X@E'9ZG%BJRC#RZ@^2.U=<_D,XMV!7(YP'%6FI8A M#-$&)BQ@)-JI4HF-7.43T0JQQJ$ZI`F/(8]3WJ:Z][KZ#=NKS'JJN[;<>LC> MJ&8E?Y)EI,H<9F\)2)_PB$ZO1%=?Y#[KKEI$.LA"`]:0U"#2L,XRZ^G=VQ2ZI-M78D"3 MEJG'DD<"==*.T>_'DG)9_9.X]SH>RL%EY1H73%&^GDKC[[8KXSEL%K)-PS=D M7)UMF+V@]<79N_,I1+/Z>#'$(PI]W$4N1;,3;QK*9,:\+!S7KD[6N06O@U7_ M#F"?L(HQ5^KCFNZ73Y3(0T$7FS@Q^/3VUV?43^#UF+P_4FRR>$%VF9D6'Z,2,`5WK M*/^IT2X7R!=6#;-R1<+H^7_)U_YE,XH_/VVQ:);+:(OJ>'/_P%02P$"'@,4````"`!#@J4^^1=\K\-U``!< MT08`$``8```````!````I($`````8W9S+3(P,3$P,S,Q+GAM;%54!0`#_@7# M375X"P`!!"4.```$.0$``%!+`0(>`Q0````(`$."I3[<(X(HBA```'7N```4 M`!@```````$```"D@0UV``!C=G,M,C`Q,3`S,S%?8V%L+GAM;%54!0`#_@7# M375X"P`!!"4.```$.0$``%!+`0(>`Q0````(`$."I3[2YZX#$B$``'KY`0`4 M`!@```````$```"D@>6&``!C=G,M,C`Q,3`S,S%?9&5F+GAM;%54!0`#_@7# M375X"P`!!"4.```$.0$``%!+`0(>`Q0````(`$."I3X/^MSQ)G$``(>M!@`4 M`!@```````$```"D@46H``!C=G,M,C`Q,3`S,S%?;&%B+GAM;%54!0`#_@7# M375X"P`!!"4.```$.0$``%!+`0(>`Q0````(`$."I3[VW\EI+3(```I-`P`4 M`!@```````$```"D@;D9`0!C=G,M,C`Q,3`S,S%?<')E+GAM;%54!0`#_@7# M375X"P`!!"4.```$.0$``%!+`0(>`Q0````(`$."I3XS'FF%T@P``)F$```0 M`!@```````$```"D@31,`0!C=G,M,C`Q,3`S,S$N>'-D550%``/^!<--=7@+ B``$$)0X```0Y`0``4$L%!@`````&``8`%`(``%!9`0`````` ` end XML 45 R17.xml IDEA: Interest Expense (Tables) 2.2.0.25falsefalse3050 - Disclosure - Interest Expense (Tables)truefalsefalse1falsefalseUSDfalsefalse1/1/2011 - 3/31/2011 USD ($) / shares USD ($) $D2011Q1http://www.sec.gov/CIK0000064803duration2011-01-01T00:00:002011-03-31T00:00:00USDPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2true0cvs_InterestExpenseDisclosureAbstractcvsfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseInterest Expense.3false0cvs_ScheduleOfInterestIncomeAndInterestExpenseTableTextBlockcvsfalsenadurationTabular disclosure of interest expense and interest income of the entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> The following are the components of net interest expense:   <table style="WIDTH: 60%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="60%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 38.88%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="38%" colspan="3"> Three Months Ended March 31,</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> In millions</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="16%"> 2011</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="15%">    2010</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="16%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="15%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> Interest expense</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 16.52%; PADDING-TOP: 0in" valign="bottom" width="16%"> $    135</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 15%; PADDING-TOP: 0in" valign="bottom" width="15%"> $    129</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.48%; PADDING-TOP: 0in" valign="bottom" width="3%">  </td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> Interest income</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="16%"> (1)</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="15%"> (1</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="3%"> )</td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 53.2%; PADDING-TOP: 0in" valign="bottom" width="53%"> Interest expense, net</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 4.44%; PADDING-TOP: 0in" valign="bottom" width="4%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 16.52%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="16%"> $    134</td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 7.36%; PADDING-TOP: 0in" valign="bottom" width="7%">  </td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 15%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="15%"> $    128</td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 3.48%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="3%">  </td></tr></table>  </td></tr></table> The following are the components of net interest expense:       Three Months Ended March 31,   InfalsefalsefalsefalsefalseOthernonnum:textBlockItemTypenaTabular disclosure of interest expense and interest income of the entity.No authoritative reference available.falsefalseComponents of net interest expense12Interest Expense (Tables)UnKnownUnKnownUnKnownUnKnownfalsetrue